<SEC-DOCUMENT>0001387131-23-002699.txt : 20230301
<SEC-HEADER>0001387131-23-002699.hdr.sgml : 20230301
<ACCEPTANCE-DATETIME>20230301172420
ACCESSION NUMBER:		0001387131-23-002699
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		38
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230301
DATE AS OF CHANGE:		20230301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			abrdn Palladium ETF Trust
		CENTRAL INDEX KEY:			0001459862
		STANDARD INDUSTRIAL CLASSIFICATION:	 [6221]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34589
		FILM NUMBER:		23695118

	BUSINESS ADDRESS:	
		STREET 1:		712 FIFTH AVENUE
		STREET 2:		49TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-446-2020

	MAIL ADDRESS:	
		STREET 1:		712 FIFTH AVENUE
		STREET 2:		49TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aberdeen Standard Palladium ETF Trust
		DATE OF NAME CHANGE:	20181001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETFS PALLADIUM TRUST
		DATE OF NAME CHANGE:	20090326
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>pall-10k_123122.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:pall="http://abrdn.com/20221231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2022_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_034_pall_abrdn.com_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220101_20221231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001459862 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_078_XDX_pall%2D10k__123122.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_075_SO_pall%2D10k__123122.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06E_OZ_0_utr%2D%2Doz -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCentralIndexKey">0001459862</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0074" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0075" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="pall-20221231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_currency_XPD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XPD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_currency_XPD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XPD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001459862</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="OZ">
      <xbrli:measure>utr:oz</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000070" toRefs="Footnote000072"></ix:relationship>
  <ix:relationship fromRefs="Fact000071" toRefs="Footnote000072"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<div>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>UNITED
STATES <br />
SECURITIES AND EXCHANGE COMMISSION </b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>Form
<span id="xdx_90C_edei--DocumentType_c20220101__20221231_zneXeouasiVd"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><span id="xdx_908_edei--DocumentAnnualReport_c20220101__20221231_zaEzW5Wo3592"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="width: 97%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>ANNUAL
                           REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 &#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>For
        the fiscal year ended <span id="xdx_90E_edei--DocumentPeriodEndDate_c20220101__20221231_zgGbBxHJqwk1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31, 2022</ix:nonNumeric></span></b>&#160;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><span id="xdx_907_edei--DocumentTransitionReport_c20220101__20221231_zj9hCveJt00j"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="width: 97%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>TRANSITION
                           REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 &#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>For
        the Transition Period from_______________to__________________</b>&#160;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File Number: <span id="xdx_903_edei--EntityFileNumber_c20220101__20221231_z0VUs20IcNwc"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityFileNumber">001-34589</ix:nonNumeric></span>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 24pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20220101__20221231_zPk9G0WSdpZ3"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityRegistrantName">abrdn
Palladium ETF Trust</ix:nonNumeric></span></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Exact
name of registrant as specified in its charter)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: top; width: 49%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220101__20221231_z87AUyjZgI0c"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">New
    York</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 4%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 47%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20220101__20221231_zOA3w41zQr32"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityTaxIdentificationNumber">26-4733157</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State
or other jurisdiction of incorporation or&#160;</i></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>organization)</i>&#160;</span></p></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S.
    Employer Identification No.)</i></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: top; width: 49%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c/o
    abrdn ETFs Sponsor LLC</b></span></td>
    <td style="vertical-align: bottom; width: 4%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20220101__20221231_zMUsPgEC162g"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine1">1900
Market Street</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20220101__20221231_zc2VNFj1tpu4"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span>&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20220101__20221231_zLMP3LfRn3Kb"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>,
<span id="xdx_90B_edei--EntityAddressStateOrProvince_c20220101__20221231_zWSWbMoCqsjd"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span></b>&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address
of principal executive offices)</i>&#160;</span></p></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20220101__20221231_zqCiRNfVJln1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityAddressPostalZipCode">19103</ix:nonNumeric></span>&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Zip
Code)</i>&#160;</span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--CityAreaCode_c20220101__20221231_ztIhp9eaXyPk"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:CityAreaCode">(844)</ix:nonNumeric></span>
<span id="xdx_90A_edei--LocalPhoneNumber_c20220101__20221231_zaebLWTifgVc"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:LocalPhoneNumber">383-7289</ix:nonNumeric></span> </b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Registrant&#8217;s
telephone number, including area code) </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; width: 33%; font-size: 10pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="text-align: center; width: 2%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 30%; font-size: 10pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 33%; font-size: 10pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange <br />
on which registered</b></span></td></tr>
<tr>
    <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20220101__20221231_zZLDjMP5rfPc"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:Security12bTitle">abrdn
    Physical Palladium Shares ETF</ix:nonNumeric></span></span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20220101__20221231_zlWn815Jb3H1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:TradingSymbol">PALL</ix:nonNumeric></span></span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--SecurityExchangeName_c20220101__20221231_zalJipIgd75c"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE
    Arca</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160;&#9744;&#160;&#160;&#160;<span id="xdx_90A_edei--EntityWellKnownSeasonedIssuer_c20220101__20221231_zGuOGHCC6tg6"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>&#160;&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes&#160;&#9744;&#160;&#160;&#160;<span id="xdx_90D_edei--EntityVoluntaryFilers_c20220101__20221231_z0fZNA5Bxow1"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>&#160;&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. <span id="xdx_90F_edei--EntityCurrentReportingStatus_c20220101__20221231_ziwj0TL0t2Vb"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#9746;&#160;&#160;&#160;No&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files). <span id="xdx_901_edei--EntityInteractiveDataCurrent_c20220101__20221231_zBIulZWa8aKl"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;&#160;&#160;&#160;No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer,&#160;a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated
filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221;&#160;in Rule 12b-2 of the Exchange
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 24%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated Filer</span></td>
    <td style="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="vertical-align: top; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFilerCategory_c20220101__20221231_zIhX0jFBcP5g"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Accelerated
    Filer</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr>
<tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Accelerated
    Filer</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    Reporting Company</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntitySmallBusiness_c20220101__20221231_z4hmPM04Ciy9"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntitySmallBusiness">&#9744;</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    Growth Company</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20220101__20221231_znIOlK26bHB3"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt TimesNewRomanPSMT,serif; margin: 0">Indicate by check mark whether the registrant has filed a report on and attestation
to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the
Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#9;<span id="xdx_906_edei--IcfrAuditorAttestationFlag_c20220101__20221231_zITHQmDAhSlk"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt TimesNewRomanPSMT,serif; margin: 0">&#160;</p>

<p style="font: 10pt TimesNewRomanPSMT,serif; margin: 0">If securities are registered pursuant to Section 12(b) of the Act, indicate by
check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously
issued financial statements.&#9;&#9;&#9744;</p>

<p style="font: 10pt TimesNewRomanPSMT,serif; margin: 0">&#160;</p>

<p style="font: 10pt TimesNewRomanPSMT,serif; margin: 0">Indicate by check mark whether any of those error corrections are restatements
that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during
the relevant recovery period pursuant to &#167;240.10D-1(b).&#9;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#9744;
Yes&#160;&#160;&#160;&#160;&#9746; <span id="xdx_90F_edei--EntityShellCompany_c20220101__20221231_zT78hpKky148"><span id="xdx_90F_edei--EntityShellCompany_c20220101__20221231_zIwjT4So05Ge"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></ix:nonNumeric></span></span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
market value of the registrant&#8217;s shares outstanding based upon the closing price of a share on June 30, 2022 as reported
by the NYSE Arca, Inc. on that date: $<span id="xdx_909_edei--EntityPublicFloat_iI_c20220630_zaqNOpzJI9y6"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,320,992</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 23, 2023, abrdn Palladium ETF Trust had  <span id="xdx_90E_edei--EntityCommonStockSharesOutstanding_iI_c20230223_zxLqanDZ8VS7"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-02-23" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,925,000</ix:nonFraction></span> abrdn Physical Palladium Shares ETF outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE:</b> None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORWARD
LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K contains various &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and within the Private
Securities Litigation Reform Act of 1995, as amended. Forward-looking statements usually include the words, &#8220;anticipates,&#8221;
&#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221;
&#8220;understands&#8221; and other words suggesting uncertainty. We remind readers that forward-looking statements are merely
predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could
cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different
from any future results, performance, levels of activity, or our achievements expressed or implied by such forward-looking statements.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
The Trust undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of unanticipated events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
significant uncertainties and other factors affecting forward-looking statements are presented in the Risk Factors section herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 92%; text-indent: -0.125in; padding-left: 0.125in"><a href="#pall10k123122a001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART I</b></span></a></td>
    <td style="vertical-align: bottom; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1. Business</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trust Objective</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview of the Palladium Industry</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operation of the Palladium Markets</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Secondary Market Trading</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation of Palladium and Computation of Net Asset Value</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trust Expenses</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Creation and Redemption of Shares</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Creation and Redemption Transaction Fee</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Sponsor</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">15</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Trustee</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Custodian</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inspection of Palladium</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">17</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Shares</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custody of the Trust&#8217;s Palladium</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">19</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>United States Federal Income Tax Consequences</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">19</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in"><a href="#pall10k123122a018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ERISA and Related Considerations</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1A. Risk Factors</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">23</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1B. Unresolved Staff Comments</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 2. Properties</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 3. Legal Proceedings</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 4. Mine Safety Disclosures</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">34</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><a href="#pall10k123122a024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART II</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
<tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-indent: 0"><a href="#pall10k123122a025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</b>&#160;</span></a></p></td>
    <td style="vertical-align: bottom; text-align: center">35</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: 0; padding-left: 0.125in"><a href="#pall10k123122a026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7A. Quantitative and Qualitative Disclosures about Market Risk</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">41</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8. Financial Statements and Supplementary Data</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures </b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">43</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9A. Controls and Procedures</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9B. Other Information </b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><a href="#pall10k123122a032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART III</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">48</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 10. Directors, Executive Officers and Corporate Governance</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">48</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 11. Executive Compensation</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">48</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 12. Security </b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 13. Certain Relationships and Related Transactions, and Director Independence</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 14. Principal Accounting Fees and Services</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART IV</b></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 15. Exhibits, Financial Statement Schedule</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center">51</td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in"><a href="#pall10k123122a040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 16. Form 10K Summary</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td></tr>
<tr>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a001"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a002"></span>Item
1. Business </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the&#160;abrdn Palladium ETF Trust (known as Aberdeen Standard Palladium ETF Trust prior to March 31, 2022) (the &#8220;Trust&#8221;)
is to own palladium transferred to the Trust in exchange for shares issued by the Trust (&#8220;Shares&#8221;). Each Share represents
a fractional undivided beneficial interest in and ownership of the Trust. The assets of the Trust&#160;consist solely of&#160;palladium
bullion.&#160;The Trust was formed on December 30, 2009 when an initial deposit of palladium was made in exchange for the issuance
of two Baskets (a &#8220;Basket&#8221; consists of 50,000 Shares).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sponsor of the Trust is abrdn ETFs Sponsor LLC (known as Aberdeen Standard ETFs Sponsor LLC prior to March 1, 2022) (the &#8220;Sponsor&#8221;).
The trustee of the Trust is The Bank of New York Mellon (the &#8220;Trustee&#8221;) and the custodian is JPMorgan Chase Bank N.A.,
London Branch (the &#8220;Custodian&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s Shares at redeemable value decreased from $357,971,468 at December 31, 2021 to $295,490,794 at December 31, 2022,
the Trust&#8217;s fiscal year end. Outstanding Shares in the Trust decreased from 1,950,000 Shares at December 31, 2021 to 1,800,000
Shares at December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is not managed like a corporation or an active investment vehicle. The Trust has no directors, officers or employees. It
does not engage in any activities designed to obtain a profit from or to improve the losses caused by changes in the price of&#160;palladium.
The&#160;palladium held by the Trust will only be delivered to pay the remuneration due to the Sponsor (the &#8220;Sponsor&#8217;s
Fee&#8221;), distributed to Authorized Participants (defined below) in connection with the redemption of Baskets or sold (1) on
an as-needed basis to pay Trust expenses not assumed by the Sponsor, (2) in the event the Trust terminates and liquidates its
assets, or (3) as otherwise required by law or regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is not registered as an investment company under the Investment Company Act of 1940 and is not required to register under
such act. The Trust does not and will not hold or trade in commodities futures contracts, &#8220;commodity interests&#8221; or
any other instruments regulated by the Commodity Exchange Act (the &#8220;CEA&#8221;), as administered by the Commodity Futures
Trading Commission (the &#8220;CFTC&#8221;) and the National Futures Association (&#8220;NFA&#8221;). The Trust is not a commodity
pool for purposes of the CEA and the Shares are not &#8220;commodity interests,&#8221; and neither the Sponsor nor the Trustee
is subject to regulation as a commodity pool operator or a commodity trading advisor in connection with the Shares. The Trust
has no fixed termination date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor of the registrant maintains an Internet website at www.abrdn.com/us/etf through which the registrant&#8217;s annual reports
on Form 10-K, quarterly reports on Form 10-Q, and amendments to those reports filed or furnished pursuant to Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are made available free of charge as soon as reasonably
practicable after they have been filed or furnished to the Securities and Exchange Commission (the &#8220;SEC&#8221;). Additional
information regarding the Trust may also be found on the SEC&#8217;s EDGAR database at www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a003"></span>Trust
Objective</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investment objective of the Trust is for the Shares to reflect the performance of the price of physical&#160;palladium bullion,
less the Trust&#8217;s&#160;expenses. The Shares are intended to constitute a simple and cost-effective means of making an investment
similar to an investment in physical palladium. An investment in physical&#160;palladium requires expensive and sometimes complicated
arrangements in connection with the assay, transportation, warehousing and insurance of the metal. Traditionally, such expense
and complications have resulted in investments in physical&#160;palladium being efficient only in amounts beyond the reach of
many investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares are intended to provide institutional and retail investors with a simple and cost-efficient means, with minimal credit
risk, of gaining investment benefits similar to those of holding&#160;palladium bullion. The Shares offer an investment that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;<i>Easily
Accessible and Relatively Cost Effective</i>. Investors can access the palladium bullion market&#160;through a traditional brokerage
account. The Sponsor believes that investors will be able to more effectively implement strategic and tactical asset allocation
strategies that use&#160;palladium bullion by using the Shares instead of using the traditional means of purchasing, trading and
holding&#160;palladium bullion and for many investors, transaction costs related to the Shares will be lower than those associated
with the purchase, storage and insurance of physical palladium bullion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;&#160;Exchange
Traded and Transparent. </i>The Shares trade on the NYSE Arca, providing investors with an efficient means to implement various
investment strategies. The Shares are eligible for margin accounts and are backed by the assets of the Trust and the Trust does
not hold or employ any derivative securities. Furthermore, the value of the Trust&#8217;s holdings are reported on the Trust&#8217;s
website daily.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<i>Minimal Credit Risk</i>. The Shares represent an interest in physical&#160;palladium owned by the Trust (other than an amount
held in unallocated form which is not sufficient to make up a whole&#160;plate or ingot of which is held temporarily to effect
a creation or redemption of Shares). Physical&#160;palladium of the Trust in the Custodian&#8217;s possession is not subject to
borrowing arrangements with third parties. Other than the&#160;palladium temporarily being held in an unallocated&#160;palladium
account with the Custodian, the physical&#160;palladium of the Trust is not subject to counterparty or credit risks. See <i>&#8220;Risk
Factors&#8212;Palladium held in the Trust&#8217;s unallocated&#160;palladium account and any Authorized Participant&#8217;s unallocated&#160;palladium
account is not segregated from the Custodian&#8217;s assets...&#8221; </i>This contrasts with most other financial products that
gain exposure to&#160;palladium through the use of derivatives that are subject to counterparty and credit risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in the Shares does not insulate the investor from certain risks, including price volatility. See &#8220;Risk Factors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a004"></span>Overview
of the Palladium</b>&#160;<b>Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section provides a brief introduction to the palladium industry by looking at some of the key participants, detailing the primary
sources of demand and supply.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this annual report, the term &#8220;ounces&#8221; refers to troy ounces.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Platinum&#160;Group
Metals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Platinum
and palladium are the two best known metals of the six platinum group metals (&#8220;PGMs&#8221;). Platinum and palladium have
the greatest economic importance and are found in the largest quantities. The other four&#8212;iridium, rhodium, ruthenium and
osmium&#8212;are produced only as co-products of platinum and palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PGMs
are found primarily in South Africa and Russia. South Africa is the world&#8217;s leading platinum producer and one of the largest
palladium producers. Russia is the largest producer of palladium and most production is concentrated in the Norilsk region. All
of South Africa&#8217;s production is sourced from the Bushveld Igneous Complex, which hosts the world&#8217;s largest resource
of PGMs. Together, South Africa and Russia accounted for over 78% of&#160;palladium supply in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>World
Palladium Supply and Demand 2012-2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of the world palladium supply and demand from 2012 to 2021 and is based on information reported
by Johnson Matthey, PGM Market Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 0.5pt solid; font-style: italic; vertical-align: middle; width: 20%">(thousands of ounces)</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2012</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2013</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2014</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2015</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2016</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2017</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2018</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2019</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2020</td>
    <td style="border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: center; width: 8%">2021</td></tr>
  <tr style="background-color: white">
    <td style="font-weight: bold; vertical-align: middle">Supply</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">South Africa</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,359</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,464</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,126</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,683</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,570</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,547</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,543</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,588</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,975</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,652</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Russia</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,887</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,628</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,589</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,434</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,781</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,452</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,976</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,987</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,636</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,689</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">North America</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;811</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;831</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;893</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;872</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;917</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;956</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;978</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,010</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;956</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;874</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Zimbabwe</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;266</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;322</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;327</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;320</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;396</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;386</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;393</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;379</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;410</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;392</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Others</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;162</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;152</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;160</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;144</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;129</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;131</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;135</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;140</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;185</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;187</td></tr>
  <tr style="background-color: white">
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle">Total Supply</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,485</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,397</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,095</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,453</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,793</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,472</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,025</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,104</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,162</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,794</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">&#65279;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="font-weight: bold; vertical-align: middle">Demand by Application</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Autocatalyst</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,673</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,069</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,518</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,691</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,042</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,423</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,837</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,653</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,503</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,340</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Chemical</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;524</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;378</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;313</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;449</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;419</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;435</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;605</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;511</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;524</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;589</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Dental &amp; Biomedical</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;510</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;457</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;464</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;468</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;429</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;398</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;364</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;320</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;228</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;210</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Electrical &amp; Electronics</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,190</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,017</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;970</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;903</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;872</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;844</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;768</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;711</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;634</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;655</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Investment</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;467</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;943</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(659)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(646)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(386)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(574)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(87)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(190)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;17</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Jewelry</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;442</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;354</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;272</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;220</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;189</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;167</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;148</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;128</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;85</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;91</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Pollution Control</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;78</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;87</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;76</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;96</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Other</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;104</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;109</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;111</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;134</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;157</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;91</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;117</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;121</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;94</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;99</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle">Total Gross Demand</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,910</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,376</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10,591</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,206</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,462</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10,050</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10,352</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11,445</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9,954</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10,097</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">&#65279;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="font-weight: bold; vertical-align: middle">Recycling</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Autocatalyst</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,675)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,899)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,117)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,931)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,986)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,357)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,624)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,916)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,686)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,891)</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="vertical-align: middle">Electrical</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(443)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(463)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(474)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(475)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(481)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(479)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(475)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(477)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(450)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(463)</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">Jewellery</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(194)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(157)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(89)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(46)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(21)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(21)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(12)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(12)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(9)</td>
    <td style="vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(9)</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle">Total Recycling</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,312)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,519)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,680)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,452)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,488)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,857)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3,111)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3,405)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3,145)</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3,363)</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">&#65279;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: middle">Total Net Demand</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,598</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,857</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,911</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,754</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,974</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,193</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7,241</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8,040</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,809</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,734</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: middle">&#65279;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: #CEF5FE">
    <td style="font-weight: bold; vertical-align: middle">Movements in Stocks</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,113)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(460)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,816)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(301)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(181)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(721)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(216)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(936)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(647)</td>
    <td style="font-weight: bold; vertical-align: bottom; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;60</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source: Johnson Matthey PGM Market Reports (2012-2022)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are some of the main characteristics of the palladium market illustrated by the table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Russia has traditionally been the largest producer of palladium, providing
on average 41% of supply over the past 10 years. South Africa has, on average, supplied approximately 37% of production over the past
10 years. In 2021, Russia provided 39.6% of mine supplies, while South Africa produced 39%. North America contributed approximately 13%
of mine supply in 2021. Scrap supply, from recycling of autocatalyst and other sources, has accounted for an average of roughly 32% of
total supply over the last 5 years, up from 26% in 2012. Autocatalysts continue to be the largest component of palladium demand, representing
nearly 83% of total demand in 2021, down from a high of 85% of total demand in 2020. Jewelry demand for palladium has tapered off considerably
over the last 10 years, contributing only 0.9% of total demand in 2021, down from a high of 4.5% in 2012 . Other industrial demand (chemical,
dental and electrical) has fallen from 22.4% of total demand in 2012 to 14.4% of total demand in 2021. Since 2017 pollution control demand
has increased from 0.8% to 1% of total demand. Pollution control demand captures the production demand for emissions control in non-automotive
applications.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Historical
Chart of the Price of Palladium </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of palladium is volatile and fluctuations are expected to have a direct impact on the value of the Shares. However, movements
in the price of palladium in the past are not a reliable indicator of future movements. The following chart illustrates the movements
in the price of an ounce of palladium in U.S. Dollars from December 31, 2012 to December 31, 2022 and is based on information
provided by Bloomberg:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<img src="pall-img001.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Source: Bloomberg, abrdn. Chart data from 12/31/2012 to 12/31/2022.
Palladium Price = PLDMLNPM Index.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Rising palladium prices tempered in 2011, but concerns over supply
shortages due to labor problems at mines in South Africa and dwindling Russian stocks provided some price support into mid-2012. Palladium
rose to a 13 year high of $907 per ounce in September 2014, a 27% increase from the start of the year. The rally was driven by supply
side concerns following the longest strike in South African mining history and escalating tensions between Russia and Ukraine. The strong
rally in 2014 was completely unwound in 2015, when South African mine supply resumed back to pre-strike levels and pessimism about industrial
demand in China overwhelmed the true tightness in the market. Palladium was then the top performer of the precious metals complex for
3 consecutive years from 2017 to 2019, where it rose nearly 182% from $676 per troy ounce on December 31, 2016 to $1,905 per troy ounce
on December 31, 2019. The price of palladium reached an all-time high of $2,781/oz on February 19, 2020, before closing out the year at
a price of $2,342/oz on December 31, 2020. Similar to other precious metals, palladium took a step back in 2021 as it returned -16% (as
of December 31, 2021). A decline in autocatalyst demand due to the pandemic was a big reason for the negative performance seen during
the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">The price of Palladium reached a record high of $3,015 per ounce
on March 7, 2022, as Russian&#8217;s invasion of Ukraine infused uncertainty into global markets and created additional price pressure
that pushed the price of palladium nearly 53% above its 2021 close. While each of the precious metals (Gold, Silver, Platinum) saw prices
fluctuate throughout the year, the price of palladium showed greater correlation with the price of Platinum during the first quarter.
The price of palladium fell by roughly 25% between March 8<sup>th</sup> and March 31<sup>st</sup>, ending the first quarter at a price
of $2,259 per ounce. On June 14<sup>th</sup>, 2022 the price of palladium fell as low as $1,810 per ounce, as aggressive interest rate
policies from the U.S. Federal Reserve drove the U.S. Dollar higher. Contrary to the other three precious metals, the price of palladium
increased as high as $2,315 per ounce on October 4<sup>th</sup>, 2022, as supplies were further constrained by operational challenges
in South African and North American mines, as well as a weaker automotive recycling market. Throughout the year, tailwinds from supply
disruptions were countered by weaker automotive and investment demand, higher interest rates and the risk of a potential recession. As
a result, while the other three precious metals rallied to end the year, the price of palladium reversed course during the fourth quarter
to end the year at $1,775 per ounce, down 10% from the end of 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a005"></span>Operation
of the Palladium Bullion Market</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global trade in&#160;palladium consists of Over-the-Counter (&#8220;OTC&#8221;) transactions in spot, forwards, and options and
other derivatives, together with exchange-traded futures and options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Global
Over-The-Counter Market</i><br />
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OTC market trades on a 24-hour per day continuous basis and accounts for most global palladium trading. Market makers, as well
as others in the OTC market, trade with each other and with their clients on a principal-to-principal basis. All risks and issues
of credit are between the parties directly involved in the transaction. Market makers include the market-making members of the
London Platinum and Palladium Market (&#8220;LPPM&#8221;), the trade association that acts as the coordinator for activities conducted
on behalf of its members and other participants in the LPPM. Five member participants of the LPPM are currently participating
in the electronic LME PM fix process (as described below) administered by the London Metal Exchange (&#8220;LME&#8221;). The OTC
market provides a relatively flexible market in terms of quotes, price, size, destinations for delivery and other factors. Bullion
dealers customize transactions to meet clients&#8217; requirements. The OTC market has no formal structure and no open-outcry
meeting place. The main centers of the OTC market are London, New York, Hong Kong and Zurich. Mining companies, manufacturers
of jewelry and industrial products, together with investors and speculators, tend to transact their business through one of these
market centers. Centers such as Dubai and several cities in the Far East also transact substantial OTC market business, typically
involving jewelry and small plates or ingots (1 kilogram or less) and will hedge their exposure by selling into one of these main
OTC centers. Precious metals dealers have offices around the world and most of the world&#8217;s major bullion dealers are either
members or associate members of the London Bullion Market Association (&#8220;LBMA&#8221;) and/or the LPPM. In the OTC market,
the standard size of palladium trades between market makers is 1,000 ounces. Liquidity in the OTC market can vary from time to
time during the course of the 24-hour trading day. Fluctuations in liquidity are reflected in adjustments to dealing spreads&#8212;the
differential between a dealer&#8217;s &#8220;buy&#8221; and &#8220;sell&#8221; prices. The period of greatest liquidity in the
palladium market generally occurs at the time of day when trading in the European time zones overlaps with trading in the United
States, which is when OTC market trading in London, New York, Zurich and other centers coincides with futures and options trading
on the Commodity Exchange, Inc. (&#8220;COMEX&#8221;), a designated contract market within the CME Group. This period lasts for
approximately four hours each New York business day morning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Zurich and London Palladium Bullion Markets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the market for physical palladium is distributed globally, most palladium is stored and most OTC market trades are cleared through
Zurich. As of September 1, 2009, London also serves as a center for the clearing of OTC trades in palladium. In addition to coordinating
market activities, the LPPM acts as the principal point of contact between the market and its regulators. A primary function of
the LPPM is its involvement in the promotion of refining standards by maintenance of the &#8220;London/Zurich Good Delivery Lists,&#8221;
which are the lists of LPPM accredited refiners of palladium. The LPPM also coordinates market clearing and vaulting, promotes
good trading practices and develops standard documentation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
is traded generally on a loco Zurich basis, meaning the precious metal is physically held in vaults in Zurich or is transferred
into accounts established in Zurich. As of September 1, 2009, palladium began trading on a loco London basis as well, meaning
that the precious metal is physically held in vaults in London or is transferred into accounts established in London. The basis
for settlement and delivery of a loco Zurich spot trade is payment (generally in U.S. Dollars) two business days after the trade
date against delivery. Delivery of the palladium can either be by physical delivery or through the clearing systems to an unallocated
account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unit of trade in London and Zurich is the troy ounce, whose conversion between grams is: 1,000 grams equals 32.1507465 troy ounces,
and one troy ounce equals 31.1034768 grams. A good delivery palladium plate or ingot on the LPPM approved list is acceptable for
delivery in settlement of a transaction on the OTC market (a &#8220;Good Delivery Plate or Ingot&#8221;). A Good Delivery Plate
or Ingot must contain between 32 and 192 troy ounces of palladium with a minimum fineness (or purity) of 999.5 parts per 1,000
(99.95%), be of good appearance, and be easy to handle and stack. The palladium content of a palladium plate or ingot is calculated
by multiplying the gross weight by the fineness of the plate or ingot. A Good Delivery Plate or Ingot must also bear the stamp
of one of the refiners who are on the LPPM approved list. Unless otherwise specified, the palladium spot price always refers to
that of &#8220;Good Delivery Standards&#8221; set by the LPPM. Business is generally conducted over the phone and through electronic
dealing systems.&#8195;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 1, 2014, the LME has been administering the operation of electronic palladium bullion price fixing systems (&#8220;LMEbullion&#8221;)
that replicate electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium
Fixing Company Ltd (&#8220;LPPFCL&#8221;) as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. The LME&#8217;s electronic price fixing processes, like the previous
London palladium fix processes, establishes and publishes fixed prices for troy ounces of palladium twice each London trading
day during fixing sessions beginning at 9:45 a.m. London time (the LME AM Fix) and 2:00 p.m. London time (the LME PM Fix). In
addition to utilizing the same London palladium fix standards and methods, the LME also supervises the palladium electronic price
fixing processes through its market operations, compliance, internal audit and third-party complaint handling capabilities in
order to support the integrity of the LME PM Fix. The LME, in administering LMEbullion, uses a pricing methodology that meets
the administrative and regulatory needs of palladium market participants, including the International Organization of Securities
Commission&#8217;s (IOSCO) Principles for Financial Benchmarks, (the "IOSCO Principles").</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daily
during London trading hours the LME AM Fix and the LME PM Fix each provide reference palladium prices for that day&#8217;s trading.
Many long-term contracts will be priced on the basis of either the LME AM Fix or the LME PM Fix, and market participants will
usually refer to one or the other of these prices when looking for a basis for valuations. The Trust values its palladium on the
basis of the LME PM Fix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Formal
participation in the LME PM Fix is limited to participating LPPM members. Five LPPM members are currently participating in establishing
the LME PM Fix (Goldman Sachs International, HSBC Bank USA NA, ICBC Standard Bank plc, Johnson Matthey plc and BASF Metals Ltd.).
Any other market participant wishing to participate in the trading on the LME PM Fix is required to do so through one of the participating
LPPM members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orders
are placed either with one of the participating LPPM member participants or with another precious metals dealer who will then
be in contact with a participating LPPM member during the fixing. The fix begins with the chair reflecting the market price and
other data, prevailing at the opening of the fix. This is relayed by the LPPM member participants to their dealing rooms which
have direct communication with all interested parties. Any market member may enter the fixing process at any time, or adjust or
withdraw his order. The palladium price is adjusted up or down until all the buy and sell orders are electronically matched, at
which time the price is declared fixed. All fixing orders are transacted on the basis of this fixed price, which is instantly
relayed to the market through various media.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
LBMA and the LME have asserted that the LME&#8217;s electronic price fixing processes are similar to the non-electronic processes
previously used to establish the applicable London palladium fix where the London palladium fix process adjusted the palladium
price up or down until all the buy and sell orders entered by the participating LPPM members are matched, at which time the price
was declared fixed. Nevertheless, the LME PM Fix has several advantages over the previous London palladium fix. The LME&#8217;s
electronic price fixing processes are intended to be transparent. The LME asserts that its electronic price fixing processes are
fully auditable by third parties since an audit trail exists from the beginning of each fixing session. The LME also asserts that
the market operation, compliance, internal audit and third-party complaint handling capabilities of the LME will support the integrity
of the LME PM Fix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 1, 2014, the Sponsor determined that the London palladium fix, which has been revised based on the new LME method and
is now known as the LME PM Fix, is an appropriate basis for valuing palladium bullion received upon purchase of the Trust&#8217;s
Shares, delivered upon redemption of the Trust&#8217;s Shares and for determining the value of the Trust&#8217;s palladium bullion
each trading day. The Sponsor also has determined that the LME PM Fix will fairly represent the commercial value of palladium
bullion held by the Trust and, the &#8220;Benchmark Price&#8221; (as defined in the Trust Agreement) of the Trust&#8217;s palladium
bullion as of any day is the LME PM Fix for such day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 1, 2014, the LPPFCL transferred ownership of the historic and future intellectual property of the twice daily &#8220;fix&#8221;
for platinum and palladium bullion to a subsidiary company of the LBMA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Futures
Exchanges</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
most significant palladium futures exchanges are the COMEX, a designated contract market within the CME Group,&#160;and the Tokyo Commodity Exchange (&#8220;TOCOM&#8221;). The COMEX
is the largest exchange in the world for trading precious metals futures and options and launched palladium futures in 1968, followed
with options in 2010. The TOCOM has been trading palladium since 1992. Trading on these exchanges is based on fixed delivery dates
and transaction sizes for the futures and options contracts traded. Trading costs are negotiable. As a matter of practice, only
a small percentage of the futures market turnover ever comes to physical delivery of the palladium represented by the contracts
traded. Both exchanges permit trading on margin. Margin trading can add to the speculative risk involved given the potential for
margin calls if the price moves against the contract holder. The COMEX trades palladium futures almost continuously (with one
short break in the evening) through its CME Globex electronic trading system and clears through its central clearing system. On
June 6, 2003, the TOCOM adopted a similar clearing system. In each case, the exchange acts as a counterparty for each member for
clearing purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global&#160;palladium markets are overseen and regulated by both governmental and self-regulatory organizations. In addition,
certain trade associations have established rules and protocols for market practices and participants. In the United Kingdom,
responsibility for the regulation of the financial market participants, including the major participating members of the&#160;LPPM
falls under the authority of the&#160;Financial Conduct Authority (&#8220;FCA&#8221;)&#160;as provided by the Financial Services
and Markets Act 2000 (&#8220;FSM Act&#8221;). Under this act, all UK-based banks, together with other investment firms, are subject
to a range of requirements, including fitness and properness, capital adequacy, liquidity, and systems and controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FCA is responsible for regulating investment products, including derivatives, and those who deal in investment products. Regulation
of spot, commercial forwards, and deposits of&#160;palladium not covered by the FSM Act is provided for by The London Code of
Conduct for Non-Investment Products, which was established by market participants in conjunction with the Bank of England.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
TOCOM has authority to perform financial and operational surveillance on its members&#8217; trading activities, scrutinize positions
held by members and large-scale customers, and monitor the price movements of futures markets by comparing them with cash and
other derivative markets&#8217; prices. To act as a Futures Commission Merchant Broker on the TOCOM, a broker must obtain a license
from Japan&#8217;s Ministry of Economy, Trade and Industry (&#8220;METI&#8221;), the regulatory authority that oversees the operations
of the TOCOM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CFTC regulates trading in commodity contracts, such as futures, options and swaps. In addition, under the CEA, the CFTC has jurisdiction
to prosecute manipulation and fraud in any commodity (including precious metals) traded in interstate commerce as spot as well
as deliverable forwards. The CFTC is the exclusive regulator of U.S. commodity exchanges and clearing houses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a006"></span>Secondary
Market Trading </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Trust&#8217;s investment objective is for the Shares to reflect the performance of&#160;palladium bullion, less the expenses of
the Trust, the Shares may trade in the secondary market on the NYSE Arca at prices that are lower or higher relative to their net
asset value (the value of the Trust&#8217;s assets less its liabilities (&#8220;NAV&#8221;)) per Share. The amount of the discount
or premium in the trading price relative to the NAV per Share may be influenced by non-concurrent trading hours between the NYSE
Arca, COMEX and the London and Zurich&#160;palladium markets. While the Shares trade on the NYSE Arca until 4:00 PM New York time,
liquidity in the global&#160;palladium market is reduced after the close of the COMEX at 1:30 PM New York time. As a result, during
this time, trading spreads, and the resulting premium or discount, on the Shares may widen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a007"></span>Valuation
of Palladium and Computation of Net Asset Value </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
each day that the NYSE Arca is open for regular trading, as promptly as practicable after 4:00 p.m., New York time, on such day
(the &#8220;Evaluation Time&#8221;), the Trustee evaluates the palladium held by the Trust and determines both the adjusted net
asset value (&#8220;ANAV&#8221;) and the NAV of the Trust. For the purposes of making these calculations, a business day means
any day other than a day when NYSE Arca is closed for regular trading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Evaluation Time, the Trustee values the Trust&#8217;s palladium on the basis of that day&#8217;s LME PM Fix or, if no LME
PM Fix is made on such day, the next most recent LME PM Fix determined prior to the Evaluation Time will be used, unless the Sponsor
determines that such price is inappropriate as a basis for evaluation. In the event the Sponsor determines that the LME PM Fix
or such other publicly available price as the Sponsor may deem fairly represents the commercial value of the Trust&#8217;s palladium
is not an appropriate basis for evaluation of the Trust&#8217;s palladium, it shall identify an alternative basis for such evaluation
to be employed by the Trustee. Neither the Trustee nor the Sponsor shall be liable to any person for the determination that the
LME PM Fix or such other publicly available price is not appropriate as a basis for evaluation of the Trust&#8217;s palladium
or for any determination as to the alternative basis for such evaluation provided that such determination is made in good faith.
See <i>&#8220;Operation of the Palladium Market&#8212;The Zurich and London Palladium Bullion Markets&#8221;</i> for a description
of the LME PM Fix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the value of the&#160;palladium has been determined, the Trustee subtracts all estimated accrued but unpaid&#160;fees (other than
the fees accruing for such day on which the valuation takes place which are&#160;computed by reference to the value of the Trust or
its assets), expenses and other liabilities of the Trust from the total value of the&#160;palladium and&#160;any other assets of the
Trust. The resulting figure is the ANAV of the Trust. The ANAV of the Trust is used to compute the Sponsor&#8217;s Fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
fees accruing for the day on which the valuation takes place which are&#160;computed by reference to the value of the Trust or
its assets are calculated using the ANAV calculated for such day. The Trustee subtracts from the ANAV the amount of accrued fees
so computed for such day and the resulting figure is the NAV of the Trust. The Trustee&#160;also determines the NAV per Share
by dividing the NAV of the Trust by the number of the Shares outstanding as of the close of trading on the NYSE Arca (which includes
the net number of any Shares created or redeemed on such evaluation day).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
estimate of the accrued but unpaid fees, expenses and liabilities&#160;of the Trust for purposes of computing the NAV of the Trust
and ANAV made by the Trustee in good faith shall be conclusive upon all persons interested in the Trust and no revision or correction
in any computation made under the Trust Agreement will be required by reason of any difference in amounts estimated from those
actually paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and the Shareholders may rely on any evaluation furnished by the Trustee, and the Sponsor has no responsibility for the
evaluation&#8217;s accuracy. The determinations the Trustee makes will be made in good faith upon the basis of, and the Trustee
will not be liable for any errors contained in, information reasonably available to it. The Trustee will not be liable to the
Sponsor, DTC, Authorized Participants, the Shareholders or any other person for errors in judgment. However, the preceding liability
exclusion will not protect the Trustee against any liability resulting from bad faith or gross negligence in the performance of
its duties.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a008"></span>Trust
Expenses </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s only ordinary recurring expense is the Sponsor&#8217;s Fee. In exchange for the Sponsor&#8217;s Fee, the Sponsor
has agreed to assume the following administrative and marketing expenses incurred by the Trust: the Trustee&#8217;s monthly fee
and out-of-pocket expenses, the Custodian&#8217;s fee and reimbursement of the Custodian&#8217;s expenses under the Custody Agreements,
Exchange listing fees, SEC registration fees, printing and mailing costs, audit fees and up to $100,000 per annum in legal expenses.
The Sponsor also paid the costs of the Trust&#8217;s organization and the initial sale of the Shares, including the applicable SEC registration
fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor&#8217;s Fee accrues daily at an annualized rate equal to 0.60% of the ANAV of the Trust and is payable monthly in arrears.
The Sponsor, from time to time, may temporarily waive all or a portion of the Sponsor&#8217;s Fee at its discretion for a stated
period of time. Presently, the Sponsor does not intend to waive any of its fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the Sponsor may, in its sole discretion, agree to rebate all or a portion of the Sponsor&#8217;s Fee attributable to Shares held
by institutional investors subject to minimum shareholding and lock up requirements as determined by the Sponsor to foster stability
in the Trust&#8217;s asset levels. Any such rebate will be subject to negotiation and written agreement between the Sponsor and
the investor on a case by case basis. The Sponsor is under no obligation to provide any rebates of the Sponsor&#8217;s Fee. Neither
the Trust nor the Trustee will be a party to any Sponsor&#8217;s Fee rebate arrangements negotiated by the Sponsor. Any Sponsor&#8217;s
Fee rebate shall be paid from the funds of the Sponsor and not from the assets of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor&#8217;s Fee is paid by delivery of palladium to an account maintained by the Custodian for the Sponsor on an unallocated
basis, monthly on the first business day of the month in respect of fees payable for the prior month. The delivery is of that
number of ounces of palladium which equals the daily accrual of the Sponsor&#8217;s Fee for such prior month calculated at the
LME PM Fix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee will, when directed by the Sponsor, and, in the absence of such direction, may, in its discretion, sell&#160;palladium
in such quantity and at such times as may be necessary to permit payment in cash of Trust expenses not assumed by the Sponsor.
The Trustee is authorized to sell&#160;palladium at such times and in the smallest amounts required to permit such payments as
they become due, it being the intention to avoid or minimize the Trust&#8217;s holdings of assets other than palladium. Accordingly,
the amount of&#160;palladium to be sold will vary from time to time depending on the level of the Trust&#8217;s expenses and the
market price of&#160;palladium. The Custodian is authorized to purchase from the Trust, at the request of the Trustee,&#160;palladium
needed to cover Trust expenses not assumed by the Sponsor at the price used by the Trustee to determine the value of the&#160;palladium
held by the Trust on the date of the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor&#8217;s Fee for the year ended December 31, 2022 was $2,226,662 (December 31, 2021: $2,447,225; December 31, 2020: $2,012,865).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
held by the Trustee pending payment of the Trust&#8217;s expenses will not bear any interest. Each delivery or sale of palladium by
the&#160;Trust to&#160;pay the Sponsor&#8217;s Fee of other Trust expenses will be a taxable event to Shareholders.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a009"></span>Creation
and Redemption of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust creates and redeems Shares from time to time, but only in one or more Baskets. Prior to April 1, 2019, the number of Shares
that constituted a Basket was 50,000 Shares. Effective April 1, 2019, the Basket size was decreased to 25,000 Shares.&#160;The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants are the only persons that may place orders to create and redeem Baskets. Authorized Participants must be (1) registered
broker-dealers or other securities market participants, such as banks and other financial institutions,&#160;which are not required
to register as broker-dealers to engage in securities transactions, and (2) participants in DTC. To become an Authorized Participant,
a person must enter into an Authorized Participant Agreement with the Sponsor and the Trustee. The Authorized Participant Agreement
provides the procedures for the creation and redemption of Baskets and for the delivery of the&#160;palladium and any cash required
for such creations and redemptions. The Authorized Participant Agreement and the related procedures attached thereto may be amended
by the Trustee and the Sponsor, without the consent of any Shareholder or Authorized Participant. Authorized Participants pay
a transaction fee of $500 to the Trustee for each order they place to create or redeem one or more Baskets. Authorized Participants
who make deposits with the Trust in exchange for Baskets receive no fees, commissions or other form of compensation or inducement
of any kind from either the Sponsor or the Trust for serving as an Authorized Participant, and no such person has any obligation
or responsibility to the Sponsor or the Trust to effect any sale or resale of Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants are cautioned that some of their activities will result in their being deemed participants in a distribution in a
manner which would render them statutory underwriters and subject them to the prospectus-delivery and liability provisions of
the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to initiating any creation or redemption order, an Authorized Participant must have entered into an agreement with the Custodian
or a&#160;palladium clearing bank to establish an Authorized Participant Unallocated Account in London or Zurich (&#8220;Authorized
Participant Unallocated Bullion Account Agreement&#8221;).&#160;Palladium held in Authorized Participant Unallocated Accounts is
typically not segregated from the Custodian&#8217;s or other&#160;palladium clearing bank&#8217;s assets, as a consequence of
which an Authorized Participant will have no proprietary interest in any specific&#160;plates or ingots of palladium held by the
Custodian or&#160;the clearing bank. Credits to its Authorized Participant Unallocated Account are therefore at risk of the Custodian&#8217;s
or other&#160;palladium clearing bank&#8217;s insolvency. No fees will be charged by the Custodian for the use of the Authorized
Participant Unallocated Account as long as the Authorized Participant Unallocated Account is used solely for&#160;palladium transfers
to and from the Trust Unallocated Account and the Custodian (or one of its affiliates) receives compensation for maintaining the
Trust Allocated Account. Authorized Participants should be aware that the Custodian&#8217;s liability threshold under the Authorized
Participant Unallocated Bullion Account Agreement is generally gross negligence, not negligence, which is the Custodian&#8217;s
liability threshold under the Trust&#8217;s Custody Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the terms of the Authorized Participant Unallocated Bullion Account Agreement differ in certain respects from the terms of the
Trust Unallocated Account Agreement, potential Authorized Participants should review the terms of the Authorized Participant Unallocated
Bullion Account Agreement carefully. A copy of the Authorized Participant Agreement may be obtained by potential Authorized Participants
from the Trustee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
Authorized Participants are expected to have the facility to participate directly in the physical palladium market and the palladium&#160;futures
markets. In some cases, an Authorized Participant may from time to time acquire&#160;palladium from or sell&#160;palladium to
its affiliated&#160;palladium trading desk, which may profit in these instances. Each Authorized Participant must be registered
as a broker-dealer under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) and regulated by FINRA or be exempt from
being or otherwise not be required to be so regulated or registered, and&#160;be qualified to act as a broker or dealer in the
states or other jurisdictions where the nature of its business so requires. Certain Authorized Participants are regulated under
federal and state banking laws and regulations. Each Authorized Participant has its own set of rules and procedures, internal
controls and information barriers as it determines is appropriate in light of its own regulatory regime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants may act for their own accounts or as agents for broker-dealers, custodians and other securities market participants
that wish to create or redeem Baskets. An order for one or more Baskets may be placed by an Authorized Participant on behalf of
multiple clients. As of the date of this report, Credit Suisse Securities (USA) LLC, Goldman Sachs &amp; Co. LLC, HSBC Securities
(USA) Inc., J.P. Morgan Securities LLC, Merrill Lynch Professional Clearing Corp., Mizuho Securities USA LLC,&#160;Morgan Stanley
&amp; Co. LLC, Scotia Capital (USA) Inc., UBS Securities LLC and&#160;Virtu Americas, LLC have each signed an Authorized
Participant Agreement with the Trust and, upon the effectiveness of such agreement, may create and redeem Baskets as described
above. Persons interested in purchasing Baskets should contact the Sponsor or the Trustee to obtain the contact information for
the Authorized Participants. Shareholders who are not Authorized Participants&#160;will only be&#160;able to redeem their Shares
through an Authorized Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All&#160;palladium&#160;will
be&#160;delivered to the Trust and distributed by the Trust in unallocated form through credits and debits between Authorized
Participant Unallocated Accounts and the Trust Unallocated Account.&#160;Palladium transferred from an Authorized Participant
Unallocated Account to the Trust in unallocated form will first be credited to the Trust Unallocated Account. Thereafter, the
Custodian will allocate, or cause the allocation by the Zurich Sub-Custodian of, specific plates or ingots of palladium, in each
case representing the amount of&#160;palladium credited to the Trust Unallocated Account (to the extent such amount is representable
by palladium plates or ingots) to the Trust Allocated Account. The movement of&#160;palladium is reversed for the distribution
of&#160;palladium to an Authorized Participant in connection with the redemption of Baskets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
physical&#160;palladium represented by a credit to any Authorized Participant Unallocated Account and to the Trust Unallocated
Account and all physical&#160;palladium held in the Trust Allocated Account with the Custodian or for the Custodian by the Zurich
Sub-Custodian must be of at least a minimum fineness (or purity) of 999.5 parts per 1,000 (99.95%) and otherwise conform to the
rules, regulations practices and customs of the LPPM, including the specifications for a Good Delivery Palladium Plate or Ingot.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Authorized Participant Agreement, the Sponsor has agreed to indemnify the Authorized Participants against certain liabilities,
including liabilities under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loco
London &amp; Loco Zurich Palladium Delivery Elections.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants can elect to deliver palladium loco London or loco Zurich in connection with the creation of a Basket. Authorized
Participants can also elect to receive delivery of palladium loco London or loco Zurich in connection with the redemption of a
Basket. A Basket creation order that elects a loco London or loco Zurich delivery of palladium will cause the Custodian to effect
an allocation of such palladium to the Trust Allocated Account maintained by the Custodian in its London vault premises or by
the Zurich Sub-Custodian in its Zurich vault premises. Likewise, a Basket redemption order that elects a loco London or loco Zurich
delivery of palladium will cause the Custodian to effect a de-allocation of palladium necessary to satisfy such redemption requests
from the Trust Allocated Account maintained by the Custodian to the Trust Unallocated Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that there is not sufficient palladium in the Trust Allocated Account in London to satisfy loco London
redemptions, the Custodian shall cause the Zurich Sub-Custodian to de-allocate sufficient palladium held in the Trust
Allocated Account in Zurich and cause a transfer of palladium from the Trust Unallocated Account maintained by the Custodian
in Zurich to the Authorized Participant Unallocated Account maintained in London. Likewise, in the event that there is not
sufficient palladium in the Trust Allocated Account in Zurich to satisfy loco Zurich redemptions, the Custodian will initiate
the reverse procedure to transfer palladium from London to Zurich. These transfers between London and Zurich unallocated
accounts will generally occur pursuant to loco swap arrangements and will not expose the Authorized Participant or the Trust
to any additional expense. The Custodian has assumed the responsibility and expenses for loco swap transfers and shall bear
any risk of loss related to the palladium being transferred. If no loco swap counterparty is available, the Custodian shall
arrange, at its own expense and risk, for the physical transportation of palladium between the Zurich Sub-Custodian&#8217;s
Zurich vault premises and the Custodian&#8217;s London vault premises. If such a loco swap or physical transfer is necessary
to effect a loco London or loco Zurich redemption, the settlement of loco London or loco Zurich redemption deliveries may be
delayed more than two, but not more than five, business days. The Custodian, in its sole discretion, has the right to limit
the location where Authorized Participants can elect to receive delivery of palladium to either loco London or loco
Zurich.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the procedures for the creation and redemption of Baskets is only a summary and an investor should refer
to the relevant provisions of the Trust Agreement and the form of Authorized Participant Agreement for more detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Creation
Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
any business day, an Authorized Participant may place an order with the Trustee to create one or more Baskets. Creation and redemption
orders are accepted on &#8220;business days&#8221; the NYSE Arca is open for regular trading. Settlements of such orders requiring
receipt or delivery, or confirmation of receipt or delivery, of palladium in the United Kingdom, Zurich or another jurisdiction
will occur on &#8220;business days&#8221; when (1) banks in the United Kingdom, Zurich and such other jurisdiction and (2) the
London and Zurich palladium markets are regularly open for business. If such banks or the London or Zurich palladium markets are
not open for regular business for a full day, such a day will only be a &#8220;business day&#8221; for settlement purposes if
the settlement procedures can be completed by the end of such day. Redemption settlements including palladium deliveries loco
London may be delayed longer than two, but no more than five, business days following the redemption order date. Settlement of
orders requiring receipt or delivery, or confirmation of receipt or delivery, of Shares will occur, after confirmation of the
applicable palladium delivery, on &#8220;business days&#8221; when the NYSE Arca is open for regular trading. In the event of
a level 3 market-wide circuit breaker resulting in a trading halt for the remainder of the trading day, the time of the market-wide
trading halt is considered the close of regular trading and no creation orders for the current trade date will be accepted after
that time (the &#8220;cutoff&#8221;). Orders placed after the cutoff will be deemed to be rejected and will not be processed.
Orders should be placed in proper form on the following business day. Purchase orders must be placed no later than 3:59:59 p.m.
on each business day the NYSE Arca is open for regular trading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
placing a purchase order, an Authorized Participant agrees to deposit palladium with the Trust. Prior to the delivery of Baskets
for a purchase order, the Authorized Participant must also have wired to the Trustee the non-refundable transaction fee due for
the purchase order.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination
of required deposits</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of the required palladium deposit is determined by dividing the number of ounces of palladium held by the Trust by the
number of Baskets outstanding, as adjusted for the amount of palladium constituting estimated accrued but unpaid fees and expenses
of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fractions
of a fine ounce of palladium smaller than 0.001 of a fine ounce which are included in the palladium deposit amount are disregarded
in the foregoing calculation. All questions as to the composition of a Creation Basket Deposit will be finally determined by the
Trustee. The Trustee&#8217;s determination of the Creation Basket Deposit shall be final and binding on all persons interested
in the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delivery
of required deposits</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Authorized Participant who places a purchase order is responsible for crediting its Authorized Participant Unallocated Account
with the required palladium deposit amount by the second business day in London or Zurich following the purchase order date. Upon
receipt of the palladium deposit amount, the Custodian, after receiving appropriate instructions from the Authorized Participant
and the Trustee, will transfer on the second business day following the purchase order date the palladium deposit amount from
the Authorized Participant Unallocated Account to the Trust Unallocated Account and the Trustee will direct DTC to credit the
number of Baskets ordered to the Authorized Participant&#8217;s DTC account. The expense and risk of delivery, ownership and safekeeping
of palladium until such palladium has been received by the Trust shall be borne solely by the Authorized Participant. The Trustee
may accept delivery of palladium by such other means as the Sponsor, from time to time, my determine with the Trustee to be acceptable
for the Trust, provided that the same is disclosed in a prospectus relating to the Trust filed with the SEC pursuant to Rule 424
under the Securities Act. If palladium is to be delivered other than as described above, the Sponsor is authorized to establish
such procedures and to appoint such custodians and establish such custody accounts in addition to those described in this report,
as the Sponsor determines to be desirable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acting
on standing instructions given by the Trustee, the Custodian will transfer the palladium deposit amount from the Trust Unallocated
Account to the Trust Allocated Account by transferring palladium plates and ingots from its inventory or the inventory of the
Zurich Sub-Custodian to the Trust Allocated Account. The Custodian uses commercially reasonable efforts to complete the transfer
of palladium to the Trust Allocated Account prior to the time by which the Trustee is to credit the Basket to the Authorized Participant&#8217;s
DTC account; if, however, such transfers have not been completed by such time, the number of Baskets ordered will be delivered
against receipt of the palladium deposit amount in the Trust Unallocated Account, and all Shareholders will be exposed to the
risks of unallocated palladium to the extent of that palladium deposit amount until the Custodian completes the allocation process
or a Zurich Sub-Custodian completes the allocation process for the Custodian. See &#8220;Risk Factors&#8212;Palladium held in
the Trust&#8217;s unallocated palladium account and any Authorized Participant&#8217;s unallocated palladium account is not segregated
from the Custodian&#8217;s assets....&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
palladium is only allocated in multiples of whole plates or ingots, the amount of palladium allocated from the Trust Unallocated
Account to the Trust Allocated Account may be less than the total fine ounces of palladium credited to the Trust Unallocated Account.
Any balance will be held in the Trust Unallocated Account. The Custodian uses commercially reasonable efforts to minimize the
amount of palladium held in the Trust Unallocated Account; no more than 192.904 troy ounces of palladium (maximum weight to make
one Good Delivery Palladium Plate or Ingot) is expected to be held in the Trust Unallocated Account at the close of each business
day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rejection
of purchase orders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee may reject a purchase order or a Creation Basket Deposit if such order or Creation Basket Deposit is not presented in
proper form as described in the Authorized Participant Agreement or if the fulfillment of the order, in the opinion of counsel,
might be unlawful. None of the Trustee, the Sponsor or the Custodian will be liable for the rejection of any purchase order or
Creation Basket Deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption
Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
procedures by which an Authorized Participant can redeem one or more Baskets mirror the procedures for the creation of Baskets.
On any business day, an Authorized Participant may place an order with the Trustee to redeem one or more Baskets. Redemption orders
must be placed no later than 3:59:59 p.m. on each business day the NYSE Arca is open for regular trading. In the event of a level
3 market-wide circuit breaker resulting in a trading halt for the remainder of the trading day, the time of the market wide trading
halt is considered the close of regular trading and no redemption orders for the current trade date will be accepted after that
time (the &#8220;cutoff&#8221;). Orders placed after the cutoff will be deemed to be rejected and will not be processed. Orders
should be placed in proper form on the following business day. A redemption order so received is effective on the date it is received
in satisfactory form by the Trustee. The redemption procedures allow Authorized Participants to redeem Baskets and do not entitle
an individual Shareholder to redeem any Shares in an amount less than a Basket, or to redeem Baskets other than through an Authorized
Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
placing a redemption order, an Authorized Participant agrees to deliver the Baskets to be redeemed through DTC&#8217;s book entry
system to the Trust not later than the second business day following the effective date of the redemption order. Prior to the
delivery of the redemption distribution for a redemption order, the Authorized Participant must also have wired to the Trustee
the non-refundable transaction fee due for the redemption order.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination
of redemption distribution</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption distribution from the Trust consists of a credit to the redeeming Authorized Participant&#8217;s Authorized Participant
Unallocated Account representing the amount of the palladium held by the Trust evidenced by the Shares being redeemed. Fractions
of a fine ounce of palladium included in the redemption distribution smaller than 0.001 of a fine ounce are disregarded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
distributions will be subject to the deduction of any applicable tax or other governmental charges which may be due.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delivery
of redemption distribution</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption distribution due from the Trust will be delivered to the Authorized Participant on the second business day following
a loco Zurich redemption order date if, by 10:00 a.m. New York time on such second business day, the Trustee&#8217;s DTC account
has been credited with the Baskets to be redeemed. The redemption distribution due from the Trust will be delivered to the Authorized
Participant on or before the fifth business day following a loco London redemption order date if, by 10:00 a.m. New York time
on the second business day after the loco London redemption order date, the Trustee&#8217;s DTC account has been credited with
the Baskets to be redeemed. If a loco swap or physical transfer is necessary to effect a loco London or loco Zurich redemption,
the redemption distribution due from the Trust will be delivered to the Authorized Participant on or before the fifth business
day following such a loco London or loco Zurich redemption order date if, by 10:00 a.m. New York time on the second business day
after the loco London or loco Zurich redemption order date, the Trustee&#8217;s DTC account has been credited with the Baskets
to be redeemed. In the event that, by 10:00 a.m. New York time on the second business day following the order date of a redemption
order, the Trustee&#8217;s DTC account has not been credited with the total number of Shares corresponding to the total number
of Baskets to be redeemed pursuant to such redemption order, the Trustee shall send to the Authorized Participant and the Custodian
via fax or electronic mail message notice of such fact and the Authorized Participant shall have two business days following receipt
of such notice to correct such failure. If such failure is not cured within such two business day period, the Trustee (in consultation
with the Sponsor) will cancel such redemption order and will send via fax or electronic mail message notice of such cancellation
to the Authorized Participant and the Custodian, and the Authorized Participant will be solely responsible for all costs incurred
by the Trust, the Trustee or the Custodian related to the cancelled order. The Trustee is also authorized to deliver the redemption
distribution notwithstanding that the Baskets to be redeemed are not credited to the Trustee&#8217;s DTC account by 10:00 a.m.
New York time on the second business day following the redemption order date if the Authorized Participant has collateralized
its obligation to deliver the Baskets through DTC&#8217;s book entry system on such terms as the Sponsor and the Trustee may from
time to time agree upon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian transfers the redemption palladium amount from the Trust Allocated Account to the Trust Unallocated Account and, thereafter,
to the redeeming Authorized Participant&#8217;s Authorized Participant Unallocated Account. The Authorized Participant and the
Trust are each at risk in respect of palladium credited to their respective unallocated accounts in the event of the Custodian&#8217;s
insolvency. See &#8220;Risk Factors&#8212;Palladium held in the Trust&#8217;s unallocated palladium account and any Authorized
Participant&#8217;s unallocated palladium account is not segregated from the Custodian&#8217;s assets....&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with the allocation of palladium to the Trust Allocated Account which occurs upon a purchase order, if in transferring palladium
from the Trust Allocated Account to the Trust Unallocated Account in connection with a redemption order there is an excess amount
of palladium transferred to the Trust Unallocated Account, the excess over the palladium redemption amount will be held in the
Trust Unallocated Account. The Custodian uses commercially reasonable efforts to minimize the amount of palladium held in the
Trust Unallocated Account; no more than 192 ounces of palladium (maximum weight to make one Good Delivery Palladium Plate or Ingot)
is expected to be held in the Trust Unallocated Account at the close of each business day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Suspension
or rejection of redemption orders</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee may, in its discretion, and will when directed by the Sponsor, suspend the right of redemption, or postpone the redemption
settlement date, (1) for any period during which the NYSE Arca is closed other than customary weekend or holiday closings, or
trading on the NYSE Arca is suspended or restricted or (2) for any period during which an emergency exists as a result of which
delivery, disposal or evaluation of palladium is not reasonably practicable. None of the Sponsor, the Trustee or the Custodian
are liable to any person or in any way for any loss or damages that may result from any such suspension or postponement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee will reject a redemption order if the order is not in proper form as described in the Authorized Participant Agreement
or if the fulfillment of the order, in the opinion of its counsel, might be unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a010"></span>Creation
and Redemption Transaction Fe</b>e</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
compensate the Trustee for services in processing the creation and redemption of Baskets, an Authorized Participant is required
to pay a transaction fee to the Trustee of $500 per order to create or redeem Baskets. An order may include multiple Baskets.
The transaction fee may be reduced, increased or otherwise changed by the Trustee with the consent of the Sponsor. From time to
time, the Trustee, with the consent of the Sponsor, may waive all or a portion of the applicable transaction fee. The Trustee shall
notify DTC of any agreement to change the transaction fee and will not implement any increase in the fee for the redemption of
Baskets until 30 days after the date of the notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a011"></span>The
Sponsor </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s Sponsor is abrdn ETFs Sponsor LLC (known as Aberdeen Standard Investments ETFs Sponsor LLC prior to March 1, 2022 and
ETF Securities USA LLC prior to October 1, 2018), a Delaware limited liability company formed on June 17, 2009.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
Sponsor&#8217;s office is located at c/o&#160;abrdn ETFs Sponsor LLC, 1900 Market Street, Suite 200, Philadelphia, PA 19103. Prior
to April 27, 2018, the Sponsor was wholly-owned by ETF Securities Limited, a Jersey, Channel Islands based company. Effective
April 27, 2018, ETF Securities Limited sold its membership interest in the Sponsor to abrdn Inc. (known as Aberdeen Standard Investments
Inc. prior to January 1, 2022), a Delaware corporation. As a result of the sale, abrdn Inc. became the sole member of the Sponsor.
abrdn Inc. is a wholly-owned indirect subsidiary of abrdn plc, which together with its affiliates and subsidiaries, is collectively
referred to as &#8220;abrdn.&#8221; Under the Delaware Limited Liability Company Act and the governing documents of the Sponsor,
the sole member of the Sponsor, abrdn Inc., is not responsible for the debts, obligations and liabilities of the Sponsor solely
by reason of being the sole member of the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Sponsor&#8217;s Role</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor arranged for the creation of the Trust, and is responsible for the ongoing registration of the Shares for their public
offering in the United States and the listing of the Shares on the NYSE Arca. The Sponsor has agreed to assume the following administrative
and marketing expenses incurred by the Trust: the Trustee&#8217;s monthly fee and out-of-pocket expenses, the Custodian&#8217;s
fee and the reimbursement of the Custodian&#8217;s expenses under the Custody Agreements, Exchange listing fees, SEC registration
fees, printing and mailing costs, audit fees and up to $100,000 per annum in legal expenses. The Sponsor also paid the costs of
the Trust&#8217;s organization and the initial sale of the Shares, including the applicable SEC registration fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor does not exercise day-to-day oversight over the Trustee or the Custodian. The Sponsor may remove the Trustee and appoint
a successor Trustee (i) if the Trustee ceases to meet certain objective requirements (including the requirement that it have capital,
surplus and undivided profits of at least $150 million), (ii) if, having received written notice of a material breach of its obligations
under the Trust Agreement, the Trustee has not cured the breach within 30 days, or (iii) if the Trustee refuses to consent to
the implementation of an amendment to the Trust&#8217;s initial Internal Control Over Financial Reporting. The Sponsor also has
the right to replace the Trustee during the 90 days following any merger, consolidation or conversion in which the Trustee is
not the surviving entity or, in its discretion, on the fifth anniversary of the creation of the Trust or on any subsequent third
anniversary thereafter. The Sponsor also has the right to approve any new or additional custodian that the Trustee may wish to
appoint and any new or additional Zurich Sub-Custodian that the Custodian may wish to appoint.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor or one of its affiliates or agents (1) develops a marketing plan for the Trust on an ongoing basis, (2) prepares marketing
materials regarding the Shares, including the content of the Trust&#8217;s website and (3) executes the marketing plan for the
Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a012"></span>The
Trustee </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bank of New York Mellon, a banking corporation organized under the laws of the State of New York with trust powers (&#8220;BNYM&#8221;),
serves as the Trustee. BNYM has a trust office at 240 Greenwich Street, New York, NY 10286. BNYM is subject to supervision by
the New York State Financial Services Department and the Board of Governors of the Federal Reserve System. Information regarding
creation and redemption Basket composition, NAV of the Trust, transaction fees and the names of the parties that have each executed
an Authorized Participant Agreement may be obtained from BNYM. A copy of the Trust Agreement is available for inspection at BNYM&#8217;s
trust office identified above. Under the Trust Agreement, the Trustee is required to have capital, surplus and undivided profits
of at least $150 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trustee&#8217;s Role </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee is generally responsible for the day-to-day administration of the Trust, including keeping the Trust&#8217;s operational
records. The Trustee&#8217;s principal responsibilities include (1) transferring the Trust&#8217;s&#160;palladium as needed to
pay&#160;the Sponsor&#8217;s Fee in&#160;palladium (palladium transfers are expected to occur approximately monthly in the ordinary
course), (2) valuing the Trust&#8217;s palladium and calculating the NAV of the Trust and the NAV per Share, (3) receiving and
processing orders from Authorized Participants to create and redeem Baskets and coordinating the processing of such orders with
the Custodian and DTC, (4) selling the Trust&#8217;s&#160;palladium as needed to pay any extraordinary Trust expenses that are
not assumed by the Sponsor, (5) when appropriate, making distributions of cash or other property to Shareholders, and (6) receiving
and reviewing reports from or on the Custodian&#8217;s custody of and transactions in the Trust&#8217;s palladium. The Trustee
shall, with respect to directing the Custodian, act in accordance with the instructions of the Sponsor. If the Custodian resigns,
the Trustee shall appoint an additional or replacement Custodian selected by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee intends to regularly communicate with the Sponsor to monitor the overall performance of the Trust. The Trustee does not
monitor the performance of the Custodian, the Zurich Sub-Custodian, or any other sub-custodian other than to review the reports
provided by the Custodian pursuant to the Custody Agreements. The Trustee, along with the Sponsor, will liaise with the Trust&#8217;s
legal, accounting and other professional service providers as needed. The Trustee will assist and support the Sponsor with the
preparation of all periodic reports required to be filed with the SEC on behalf of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee&#8217;s monthly fees and out-of-pocket expenses are paid by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliates
of the Trustee may from time to time act as Authorized Participants or purchase or sell&#160;palladium or Shares for their own
account, as agent for their customers and for accounts over which they exercise investment discretion. Affiliates of the Trustee
are subject to the same transaction fee as other Authorized Participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a013"></span>The
Custodian </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan
Chase Bank, N.A. (&#8220;JPMorgan&#8221;) serves as the Custodian of the Trust&#8217;s palladium. JPMorgan is a national banking
association organized under the laws of the United States of America. JPMorgan is subject to supervision by the Federal Reserve
Bank of New York and the Federal Deposit Insurance Corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">JPMorgan&#8217;s
London office is regulated by the FCA and is located at 25 Bank Street, Canary Wharf, London, E14 5JP, United Kingdom. JPMorgan
is a subsidiary of JPMorgan Chase &amp; Co.&#160;&#160;While the United Kingdom operations of the Custodian are regulated by the
FCA, the custodial services provided by the Custodian and any sub-custodian, including the Zurich Sub-Custodian under the Custody
Agreements, are presently not a regulated activity subject to the supervision and rules of the FCA. The Zurich Sub-Custodian that
the Custodian currently uses is UBS AG, which is located at 45 Bahnhofstrasse, 8001 Zurich, Switzerland.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Custodian&#8217;s Role</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian is responsible for safekeeping of the Trust&#8217;s palladium deposited with it by Authorized Participants in connection
with the creation of Baskets. The Custodian is also responsible for selecting the Zurich Sub-Custodian and its other direct sub-custodians,
if any. The Custodian facilitates the transfer of palladium in and out of the Trust through the unallocated palladium accounts
it will maintain for each Authorized Participant and the unallocated and allocated palladium accounts it will maintain for the
Trust. The Custodian holds at its London, England vault premises that portion of the Trust&#8217;s allocated palladium to be held
in London. The Zurich Sub-Custodian holds at its Zurich, Switzerland vault premises that portion of the Trust&#8217;s allocated
palladium to be held in Zurich on behalf of the Custodian. The Custodian is responsible for allocating specific plates or ingots
of physical palladium to the Trust&#8217;s allocated palladium account. The Custodian provides the Trustee with regular reports
detailing the palladium transfers in and out of the Trust&#8217;s unallocated and allocated palladium accounts and identifying
the palladium plates or ingots held in the Trust&#8217;s allocated palladium account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian&#8217;s fees and expenses under the Custody Agreements are paid by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian and its affiliates may from time to time act as Authorized Participants or purchase or sell palladium or Shares for
their own account, as agent for their customers and for accounts over which they exercise investment discretion. The Custodian
and its affiliates are subject to the same transaction fee as other Authorized Participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a014"></span>Inspection
of Palladium</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Custody Agreements, the Trustee, the Sponsor and the Trust&#8217;s auditors and inspectors may, only up to twice a year, visit
the premises of the Custodian and the Zurich Sub-Custodian for the purpose of examining the Trust&#8217;s&#160;palladium and certain
related records maintained by the Custodian. &#160;Under the Allocated Account Agreement, the Custodian agreed to procure similar
inspection rights from the Zurich Sub-Custodian. Any such inspection rights with respect to the Zurich Sub-Custodian are expected
to be granted in accordance with the normal course of dealing between the Custodian and the Zurich Sub-Custodian. Visits by auditors
and inspectors to the Zurich Sub-Custodian&#8217;s facilities will be arranged through the Custodian. Other than with respect
to the Zurich Sub-Custodian, the Trustee and the Sponsor have no right to visit the premises of any sub-custodian for the purposes
of examining the Trust&#8217;s&#160;palladium or any records maintained by the sub-custodian, and no sub-custodian is obligated
to cooperate in any review the Trustee or the Sponsor may wish to conduct of the facilities, procedures, records or creditworthiness
of such sub-custodian.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has exercised its right to visit the Custodian and the Zurich Sub-Custodian, in order to examine the palladium&#160;and
the records maintained by the&#160;them. Inspections were conducted by Bureau Veritas Commodities UK Ltd, a leading commodity
inspection and testing company retained by the Sponsor, as of June 30, 2022 and December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no guarantee that the Sponsor or the Trust&#8217;s auditors and inspectors will be able to perform physical inspections
of the Trust&#8217;s&#160;palladium as planned. Local policies, regulations, or ordinances, as well as polices or restrictions
adopted by the Custodian or a sub-custodian, may temporarily prevent, or otherwise impair the ability of, the Sponsor or the Trust&#8217;s
auditors and inspectors, from performing a physical inspection of the Trust&#8217;s&#160;palladium on a desired date. In those
situations, the Sponsor or the Trust&#8217;s auditors and inspectors may seek to verify the palladium&#160;held by the Trust by
alternate means, including through virtual inspections of the Trust&#8217;s palladium and/or a review of pertinent records.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a015"></span>Description
of the Shares </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee is authorized under the Trust Agreement to create and issue an unlimited number of Shares. The Trustee creates Shares
only in Baskets and only upon the order of an Authorized Participant. Effective April 1, 2019, the number of Shares that constitute
a Basket for the purposes of creations and redemptions is 25,000 Shares. Prior to April 1, 2019, a Basket consisted of 50,000
Shares. The Shares represent units of fractional undivided beneficial interest in and ownership of the Trust and have no par value.
Any creation and issuance of Shares above the amount registered on the Trust&#8217;s then-current and effective registration statement
with the SEC will require the registration of such additional Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Description
of Limited Rights </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares do not represent a traditional investment and Shareholders should not view them as similar to shares of a corporation operating
a business enterprise with management and a board of directors. Shareholders do not have the statutory rights normally associated
with the ownership of shares of a corporation, including, for example, the right to bring &#8220;oppression&#8221; or &#8220;derivative&#8221;
actions. All Shares are of the same class with equal rights and privileges. Each Share is transferable, is fully paid and non-assessable
and entitles the holder to vote on the limited matters upon which Shareholders may vote under the Trust Agreement. The Shares
do not entitle their holders to any conversion or pre-emptive rights, or, except as provided below, any redemption rights or rights
to distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Trust is terminated and liquidated, the Trustee will distribute to the Shareholders any amounts remaining after the satisfaction
of all outstanding liabilities of the Trust and the establishment of such reserves for applicable taxes, other governmental charges
and contingent or future liabilities as the Trustee shall determine. Shareholders of record on the record date fixed by the Trustee
for a distribution will be entitled to receive their pro rata portion of any distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
and Approvals </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Trust Agreement, Shareholders have no voting rights, except in limited circumstances. The Trustee may terminate the Trust
upon the agreement of Shareholders owning at least 75% of the outstanding Shares. In addition, certain amendments to the Trust
Agreement require advance notice to the Shareholders before the effectiveness of such amendments, but no Shareholder vote or approval
is required for any amendment to the Trust Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of the Shares </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares may only be redeemed by or through an Authorized Participant and only in Baskets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Book-Entry
Form </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
certificates will not be issued for the Shares. Instead, one or more global certificates is deposited by the Trustee with DTC
and registered in the name of Cede &amp; Co., as nominee for DTC. The global certificates evidence all of the Shares outstanding
at any time. Under the Trust Agreement, Shareholders are limited to (1) participants in DTC such as banks, brokers, dealers and
trust companies (DTC Participants), (2) those who maintain, either directly or indirectly, a custodial relationship with a DTC
Participant (Indirect Participants), and (3) those banks, brokers, dealers, trust companies and others who hold interests in the
Shares through DTC Participants or Indirect Participants. The Shares are only transferable through the book-entry system of DTC.
Shareholders who are not DTC Participants may transfer their Shares through DTC by instructing the DTC Participant holding their
Shares (or by instructing the Indirect Participant or other entity through which their Shares are held) to transfer the Shares.
Transfers will be made in accordance with standard securities industry practice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a016"></span>Custody
of the Trust&#8217;s Palladium </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Custody
of the physical palladium deposited with and held by the Trust is provided by the Custodian at its London, England vaults and
by the Zurich Sub-Custodian selected by the Custodian in its Zurich vaults and by other sub-custodians on a temporary basis. The
Custodian is a market maker, clearer and approved weigher under the rules of the LPPM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian is the custodian of the physical palladium credited to the Trust Allocated Account in accordance with the Custody
Agreements. The Custodian segregates the physical palladium credited to the Trust&#8217;s Allocated Account from any other precious
metal it holds or holds for others by entering appropriate entries in its books and records, and requires the Zurich Sub-Custodian
to also segregate the physical palladium of the Trust that it holds from the other palladium held by it for other customers of the
Custodian and the Zurich Sub-Custodian&#8217;s other customers. The Custodian requires the Zurich Sub-Custodian to identify in its
books and records the Trust as having the rights to the physical palladium credited to its Trust Allocated Account. Under the
Custody Agreements, the Trustee, the Sponsor and the Trust&#8217;s auditors and inspectors may inspect the vaults of the Custodian
and the Zurich Sub-Custodian. See &#8220;Inspection of Platinum&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian, as instructed by the Trustee on behalf of the Trust, is authorized to accept, on behalf of the Trust, deposits of palladium
in unallocated form. Acting on standing instructions specified in the Custody Agreements, the Custodian will or will require the
Zurich Sub-Custodian to allocate palladium deposited in unallocated form with the Trust by selecting plates or ingots of palladium
for deposit to the Trust Allocated Account. All physical palladium allocated to the Trust must conform to the rules, regulations,
practices and customs of the LPPM, and the Custodian must replace any non-conforming palladium with conforming palladium as soon
as practical upon a determination by the Custodian any palladium is non-conforming.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
process of withdrawing&#160;palladium from the Trust for a redemption of a Basket follows the same general procedure as for depositing&#160;palladium
with the Trust for a creation of a Basket, only in reverse. Each transfer of&#160;palladium between the Trust Allocated Account
and the Trust Unallocated Account connected with a creation or redemption of a Basket may result in a small amount of&#160;palladium
being held in the Trust Unallocated Account after the completion of the transfer. In making deposits and withdrawals between the
Trust Allocated Account and the Trust Unallocated Account, the Custodian will use commercially reasonable efforts to minimize
the&#160;amount of palladium held in the Trust Unallocated Account as of the close of each business day. See &#8220;Creation and
Redemption of Shares.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a017"></span>United
States Federal Income Tax Consequences</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion of the material US federal income tax consequences generally applies to the purchase, ownership and disposition
of Shares by a US Shareholder (as defined below), and certain US federal income tax consequences that may apply to an investment in Shares by a Non-US
Shareholder (as defined below). The discussion is based on the United States Internal Revenue Code of 1986 as amended (the
&#8220;Code&#8221;). The discussion below is based on the Code, United States Treasury Regulations (&#8220;Treasury
Regulations&#8221;) promulgated under the Code and judicial and administrative interpretations of the Code, all as in effect on the
date of this annual report and all of which are subject to change either prospectively or retroactively. The tax treatment of
Shareholders may vary depending upon their own particular circumstances. Certain Shareholders (including broker-dealers, traders,
banks and other financial institutions, insurance companies, real estate investment trusts, tax-exempt entities, Shareholders whose
functional currency is not the U.S. Dollar or other investors with special circumstances) may be subject to special rules not
discussed below. In addition, the following discussion applies only to investors who hold Shares as &#8220;capital assets&#8221;
within the meaning of Code section 1221 and not as part of a straddle, hedging transaction or a conversion or constructive sale
transaction. Moreover, the discussion below does not address the effect of any state, local or foreign tax law or any transfer tax
on an owner of Shares. Purchasers of Shares are urged to consult their own tax advisors with respect to all federal, state, local
and foreign tax law or any transfer tax considerations potentially applicable to their investment in Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;US Shareholder&#8221; is a Shareholder that is:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;An
individual who is a citizen or resident of the United States;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;A
corporation (or other entity treated as a corporation for US federal tax purposes) created or organized in or under the laws of
the United States or any political subdivision thereof;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;An
estate, the income of which is includible in gross income for US federal income tax purposes regardless of its source; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;A
trust, if a court within the United States is able to exercise primary supervision over the administration of the trust and one
or more US persons have the authority to control all substantial decisions of the trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Shareholder that is not a US Shareholder as defined above (other than a partnership, or an entity treated as a partnership for
US federal tax purposes) generally is considered a &#8220;Non-US Shareholder&#8221; for purposes of this discussion. For US federal
income tax purposes, the treatment of any beneficial owner of an interest in a partnership, including any entity treated as a
partnership for US federal income tax purposes, generally depends upon the status of the partner and upon the activities of the
partnership. Partnerships and partners in partnerships should consult their tax advisors about the US federal income tax consequences
of purchasing, owning and disposing of Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of the Trust </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is classified as a &#8220;grantor trust&#8221; for US federal income tax purposes. As a result, the Trust itself is not
subject to US federal income tax. Instead, the Trust&#8217;s income and expenses &#8220;flow through&#8221; to the Shareholders,
and the Trustee reports the Trust&#8217;s income, gains, losses and deductions to the Internal Revenue Service (&#8220;IRS&#8221;)
on that basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of US Shareholders </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
generally are treated, for US federal income tax purposes, as if they directly owned a pro rata share of the underlying assets
held by the Trust. Shareholders are also treated as if they directly received their respective pro rata share of the Trust&#8217;s
income, if any, and as if they directly incurred their respective pro rata share of the Trust&#8217;s expenses. In the case of
a Shareholder that purchases Shares for cash, its initial tax basis in its pro rata share of the assets held by the Trust at the
time it acquires its Shares is equal to its cost of acquiring the Shares. In the case of a Shareholder that acquires its Shares
as part of a creation of a Basket, the delivery of&#160;palladium to the Trust in exchange for the Shares is not a taxable event
to the Shareholder, and the Shareholder&#8217;s tax basis and holding period for the Shares are the same as its tax basis and
holding period for the&#160;palladium delivered in exchange therefore (except to the extent of any cash contributed for such Shares).
For purposes of this discussion, it is assumed that all of a Shareholder&#8217;s Shares are acquired on the same date and at the
same price per Share. Shareholders that hold multiple lots of Shares, or that are contemplating acquiring multiple lots of Shares,
should consult their tax advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Trust sells or transfers palladium, for example to pay expenses, a Shareholder generally will recognize a gain or loss in
an amount equal to the difference between (1) the Shareholder&#8217;s pro rata share of the amount realized by the Trust upon
the sale or transfer and (2) the Shareholder&#8217;s tax basis for its pro rata share of the palladium that was sold or transferred.
Such gain or loss will generally be long-term or short-term capital gain or loss, depending upon whether the Shareholder has a
holding period in its Shares of longer than one year. A Shareholder&#8217;s tax basis for its share of any palladium sold by the
Trust generally will be determined by multiplying the Shareholder&#8217;s total basis for its Shares immediately prior to the
sale, by a fraction the numerator of which is the amount of palladium sold, and the denominator of which is the total amount of
the palladium held by the Trust immediately prior to the sale. After any such sale, a Shareholder&#8217;s tax basis for its pro
rata share of the palladium remaining in the Trust will be equal to its tax basis for its Shares immediately prior to the sale,
less the portion of such basis allocable to its share of the palladium that was sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a Shareholder&#8217;s sale of some or all of its Shares, the Shareholder will be treated as having sold a pro rata share of the&#160;palladium
held in the Trust at the time of the sale. Accordingly, the Shareholder generally will recognize a&#160;gain or loss on the sale
in an amount equal to the difference between (1) the amount realized pursuant to the sale of the Shares, and (2) the Shareholder&#8217;s
tax basis for the Shares sold, as determined in the manner described in the preceding paragraph.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
redemption of some or all of a Shareholder&#8217;s Shares in exchange for the underlying&#160;palladium represented by the Shares
redeemed generally will not be a taxable event to the Shareholder. The Shareholder&#8217;s tax basis for the&#160;palladium received
in the redemption generally will be the same as the Shareholder&#8217;s tax basis for the Shares redeemed. The Shareholder&#8217;s
holding period with respect to the&#160;palladium received should include the period during which the Shareholder held the Shares
redeemed. A subsequent sale of the&#160;palladium received by the Shareholder will be a taxable event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Authorized Participant and other investors may be able to re-invest, on a tax-deferred basis, in-kind redemption proceeds received
from exchange-traded products that are substantially similar to the Trust in the Trust&#8217;s Shares. Authorized Participants
and other investors should consult their tax advisors as to whether and under what circumstances the reinvestment in the Shares
of proceeds from substantially similar exchange-traded products can be accomplished on a tax-deferred basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
current law, gains recognized by individuals, estates or trusts from the sale of &#8220;collectibles,&#8221; including physical
palladium, held for more than one year are taxed at a maximum federal income tax rate of 28%, rather than the 20% rate applicable
to most other long-term capital gains. For these purposes, gains recognized by an individual upon the sale of Shares held for
more than one year, or attributable to the Trust&#8217;s sale of any physical&#160;palladium which the Shareholder is treated
(through its ownership of Shares) as having held for more than one year, generally will be taxed at a maximum rate of 28%. The
tax rates for capital gains recognized upon the sale of assets held by an individual US Shareholder for one year or less or by
a corporate taxpayer are generally the same as those at which ordinary income is taxed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, high-income individuals and certain trusts and estates are subject to a 3.8% Medicare contribution tax that is imposed
on net investment income and gain. Shareholders should consult their tax advisor regarding this tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Brokerage
Fees and Trust Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
brokerage or other transaction fees incurred by a Shareholder in purchasing Shares is treated as part of the Shareholder&#8217;s
tax basis in the Shares. Similarly, any brokerage fee incurred by a Shareholder in selling Shares reduces the amount realized
by the Shareholder with respect to the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
will be required to recognize gain or loss upon a sale of&#160;palladium by the Trust (as discussed above), even though some or
all of the proceeds of such sale are used by the Trustee to pay Trust expenses. Shareholders may deduct their respective pro rata
share of each expense incurred by the Trust to the same extent as if they directly incurred the expense. Shareholders who are
individuals, estates or trusts, however, may be required to treat some or all of the expenses of the Trust, to the extent that
such expenses may be deducted, as miscellaneous itemized deductions. Miscellaneous itemized deductions, including expenses for
the production of income, will not be deductible for either regular federal income tax or alternative minimum tax purposes for
taxable years beginning after December 31, 2017 and before January 1, 2026 and thereafter generally are (i) deductible only to
the extent that the aggregate of a Shareholder&#8217;s miscellaneous itemized deductions exceeds 2% of such Shareholder&#8217;s adjusted gross
income for federal income tax purposes, (ii) not deductible for the purposes of the alternative minimum tax and (iii) are subject
to the overall limitation on itemized deductions under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
by Regulated Investment Companies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mutual
funds and other investment vehicles which are &#8220;regulated investment companies&#8221; within the meaning of Code section
851 should consult with their tax advisors concerning (1) the likelihood that an investment in Shares, although they are a &#8220;security&#8221;
within the meaning of the Investment Company Act of 1940, may be considered an investment in the underlying&#160;palladium for
purposes of Code section 851(b), and (2) the extent to which an investment in Shares might nevertheless be consistent with preservation
of their qualification under Code section 851. In administrative guidance, the IRS stated that it will no longer issue rulings
under Code section 851(b) relating to the determination of whether or not an instrument or position is a &#8220;security&#8221;,
but, instead, intends to defer to guidance from the SEC for such determination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>United
States Information Reporting and Backup Withholding Tax for US and Non-US Shareholders </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee or the appropriate broker will file certain information returns with the IRS, and provides certain tax-related information
to Shareholders, in accordance with applicable Treasury Regulations. Each Shareholder will be provided with information regarding
its allocable portion of the Trust&#8217;s annual income (if any) and expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
US Shareholder may be subject to US backup withholding tax in certain circumstances unless it provides its taxpayer identification
number and complies with certain certification procedures. Non-US Shareholders may have to comply with certification procedures
to establish that they are not a US person in order to avoid the backup withholding tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of any backup withholding tax will be allowed as a credit against a Shareholder&#8217;s US federal income tax liability
and may entitle such a Shareholder to a refund, provided that the required information is furnished to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income
Taxation of Non-US Shareholders </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust does not expect to generate taxable income except for gains (if any) upon the sale of palladium. A Non-US Shareholder generally
is not subject to US federal income tax with respect to gains recognized upon the sale or other disposition of Shares, or upon
the sale of&#160;palladium by the Trust, unless (1) the Non-US Shareholder is an individual and is present in the United States
for 183 days or more during the taxable year of the sale or other disposition, and the gain is treated as being from United States
sources; or (2) the gain is effectively connected with the conduct by the Non-US Shareholder of a trade or business in the United
States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
in Jurisdictions other than the United States</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospective
purchasers of Shares that are based in or acting out of a jurisdiction other than the United States are advised to consult their
own tax advisers as to the tax consequences, under the laws of such jurisdiction (or any other jurisdiction not being the United
States to which they are subject), of their purchase, holding, sale and redemption of or any other dealing in Shares and, in particular,
as to whether any value added tax, other consumption tax or transfer tax is payable in relation to such purchase, holding, sale,
redemption or other dealing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a018"></span>ERISA
and Related Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), and/or Code section 4975 impose certain requirements
on certain employee benefit plans and certain other plans and arrangements, including individual retirement accounts and annuities,
Keogh plans, and certain commingled investment vehicles or insurance company general or separate accounts in which such plans
or arrangements are invested (collectively, &#8220;Plans&#8221;), and on persons who are fiduciaries with respect to the investment
of &#8220;plan assets&#8221; of a Plan. Government plans and some church plans are not subject to the fiduciary responsibility
provisions of ERISA or the provisions of section 4975 of the Code, but may be subject to substantially similar rules under other
federal law, or under state or local law (&#8220;Other Law&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
contemplating an investment of a portion of Plan assets in Shares, the Plan fiduciary responsible for making such investment should
carefully consider, taking into account the facts and circumstances of the Plan and the &#8220;Risk Factors&#8221; discussed above
and whether such investment is consistent with its fiduciary responsibilities under ERISA or Other Law, including, but not limited
to: (1) whether the investment is permitted under the Plan&#8217;s governing documents, (2) whether the fiduciary has the authority
to make the investment, (3) whether the investment is consistent with the Plan&#8217;s funding objectives, (4) the tax effects
of the investment on the Plan, and (5) whether the investment is prudent considering the factors discussed in this report. In
addition, ERISA and Code section 4975 prohibit a broad range of transactions involving assets of a plan and persons who are &#8220;parties
in interest&#8221; under ERISA or &#8220;disqualified persons&#8221; under section 4975 of the Code. A violation of these rules
may result in the imposition of significant excise taxes and other liabilities. Plans subject to Other Law may be subject to similar
restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that the Shares will constitute &#8220;publicly offered securities&#8221; as defined in the Department of Labor
&#8220;Plan Asset Regulations,&#8221; &#167;2510.3-101 (b)(2) as modified by section 3(42) of ERISA. Accordingly, pursuant to
the Plan Asset Regulations, only Shares purchased by a Plan, and not an interest in the underlying assets held in the Trust, should
be treated as assets of the Plan, for purposes of applying the &#8220;fiduciary responsibility&#8221; rules of ERISA and the &#8220;prohibited
transaction&#8221; rules of ERISA and the Code. Fiduciaries of plans subject to Other Law should consult legal counsel to determine
whether there would be a similar result under the Other Law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
by Certain Retirement Plans </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
section 408(m) provides that the acquisition of a &#8220;collectible&#8221; by an individual retirement account (&#8220;IRA&#8221;)
or a participant-directed account maintained under any plan that is tax-qualified under Code section 401(a) (&#8220;Tax Qualified
Account&#8221;) is treated as a taxable distribution from the account to the owner of the IRA, or to the participant for whom
the Tax Qualified Account is maintained, of an amount equal to the cost to the account of acquiring the collectible. The term
&#8220;collectible&#8221; is defined to include, with certain exceptions, &#8220;any metal or gem&#8221;. The IRS has issued several
private letter rulings to the effect that a purchase by an IRA, or by a participant-directed account under a Code section 401(a)
plan, of publicly-traded shares in a trust holding&#160;precious metals&#160;will not be treated as resulting in a taxable distribution
to the IRA owner or Tax Qualified Account participant under Code section 408(m). However the private letter rulings provide that,
if any of the Shares so purchased are distributed from the IRA or Tax Qualified Account to the IRA owner or Tax Qualified Account
participant, or if any&#160;precious metal is received by such IRA or Tax Qualified Account upon the redemption of any of the
Shares purchased by it, the Shares or&#160;precious metal&#160;so distributed will be subject to federal income tax in the year
of distribution, to the extent provided under the applicable provisions of Code sections 408(d), 408(m) or 402. Accordingly, potential
IRA or Tax Qualified Account investors are urged to consult with their own professional advisors concerning the treatment of an
investment in Shares under Code section 408(m).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a019"></span>Item
1A. Risk Factors </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
should consider carefully the risks described below before making an investment decision. Shareholders should also refer to the
other information included in this report, including the Trust&#8217;s financial statements and the related notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO PALLADIUM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
price of palladium may be affected by the sale of ETVs tracking the palladium markets.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.95pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent existing exchange traded vehicles (&#8220;ETVs&#8221;) tracking the palladium markets represent a significant proportion
of demand for physical palladium bullion, large redemptions of the securities of these ETVs could negatively affect physical palladium
bullion prices and the price and NAV of the Shares.&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Crises
may motivate large-scale sales of palladium which could decrease the price of palladium and adversely affect an investment in
the Shares.</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
possibility of large-scale distress sales of palladium in times of crisis may have a short-term negative impact on the price of
palladium and adversely affect an investment in the Shares. For example, the 2008 financial credit crisis resulted in significantly
depressed prices of palladium largely due to forced sales and deleveraging from institutional investors such as hedge funds and
pension funds as expectations of economic growth slumped. Crises in the future may impair palladium&#8217;s price performance
which would, in turn, adversely affect an investment in the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Several
factors may have the effect of causing a decline in the prices of palladium and a corresponding decline in the price of Shares.
Among them:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-right: 18.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         significant increase in palladium hedging activity by palladium producers. Should there
                                         be an increase in the level of hedge activity of palladium producing companies, it could
                                         cause a decline in world palladium prices, adversely affecting the price of the Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-right: 29.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         significant change in the attitude of speculators, investors and central banks towards
                                         palladium. Should the speculative community take a negative view towards palladium or
                                         central banking authorities determine to sell national palladium reserves, either event
                                         could cause a decline in world palladium prices, negatively impacting the price of the
                                         Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.55pt"></td><td style="width: 17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-right: 9.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         widening of interest rate differentials between the cost of money and the cost of palladium
                                         could negatively affect the price of palladium which, in turn, could negatively affect
                                         the price of the Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify; padding-right: 10.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         combination of rising money interest rates and a continuation of the current low cost
                                         of borrowing palladium could improve the economics of selling palladium forward. This
                                         could result in an increase in hedging by palladium mining companies and short selling
                                         by speculative interests, which would negatively affect the price of palladium. Under
                                         such circumstances, the price of the Shares would be similarly affected.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="padding-right: 21.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autocatalysts,
                                         automobile components that use palladium, accounted for approximately 83% of the net
                                         global demand in palladium in 2021. While the automotive sector in China and the US is
                                         showing signs of recovery, the European market is currently experiencing declining demand
                                         and, in certain cases, solvency concerns. Reduced automotive industry sales in Europe
                                         may result in a decline in autocatalyst demand.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.6pt"></td><td style="width: 17.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         decline in the global automotive industry may impact the price of palladium and affect
                                         the price of the Shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversely,
several factors may trigger a temporary increase in the price of palladium prior to your investment in the Shares. For example,
sudden increased investor interest in palladium may cause an increase in world palladium prices, increasing the price of the Shares.
If that is the case, you will be buying Shares at prices affected by the temporarily high prices of palladium, and you may incur
losses when the causes for the temporary increase disappear.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.25pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>A
decline in the automobile industry or a shift from gasoline-powered to electric vehicles may have the effect of causing a decline
in the price of palladium and a corresponding decline in the price of Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.25pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autocatalysts,
automobile components for emissions control that use palladium, accounted for approximately 83% of the global demand in palladium
in 2021. Reduced automotive industry sales or a shift from gasoline-powered to electric vehicles may result in a decline in autocatalyst
demand. A contraction in the global automotive industry or more widespread acceptance of electric vehicles may impact the price
of palladium and the price of Shares.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
value of the Shares relates directly to the value of the palladium held by the Trust and fluctuations in the price of palladium
could materially adversely affect an investment in the Shares.</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares are designed to mirror as closely as possible the performance of the price of palladium bullion, and the value of the Shares
relates directly to the value of the palladium held by the Trust, less the Trust&#8217;s liabilities (including estimated accrued
but unpaid expenses). The price of palladium has fluctuated widely over the past several years. Several factors may affect the
price of palladium, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
palladium supply, which is influenced by such factors as production and cost levels in major palladium-producing countries such as Russia
and South Africa.&#160;&#160;Recycling, autocatalyst demand, industrial demand, jewelry demand and investment demand are also important
drivers of palladium supply and demand. Sales of existing stockpiles of palladium have been a key source of supply in the past decade
and could potentially soon be exhausted, placing a higher burden on new mine supply;</span></p></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency
exchange rates;</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
rates;</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
and trading activities of hedge funds and commodity funds</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
or regional political, economic or financial events and situations; and</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"><td style="width: 22.6pt"></td><td style="width: 17.9pt">&#9679;</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant change in investor interest, including in response to online campaigns or other activities specifically targeting
investments in palladium.</span></td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, investors should be aware that there is no assurance that palladium will maintain its long-term value in terms of purchasing
power in the future. In the event that the price of palladium declines, the Sponsor expects the value of an investment in the
Shares to decline proportionately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO THE SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
sale of the Trust&#8217;s palladium to pay expenses not assumed by the Sponsor, or unexpected liabilities affecting the Trust,
at a time of low palladium prices could adversely affect the value of the Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee sells palladium held by the Trust to pay Trust expenses not assumed by the Sponsor on an as-needed basis irrespective
of then-current palladium prices. The Trust is not actively managed and no attempt will be made to buy or sell palladium to protect
against or to take advantage of fluctuations in the price of palladium. Consequently, the Trust&#8217;s palladium may be sold
at a time when the palladium price is low, resulting in the sale of more palladium than would be required if the Trust sold when
prices were higher. The sale of the Trust&#8217;s palladium to pay expenses not assumed by the Sponsor, or unexpected liabilities affecting
the Trust, at a time of low palladium prices could adversely affect the value of the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
value of the Shares will be adversely affected if the Trust is required to indemnify the Sponsor or the Trustee under the Trust
Agreement.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Trust Agreement, each of the Sponsor and the Trustee has a right to be indemnified from the Trust for any liability or expense
it incurs without gross negligence, bad faith, willful misconduct, willful malfeasance or reckless disregard on its part. That
means the Sponsor or the Trustee may require the assets of the Trust to be sold in order to cover losses or liability suffered
by it. Any sale of that kind would reduce the NAV of the Trust and the value of the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Shares may trade at a price which is at, above or below the NAV per Share and any discount or premium in the trading price relative
to the NAV per Share may widen as a result of non-concurrent trading hours between the NYSE Arca and London, Zurich and COMEX.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares may trade at, above or below the NAV per Share. The NAV per Share fluctuates with changes in the market value of the Trust&#8217;s
assets. The trading price of the Shares fluctuates in accordance with changes in the NAV per Share as well as market supply and
demand. The amount of the discount or premium in the trading price relative to the NAV per Share may be influenced by non-concurrent
trading hours between the NYSE Arca and the major palladium markets. While the Shares trade on the NYSE Arca until 4:00 p.m. New
York time, liquidity in the market for palladium is reduced after the close of the major world palladium markets, including London,
Zurich and the COMEX. As a result, during this time, trading spreads, and the resulting premium or discount on the Shares, may
widen.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>A
possible &#8220;short squeeze&#8221; due to a sudden increase in demand of Shares that largely exceeds supply may lead to price
volatility in the Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
may purchase Shares to hedge existing palladium exposure or to speculate on the price of palladium. Speculation on the price of
palladium may involve long and short exposures. To the extent aggregate short exposure exceeds the number of Shares available
for purchase (for example, in the event that large redemption requests by Authorized Participants dramatically affect Share liquidity),
investors with short exposure may have to pay a premium to repurchase Shares for delivery to Share lenders. Those repurchases
may in turn, dramatically increase the price of the Shares until additional Shares are created through the creation process. This
is often referred to as a &#8220;short squeeze.&#8221; A short squeeze could lead to volatile price movements in Shares that are
not directly correlated to the price of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchasing
activity in the palladium market associated with Basket creations or selling activity following Basket redemptions may affect
the price of palladium and Share trading prices. These price changes may adversely affect an investment in the Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasing
activity associated with acquiring the palladium required for deposit into the Trust in connection with the creation of Baskets
may temporarily increase the market price of palladium, which will result in higher prices for the Shares. Temporary increases
in the market price of palladium may also occur as a result of the purchasing activity of other market participants. Other market
participants may attempt to benefit from an increase in the market price of palladium that may result from increased purchasing
activity of palladium connected with the issuance of Baskets. Consequently, the market price of palladium may decline immediately
after Baskets are created. If the price of palladium declines, the trading price of the Shares may also decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
activity associated with sales of palladium withdrawn from the Trust in connection with the redemption of Baskets may temporarily
decrease the market price of palladium, which will result in lower prices for the Shares. Temporary decreases in the market price
of palladium may also occur as a result of the selling activity of other market participants. If the price of palladium declines,
the trading price of the Shares may also decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor is unable to ascertain whether the palladium price movements since the commencement of the Trust&#8217;s initial public
offering on January 8, 2010 were attributable to the Trust&#8217;s Basket creation and redemption process or independent metal
market forces or both. Nevertheless, the Trust and the Sponsor cannot assure Shareholders that future Basket creations or redemptions
will have no effect on the palladium metal prices and, consequently, Share trading prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Since
there is no limit on the amount of palladium that the Trust may acquire, the Trust, as it grows, may have an impact on the supply
and demand of palladium that ultimately may affect the price of the Shares in a manner unrelated to other factors affecting the
global market for palladium.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust Agreement places no limit on the amount of palladium the Trust may hold. Moreover, the Trust may issue an unlimited number
of Shares, subject to registration requirements, and thereby acquire an unlimited amount of palladium. The global market for palladium
is characterized by supply and demand constraints that are generally not present in the markets for other precious metals such
as gold and silver. From 2017 to 2021, world palladium mine supply averaged 6.7 million ounces, while world gross demand averaged
10.4 million ounces. If the amount of palladium acquired by the Trust is large enough in relation to global palladium supply and
demand, further in-kind creations and redemptions of Shares could have an impact on the supply and demand of palladium unrelated
to other factors affecting the global market for palladium. Such an impact could affect the price for palladium that would directly
affect the price at which Shares are traded on the Exchange or the price of future Baskets created or redeemed by the Trust.&#160;The
Trust and the Sponsor cannot provide Shareholders any assurance that increased metal holdings by the Trust in the future will
have no such long-term metal price impact thereby affecting Share trading prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Shares and their value could decrease if unanticipated operational or trading problems arise.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
may be unanticipated problems or issues with respect to the mechanics of the Trust&#8217;s operations and the trading of the Shares
that could have a material adverse effect on an investment in the Shares. In addition, although the Trust is not actively &#8220;managed&#8221;
by traditional methods, to the extent that unanticipated operational or trading problems or issues arise, the Sponsor&#8217;s
past experience and qualifications may not be suitable for solving these problems or issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Discrepancies,
disruptions or unreliability of the LME PM Fix could impact the value of the Trust&#8217;s palladium and the market price of the
Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee values the Trust&#8217;s palladium pursuant to the LME PM Fix. In the event that the LME PM Fix proves to be an inaccurate
benchmark, or the LME PM Fix varies materially from the prices determined by other mechanisms for valuing palladium, the value
of the Trust&#8217;s palladium and the market price of the Shares could be adversely impacted. Any future developments in the
LME PM Fix, to the extent it has a material impact on the LME PM Fix, could adversely impact the value of the Trust&#8217;s palladium
and the market price of the Shares. It is possible that electronic failures or other unanticipated events may occur that could
result in delays in the announcement of, or the inability of the benchmark to produce, the LME PM Fix on any given date. Furthermore,
any actual or perceived disruptions that result in the perception that the LME PM Fix is vulnerable to actual or attempted manipulation
could adversely affect the behavior of market participants, which may have an effect on the price of palladium. If the LME PM
Fix is unreliable for any reason, the price of palladium and the market price for the Shares may decline or be subject to greater
volatility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>If
the process of creation and redemption of Baskets encounters any unanticipated difficulties, the possibility for arbitrage transactions
intended to keep the price of the Shares closely linked to the price of palladium may not exist and, as a result, the price of
the Shares may fall.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the processes of creation and redemption of Shares (which depend on timely transfers of palladium to and by the Custodian) encounter
any unanticipated difficulties, potential market participants who would otherwise be willing to purchase or redeem Baskets to
take advantage of any arbitrage opportunity arising from discrepancies between the price of the Shares and the price of the underlying
palladium may not take the risk that, as a result of those difficulties, they may not be able to realize the profit they expect.
If this is the case, the liquidity of Shares may decline and the price of the Shares may fluctuate independently of the price
of palladium and may fall. Additionally, redemptions could be suspended for any period during which (1) the NYSE Arca is closed
(other than customary weekend or holiday closings) or trading on the NYSE Arca is suspended or restricted, or (2) an emergency
exists as a result of which delivery, disposal or evaluation of the palladium is not reasonably practicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
liquidity of the Shares may be affected by the withdrawal from participation of one or more Authorized Participants.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that one or more Authorized Participants having substantial interests in Shares or otherwise responsible for a significant
portion of the Shares&#8217; daily trading volume on the Exchange withdraw from participation, the liquidity of the Shares will
likely decrease which could adversely affect the market price of the Shares and result in Shareholders incurring a loss on their
investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholders
do not have the protections associated with ownership of shares in an investment company registered under the Investment Company
Act of 1940 or the protections afforded by the Commodity Exchange Act (&#8220;CEA&#8221;).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is not registered as an investment company under the Investment Company Act of 1940 and is not required to register under
such act. Consequently, Shareholders do not&#160;have the regulatory protections provided to investors in investment companies.
The Trust does not and will not hold or trade in commodity futures contracts, &#8220;commodity interests&#8221; or any other instruments
regulated by the CEA, as administered by the CFTC and the National Futures Association (&#8220;NFA&#8221;). Furthermore, the Trust
is not a commodity pool for purposes of the CEA and the Shares are not &#8220;commodity interests&#8221;, and neither the Sponsor
nor the Trustee is subject to regulation by the CFTC as a commodity pool operator or a commodity trading advisor in connection
with the Trust or the Shares. Consequently, Shareholders do not have the regulatory protections provided to investors in CEA-regulated
instruments or commodity pools operated by registered commodity pool operators or advised by registered commodity trading advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust may be required to terminate and liquidate at a time that is disadvantageous to Shareholders.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Trust is required to terminate and liquidate, such termination and liquidation could occur at a time which is disadvantageous
to Shareholders, such as when&#160;palladium prices are lower than the&#160;palladium prices at the time when Shareholders purchased
their Shares. In such a case, when the Trust&#8217;s&#160;palladium is sold as part of the Trust&#8217;s liquidation, the resulting
proceeds distributed to Shareholders will be less than if&#160;palladium prices were higher at the time of sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
lack of an active trading market for the Shares may result in losses on investment at the time of disposition of the Shares.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Shares are listed for trading on the NYSE Arca, it cannot be assumed that an active trading market for the Shares will develop
or be maintained. If an investor needs to sell Shares at a time when no active market for Shares exists, such lack of an active
market will most likely adversely affect the price the investor receives for the Shares (assuming the investor is able to sell
them).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholders
do not have the rights enjoyed by investors in certain other vehicles.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
interests in an investment trust, the Shares have none of the statutory rights normally associated with the ownership of shares
of a corporation (including, for example, the right to bring &#8220;oppression&#8221; or &#8220;derivative&#8221; actions). In
addition, the Shares have limited voting and distribution rights (for example, Shareholders do not have the right to elect directors
or approve amendments to the Trust Agreement and do not receive dividends).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>An
investment in the Shares may be adversely affected by competition from other methods of investing in palladium.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust competes with other financial vehicles, including traditional debt and equity securities issued by companies in the&#160;palladium
industry and other securities backed by or linked to palladium, direct investments in&#160;palladium and investment vehicles similar
to the Trust. Market and financial conditions, and other conditions beyond the Sponsor&#8217;s control, may make it more attractive
to invest in other financial vehicles or to invest in&#160;palladium directly, which could limit the market for the Shares and
reduce the liquidity of the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
amount of&#160;palladium represented by each Share will decrease over the life of the Trust due to the recurring deliveries of&#160;palladium
necessary to pay the Sponsor&#8217;s Fee in-kind and potential sales of&#160;palladium to pay in cash the Trust expenses not assumed
by the Sponsor. Without increases in the price of&#160;palladium sufficient to compensate for that decrease, the price of the
Shares will also decline proportionately over the life of the Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of&#160;palladium represented by each Share decreases each day by the Sponsor&#8217;s Fee. In addition, although the Sponsor
has agreed to assume all organizational and certain administrative and marketing expenses incurred by the Trust (the Trustee&#8217;s
monthly fee and out-of-pocket expenses, the Custodian&#8217;s fee and reimbursement of the Custodian&#8217;s expenses under the Custody Agreements,
Exchange listing fees, SEC registration fees, printing and mailing costs, audit fees and up to $100,000 per annum in legal expenses),
in exceptional cases certain Trust expenses may need to be paid by the Trust. Because the Trust does not have any income, it must
either make payments in-kind by deliveries of&#160;palladium (as is the case with the Sponsor&#8217;s Fee) or it must sell&#160;palladium
to obtain cash (as in the case of any exceptional expenses).&#160; The result of these sales of&#160;palladium and recurring deliveries
of&#160;palladium to pay the Sponsor&#8217;s Fee in-kind is a decrease in the amount of&#160;palladium represented by each Share.
New deposits of palladium, received in exchange for new Shares issued by the Trust, will not reverse this trend.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
decrease in the amount of&#160;palladium represented by each Share results in a decrease in each Share&#8217;s price even if the
price of&#160;palladium bullion does not&#160;change. To retain the Share&#8217;s original price, the price of&#160;palladium
must increase. Without that increase, the lesser amount of&#160;palladium represented by the Share will have a correspondingly
lower price. If this increase does not occur, or is not sufficient to counter the lesser amount of&#160;palladium represented
by each Share, Shareholders will sustain losses on their investment in Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
increase in Trust expenses not assumed by the Sponsor, or the existence of unexpected liabilities affecting the Trust, will require
the Trustee to sell larger amounts of palladium, and will result in a more rapid decrease of the amount of&#160;palladium represented
by each Share and a&#160;corresponding decrease in its value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS
RELATED TO THE CUSTODY OF PALLADIUM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust&#8217;s&#160;palladium may be subject to loss, damage, theft or restriction on access.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a risk that part or all of the Trust&#8217;s&#160;palladium could be lost, damaged or stolen. Access to the Trust&#8217;s&#160;palladium
could also be restricted by natural events (such as an earthquake) or human actions (such as a terrorist attack). Any of these
events may adversely affect the operations of the Trust and, consequently, an investment in the Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust&#8217;s lack of insurance protection and the Shareholders&#8217; limited rights of legal recourse against the Trust, the
Trustee, the Sponsor, the Custodian, the Zurich Sub-Custodian and any other sub-custodian exposes the Trust and its Shareholders
to the risk of loss of the Trust&#8217;s&#160;palladium for which no person is liable.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust does not insure its palladium. The Custodian maintains insurance with regard to its business on such terms and conditions
as it considers appropriate in connection with its custodial obligations and is responsible for all costs, fees and expenses arising
from the insurance policy or policies. The Trust is not a beneficiary of any such insurance and does not have the ability to dictate
the existence, nature or amount of coverage. Therefore, Shareholders cannot be assured that the Custodian maintains adequate insurance
or any insurance with respect to the&#160;palladium held by the Custodian on behalf of the Trust. In addition, the Custodian and
the Trustee do not require the Zurich Sub-Custodian or any other direct or indirect sub-custodians to be insured or bonded with
respect to their custodial activities or in respect of the&#160;palladium held by them on behalf of the Trust. Further, Shareholders&#8217;
recourse against the Trust, the Trustee and the Sponsor under New York law, the Custodian, the Zurich Sub-Custodian and any other
sub-custodian under English law, and any other sub-custodian under the law governing their custody operations is limited. Consequently,
a loss may be suffered with respect to the Trust&#8217;s&#160;palladium which is not covered by insurance and for which no person
is liable in damages.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Custodian&#8217;s limited liability under the Custody Agreements and English law may impair the ability of the Trust to recover
losses concerning its&#160;palladium and any recovery may be limited, even in the event of fraud, to the market value of the&#160;palladium
at the time the fraud is discovered.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability of the Custodian is limited under the Custody Agreements. Under the Custody Agreements between the Trustee and the Custodian
which establish the Trust&#8217;s unallocated&#160;palladium account (&#8220;Unallocated Account&#8221;) and the Trust&#8217;s
allocated&#160;palladium account (&#8220;Allocated Account&#8221;), the Custodian is only liable for losses that are the direct
result of its own negligence, fraud or willful default in the performance of its duties. Any such liability is further limited
to the market value of the&#160;palladium lost or damaged at the time such negligence, fraud or willful default is discovered
by the Custodian provided the Custodian notifies the Trust and the Trustee promptly after the discovery of the loss or damage.
Under each Authorized Participant Unallocated&#160;Bullion Account Agreement (between the Custodian and an Authorized Participant
establishing an Authorized Participant Unallocated Account), the Custodian is not contractually or otherwise liable for any losses
suffered by any Authorized Participant or Shareholder that are not the direct result of its own gross negligence, fraud or willful
default in the performance of its duties under such agreement, and in no event will its liability exceed the market value of the
balance in the Authorized Participant Unallocated Account at the time such gross negligence, fraud or willful default is discovered
by the Custodian. For any Authorized Participant Unallocated Bullion Account Agreement between an Authorized Participant and another
palladium clearing bank, the liability of the palladium clearing bank to the Authorized Participant may be greater or lesser than
the Custodian&#8217;s liability to the Authorized Participant described in the preceding sentence, depending on the terms of the
agreement. In addition, the Custodian will not be liable for any delay in performance or any non-performance of any of its obligations
under the Allocated Account Agreement, the Unallocated Account Agreement or the Authorized Participant Unallocated&#160;Bullion
Account Agreement by reason of any cause beyond its reasonable control, including acts of God, war or terrorism. As a result,
the recourse of the Trustee or a Shareholder, under English law, is limited. Furthermore, under English common law, the Custodian,&#160;the
Zurich Sub-Custodian, or any other sub-custodian will not be liable for any delay in the performance or any non-performance of
its custodial obligations by reason of any cause beyond its reasonable control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
obligations of the Custodian,&#160;the Zurich Sub-Custodian and any other sub-custodians are governed by English law, which may
frustrate the Trust in attempting to seek legal redress against the Custodian, the Zurich Sub-Custodian&#160;or any other sub-custodian
concerning its palladium.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Custodian under the Custody Agreements are, and the Authorized Participant Unallocated&#160;Bullion Account
Agreements may be, governed by English law. The Custodian has entered into arrangements with the Zurich Sub-Custodian and may
enter into arrangements with any other sub-custodians for the temporary custody of the Trust&#8217;s palladium, which arrangements
may also be governed by English law. The Trust is a New York common law trust. Any United States, New York or other court situated
in the United States may have difficulty interpreting English law (which, insofar as it relates to custody arrangements, is largely
derived from court rulings rather than statute),&#160;LPPM rules or the customs and practices in the London custody market. It
may be difficult or impossible for the Trust to sue&#160;the Zurich Sub-Custodian or any other sub-custodian in a United States,
New York or other court situated in the United States. In addition, it may be difficult, time consuming and/or expensive for the
Trust to enforce in a foreign court a judgment rendered by a United States, New York or other court situated in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Although
the relationship between the Custodian and the Zurich Sub-Custodian concerning the Trust&#8217;s allocated&#160;palladium is expressly
governed by English law, a court hearing any legal dispute concerning their arrangement may disregard that choice of law and apply
Swiss law, in which case the ability of the Trust to seek legal redress against&#160;the Zurich Sub-Custodian may be frustrated.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Zurich Sub-Custodian under its arrangement with the Custodian with respect to the Trust&#8217;s allocated&#160;palladium
is expressly governed by English law. Nevertheless, a court in the United States, England or Switzerland may determine that English
law should not apply and, instead, apply Swiss law to that arrangement. Not only might it be difficult or impossible for a United
States or English court to apply Swiss law to the Zurich Sub-Custodian&#8217;s arrangement, but application of Swiss law may, among
other things, alter the relative rights and obligations of the Custodian and the Zurich Sub-Custodian to the extent that a loss
to the Trust&#8217;s&#160;palladium may not have adequate or any legal redress. Further, the ability of the Trust to seek legal
redress against&#160;the Zurich Sub-Custodian may be frustrated by application of Swiss law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust may not have adequate sources of recovery if its&#160;palladium is lost, damaged, stolen or destroyed.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Trust&#8217;s&#160;palladium is lost, damaged, stolen or destroyed under circumstances rendering a party liable to the Trust,
the responsible party may not have the financial resources sufficient to satisfy the Trust&#8217;s claim. For example, as to a
particular event of loss, the only source of recovery for the Trust might be limited to the Custodian, the Zurich Sub-Custodian
or any other sub-custodian or, to the extent identifiable, other responsible third parties (e.g., a thief or terrorist), any of
which may not have the financial resources (including liability insurance coverage) to satisfy a valid claim of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholders
and Authorized Participants lack the right under the Custody Agreements to assert claims directly against the Custodian, the Zurich
Sub-Custodian, and any other sub-custodian.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Shareholders nor any Authorized Participant have a right under the Custody Agreements to assert a claim of the Trust against
the Custodian, the Zurich Sub-Custodian or any other sub-custodian. Claims under the Custody Agreements may only be asserted by
the Trustee on behalf of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Custodian is reliant on the Zurich Sub-Custodian for the safekeeping of all or a substantial portion of the Trust&#8217;s palladium.
Furthermore, the Custodian has limited obligations to oversee or monitor the Zurich Sub-Custodian. As a result, failure by any
Zurich Sub-Custodian to exercise due care in the safekeeping of the Trust&#8217;s palladium could result in a loss to the Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
generally trades on a loco London or loco Zurich basis whereby the physical palladium is held in vaults located in London or Zurich
or is transferred into accounts established in London or Zurich. The Custodian does not have a vault in Zurich and is reliant
on the Zurich Sub-Custodian for the safekeeping of all or a substantial portion of the Trust&#8217;s allocated palladium. Other
than obligations to (1) use reasonable care in appointing the Zurich Sub-Custodian, (2) require any Zurich Sub-Custodian to segregate
the palladium held by it for the Trust from any other palladium held by it for the Custodian and any other customers of the Custodian
by making appropriate entries in its books and records and (3) ensure that the Zurich Sub-Custodian provides confirmation to the
Trustee that it has undertaken to segregate the palladium held by it for the Trust, the Custodian is not liable for the acts or
omissions of the Zurich Sub-Custodian. Other than as described above, the Custodian does not undertake to monitor the performance
by the Zurich Sub-Custodian of its custody functions. The Trustee&#8217;s obligation to monitor the performance of the Custodian
is limited to receiving and reviewing the reports of the Custodian. The Trustee does not monitor the performance of the Zurich
Sub-Custodian or any other sub-custodian. In addition, the ability of the Trustee and the Sponsor to monitor the performance of
the Custodian may be limited because under the Custody Agreements, the Trustee and the Sponsor have only limited rights to visit
the premises of the Custodian or the Zurich Sub-Custodian for the purpose of examining the Trust&#8217;s palladium and certain
related records maintained by the Custodian or Zurich Sub-Custodian.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above, any failure by any Zurich Sub-Custodian to exercise due care in the safekeeping of the Trust&#8217;s palladium
may not be detectable or controllable by the Custodian, the Sponsor or the Trustee and could result in a loss to the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Custodian relies on its Zurich Sub-Custodian to hold the palladium allocated to the Trust Allocated Account and used to settle
redemptions. As a result, settlement of palladium in connection with redemptions loco London may require more than two business
days.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian is reliant on its Zurich Sub-Custodian to hold the palladium allocated to the Trust Allocated Account in order to effect
redemption of Shares. As a result, in the case for redemption orders electing palladium deliveries to be received loco London,
it may take longer than two business days for palladium to be credited to the Authorized Participant Unallocated Account, which
may result in a delay of settlement of the redemption order that is settled loco London.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Because
the Trustee does not, and the Custodian has limited obligations to, oversee or monitor the activities of sub-custodians who may
hold the Trust&#8217;s palladium, failure by the sub-custodians to exercise due care in the safekeeping of the Trust&#8217;s palladium
could result in a loss to the Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Allocated Account Agreement, the Custodian may appoint from time to time one or more sub-custodians to hold the Trust&#8217;s
palladium on a temporary basis pending delivery to the Custodian. The Custodian currently uses UBS AG for palladium. The Custodian may also use LPPM market-making members that provide bullion vaulting
and clearing services to third parties. The Custodian selects the Zurich Sub-Custodian, and
the Zurich Sub-Custodian maintains custody of all of the Trust&#8217;s allocated palladium to be held in Zurich for the Custodian.
The Custodian is required under the Allocated Account Agreement to use reasonable care in appointing the Zurich Sub-Custodian
and any other sub-custodians, making the Custodian liable only for negligence or bad faith in the selection of such sub-custodians,
and has an obligation to use commercially reasonable efforts to obtain delivery of the Trust&#8217;s palladium from any sub-custodians
appointed by the Custodian. Otherwise, the Custodian is not liable for the acts or omissions of its sub-custodians. These sub-custodians
may in turn appoint further sub-custodians, but the Custodian is not responsible for the appointment of these further sub-custodians.
The Custodian does not undertake to monitor the performance by sub-custodians of their custody functions or their selection of
further sub-custodians. The Trustee does not monitor the performance of the Custodian other than to review the reports provided
by the Custodian pursuant to the Custody Agreements and does not undertake to monitor the performance of any sub-custodian. Furthermore,
except for the Zurich Sub-Custodian, the Trustee may have no right to visit the premises of any sub-custodian for the purposes
of examining the Trust&#8217;s palladium or any records maintained by the sub-custodian, and no sub-custodian will be obligated
to cooperate in any review the Trustee may wish to conduct of the facilities, procedures, records or creditworthiness of such
sub-custodian. In addition, the ability of the Trustee to monitor the performance of the Custodian and the Zurich Sub-Custodian
may be limited because under the Allocated Account Agreement and the Unallocated Account Agreement the Trustee has only limited
rights to visit the premises of the Custodian and the Zurich Sub-Custodian for the purpose of examining the Trust&#8217;s palladium
and certain related records maintained by the Custodian and the Zurich Sub-Custodian.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
obligations of any sub-custodian of the Trust&#8217;s palladium are not determined by contractual arrangements but by LPPM rules
and London palladium market customs and practices, which may prevent the Trust&#8217;s recovery of damages for losses on its palladium
custodied with sub-custodians.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the Custodian&#8217;s arrangement with the Zurich Sub-Custodian, there are expected to be no written contractual arrangements
between sub-custodians that hold the Trust&#8217;s palladium and the Trustee or the Custodian because traditionally such arrangements
are based on the LPPM&#8217;s rules and on the customs and practices of the London bullion market. In the event of a legal dispute
with respect to or arising from such arrangements, it may be difficult to define such customs and practices. The LPPM&#8217;s
rules may be subject to change outside the control of the Trust. Under English law, neither the Trustee nor the Custodian would
have a supportable breach of contract claim against a sub-custodian for losses relating to the safekeeping of palladium. If the
Trust&#8217;s palladium is lost or damaged while in the custody of a sub-custodian, the Trust may not be able to recover damages
from the Custodian or the sub-custodian. Whether a sub-custodian will be liable for the failure of sub-custodians appointed by
it to exercise due care in the safekeeping of the Trust&#8217;s palladium will depend on the facts and circumstances of the particular
situation. Shareholders cannot be assured that the Trustee will be able to recover damages from sub-custodians whether appointed
by the Custodian or by another sub-custodian for any losses relating to the safekeeping of palladium by such sub-custodians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Palladium
bullion allocated to the Trust in connection with the creation of a Basket may not meet the London/Zurich Good Delivery Standards
and, if a Basket is issued against such palladium, the Trust may suffer a loss.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Trustee nor the Custodian independently confirms the fineness of the palladium allocated to the Trust in connection with the
creation of a Basket. The palladium bullion allocated to the Trust by the Custodian may be different from the reported fineness
or weight required by the LPPM&#8217;s standards for palladium plates or ingots delivered in settlement of a palladium trade (London/Zurich
Good Delivery Standards), the standards required by the Trust. If the Trustee nevertheless issues a Basket against such palladium,
and if the Custodian fails to satisfy its obligation to credit the Trust the amount of any deficiency, the Trust may suffer a
loss<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Palladium
held in the Trust&#8217;s unallocated palladium account and any Authorized Participant&#8217;s unallocated palladium account is
not segregated from the Custodian&#8217;s assets. If the Custodian becomes insolvent, its assets may not be adequate to satisfy
a claim by the Trust or any Authorized Participant. In addition, in the event of the Custodian&#8217;s insolvency, there may be
a delay and costs incurred in identifying the bullion held in the Trust&#8217;s allocated palladium account.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
which is part of a deposit for a purchase order or part of a redemption distribution is held for a time in the Trust Unallocated
Account and, previously or subsequently in, the Authorized Participant Unallocated Account of the purchasing or redeeming Authorized
Participant. During those times, the Trust and the Authorized Participant, as the case may be, have no proprietary rights to any
specific plates or ingots of palladium held by the Custodian and are each an unsecured creditor of the Custodian with respect
to the amount of palladium held in such unallocated accounts. In addition, if the Custodian fails to allocate the Trust&#8217;s
palladium in a timely manner, in the proper amounts or otherwise in accordance with the terms of the Unallocated Account Agreement,
or if a sub-custodian fails to so segregate palladium held by it on behalf of the Trust, unallocated palladium will not be segregated
from the Custodian&#8217;s assets, and the Trust will be an unsecured creditor of the Custodian with respect to the amount so
held in the event of the insolvency of the Custodian. In the event the Custodian becomes insolvent, the Custodian&#8217;s assets
might not be adequate to satisfy a claim by the Trust or the Authorized Participant for the amount of palladium held in their
respective unallocated palladium accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of the insolvency of the Custodian, a liquidator may seek to freeze access to the&#160;palladium held in all of the accounts
held by the Custodian, including the Trust Allocated Account. Although the Trust would be able to claim ownership of properly
allocated palladium, the Trust could incur expenses in connection with asserting such claims, and the assertion of such a claim
by the liquidator could delay creations and redemptions of Baskets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In
issuing Baskets, the Trustee relies on certain information received from the Custodian which is subject to confirmation after
the Trustee has relied on the information. If such information turns out to be incorrect, Baskets may be issued in exchange for
an amount of&#160;palladium which is more or less than the amount of&#160;palladium which is required to be deposited with the
Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian&#8217;s definitive records are prepared after the close of its business day. However, when issuing Baskets, the Trustee
relies on information reporting the amount of&#160;palladium credited to the Trust&#8217;s accounts which it receives from the
Custodian during the business day and which is subject to correction during the preparation of the Custodian&#8217;s definitive
records after the close of business. If the information relied upon by the Trustee is incorrect, the amount of&#160;palladium
actually received by the Trust may be more or less than the amount required to be deposited for the issuance of Baskets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL
RISKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust relies on the information and technology systems of the Trustee, the Custodian, the Marketing Agent and, to a lesser degree,
the Sponsor, which could be adversely affected by information systems interruptions, cybersecurity attacks or other disruptions
which could have a material adverse effect on the Trust&#8217;s record keeping and operations.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Custodian, the Trustee, the Marketing Agent and the Sponsor depend upon information technology infrastructure, including network,
hardware and software systems to conduct their business as it relates to the Trust. A cybersecurity incident, or a failure to
protect their computer systems, networks and information against cybersecurity threats, could result in a loss of information
and adversely impact their ability to conduct their business, including their business on behalf of the Trust. Despite implementation
of network and other cybersecurity measures, their security measures may not be adequate to protect against all cybersecurity
threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>War,
a major terrorist attack and other geopolitical events, including but not limited to the war between Russia and Ukraine, outbreaks
or public health emergencies (as declared by the World Health Organization), the continuation or expansion of war or other hostilities,
or a prolonged government shutdown may cause volatility in the price of Bullion due to the importance of a country or region to
the Bullion markets, market access restrictions imposed on some local Bullion producers and refiners, potential impacts to global
transportation and shipping and other supply chain disruptions. These events are unpredictable and may lead to extended periods
of price volatility.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of the Trust, the exchanges, brokers and counterparties with which the Trust does business, and the markets in which
the Trust does business, could be severely disrupted in the event of war, a major terrorist attack and other geopolitical events,
including but not limited to, the war between Russia and Ukraine, outbreaks or public health emergencies (as declared by the World
Health Organization), the continuation or expansion of war or other hostilities, or a prolonged government shutdown. Such events
may cause volatility in the price of Bullion due to the importance of a country or region to the Bullion markets, market access
restrictions imposed on some local Bullion producers and refiners, or potential impacts to global transportation, shipping, and
other supply chain disruptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
late February 2022, Russia invaded Ukraine, significantly amplifying already existing geopolitical tensions among Russia and other
countries in the region and in the West. The responses of countries and political bodies to Russia&#8217;s actions, the larger overarching
tensions, and Ukraine&#8217;s military response and the potential for wider conflict may increase financial market volatility generally,
have severe adverse effects on regional and global economic markets, and cause volatility in the price of palladium and the share price
of the Trust. The conflict in Ukraine, along with global political fallout and implications including sanctions, shipping disruptions,
collateral war damage, and a potential expansion of the conflict beyond Ukraine&#8217;s borders, could disturb the Bullion markets.
Russia is one of the world&#8217;s largest producers of gold, palladium, platinum and silver. On March 7, 2022, the LBMA suspended its
accreditation of six Russian refiners of gold and silver, and, on April 8, 2022, the LPPM suspended its accreditation of two Russian
refiners of platinum and palladium. The LBMA and LPPM each stated that existing bars produced by the refiners before their suspension
will still be accepted as good delivery. Following an announcement at the G7 Summit to collectively ban the import of Russian
gold, the UK passed regulations which prohibit the direct or indirect (i) import of gold that originated in Russia, (ii) acquisition
of gold that originated in Russia or is located in Russia and (iii) supply or delivery of gold that originated in Russia, all
after July 21, 2022. Similarly, US regulations prohibit the import of gold of Russian origin into the United States on or after
June 28, 2022 and EU regulations prohibit the direct or indirect import, purchase or transfer of gold if it originates in Russia
and has been exported from Russia after July 22, 2022. War and other geopolitical events in eastern Europe, including but not
limited to Russia and Ukraine, may cause volatility in commodity prices including precious metals prices. These events are unpredictable
and may lead to extended periods of price volatility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Trust as well as the Sponsor and its service providers are vulnerable to the effects of public health crises, including the ongoing
novel coronavirus pandemic.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic has caused major disruptions to economies and markets around the world, including the markets in which the Trust
invests, and which has and may continue to negatively impact the value of certain of the Trust&#8217;s investments. Although vaccines
for COVID-19 and variants thereof are becoming more widely available, the COVID-19 pandemic and impacts thereof may continue for
an extended period of time and may vary from market to market. To the extent the impacts of COVID-19 continue, the Trust may experience
negative impacts to its business that could exacerbate other risks to which the Trust is subject. Policy and legislative changes
in countries around the world are affecting many aspects of financial regulation, and governmental and quasi-governmental authorities
and regulators throughout the world have previously responded to serious economic disruptions with a variety of significant fiscal
and monetary policy changes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential
conflicts of interest may arise among the Sponsor or its affiliates and the Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conflicts
of interest may arise among the Sponsor and its affiliates, on the one hand, and the Trust and its Shareholders, on the other
hand. As a result of these conflicts, the Sponsor may favor its own interests and the interests of its affiliates over the Trust
and its Shareholders. As an example, the Sponsor, its affiliates and their officers and employees are not prohibited from engaging
in other businesses or activities, including those that might be in direct competition with the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a020"></span>Item
1B. Unresolved Staff Comments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a021"></span>Item
2. Properties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a022"></span>Item
3. Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a023"></span>Item
4. Mine Safety Disclosure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a024"></span>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a025"></span>Item
5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s Shares have been listed on the NYSE Arca under the symbol PALL since its initial public offering on January 8, 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set out the range of high and low closing prices for the Shares as reported for NYSE Arca transactions for each
of the quarters during the years ended December 31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year Ended December 31, 2022: Quarter Ended</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 69%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2022</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">295.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">169.33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">229.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">166.23</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">211.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">171.02</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">215.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">154.25</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year Ended December 31, 2021: Quarter Ended</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 69%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31, 2021</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">252.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">208.37</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">279.31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">231.17</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">267.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">172.75</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">204.67</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148.60</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of outstanding Share of the Trust as of February 23, 2023 was 1,925,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Monthly
Share Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, for each of the most recent six months, the high and low closing prices of the Shares, as reported
for NYSE Arca transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration: underline">Month</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 69%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2022</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">211.05</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">183.66</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">211.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184.35</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">215.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">171.63</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">194.87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">166.71</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">180.58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">154.25</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2023</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166.83</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149.68</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuer
Purchase of Equity Securities </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust issues and redeems Shares only with Authorized Participants in exchange for palladium, only in aggregations of 25,000 Shares,
referred to as a Basket. A list of current Authorized Participants is available from the Sponsor or the Trustee and is included
in Item 7 of this report. Although the Trust does not purchase Shares directly from its Shareholders, in connection with the redemption
of Baskets, the Trust redeemed as follows during the years ended December 31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration: underline">Month</span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total number of</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">Shares redeemed</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Average ounces</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">of palladium per Share</p></td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2022</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">125,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">0.093</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2022</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2022</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">75,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.093</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">775,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="text-decoration: underline">Month</span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total number of</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">Shares redeemed</p></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Average ounces of</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">palladium per Share</p></td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">January 2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#8212;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#8212;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">February 2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#8212;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#8212;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2021</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">0.093</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2021</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2021</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">100,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.093</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">575,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.093</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a026"></span>Item
7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
information should be read in conjunction with the financial statements and notes to the financial statements included with this
report. The discussion and analysis that follows may contain statements that relate to future events or future performance. In
some cases, such forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;should,&#8221;
&#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221;
&#8220;potential&#8221; or the negative of these terms or other comparable terminology. We remind readers that forward-looking
statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown
risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially
different from any future results, performance, levels of activity, or our achievements expressed or implied by such forward-looking
statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the
date hereof. The Trust undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Introduction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
abrdn Standard Palladium ETF Trust (the &#8220;Trust&#8221;) is a trust formed under the laws of the State of New York. The Trust
does not have any officers, directors, or employees, and is administered by The Bank of New York Mellon (the &#8220;Trustee&#8221;)
acting as trustee pursuant to the Depositary Trust Agreement (the &#8220;Trust Agreement&#8221;) between the Trustee and abrdn
ETFs Sponsor LLC, the sponsor of the Trust (the &#8220;Sponsor&#8221;). The Trust issues shares (&#8220;Shares&#8221;) representing
fractional undivided beneficial interests in its net assets. The assets of the Trust consist of palladium bullion held by a custodian
as an agent of the Trust and responsible only to the Trustee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is a passive investment vehicle and the objective of the Trust is for the value of each Share to approximately reflect,
at any given time, the price of the palladium bullion owned by the Trust, less the Trust&#8217;s liabilities (anticipated to be
principally for accrued operating expenses), divided by the number of outstanding Shares. The Trust does not engage in any activities
designed to obtain a profit from, or ameliorate losses caused by, changes in the price of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust issues and redeems Shares only in exchange for palladium, only in aggregations of 25,000 Shares effective April 1, 2019
(prior to April 1, 2019, the number of Shares that constituted a Basket was 50,000 Shares) or integral multiples thereof (each,
a &#8220;Basket&#8221;), and only in transactions with registered broker-dealers (or other securities market participants not
required to register as broker-dealers, such as a bank or other financial institution) that (1) are participants in DTC and (2)
have previously entered into an agreement with the Trust governing the terms and conditions of such issuance (such dealers, the
&#8220;Authorized Participants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this annual report the Authorized Participants that have signed an Authorized Participant Agreement with the Trust
are Credit Suisse Securities (USA) LLC, Goldman Sachs &amp; Co. LLC, HSBC Securities (USA) Inc., J.P. Morgan Securities LLC,
Merrill Lynch Professional Clearing Corp., Mizuho Securities USA LLC, Morgan Stanley &amp; Co. LLC, Scotia Capital (USA) Inc.,
UBS Securities LLC and Virtu Americas, LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of the Trust trade on the NYSE Arca under the symbol &#8220;PALL.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in the Shares does not insulate the investor from certain risks, including price volatility. The following table illustrates the
movement in the NAV of the Shares against the corresponding palladium price (per 1/10 of an oz. of palladium) since inception:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV
per Share vs. Palladium Price from December 30, 2009 (the Date of Inception) to December 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img src="pall-img002.jpg" alt="" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
divergence of the NAV per Share from the palladium price over time reflects the cumulative effect of the Trust expenses that arise
if an investment had been held since inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Critical
Accounting Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United
States of America. The preparation of these financial statements relies on estimates and assumptions that impact the Trust&#8217;s
financial position and results of operations. These estimates and assumptions affect the Trust&#8217;s application of accounting
policies. Below we describe the valuation of palladium bullion, a critical accounting policy that we believe is important to&#160;understanding
the&#160;results of operations and financial position. In addition, please refer to Note 2 to the Financial Statements for further
discussion of our&#160;accounting policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation
of Palladium </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
is held by JPMorgan Chase Bank, N.A. (the &#8220;Custodian&#8221;) on behalf of the Trust, at its London, England vaulting premises.
Palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold the Trust&#8217;s palladium in the Trust&#8217;s
allocated account in the firm&#8217;s Zurich vault premises and whose appointment has been approved by the Sponsor, at its Zurich,
Switzerland vaulting premises. Palladium is recorded at fair value. The cost of palladium is determined according to the average
cost method and the fair value is based on the LME PM Fix (the afternoon session of LME&#8217;s twice daily electronic price fixing
process). Realized gains and losses on transfers of palladium, or palladium distributed for the redemption of Shares, are calculated
on a trade date basis as the difference between the fair value and cost of palladium transferred<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2022&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2021&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2020&#160;</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left">Investment in palladium - cost</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">334,209</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">334,434</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">224,166</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Unrealized gain/(loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(38,571</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">23,727</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">132,258</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Investment in palladium - fair value</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">295,638</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">358,161</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">356,424</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inspection
of Palladium</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Custody Agreements, the Trustee, the Sponsor and the Trust&#8217;s auditors and inspectors may, only up to twice a year, visit
the premises of the Custodian and the Zurich Sub-Custodian for the purpose of examining the Trust&#8217;s&#160;palladium and certain
related records maintained by the Custodian. &#160;Under the Allocated Account Agreement, the Custodian agreed to procure similar
inspection rights from the Zurich Sub-Custodian. Any such inspection rights with respect to the Zurich Sub-Custodian are expected
to be granted in accordance with the normal course of dealing between the Custodian and the Zurich Sub-Custodian. Visits by auditors
and inspectors to the Zurich Sub-Custodian&#8217;s facilities will be arranged through the Custodian. Other than with respect
to the Zurich Sub-Custodian, the Trustee and the Sponsor have no right to visit the premises of any sub-custodian for the purposes
of examining the Trust&#8217;s&#160;palladium or any records maintained by the sub-custodian, and no sub-custodian is obligated
to cooperate in any review the Trustee or the Sponsor may wish to conduct of the facilities, procedures, records or creditworthiness
of such sub-custodian.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has exercised its right to visit the Custodian and the Zurich Sub-Custodian, in order to examine the palladium&#160;and
the records maintained by them. Inspections were conducted by Bureau Veritas Commodities UK Ltd, a leading commodity inspection
and testing company retained by the Sponsor, as of June 30, 2022 and December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no guarantee that the Sponsor or the Trust&#8217;s auditors and inspectors will be able to perform physical inspections
of the Trust&#8217;s&#160;palladium as planned. Local policies, regulations, or ordinances, as well as polices or restrictions
adopted by the Custodian or a sub-custodian, may temporarily prevent, or otherwise impair the ability of, the Sponsor or the Trust&#8217;s
auditors and inspectors, from performing a physical inspection of the Trust&#8217;s&#160;palladium on a desired date. In those
situations, the Sponsor or the Trust&#8217;s auditors and inspectors may seek to verify the palladium&#160;held by the Trust by
alternate means, including through virtual inspections of the Trust&#8217;s palladium and/or a review of pertinent records.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is not aware of any trends, demands, conditions, events or uncertainties that are reasonably likely to result in material
changes to its liquidity needs. In exchange for the Sponsor&#8217;s Fee, the Sponsor has agreed to assume most of the expenses
incurred by the Trust. As a result, the only expense of the Trust during the period covered by this report was the Sponsor&#8217;s
Fee. The Trust&#8217;s only source of liquidity is its transfers and sales of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trustee will, at the direction of the Sponsor or in its own discretion, sell the Trust&#8217;s&#160;palladium&#160;as necessary
to pay the Trust&#8217;s expenses not otherwise assumed by the Sponsor. The Trustee will not sell&#160;palladium to pay the Sponsor&#8217;s
Fee but will pay the Sponsor&#8217;s Fee through in-kind transfers of&#160;palladium to the Sponsor. At&#160;December 31, 2022
and 2021, the Trust did not have any cash balances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review
of Financial Results</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financial
Highlights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left">Total gain/(loss) on palladium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(58,254</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(70,471</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">62,621</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net change assets from operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(60,481</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(72,918</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">60,608</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by operating activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net asset value (&#8220;NAV&#8221;) of the Trust is obtained by subtracting the Trust&#8217;s expenses and liabilities on any day
from the value of the palladium owned by the Trust plus any palladium receivable on that day; the NAV per Share is obtained by
dividing the NAV of the Trust on a given day by the number of Shares outstanding on that day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
year ended December 31, 2022</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s NAV decreased from $357,971,468 at December 31, 2021 to $295,490,794 at December 31, 2022, a 17.45% decrease for
the year. The decrease in the Trust&#8217;s NAV resulted primarily from a decrease in outstanding shares, which fell from 1,950,000
at December 31, 2021 to 1,800,000 at December 31, 2022, a result of 625,000 Shares (25 baskets) being created and 775,000 Shares
(31 Baskets) being redeemed during the year. There was a decrease in the price per ounce of palladium, which fell 9.38% from $1,973.00
at December 31, 2021 to $1,775.00 at December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share decreased 10.58% from $183.58 at December 31, 2021 to $164.16 at December 31, 2022. The Trust&#8217;s NAV per Share
fell slightly more than the price per ounce of palladium on a percentage basis due to the Sponsor&#8217;s Fee, which was $2,226,662
for the year, or 0.60% of the Trust&#8217;s ANAV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share of $280.22 at March 7, 2022 was the highest during the year, compared with a low of $154.94 at December 20, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in net assets from operations for the year ended December 31, 2022 was $60,480,880, resulting from a realized gain of
$154,729 on the transfer of palladium to pay expenses and a realized gain of $3,889,466 on palladium distributed for the redemption
of Shares, offset by a change in unrealized loss on investment in palladium of $62,298,413 and the Sponsor&#8217;s Fee of $2,226,662.
Other than the Sponsor&#8217;s Fee, the Trust had no expenses during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
year ended December 31, 2021</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s NAV increased from $356,238,300 at December 31, 2020 to $357,971,468 at December 31, 2021, a 0.49% increase for
the year. The increase in the Trust&#8217;s NAV resulted primarily from an increase in outstanding shares, which rose from 1,625,000
at December 31, 2020 to 1,950,000 at December 31, 2021, a result of 900,000 Shares (36 baskets) being created and 575,000 Shares
(23 Baskets) being redeemed during the year. There was a decrease in the price per ounce of palladium, which fell 15.76% from
$2,342.00 at December 31, 2020 to $1,973.00 at December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share decreased 16.26% from $219.22 at December 31, 2020 to $183.58 at December 31, 2021. The Trust&#8217;s NAV per Share
fell slightly more than the price per ounce of palladium on a percentage basis due to the Sponsor&#8217;s Fee, which was $2,447,225
for the year, or 0.60% of the Trust&#8217;s ANAV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share of $280.24 at May 4, 2021 was the highest during the year, compared with a low of $146.68 at December 15, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in net assets from operations for the year ended December 31, 2021 was $72,918,240, resulting from a realized gain of
$742,787 on the transfer of palladium to pay expenses and a realized gain of $37,316,892 on palladium distributed for the redemption
of Shares, offset by a change in unrealized loss on investment in palladium of $108,530,694 and the Sponsor&#8217;s Fee of $2,447,225.
Other than the Sponsor&#8217;s Fee, the Trust had no expenses during the year ended December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
year ended December 31, 2020</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s NAV increased from $300,485,250 at December 31, 2019 to $356,238,300 at December 31, 2020, an 18.55% increase for
the year. The increase in the Trust&#8217;s NAV resulted primarily from an increase in the price per ounce of palladium, which
rose 22.94% from $1,905.00 at December 31, 2019 to $2,342.00 at December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was a decrease in outstanding Shares, which fell from 1,675,000 Shares at December 31, 2019 to 1,625,000 Shares at December 31,
2020, a result of 750,000 Shares (30 Baskets) being created and 800,000 Shares (32 Baskets) being redeemed during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share increased 22.20% from $179.39 at December 31, 2019 to $219.22 at December 31, 2020. The Trust&#8217;s NAV per Share
rose slightly less than the price per ounce of palladium on a percentage basis due to the Sponsor&#8217;s Fee, which was $2,012,865
for the year, or 0.60% of the Trust&#8217;s ANAV.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NAV per Share of $261.67 at February 19, 2020 was the highest during the year, compared with a low of $146.44 at March 16, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in net assets from operations for the year ended December 31, 2020 was $60,607,957, resulting from a realized gain of
$772,814 on the transfer of palladium to pay expenses, a realized gain of $60,188,024 on palladium distributed for the redemption
of Shares, a change in unrealized gain on investment in palladium of $1,659,984, offset by the Sponsor&#8217;s Fee of $2,012,865.
Other than the Sponsor&#8217;s Fee, the Trust had no expenses during the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Off-Balance
Sheet Arrangements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is not a party to any off-balance sheet arrangements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a027"></span>Item
7A. Quantitative and Qualitative Disclosures about Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust Agreement does not authorize the Trustee to borrow for payment of the Trust&#8217;s ordinary expenses. The Trust does not
engage in transactions in foreign currencies which could expose the Trust or holders of Shares to any foreign currency related
market risk. The Trust invests in no derivative financial instruments and has no foreign operations or long-term debt instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a028"></span>Item
8. Financial Statements and Supplementary Data <i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quarterly
Income Statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
Ended December 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic"></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September&#160;30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Amounts in 000&#8217;s
    of US$, except for Share and per Share data)</i></span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">EXPENSES</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-bottom: 1pt">Sponsor&#8217;s Fee</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">594</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">629</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">538</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">466</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">2,227</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">594</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">538</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,227</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net investment loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(594</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(629</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(538</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(466</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,227</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">REALIZED AND UNREALIZED GAINS / (LOSSES)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">155</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Realized gain / (loss) on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">439</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,430</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,889</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in unrealized gain on investment in Bullion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,908</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70,791</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,306</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62,298</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized gain on unsettled creations or redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,061</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,061</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total gain / (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,339</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(71,322</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">55,460</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(69,731</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58,254</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Change in net assets from operations</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">26,745</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">(71,951</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">54,922</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">(70,197</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">(60,481</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Net increase/(decrease) in net assets per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.67</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(35.53</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30.38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(40.24</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(32.12</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Weighted average number of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,956,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,025,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,807,609</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,744,565</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,882,740</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Year Ended December 31, 2021</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year ended</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic"></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September&#160;30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Amounts in 000&#8217;s
    of US$, except for Share and per Share data)</i></span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">EXPENSES</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; text-align: left; padding-bottom: 1pt">Sponsor&#8217;s Fee</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">563</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">679</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">649</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">556</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">2,447</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,447</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net investment loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(563</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(679</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(649</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(556</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,447</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">REALIZED AND UNREALIZED GAINS / (LOSSES)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Realized gain / (loss) on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,510</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,317</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in unrealized gain on investment in Bullion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(163,964</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,838</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(108,531</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized gain on unsettled creations or redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">159</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(159</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total gain / (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44,442</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,487</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(139,205</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,805</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(70,471</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2pt">Change in net assets from operations</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">43,879</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">11,808</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">(139,854</td><td style="padding-bottom: 2pt; text-align: left">)</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">11,249</td><td style="padding-bottom: 2pt; text-align: left">&#160;</td><td style="padding-bottom: 2pt">&#160;</td>
    <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">(72,918</td><td style="padding-bottom: 2pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left">Net increase/(decrease) in net assets per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">26.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(73.38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(39.95</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Weighted average number of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,651,389</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,774,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,905,978</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,964,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,825,342</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Note:
Quarterly balances may not add to totals due to independent rounding.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements required by Regulation S-X, together with the report of the Trust&#8217;s independent registered public accounting
firm appear on pages F-1 to F-13 of this filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a029"></span>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a030"></span>Item
9A. Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in its
Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange
Commission&#8217;s rules and forms, and that such information is accumulated and communicated to the Chief Executive Officer and
Chief Financial Officer of the Sponsor, and to the audit committee, as appropriate, to allow timely decisions regarding required
disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer of the Sponsor, the
Sponsor conducted an evaluation of the Trust&#8217;s disclosure controls and procedures, as defined under Exchange Act Rules 13a-15(e)
and 15d-15(e). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer of the Sponsor concluded
that, as of December 31, 2022, the Trust&#8217;s disclosure controls and procedures were effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal
controls over financial reporting have been maintained throughout the Trust&#8217;s fiscal year ended December 31, 2022. There
have been no changes that have materially affected, or are reasonably likely to materially affect, the Trust&#8217;s or Sponsor&#8217;s
internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management&#8217;s
Report on Internal Control over Financial Reporting </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor&#8217;s management is responsible for establishing and maintaining adequate internal control over financial reporting,
as defined under Exchange Act Rules 13a-15(f) and 15d-15(f). The Trust&#8217;s internal control over financial reporting is a
process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with accounting principles generally accepted in the United States. Internal control
over financial reporting includes those policies and procedures that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
                                         to the maintenance of records that, in reasonable detail, accurately and fairly reflect
                                         the transactions and dispositions of the Trust&#8217;s assets;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                         reasonable assurance that transactions are recorded as necessary to permit preparation
                                         of financial statements in accordance with generally accepted accounting principles,
                                         and that the Trust&#8217;s receipts and expenditures are being made only in accordance
                                         with appropriate authorizations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                         reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
                                         use, or disposition of the Trust&#8217;s assets that could have a material effect on
                                         the financial statements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become ineffective because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chief Executive Officer and Chief Financial Officer of the Sponsor assessed the effectiveness of the Trust&#8217;s internal control
over financial reporting as of December 31, 2021. In making this assessment, they used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (COSO) in <i>Internal Control&#8212;Integrated Framework (2013)</i>. Their
assessment included an evaluation of the design of the Trust&#8217;s internal control over financial reporting and testing of
the operational effectiveness of its internal control over financial reporting. Based on their assessment and those criteria,
the Chief Executive Officer and Chief Financial Officer of the Sponsor concluded that the Trust maintained effective internal
control over financial reporting as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KPMG
LLP, the independent registered public accounting firm that audited and reported on the financial statements included in this
Form 10-K, as stated in their report which is included herein, issued an attestation report on the effectiveness of the Trust&#8217;s
internal control over financial reporting as of December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 4.65pt 108.55pt 0 109.4pt; text-align: center">Report of Independent
Registered Public Accounting Firm</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 7.9pt 307.5pt 0 5.9pt">To the Sponsor, Trustee and Shareholders <br />
abrdn Palladium
ETF Trust:</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 5.9pt"><i>Opinion on Internal Control Over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.5pt 8.5pt 0 5.9pt">We have audited abrdn Palladium ETF Trust's (known as
Aberdeen Standard Palladium ETF Trust prior to March 31, 2022) (the Trust) internal control over financial reporting as of December 31,
2022, based on criteria established in <i>Internal Control &#8211; Integrated Framework (2013) </i>issued by the Committee of Sponsoring
Organizations of the Treadway Commission. In our opinion, the Trust maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2022, based on criteria established in <i>Internal Control &#8211; Integrated Framework (2013)
</i>issued by the Committee of Sponsoring Organizations of the Treadway Commission.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 4pt 0 5.9pt">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB), the statements of assets and liabilities of the Trust, including the
schedules of investments, as of December 31, 2022 and 2021, the related statements of operations and changes in net assets and the financial
highlights for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the financial
statements), and our report dated February 28, 2023 expressed an unqualified opinion on those financial statements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.9pt"><i>Basis for Opinion</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.4pt 6.8pt 0 5.9pt">The Trust&#8217;s management is responsible for maintaining
effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting,
included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express
an opinion on the Trust&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered
with the PCAOB and are required to be independent with respect to the Trust in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.35pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.75pt 0 5.9pt">We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing
and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing
such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.9pt"><i>Definition and Limitations of Internal Control Over Financial
Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.55pt 4.05pt 0 5.9pt">A company&#8217;s internal control over financial reporting
is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over
financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and
that receipts and expenditures of the</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 14.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 4.65pt 5.15pt 0 5.9pt; text-align: justify">company are being made only in
accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the
financial statements.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.3pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.9pt">Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.5in">/s/ KPMG LLP</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6.85pt 404.85pt 0 5.9pt">New York, New York <br />
February 28, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a031"></span>Item
9B. Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a032"></span>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a033"></span>Item
10. Directors, Executive Officers and Corporate Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust has no directors or executive officers. The biographies of the President and Chief Executive Officer of the Sponsor and
the Chief Financial Officer and Treasurer of the Sponsor are set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Steven
Dunn&#160;&#8211; President and Chief Executive Officer </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Dunn, CIMA&#174;, is the Head of Exchange Traded Funds at abrdn Inc.. Mr. Dunn guides the firm&#8217;s strategic direction and distribution
strategy for ETFs. Previously, he was a Director with Deutsche Asset and Wealth Management in charge of managing relationships
with US ETF Strategists and overseeing the Eastern Division sales team. Prior to that, Mr. Dunn was a consultant at Brandywine
Global Investment Management and has also held sales and distribution strategy positions at iShares, Blackrock and Vanguard. Mr.
Dunn holds a B.A. degree in Public Administration from Shippensburg University of Pennsylvania and has completed his MBA at Pennsylvania
State University. He holds the Series 7, 24, and 63 registrations as well as the Certified Investment Management Analyst&#174;
(CIMA&#174;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Andrea
Melia &#8211; Chief Financial Officer and Treasurer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Melia is Vice President and Senior Director of Product Management for abrdn Inc. Ms. Melia has managed the fund administration
team since joining&#160;abrdn Inc.&#160;in September 2009. Prior to joining abrdn Inc., Ms. Melia was Director of fund administration
and accounting oversight for Princeton Administrators LLC, a division of BlackRock Inc. and had worked with Princeton Administrators
since 1992. Ms. Melia holds a BS in Accounting from University of Scranton and a MBA from Rider University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0px"><b><i>Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0px">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brian Kordeck, age 44, joined abrdn Inc. (the parent company of the Sponsor) as a Senior Fund Administrator in 2013 and is currently a
Senior Product Manager with the company. Prior to joining abrdn Inc., Mr. Kordeck held financial reporting manager roles at the Bank of
New York Mellon and The Investment Fund for Foundations. Mr. Kordeck began his career as an auditor with PricewaterhouseCoopers LLP, focusing
on the investment management industry. Mr. Kordeck holds a BS in Business Administration from La Salle University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described under Item 1 above,&#160;abrdn Inc.&#160;is the parent of the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a034"></span>Item
11. Executive Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust has no directors or executive officers. The only ordinary expense paid by the Trust is the Sponsor&#8217;s Fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a035"></span>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Security
Ownership of Certain Beneficial Owners</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no persons known by the Trust to own directly or indirectly beneficially more than 5% of the outstanding Shares of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Security
Ownership of Management </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in Control </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Sponsor nor the Trustee knows of any arrangements which may subsequently result in a change in control of the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a036"></span>Item
13. Certain Relationships and Related Transactions, and Director Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust has no directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a037"></span>Item
14. Principal Accounting Fees and Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees
for services performed by <span id="xdx_906_edei--AuditorName_c20220101__20221231_zad8cruEerFj"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorName">KPMG LLP</ix:nonNumeric></span> for the years ended December 31, 2022 and 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--AuditorLocation_c20220101__20221231_z3eruAf7EGAi"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorLocation">New
York, NY</ix:nonNumeric></span> Auditor ID: <span id="xdx_904_edei--AuditorFirmId_c20220101__20221231_z3RQzzMawXXg"><ix:nonNumeric contextRef="From2022-01-01to2022-12-31" name="dei:AuditorFirmId">185</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2022</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2021</b></td><td><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Audit fees &#8211; KPMG</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">77,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">77,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Audit related fees - KPMG</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
Fees are fees paid by the Sponsor to KPMG LLP for professional services for the audit of the Trust&#8217;s financial statements
included in the Form 10-K and review of financial statements included in the Form 10-Qs, and for services that are normally provided
by the accountants in connection with regulatory filings or engagements. Audit Related Fees are paid by the Sponsor to KPMG LLP
for assurance and related services that are reasonably related to the performance of the audit or review of the Trust&#8217;s
financial statements. These services include the accountant providing a consent letter related to the Trust&#8217;s registration statement
filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Approval
Policies and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
referenced in Item 10 above, the Trust has no board of directors, and as a result, has no pre-approval policies or procedures
with respect to fees paid to KPMG LLP. Such determinations are made by the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a039"></span>Item
15. Exhibits, Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Index to Financial Statements on Page F-1 for a list of the financial statements being filed herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
Financial Statement Schedules </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
have been omitted since they are either not required, not applicable, or the information has otherwise been included.&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c58962_ex4-1.htm">Depositary
    Trust Agreement, incorporated by reference to Exhibit 4.1 filed with Registration Statement No. 333-158380 on December 31,
    2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000138713118005304/ex4-1.htm" title="pall-20191231xex4_1b.htm">Amendment
    to the Depositary Trust Agreement effective September 20, 2018, incorporated by reference to Exhibit 4.1 filed with the Trust&#8217;s
    Current Report on&#160;&#160;Form 8-K on October 5, 2018</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000145986217000021/pall-20170930xex4_2.htm">Form
    of Authorized Participant Agreement, effective as of September 5, 2017, incorporated by reference to Exhibit 4.2 filed with
    the Trust&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c58962_ex4-3.htm">Certificate
    of Beneficial Interest, incorporated by reference to Exhibit 4.3 filed with Registration Statement No. 333-158380 on December
    31, 2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c58962_ex10-1.htm">Allocated
    Account Agreement, incorporated by reference to Exhibit 10.1 filed with Registration Statement No. 333-158380 on December
    31, 2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000138713118005304/ex10-1.htm">Amendment
    to the Allocated Account Agreement effective October 1, 2018, incorporated by reference to Exhibit 10.1 filed with the Trust&#8217;s
    Current Report on Form 8-K on October 5, 2018</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000138713120004570/ex10-1c.htm">Second
    amendment to the Allocated Account Agreement effective May 7, 2020, incorporated by reference to Exhibit 10.1(c) filed with
    Registration Statement No. 333-238125 on May 8, 2020</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c58962_ex10-2.htm">Unallocated
    Account Agreement, incorporated by reference to Exhibit 10.2 filed with Registration Statement No. 333-158380 on December
    31, 2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000138713118005304/ex10-2.htm">Amendment
    to the Unallocated Account Agreement, incorporated by reference to Exhibit 10.2 filed with the Trust&#8217;s Current Report
    on Form 8-K on October 5, 2018</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2(c)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000138713120004570/ex10-2c.htm">Second
    amendment to the Unallocated Account Agreement effective May 7, 2020, incorporated by reference to Exhibit 10.2(c) filed with
    Registration Statement No. 333-238125 on May 8, 2020</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c57028_ex10-3.htm">Depository
    Agreement, incorporated by reference to Exhibit 10.3 filed with Registration Statement No. 333-158380 on December 31, 2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4(a)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000093041309006538/c58962_ex10-4.htm">Marketing
    Agent Agreement, incorporated by reference to Exhibit 10.4 filed with Registration Statement No. 333-158380 on December 31,
    2009</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4(b)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1459862/000145986219000002/pall-20181231xex10_4b.htm">Novation
    of and Amendment No. 1 to the Marketing Agent Agreement effective as of October 1, 2018</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of KPMG LLP, Independent Registered Public Accounting Firm</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="text-align: justify"><a href="ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer&#8217;s Certificate, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002&#160;&#160;</span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="text-align: justify"><a href="ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer&#8217;s Certificate, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002&#160;&#160;</span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Chief Executive Officer&#8217;s Certificate, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a>&#160;&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Chief Financial Officer&#8217;s Certificate, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a>&#160;&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td style="text-align: justify; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial
    statements from the Trust&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, formatted in Inline XBRL:
    (i) Statements of Assets and Liabilities, (ii) Statements of Operations, (iii) Statements of Changes in Net Assets, and (iv)
    Notes to the Financial Statements.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Schema Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Calculation Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Definitions Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Labels Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy
    Extension Presentation Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cover page from
    the Trust&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, formatted in Inline XBRL (included as Exhibit
    101).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="pall10k123122a040"></span>Item
16. Form 10-K Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABRDN
PALLADIUM ETF TRUST</b><br />
<b>FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022</b><br />
<b>INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Assets and Liabilities at December 31, 2022 and 2021</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-3</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
    of Investments at December 31, 2022 and 2021</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Operations for the years ended December 31, 2022, 2021 and 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Changes in Net Assets for the years ended December 31, 2022, 2021 and 2020 </span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Highlights for the years ended December 31, 2022, 2021 and 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="#pall10k123122b007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Financial Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 4.65pt 108.55pt 0 109.4pt; text-align: center"><span id="pall10k123122b001"></span>Report of Independent
Registered Public Accounting Firm</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 7.9pt 307.5pt 0 0">To the Sponsor, Trustee and Shareholders <br />
abrdn Palladium
ETF Trust:</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0"><i>Opinion on the Financial Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.5pt 4.9pt 0 0">We have audited the accompanying statements of assets and
liabilities of abrdn Palladium ETF Trust (known as Aberdeen Standard Palladium ETF Trust prior to March 31, 2022) (the Trust), including
the schedules of investments, as of December 31, 2022 and 2021, the related statements of operations and changes in net assets and the
financial highlights for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the
financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the
Trust as of December 31, 2022 and 2021, and the results of its operations, changes in its net assets and financial highlights for each
of the years in the three-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 6.25pt 0 0">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB), the Trust&#8217;s internal control over financial reporting as of December
31, 2022, based on criteria established in <i>Internal Control &#8211; Integrated Framework (2013) </i>issued by the Committee of Sponsoring
Organizations of the Treadway Commission, and our report dated February 28, 2023 expressed an unqualified opinion on the effectiveness
of the Trust&#8217;s internal control over financial reporting.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Basis for Opinion</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.45pt 0 0">These financial statements are the responsibility of the Trust&#8217;s
management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting
firm registered with the PCAOB and are required to be independent with respect to the Trust in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 9.6pt 0 0">We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.55pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Critical Audit Matter</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.55pt 5.7pt 0 0">The critical audit matter communicated below is a matter
arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee
and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging,
subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the financial
statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical
audit matter or on the accounts or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.55pt 5.7pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 4.65pt 0 0"><i>Evaluation of the evidence pertaining to the existence of the
palladium holdings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 5.4pt 4pt 0 0">As presented on the December 31, 2022 schedule of investments
and in Note 2.2, the fair value of the Trust&#8217;s investment in palladium is $295,638 thousand, representing 100.05% of the Trust&#8217;s
net assets, and 166,556 ounces of palladium holdings. The investment in palladium was held by a third-party custodian or sub-custodian
(collectively, the custodian).</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.45pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 4.9pt 0 0">We identified the evaluation of the evidence pertaining
to the existence of the palladium holdings as a critical audit matter. Given the nature and volume of the palladium holdings, subjective
auditor judgment was required to evaluate the extent and nature of evidence obtained to assess the existence of palladium held by the
custodian.</p>

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0.35pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 4pt 0 0">The following are the primary procedures we performed to address
this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the
critical audit matter. This included controls over (1) the comparison of the Trust&#8217;s records of palladium held to the custodian&#8217;s
records, (2) the approval of palladium deposits and withdrawals by the trustee of the Trust and (3) the physical counts of the Trust&#8217;s
palladium holdings performed at the custodian&#8217;s locations by a third party engaged by the Trust&#8217;s sponsor. We obtained a schedule
directly from the custodian of the Trust&#8217;s palladium holdings held by the custodian as of December 31, 2022. We compared the total
ounces on such schedule to the Trust&#8217;s record of palladium holdings. We also attended and observed a part of the physical counts
of the Trust&#8217;s palladium holdings. We obtained and read the physical counts results reports of the third party and reconciled those
reports to both the Trust&#8217;s and custodian&#8217;s records.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 3.5in">/s/ KPMG LLP</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0.15pt 0 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 256.75pt 0 0">We have served as the Trust&#8217;s auditor since 2015. <br />
<br />
New
York, New York</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0">February 28, 2023</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->














<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>abrdn
Palladium ETF Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="pall10k123122b002"></span>Statements
of Assets and Liabilities&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2022&#160;and 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_pn3n3_zJJNpuFyt47f" summary="xdx: Statement - Statements of Assets and Liabilities" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231_zAvMudeuITa3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20211231_zPuA405rV9Bc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><i>(Amounts in 000&#8217;s of US$, except for Share and per Share data)</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zfBshUMPE1G1" style="vertical-align: bottom">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--InvestmentInPhysicalCommodities_i01I_maAzNsz_z9ftxedW3BD5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-bottom: 1pt">Investment in palladium (cost: December 31, 2022: $<span id="xdx_900_eus-gaap--InvestmentOwnedAtCost_iI_c20221231_zijdVdTNZVEb" title="Investment in palladium at cost"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,209</ix:nonFraction></span>; December 31, 2021: $<span id="xdx_900_eus-gaap--InvestmentOwnedAtCost_iI_c20211231_zujPnhAesYij"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,434</ix:nonFraction></span>)</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--Assets_i01TI_mtAzNsz_maANzH4c_zsEIXIDqzZG7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--LiabilitiesAbstract_iB_zDHY7jtlNnq8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fees payable to Sponsor</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AccountsPayableRelatedPartiesCurrent_i01I_pn3n3_maLzQZy_c20221231_z1bbhcy73AW5" title="Fees payable to Sponsor" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AccountsPayableRelatedPartiesCurrent_i01I_pn4n3_c20211231_z09CaGUJTBeh" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-4" scale="3" unitRef="USD">190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtLzQZy_msANzH4c_zXU1GCurKWWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AssetsNet_iTI_mtANzH4c_zT4HuoT0KLhf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NET ASSETS<sup id="xdx_F40_zoLlORtT2aF8">(1)</sup></b></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-12-31" id="Fact000070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,491</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357,971</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 3%"><span id="xdx_F04_zMlnvncMmoa1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="vertical-align: bottom; width: 97%"><span id="xdx_F19_zn4K9Bf3U665" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000072" xml:lang="en-US">Authorized
    share capital is <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20220101__20221231_z7eyZpVVt1pd" title="Common stock, shares authorized::XDX::Unlimited"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20210101__20211231_zVrHC2cowuCj" title="::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0074"><span style="-sec-ix-hidden: xdx2ixbrl0075">unlimited</span></span></span></span> with <span id="xdx_90E_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20221231_zrgnOraAZenk" title="Common stock, no par value (in dollars per share)"><span id="xdx_908_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20211231_zcBNPMoO3Nm5"><ix:nonFraction name="us-gaap:CommonStockNoParValue" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockNoParValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="USDPShares">no</ix:nonFraction></ix:nonFraction></span></span> par value per Share. Shares issued and outstanding at December 31, 2022 were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zI71TChXSDha" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zsgDKQ89FR91" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800,000</ix:nonFraction></ix:nonFraction></span></span>
    and at December 31, 2021 were <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zeK3V8mFcFP8"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zkvXQs821sIb"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,950,000</ix:nonFraction></ix:nonFraction></span></span>. Net asset values per Share at December 31, 2022 and December 31, 2021 were $<span id="xdx_90C_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20221231_zSmno3ZdzZv3" title="Net asset value per share (in dollars per share)"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">164.16</ix:nonFraction></span>
    and $<span id="xdx_90F_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20211231_zWGkOMZkRWs6"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">183.58</ix:nonFraction></span>, respectively.</ix:footnote></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
Notes to the Financial Statements</i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Options: NewSection; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>abrdn
Palladium ETF Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
of Investments&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="pall10k123122b003"></span>At
December 31, 2022 and 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_111_pn3n3_zk7FEIfesL0k" summary="xdx: Statement - Schedules of Investments" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black thin solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">oz</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Net Assets</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment in palladium</b> <i>(in 000&#8217;s of US$, except for oz and percentage data)</i></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; padding-bottom: 1pt">Palladium</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iI_pp1p0_uOZ_c20221231__srt--CurrencyAxis__currency--XPD_zv2YjhNFvhJ6" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2022-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">166,556.4</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtCost_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--XPD_zjtXdoN1Qfub" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2022-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,209</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--XPD_zLiCdDMSOOT7" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2022-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pid_dp_uPure_c20221231__srt--CurrencyAxis__currency--XPD_zxQhar6aWtwa" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2022-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.05</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total investment in palladium</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iI_pp1p0_uOZ_c20221231_ztiGGYU5Spib" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">166,556.4</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtCost_iI_pn3n3_c20221231_zRBGH9bqa245" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,209</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--InvestmentOwnedAtFairValue_iI_c20221231_zImxt9wTUpf6" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pid_dp_uPure_c20221231_zVCerJ7bNDF3" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.05</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--NonInvestmentAssetsLessNonInvestmentLiabilities_iI_pn3n3_c20221231_zvPIfmX4Uwge" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_iI_pid_dp_uPure_c20221231_zfliREX10bD" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.05</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsNet_iI_pn3n3_c20221231_z6k0KjiSq96c" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,491</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98F_ecustom--NetAssetsPercentageOfNetAssets_iI_pid_dp_uPure_c20221231_zMnv0NTAayz5" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="pall:NetAssetsPercentageOfNetAssets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black thin solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">oz</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Net Assets</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment in palladium</b> <i>(in 000&#8217;s of US$, except for oz and percentage data)</i></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; padding-bottom: 1pt">Palladium</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iI_pp1p0_uOZ_c20211231__srt--CurrencyAxis__currency--XPD_zUB0S8Khtvm3" title="Investment in palladium" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2021-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">181,531.1</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--InvestmentOwnedAtCost_iI_pn3n3_c20211231__srt--CurrencyAxis__currency--XPD_zOZeQVFlvxxc" title="Cost" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,434</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20211231__srt--CurrencyAxis__currency--XPD_zLbUKPebOKXj" title="Fair Value" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2021-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pid_dp_uPure_c20211231__srt--CurrencyAxis__currency--XPD_zujP0vlZvG6a" title="% of Net Assets" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2021-12-31_currency_XPD" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.05</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total investment in palladium</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iI_pp1p0_uOZ_c20211231_zbkBjCI6YVS" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">181,531.1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtCost_iI_pn3n3_c20211231_zJokZ8yLesV1" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtCost" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">334,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231_zkJ8if1abHPe" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_pid_dp_uPure_c20211231_zgiw9fE2RJx9" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.05</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NonInvestmentAssetsLessNonInvestmentLiabilities_iI_pn3n3_c20211231_zXkTrGZ70aLc" title="Less liabilities" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_iI_pid_dp_uPure_c20211231_zb8bQpfCvFrg" title="Less liabilities, % of Net Assets" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.05</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_pn3n3_c20211231_zX9OaAdemLrk" title="Net Assets" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357,971</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_ecustom--NetAssetsPercentageOfNetAssets_iI_pid_dp_uPure_c20211231_zOgmSvk5YeXg" title="Net Assets, % of Net Assets" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="pall:NetAssetsPercentageOfNetAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
Notes to the Financial Statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>abrdn
Palladium ETF Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="pall10k123122b004"></span>Statements
of Operations&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2022, 2021, and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_113_pn3n3_zovANfVs4mYk" summary="xdx: Statement - Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z5onar2Hr1re" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20210101__20211231_z0wh6uRtttwf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20200101__20201231_za8Ws42CN55f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><i>(Amounts in 000&#8217;s of US$, except for Share and per Share data)</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--ExpensesAbstract_iB_zwptsgdYqCB3" style="vertical-align: bottom">
    <td style="font-weight: bold">EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--SponsorFees_i01_maCzRS2_zKKGClv3Bkcg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-bottom: 1pt">Sponsor&#8217;s Fee</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,227</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,447</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,013</ix:nonFraction></td><td style="width: 1%; text-align: left; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingExpenses_i01T_mtCzRS2_msCz293_zYJljXUOJCfl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,447</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,013</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--NetInvestmentGainLoss_iT_maCzFjM_mtCz293_zwa6IiLfNN5g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net investment loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,447</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,013</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NonoperatingGainsLossesAbstract_iB_zmY2e51sbDVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">REALIZED AND UNREALIZED GAINS / (LOSSES)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_i01_maCzbyB_z258HXGFxgyh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">773</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_i01_maCzbyB_zE7197t2rnqa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,889</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,317</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,188</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_i01_maCzbyB_zywafieZcGLa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized gain / (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62,298</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108,531</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--TotalGainLossOnBullion_i01T_maCzFjM_mtCzbyB_zOfVvZkTNp78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total gain / (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:TotalGainLossOnBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58,254</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:TotalGainLossOnBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70,471</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="pall:TotalGainLossOnBullion" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,621</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_mtCzFjM_zdX8OKKCJ4Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Change in net assets from operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">60,481</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">72,918</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_zQncwDjRxrCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net increase / (decrease) in net assets per Share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">32.12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">39.95</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.51</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pp0p0_zZXTrjyjMPti" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Weighted average number of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,882,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,825,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,615,779</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
Notes to the Financial Statements&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>abrdn
Palladium ETF Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="pall10k123122b005"></span>Statements
of Changes in Net Assets&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2022, 2021 and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_114_pn3n3_ziOmZzDc5hNc" summary="xdx: Statement - Statements of Changes in Net Assets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td><i>(Amounts in 000&#8217;s of US$, except for Share data)</i></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%">Opening balance at January 1, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_uShares_c20220101__20221231_zMO2pzmfIIgh" title="Opening balance (in shares)" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,950,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231_zhQ3YZQpPj96" title="Opening balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357,971</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--NetInvestmentGainLoss_pn3n3_c20220101__20221231_z5uWmHOooVha" title="Net investment loss" style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,227</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20220101__20221231_zZFwI2Qpnxvd" title="Realized gain on investment in palladium" style="text-align: right"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,044</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in unrealized (loss) on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_c20220101__20221231_zaWTvCL5UM8h" title="Change in unrealized (loss)/gain on investment in palladium" style="text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62,298</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20221231_zl1QoPvQwfhj" title="Creations (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20220101__20221231_zMOM7cZPI5xi" title="Creations" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145,623</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_pid_di_uShares_c20220101__20221231_zD4GuPaCNrM5" title="Redemptions (in shares)" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">775,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_iN_pn3n3_di_c20220101__20221231_zVMbDwBOBS9k" title="Redemptions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,622</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Closing balance at December 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_pid_uShares_c20220101__20221231_zgKaDD99ezb" title="Closing balance (in Shares)" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_c20220101__20221231_zNKOmT14jwN8" title="Closing balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,491</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Shares</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td><i>(Amounts in 000&#8217;s of US$, except for Share data)</i></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%">Opening balance at January 1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_uShares_c20210101__20211231_zvN29jKNs9Kk" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,625,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20210101__20211231_zY56spoSft0d" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">356,238</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--NetInvestmentGainLoss_pn3n3_c20210101__20211231_z1IqFGlB1GT9" style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,447</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20211231_zaczjPE153me" style="text-align: right"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,060</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in unrealized (loss) on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_c20210101__20211231_zGSG852td7qk" style="text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108,531</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231_zALrKUO7d0Sh" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20210101__20211231_zu9eIXqYQyW9" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205,730</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_pid_di_uShares_c20210101__20211231_zb0kJfeYOyg1" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">575,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_iN_pn3n3_di_c20210101__20211231_zUv6bvS32e47" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131,079</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Closing balance at December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_uShares_c20210101__20211231_zZfOWy16ewbd" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,950,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iE_c20210101__20211231_zUyJuvfJVY7b" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">357,971</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares<b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Amount</b></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td><i>(Amounts in 000&#8217;s of US$, except for Share data)</i></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%">Opening balance at January 1, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_uShares_c20200101__20201231_zzkedkFiOyQa" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,675,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20200101__20201231_zGMslqc9txjh" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300,485</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--NetInvestmentGainLoss_pn3n3_c20200101__20201231_z9qZIGM7BK22" style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentGainLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,013</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20201231_zYy077bpBsak" style="text-align: right"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,961</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in unrealized gain on investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_c20200101__20201231_zD562EyPTBGj" style="text-align: right"><ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200101__20201231_z2Np3HcN0sAk" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20200101__20201231_zG4myGz7S58a" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_pid_di_uShares_c20200101__20201231_zK80pZF2J6K7" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_iN_pn3n3_di_c20200101__20201231_z9JDdM93Lmc8" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155,805</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Closing balance at December 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_uShares_c20200101__20201231_znbm1qsRWHdh" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,625,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--StockholdersEquity_iE_c20200101__20201231_zGrOOSQGeOkj" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">356,238</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
Notes to the Financial Statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 60; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>abrdn
Palladium ETF Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Highlights&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="pall10k123122b006"></span>For
the years&#160;ended December 31, 2022, 2021&#160;and 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_112_pn3n3_zsRLQDYrgl9i" summary="xdx: Statement - Financial Highlights" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zBpotiuqWE26" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20210101__20211231_zmngMY7m2EPb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20200101__20201231_z8nsRlN4FYA5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31, 2020</td><td style="font-weight: bold">&#160;</td></tr>
<tr id="xdx_401_ecustom--PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract_iB_zvoTf09lkYOg" style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Per Share Performance (for a Share outstanding throughout the entire period)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetAssetValuePerShare_i01S_pid_uUSDPShares_z0y6g5r76Tw8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%">Net asset value per Share at beginning of period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">183.58</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">219.22</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">179.39</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--IncomeFromInvestmentOperationsAbstract_i01B_zYCR0MO3kUDi" style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left">Income from investment operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--NetInvestmentIncomLossPerShare_i02_pid_uUSDPShares_maCzhic_zIpFZjcpgR51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0.25in">Net investment loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentIncomLossPerShare" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.18</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentIncomLossPerShare" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.34</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:NetInvestmentIncomLossPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.25</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare_i02_pid_uUSDPShares_maCzhic_zV3SuEWb4jol" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Total realized and unrealized gains or losses on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">18.24</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">34.30</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">41.08</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ChangeInNetAssetsFromOperationsPerShare_i02T_pid_uUSDPShares_mtCzhic_zsL92ANArJHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 0.25in">Change in net assets from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInNetAssetsFromOperationsPerShare" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">19.42</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInNetAssetsFromOperationsPerShare" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">35.64</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="pall:ChangeInNetAssetsFromOperationsPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.83</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--NetAssetValuePerShare_i01E_pid_uUSDPShares_z7SsjCCFrA85" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Net asset value per Share at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">164.16</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">183.58</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">219.22</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pp0p0_z7dIK2kdIHjl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">Weighted average number of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,882,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,825,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,615,779</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_ztTbfyfuM0Ye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Expense ratio</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:AnnualizedRateOfSponsorsFee" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:AnnualizedRateOfSponsorsFee" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:AnnualizedRateOfSponsorsFee" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--AnnualizedNetInvestmentIncomeLossRatio_pid_dp_uPure_zdRHDDlmh6jg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Net investment loss ratio</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:AnnualizedNetInvestmentIncomeLossRatio" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:AnnualizedNetInvestmentIncomeLossRatio" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:AnnualizedNetInvestmentIncomeLossRatio" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.60</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--TotalReturnAtNetAssetValue_pid_dp_uPure_zARCEt2MRf56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Total return, net asset value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:TotalReturnAtNetAssetValue" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">10.58</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:TotalReturnAtNetAssetValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">16.26</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:TotalReturnAtNetAssetValue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22.20</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>See
Notes to the Financial Statements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 61; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="pall10k123122b007"></span>Notes to the Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zYtXWpqb2pWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;<span id="xdx_82D_zV0exrfC3Y25">Organization</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&#160;abrdn
Palladium ETF Trust&#160;(the &#8220;Trust&#8221;) is a common law trust formed on&#160;December 30, 2009&#160;under New York
law pursuant to a depositary trust agreement (the &#8220;Trust Agreement&#8221;) executed by abrdn ETFs Sponsor LLC&#160;(the
&#8220;Sponsor&#8221;) and The Bank of New York Mellon as Trustee (the &#8220;Trustee&#8221;). The Trust holds palladium and issues abrdn
Physical Palladium Shares ETF (&#8220;Shares&#8221;) in minimum blocks of&#160;<span id="xdx_904_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zj3kuZLQSNXe" title="Minimum block of shares issued redeemed against palladium"><ix:nonFraction name="pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></span> Shares (also referred to as &#8220;Baskets&#8221;)
in exchange for deposits of palladium and distributes palladium in connection with the redemption of Baskets. Shares
represent units of fractional undivided beneficial interest in and ownership of the Trust which are issued by the Trust. The Sponsor
is a Delaware limited liability company and a wholly-owned subsidiary of abrdn Inc. abrdn Inc. is a wholly-owned indirect subsidiary
of abrdn (formerly known as Standard Life Aberdeen) plc. The Trust is governed by the Trust Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investment objective of the Trust is for the Shares to reflect the performance of the price of&#160;palladium, less the Trust&#8217;s
expenses and liabilities. The Trust is designed to provide an individual owner of beneficial interests in the Shares (a &#8220;Shareholder&#8221;)
an opportunity to participate in the&#160;palladium market through an investment in securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 25, 2021, Christopher Demetriou resigned as President and Chief Executive Officer of the Sponsor. Mr. Demetriou had served
as Principal Executive Officer of the Registrant. Effective June 25, 2021, Steven Dunn was appointed President and Chief Executive
Officer of the Sponsor. Mr. Dunn will serve as Principal Executive Officer of the Registrant.</span></p>

</ix:nonNumeric><p id="xdx_812_zeBwpAcRvDpl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zWqVQLp2nsXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;<span id="xdx_821_zRBS6OIsABl1">Significant
Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in accordance with U.S. GAAP requires those responsible for preparing financial statements
to make estimates and assumptions that affect the reported amounts and disclosures. Actual results could differ from those estimates.
The following is a summary of significant accounting policies followed by the Trust.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVX9OD50j5oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.1.&#160;&#160;&#160;&#160;<span id="xdx_864_z2oBD0gm7I2d">Basis
of Accounting</span></i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has determined that the Trust falls within the scope of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting
Standards Codification (&#8220;ASC&#8221;) 946, <i>Financial Services&#8212;Investment Companies</i>, and has concluded that for
reporting purposes, the Trust is classified as an Investment Company. The Trust is not registered as an investment company under
the Investment Company Act of 1940 and is not required to register under such act.</span></p>

</ix:nonNumeric><p id="xdx_856_z162Nle2gcqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="pall:ValuationOfBullionPolicyTextBlock"><p id="xdx_847_ecustom--ValuationOfBullionPolicyTextBlock_zfBdzQQh9Occ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.2.&#160;&#160;&#160;<span id="xdx_867_znJwFlVY3Kdk">&#160;Valuation
of&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust follows the provisions of ASC 820, <i>Fair Value Measurement </i>(&#8220;ASC 820&#8221;). ASC 820 provides guidance for
determining fair value and requires increased disclosure regarding the inputs to valuation techniques used to measure fair value.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium&#160;is held by JPMorgan Chase Bank, N.A. (the &#8220;Custodian&#8221;), on behalf of the Trust, at its London,
England vaulting premises. The Trust&#8217;s palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold
the Trust&#8217;s palladium in the Trust&#8217;s allocated account in the firm&#8217;s&#160;vault premises on a segregated basis
and whose appointment has been approved by the Sponsor. At December 31, 2022, approximately <span id="xdx_906_ecustom--PercentageOfAssetBeingHeldByTrust_iI_pid_dp_uPure_c20221231_ziSQF4DBkcI1" title="Percentage of palladium held by sub-custodians"><ix:nonFraction name="pall:PercentageOfAssetBeingHeldByTrust" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20.47</ix:nonFraction></span>%&#160;of the Trust&#8217;s palladium
was held by one or more sub-custodians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 62; Options: NewSection; Value: 8 -->
    <div id="xdx_23A_zBA6aMQmWjU8" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zVBb1I2rmyn5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zaAHWA4VVxih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zmFT17rwdOcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<ix:exclude><p id="xdx_239_zeFUTGluA8vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes to the Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium is recorded at fair value. The cost of palladium is determined according to the average cost method and the
fair value is based on the afternoon session of the twice daily fix of an ounce of&#160;palladium administered by the London Metal
Exchange (&#8220;LME&#8221;) (the &#8220;LME PM Fix&#8221;). Realized gains and losses on transfers of palladium, or palladium
distributed for the redemption of Shares, are calculated on a trade date basis as the difference between the fair value and average&#160;cost
of&#160;palladium transferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
LME is responsible for the administration of the electronic&#160;palladium price fixing system (&#8220;LMEbullion&#8221;) that
replicates electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium Fixing
Company Ltd (&#8220;LPPFCL&#8221;), as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. LMEbullion, like the previous London palladium fix processes, establishes
and publishes fixed prices for troy ounces of palladium twice each London trading day during fixing sessions beginning at 9:45
a.m. London time (the&#8221; LME AM Fix&#8221;) and 2:00 p.m. London time (the &#8220;LME PM Fix&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the value of&#160;&#160;palladium has been determined, the net asset value (the &#8220;NAV&#8221;) is computed by the Trustee
by deducting all accrued fees, expenses and other liabilities of the Trust, including the remuneration due to the Sponsor (the
&#8220;Sponsor&#8217;s Fee&#8221;), from the fair value of the&#160;palladium and all other assets held by the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust recognizes changes in fair value of the investment in&#160;palladium as changes in unrealized gains or losses on investment
in&#160;palladium through the Statement of Operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
per Share amount of&#160;palladium exchanged for a purchase or redemption is calculated daily by the Trustee using the LME PM
Fix to calculate the&#160;palladium amount in respect of any liabilities for which covering palladium&#160;sales have not yet
been made, and represents the per Share amount of&#160;palladium held by the Trust, after giving effect to its liabilities, to
cover expenses and liabilities and any losses that may have occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value Hierarchy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
1.&#160;Unadjusted quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
2.&#160;Observable inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly
or indirectly. These inputs&#160;may&#160;include&#160;quoted&#160;prices&#160;for&#160;the&#160;identical&#160;instrument on
an inactive market, prices for similar instruments and similar data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
3.&#160;Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Trust&#8217;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for
instruments categorized in level 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes,
the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the
lowest level input that is significant to the fair value measurement in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 63; Value: 8 -->
    <div id="xdx_23D_zkSFJV9rbL9e" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zu4hbhXhfFud" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div id="xdx_239_zpzlQi1rG1Z8" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zW4zcqzhleXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<ix:exclude><p id="xdx_239_zYQMmkfJ2Mz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes to the Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s investment in&#160;palladium is classified as a level&#160;1 asset,&#160;as its value&#160;is calculated using unadjusted
quoted prices from primary market sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zR0dpGA3xbo1">The
categorization of the Trust&#8217;s assets is as shown below: </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-style: italic">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">(Amounts in 000&#8217;s of US$)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Investment in palladium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_z62gJcmPBYBb" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">There were no transfers between levels during the years ended December 31, 2022 and 2021.</p>



</ix:nonNumeric><p id="xdx_857_zN7yT67E2rW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="pall:ReceivableAndPayablePolicyTextBlock"><p id="xdx_84A_ecustom--ReceivableAndPayablePolicyTextBlock_zuO1ETszXTrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.3.&#160;&#160;&#160;&#160;<span id="xdx_86E_znNotwyp1dD1">Palladium
Receivable and Payable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium&#160;receivable
or payable represents the quantity of&#160;palladium covered by contractually binding orders for the creation or redemption of
Shares respectively, where the&#160;palladium has not yet been transferred to or from the Trust&#8217;s account. Generally, ownership
of palladium is transferred within two business days of the trade date. At December 31, 2022, the Trust had <span id="xdx_90A_ecustom--BullionReceivableAtMarketValue_iI_do_c20221231_zUittAsF6Uph" title="Palladium receivable"><span id="xdx_90B_ecustom--BullionPayableAtMarketValue_iI_do_c20221231_zx8AJtIWBDkj" title="Palladium payable"><ix:nonFraction name="pall:BullionReceivableAtMarketValue" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="pall:BullionPayableAtMarketValue" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares. At December 31, 2021, the Trust had <span id="xdx_901_ecustom--BullionReceivableAtMarketValue_iI_do_c20211231_zS4NHmQilRsg"><span id="xdx_908_ecustom--BullionPayableAtMarketValue_iI_do_c20211231_z9xhUtsvDwP8"><ix:nonFraction name="pall:BullionReceivableAtMarketValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="pall:BullionPayableAtMarketValue" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares.</span></p>

</ix:nonNumeric><p id="xdx_85A_zN1BU7rDlGW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="pall:CreationsAndRedemptionsOfSharesPolicyTextBlock"><p id="xdx_841_ecustom--CreationsAndRedemptionsOfSharesPolicyTextBlock_zZGfc1ABPnFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.4.&#160;&#160;&#160;&#160;<span id="xdx_866_zZlM1LQjydrd">Creations
and Redemptions of Shares</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust expects to create and redeem Shares from time to time, but only in one or more Baskets (a Basket equals a block of&#160;<span id="xdx_909_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zhLvOmikeqR6" title="Minimum block of shares issued redeemed against palladium"><ix:nonFraction name="pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000</ix:nonFraction></span>&#160;Shares).
The Trust issues Shares in Baskets to Authorized Participants on an ongoing basis. Individual investors cannot purchase or redeem
Shares in direct transactions with the Trust. An Authorized Participant is a person who (1) is a registered broker-dealer or other
securities market participant such as a bank or other financial institution which is not required to register as a broker-dealer
to engage in securities transactions; (2) is a participant in The Depository Trust Company; (3) has entered into an Authorized
Participant Agreement with the Trustee and the Sponsor; and (4) has established an Authorized Participant Unallocated Account
with the Trust&#8217;s Custodian or other&#160;palladium bullion clearing bank. An Authorized Participant Agreement is an agreement
entered into by each Authorized Participant, the Sponsor and the Trustee which provides the procedures for the creation and redemption
of Baskets and for the delivery of the&#160;palladium&#160;required for such creations and redemptions. An Authorized Participant
Unallocated Account is an unallocated&#160;palladium account, either loco London or loco Zurich, established with the Custodian
or a&#160;palladium bullion clearing bank by an Authorized Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants may, on any business day, place an order with the Trustee to create or redeem one or more Baskets. The typical settlement
period for Shares is two business days. In the event of a trade date at period end, where a settlement is pending, a respective
account receivable and/or payable will be recorded. When&#160;palladium is exchanged in settlement of a redemption, it is considered
a sale of&#160;palladium for financial statement purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 64; Value: 8 -->
    <div id="xdx_230_zoeSFJ27E1S6" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23B_zljuQhE7Vgg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div id="xdx_231_zhhB14gubYAf" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zO4pTG5tDJWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<ix:exclude><p id="xdx_238_z0jdteDh6mA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes to the Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of&#160;palladium represented by the Baskets created or redeemed can only be settled to the nearest 1/1000th of an ounce.
As a result, the value attributed to the creation or redemption of Shares may differ from&#160;the value of palladium&#160;to
be delivered or distributed by the Trust. In order to ensure that the correct amount of&#160;palladium is available at all times
to back the Shares, the Sponsor accepts an adjustment to its management fees in the event of any shortfall or excess on each transaction.
For each transaction, this amount is not more than 1/1000th of an ounce of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Shares of the Trust are subject to redemption at the option of Authorized Participants, the Trust has classified the outstanding
Shares as Net Assets. Changes in the number of Shares outstanding are presented in the Statement of Changes in Net Assets.</span></p>

</ix:nonNumeric><p id="xdx_85D_zkp8ratMYYKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zGsBuQ9vK4Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.5.&#160;&#160;&#160;&#160;<span id="xdx_86B_zEMvHfnQ2Yq4">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is classified as a &#8220;grantor trust&#8221; for U.S. federal income tax purposes. As a result, the Trust itself will
not be subject to U.S. federal income tax. Instead, the Trust&#8217;s income and expenses will &#8220;flow through&#8221; to the
Shareholders, and the Trustee will report the Trust&#8217;s proceeds, income, deductions, gains, and losses to the Internal Revenue
Service on that basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has evaluated whether or not there are uncertain tax positions that require financial statement recognition and has determined
that <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20221231_zWw9Q0QsbWu4" title="Reserve for uncertain tax positions"><span id="xdx_905_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20211231_zU2AuJnuPpnj"><ix:nonFraction name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> reserves for uncertain tax positions are required as of&#160;December 31, 2022&#160;or December 31, 2021.</span></p>

</ix:nonNumeric><p id="xdx_858_zV91jJmwlgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_z0UdHI5CSAYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.6.&#160;&#160;&#160;&#160;<span id="xdx_863_zNgBIJumV7D6">Investment
in&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="pall:InvestmentsInBullionTableTextBlock"><p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zFcOCpBhTyle">Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31,
    2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br /> December 31,
    2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$, except for ounces data)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Ounces of palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Opening balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">181,531.1</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">152,187.5</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:CreationsOuncesOfBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">58,004.8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:CreationsOuncesOfBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">83,977.6</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:RedemptionsOuncesOfBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" sign="-" unitRef="OZ">71,914.8</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:RedemptionsOuncesOfBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" sign="-" unitRef="OZ">53,626.6</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Transfers of palladium to pay expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:TransfersOfBullionOunces" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" sign="-" unitRef="OZ">1,064.7</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:TransfersOfBullionOunces" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" sign="-" unitRef="OZ">1,007.4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">166,556.4</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedBalanceOtherMeasure" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="1" scale="0" unitRef="OZ">181,531.1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">356,424</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:CreationsValueOfBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145,623</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:CreationsValueOfBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205,730</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,622</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131,079</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,889</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,317</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfers of palladium to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:CostOfBullionTransferredToPayExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,270</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="pall:CostOfBullionTransferredToPayExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,443</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62,298</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="pall:ChangeInUnrealizedGainLossOnInvestmentInBullion" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108,531</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">295,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentInPhysicalCommodities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">358,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_z0IUIE3rgb17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_85F_zu6wiNN5xk3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 65; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z2LvSvJOBAI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zSKsfT2wsuR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:exclude>



<ix:exclude><p id="xdx_23D_zqyknk9RLBFc" style="margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zgubEMe4k6yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes to the Financial Statements</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="pall:ExpensesPolicyTextBlock"><p id="xdx_846_ecustom--ExpensesPolicyTextBlock_zoPL2gXTg5Ge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.7.&#160;&#160;&#160;&#160;<span id="xdx_86B_znnk1INfGa4e">Expenses
/ Realized Gains / Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The primary expense of the Trust is the Sponsor&#8217;s Fee, which is paid by the Trust through in-kind transfers of palladium
to the Sponsor.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust will transfer&#160;palladium to the Sponsor to pay the Sponsor&#8217;s Fee that accrues daily at an annualized rate equal
to <span id="xdx_908_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_c20220101__20221231_ztWNltr81rL1" title="Expense ratio"><ix:nonFraction name="pall:AnnualizedRateOfSponsorsFee" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.60</ix:nonFraction></span>% of the adjusted daily net asset value (&#8220;ANAV&#8221;) of the Trust, paid monthly in arrears.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to assume administrative and marketing expenses incurred by the Trust, including the Trustee&#8217;s monthly
fee and out of pocket expenses, the Custodian&#8217;s fee and the reimbursement of the Custodian&#8217;s expenses, exchange listing
fees, United States Securities and Exchange Commission (the &#8220;SEC&#8221;) registration fees, printing and mailing costs,
audit fees and up to $<span id="xdx_907_ecustom--MaximumSponsorFeeForLegalExpenses_c20220101__20221231_zTgGEOsqRtv1" title="Maximum sponsor fee for legal expenses"><ix:nonFraction name="pall:MaximumSponsorFeeForLegalExpenses" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> per annum in legal expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the&#160;years ended&#160;December 31, 2022,&#160;2021&#160;and 2020, the Sponsor&#8217;s Fee&#160;was&#160;$<span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231_ziAQYh2kocma" title="Sponsor&apos;s Fee"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2022-01-01to2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,226,662</ix:nonFraction></span>, $<span id="xdx_905_eus-gaap--SponsorFees_c20210101__20211231_zqADh61kOPuc"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,447,225</ix:nonFraction></span>&#160;and
$<span id="xdx_906_eus-gaap--SponsorFees_c20200101__20201231_zodEoWbJxNT4"><ix:nonFraction name="us-gaap:SponsorFees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,012,865</ix:nonFraction></span>, respectively.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At&#160;December
31, 2022 and at&#160;December 31, 2021, the fees payable to the Sponsor were&#160;$<span id="xdx_900_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20221231_zva69Tdjou3k" title="Fees payable to Sponsor"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,803</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231_z1HU8xY1KYsf"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">189,455</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to expenses not otherwise assumed by the Sponsor, the Trustee will, at the direction of the Sponsor or in its own discretion,
sell the Trust&#8217;s&#160;palladium as necessary to pay these expenses. When selling&#160;palladium to pay expenses, the Trustee
will endeavor to sell the smallest amounts of&#160;palladium needed to pay these expenses in order to minimize the Trust&#8217;s
holdings of assets other than palladium. Other than the Sponsor&#8217;s Fee, the Trust had <span id="xdx_900_eus-gaap--OtherCostAndExpenseOperating_do_c20220101__20221231_zBsd76ZaumSb" title="All other expenses"><span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_do_c20210101__20211231_zAg3RzIYOa9f"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2022-01-01to2022-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2021-01-012021-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> expenses during the years ended&#160;December
31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise directed by the Sponsor, when selling&#160;palladium the Trustee will endeavor to sell at the price established by the
LME PM Fix. The Trustee will place orders with dealers (which may include the Custodian) through which the Trustee expects to
receive the most favorable price and execution of orders. The Custodian may be the purchaser of such&#160;palladium only if the
sale transaction is made at the next LME PM Fix or such other publicly available price that the Sponsor deems fair, in each case
as set following the sale order. A gain or loss is recognized based on the difference between the selling price and the average
cost of the&#160;palladium sold. Neither the Trustee nor the Sponsor is liable for depreciation or loss incurred by reason of
any sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
gains and losses result from the transfer of&#160;palladium for Share redemptions and / or to pay expenses and are recognized
on a trade date basis as the difference between the fair value and average cost of&#160;palladium transferred.</span></p>

</ix:nonNumeric><p id="xdx_85B_zuPgsJk2Yyp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zG0PUfyVNrve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.8.&#160;&#160;&#160;&#160;<span id="xdx_860_zyMMjOjio31h">Subsequent
Events</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the provisions set forth in FASB ASC 855-10, <i>Subsequent Events</i>, the Trust&#8217;s management has evaluated
the possibility of subsequent events impacting the Trust&#8217;s financial statements through the filing date. In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.
Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.</span></p>

</ix:nonNumeric><p id="xdx_85A_zzT4fWXDg9Ai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_812_zkoDxu8t76ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 66; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notes to the Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zetJUQRPy8B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;<span id="xdx_826_zioxwO2LEDua">Related
Parties</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and the Trustee are considered to be related parties to the Trust. The Trustee and the Custodian and their affiliates
may from time to time act as Authorized Participants and purchase or sell Shares for their own account, as agent for their customers
and for accounts over which they exercise investment discretion. In addition, the Trustee and the Custodian and their affiliates
may from time to time purchase or sell&#160;palladium directly, for their own account, as agent for their customers and for accounts
over which they exercise investment discretion. The Trustee&#8217;s and Custodian&#8217;s fees are paid by the Sponsor and are
not separate expenses of the Trust.&#160;</span></p>

</ix:nonNumeric><p id="xdx_812_zxhmHx0e24bd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zsGconhwKTJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.&#160;&#160;&#160;&#160;<span id="xdx_827_zLfDGREXIJ1i">Concentration
of Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s sole business activity is the investment in&#160;palladium, and substantially all the Trust&#8217;s assets are holdings
of&#160;palladium, which creates a concentration of risk associated with fluctuations in the price of palladium. Several factors
could affect the price of palladium, including: (i) global palladium supply and demand, which is influenced by factors such as
production and cost levels in major palladium-producing countries, recycling, autocatalyst demand, industrial demand, jewelry
demand, investment demand, and sales of existing stockpiles of palladium, which have been a key source of supply and are likely
to be exhausted soon, placing a higher burden on new mine supply; (ii) investors&#8217; expectations with respect to the rate
of inflation; (iii) currency exchange rates; (iv) interest rates; (v) investment and trading activities of hedge funds and commodity
funds; and (vi) global or regional political, economic or financial events and situations. In addition, there is no assurance
that&#160;palladium will maintain its long-term value in terms of purchasing power in the future. In the event that the price
of&#160;palladium declines, the Sponsor expects the value of an investment in the Shares to decline proportionately. Each of these
events could have a material effect on the Trust&#8217;s financial position and results of operations.&#160;</span></p>

</ix:nonNumeric><p id="xdx_818_zlO9WmSv8GL2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlcboV76bHP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.&#160;&#160;&#160;&#160;<span id="xdx_823_zXHkNdhUbMS6">Indemnification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Trust&#8217;s organizational documents, the Trustee (and its directors, employees and agents) and the Sponsor (and its members,
managers, directors, officers, employees and affiliates) are indemnified by the Trust against any liability, cost or expense it
incurs without gross negligence, bad faith, willful misconduct or willful malfeasance on its part and without reckless disregard
on its part of its obligations and duties under the Trust&#8217;s organizational documents. The Trust&#8217;s maximum exposure
under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred.&#160;</span></p>

</ix:nonNumeric><p id="xdx_811_zGWYwB2x1Ep6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 67; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>abrdn Palladium ETF Trust</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; color: #212529; margin-top: 0; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned in the capacities
thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; width: 50%">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">abrdn ETFs Sponsor LLC </span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Date: February 28, 2023</span></td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">/s/ Steven Dunn*</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Steven Dunn **</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">President and Chief Executive Officer</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">(Principal Executive Officer)</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Date: February 28, 2023</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">/s/ Andrea Melia*</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Andrea Melia **</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">Chief Financial Officer and Treasurer</span></td></tr>
<tr>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">(Principal Financial Officer and Principal Accounting Officer)</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">*</span></td>
    <td style="padding: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The original executed copy of this Certification will be maintained at the Sponsor&#8217;s offices and will be made available for inspection upon request.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.75pt; padding-left: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">**</span></td>
    <td style="padding: 0.75pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">The Registrant is a trust and the persons are signing in their capacities as officers of abrdn ETFs Sponsor LLC, the Sponsor of the Registrant.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 68; Options: NewSection; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>

    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
</div>



</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: left"><A HREF="pall-10k_123122.htm">abrdn Palladium ETF Trust 10-K</A></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 4.65pt 108.55pt 0 109.5pt; text-align: center">Consent of Independent
Registered Public Accounting Firm</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">We consent to the incorporation by reference in the registration
statement (No. 333-238125) on Form S-3 of abrdn Palladium ETF Trust (known as Aberdeen Standard Palladium ETF Trust prior to March 31,
2022) of our reports dated February 28, 2023, with respect to the statements of assets and liabilities of abrdn Palladium ETF Trust, including
the schedules of investments, as of December 31, 2022 and 2021, the related statements of operations and changes in net assets and the
financial highlights for each of the years in the three-year period ended December 31, 2022 and the related notes (collectively, the &ldquo;financial
statements&rdquo;), and the effectiveness of internal control over financial reporting as of December 31, 2022, which reports appear in
the December 31, 2022 annual report on Form 10-K of abrdn Palladium ETF Trust. We also consent to the reference to our firm under the
heading &ldquo;Experts&rdquo; in the above noted registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3.5in">/s/ KPMG LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6.95pt 0pt 0pt">New York, New York<BR>
 February 28, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6.95pt 404.85pt 0 5.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6.95pt 404.85pt 0 5.9pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6.95pt 404.85pt 0 5.9pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31-1.htm
<DESCRIPTION>CHIEF EXECUTIVE OFFICERS CERTIFICATE, PURSUANT TO SECTION 302
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: left"><A HREF="pall-10k_123122.htm">abrdn Palladium ETF Trust 10-K</A></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT<BR>
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">I, Steven Dunn, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">1. I have reviewed this Report on Form 10-K
of abrdn Palladium ETF Trust;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">2. Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">3. Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">4. The registrant&rsquo;s other certifying officer
and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant
and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(b) Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(d) Disclosed in this report any change in the
registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the
registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant&rsquo;s internal control over financial reporting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(a) All significant deficiencies and material
weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the
registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(b) Any fraud, whether or not material, that
involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date: February 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">/s/ Steven Dunn*</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 3pt">Steven Dunn**</TD>
    <TD STYLE="padding-top: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Principal Executive Officer)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD>The original executed copy of this Certification will be maintained at the Sponsor&rsquo;s offices and will be made available for
inspection upon request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">The Registrant is a trust and Mr. Dunn is signing in his capacity as an officer of abrdn ETFs Sponsor
LLC, the Sponsor of the Registrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex31-2.htm
<DESCRIPTION>CHIEF FINANCIAL OFFICERS CERTIFICATE, PURSUANT TO SECTION 302
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: left"><A HREF="pall-10k_123122.htm">abrdn Palladium ETF Trust 10-K</A></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT<BR>
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">I, Andrea Melia, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">1. I have reviewed this Report on Form 10-K
of abrdn Palladium ETF Trust;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">2. Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">3. Based on my knowledge, the financial statements,
and other financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">4. The registrant&rsquo;s other certifying officer
and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant
and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(b) Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(d) Disclosed in this report any change in the
registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the
registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant&rsquo;s internal control over financial reporting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(a) All significant deficiencies and material
weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the
registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">(b) Any fraud, whether or not material, that
involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">&nbsp;</TD>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date: February 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt">/s/ Andrea Melia*</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 3pt">Andrea Melia**</TD>
    <TD STYLE="padding-top: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer and Treasurer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Principal Financial Officer and Principal Accounting Officer)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">The original executed copy of this Certification will be maintained at the Sponsor&rsquo;s offices and
will be made available for inspection upon request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">The Registrant is a trust and Ms. Melia is signing in her capacity as an officer of abrdn ETFs Sponsor
LLC, the Sponsor of the Registrant.</TD></TR></TABLE>

<P STYLE="font: 12pt Arial Unicode MS; text-align: justify; text-indent: -0.5in; margin-right: 0; margin-left: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial Unicode MS; text-align: justify; text-indent: -0.5in; margin-right: 0; margin-left: 0.5in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex32-1.htm
<DESCRIPTION>CHIEF EXECUTIVE OFFICERS CERTIFICATE, PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: left"><A HREF="pall-10k_123122.htm">abrdn Palladium ETF Trust 10-K</A></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">In connection with the Annual Report of abrdn
Palladium ETF Trust (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, in the capacity and on the date indicated below, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">1. The Report fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">2. The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 66%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date: February 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">/s/ Steven Dunn*</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 3pt">Steven Dunn**</TD>
    <TD STYLE="padding-top: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Principal Executive Officer)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">The original executed copy of this Certification will be maintained at the Sponsor&rsquo;s offices and
will be made available for inspection upon request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">The Registrant is a trust and Mr. Dunn is signing in his capacity as an officer of abrdn ETFs Sponsor
LLC, the Sponsor of the Registrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex32-2.htm
<DESCRIPTION>CHIEF FINANCIAL OFFICERS CERTIFICATE, PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: left"><A HREF="pall-10k_123122.htm">abrdn Palladium ETF Trust 10-K</A></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">In connection with the Annual Report of abrdn
Palladium ETF Trust (the &ldquo;Company&rdquo;) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, in the capacity and on the date indicated below, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">1. The Report fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">2. The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 66%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Date February 28, 2023</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">/s/ Andrea Melia*</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 3pt">Andrea Melia**</TD>
    <TD STYLE="padding-top: 3pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer and Treasurer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Principal Financial Officer and Principal Accounting Officer)</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">The original executed copy of this Certification will be maintained at the Sponsor&rsquo;s offices and
will be made available for inspection upon request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">The Registrant is a trust and Ms. Melia is signing in her capacity as an officer of abrdn ETFs Sponsor
LLC, the Sponsor of the Registrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0 0.5in; text-align: justify"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>pall-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSa2BebP9w5dzmelBtm99HblKfy4obh+kbiMQQpqWwTgO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:pall="http://abrdn.com/20221231" elementFormDefault="qualified" targetNamespace="http://abrdn.com/20221231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://abrdn.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" id="StatementsOfAssetsAndLiabilities">
	  <link:definition>00000002 - Statement - Statements of Assets and Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" id="StatementsOfAssetsAndLiabilitiesParenthetical">
	  <link:definition>00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/SchedulesOfInvestments" id="SchedulesOfInvestments">
	  <link:definition>00000004 - Statement - Schedules of Investments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000005 - Statement - Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/StatementsOfChangesInNetAssets" id="StatementsOfChangesInNetAssets">
	  <link:definition>00000006 - Statement - Statements of Changes in Net Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/FinancialHighlights" id="FinancialHighlights">
	  <link:definition>00000007 - Statement - Financial Highlights</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/Organization" id="Organization">
	  <link:definition>00000008 - Disclosure - Organization</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/RelatedParties" id="RelatedParties">
	  <link:definition>00000010 - Disclosure - Related Parties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/ConcentrationOfRisk" id="ConcentrationOfRisk">
	  <link:definition>00000011 - Disclosure - Concentration of Risk</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/Indemnification" id="Indemnification">
	  <link:definition>00000012 - Disclosure - Indemnification</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000013 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000014 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/OrganizationDetailsNarrative" id="OrganizationDetailsNarrative">
	  <link:definition>00000015 - Disclosure - Organization (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" id="CategorizationOfTrustsAssetsIsAsShownBelowDetails">
	  <link:definition>00000016 - Disclosure - The categorization of the Trust&#8217;s assets is as shown below: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" id="ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails">
	  <link:definition>00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000018 - Disclosure - Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="pall-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="pall-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="pall-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="pall-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="pall_NetAssetsPercentageOfNetAssets" name="NetAssetsPercentageOfNetAssets" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ExpensesAbstract" name="ExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="pall_NetInvestmentGainLoss" name="NetInvestmentGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" name="RealizedGainLossOnBullionDistributedForRedemptionOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" name="ChangeInUnrealizedGainLossOnInvestmentInBullion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_TotalGainLossOnBullion" name="TotalGainLossOnBullion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_StatementFinancialHighlightsAbstract" name="StatementFinancialHighlightsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" name="PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="pall_IncomeFromInvestmentOperationsAbstract" name="IncomeFromInvestmentOperationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="pall_NetInvestmentIncomLossPerShare" name="NetInvestmentIncomLossPerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" name="NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ChangeInNetAssetsFromOperationsPerShare" name="ChangeInNetAssetsFromOperationsPerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="pall_AnnualizedRateOfSponsorsFee" name="AnnualizedRateOfSponsorsFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="pall_AnnualizedNetInvestmentIncomeLossRatio" name="AnnualizedNetInvestmentIncomeLossRatio" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="pall_TotalReturnAtNetAssetValue" name="TotalReturnAtNetAssetValue" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ValuationOfBullionPolicyTextBlock" name="ValuationOfBullionPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ReceivableAndPayablePolicyTextBlock" name="ReceivableAndPayablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" name="CreationsAndRedemptionsOfSharesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ExpensesPolicyTextBlock" name="ExpensesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="pall_InvestmentsInBullionTableTextBlock" name="InvestmentsInBullionTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" name="MinimumBlockOfSharesIssuedRedeemedAgainstBullion" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="pall_CreationsOuncesOfBullion" name="CreationsOuncesOfBullion" nillable="true" xbrli:periodType="duration" type="dtr-types:massItemType" substitutionGroup="xbrli:item" />
    <element id="pall_RedemptionsOuncesOfBullion" name="RedemptionsOuncesOfBullion" nillable="true" xbrli:periodType="duration" type="dtr-types:massItemType" substitutionGroup="xbrli:item" />
    <element id="pall_TransfersOfBullionOunces" name="TransfersOfBullionOunces" nillable="true" xbrli:periodType="duration" type="dtr-types:massItemType" substitutionGroup="xbrli:item" />
    <element id="pall_CreationsValueOfBullion" name="CreationsValueOfBullion" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" name="ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_CostOfBullionTransferredToPayExpenses" name="CostOfBullionTransferredToPayExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_PercentageOfAssetBeingHeldByTrust" name="PercentageOfAssetBeingHeldByTrust" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="pall_BullionReceivableAtMarketValue" name="BullionReceivableAtMarketValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_BullionPayableAtMarketValue" name="BullionPayableAtMarketValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="pall_MaximumSponsorFeeForLegalExpenses" name="MaximumSponsorFeeForLegalExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>pall-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abrdn.com/role/Cover" xlink:href="pall-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilitiesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SchedulesOfInvestments" xlink:href="pall-20221231.xsd#SchedulesOfInvestments" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfOperations" xlink:href="pall-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:href="pall-20221231.xsd#StatementsOfChangesInNetAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/FinancialHighlights" xlink:href="pall-20221231.xsd#FinancialHighlights" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Organization" xlink:href="pall-20221231.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/RelatedParties" xlink:href="pall-20221231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ConcentrationOfRisk" xlink:href="pall-20221231.xsd#ConcentrationOfRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Indemnification" xlink:href="pall-20221231.xsd#Indemnification" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:href="pall-20221231.xsd#OrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:href="pall-20221231.xsd#CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:href="pall-20221231.xsd#ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:title="00000002 - Statement - Statements of Assets and Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="loc_us-gaapInvestmentInPhysicalCommodities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentInPhysicalCommodities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:title="00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SchedulesOfInvestments" xlink:title="00000004 - Statement - Schedules of Investments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfOperations" xlink:title="00000005 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentGainLoss" xlink:label="loc_pallNetInvestmentGainLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallNetInvestmentGainLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TotalGainLossOnBullion" xlink:label="loc_pallTotalGainLossOnBullion" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" xlink:label="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallTotalGainLossOnBullion" xlink:to="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:label="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallTotalGainLossOnBullion" xlink:to="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:label="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallTotalGainLossOnBullion" xlink:to="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_pallNetInvestmentGainLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_pallTotalGainLossOnBullion" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:title="00000006 - Statement - Statements of Changes in Net Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/FinancialHighlights" xlink:title="00000007 - Statement - Financial Highlights">
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInNetAssetsFromOperationsPerShare" xlink:label="loc_pallChangeInNetAssetsFromOperationsPerShare" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentIncomLossPerShare" xlink:label="loc_pallNetInvestmentIncomLossPerShare" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallChangeInNetAssetsFromOperationsPerShare" xlink:to="loc_pallNetInvestmentIncomLossPerShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:label="loc_pallNetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pallChangeInNetAssetsFromOperationsPerShare" xlink:to="loc_pallNetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Organization" xlink:title="00000008 - Disclosure - Organization" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/RelatedParties" xlink:title="00000010 - Disclosure - Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/ConcentrationOfRisk" xlink:title="00000011 - Disclosure - Concentration of Risk" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Indemnification" xlink:title="00000012 - Disclosure - Indemnification" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000013 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:title="00000014 - Disclosure - Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:title="00000015 - Disclosure - Organization (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:title="00000016 - Disclosure - The categorization of the Trust&#8217;s assets is as shown below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:title="00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000018 - Disclosure - Significant Accounting Policies (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>pall-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abrdn.com/role/Cover" xlink:href="pall-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilitiesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SchedulesOfInvestments" xlink:href="pall-20221231.xsd#SchedulesOfInvestments" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfOperations" xlink:href="pall-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:href="pall-20221231.xsd#StatementsOfChangesInNetAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/FinancialHighlights" xlink:href="pall-20221231.xsd#FinancialHighlights" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Organization" xlink:href="pall-20221231.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/RelatedParties" xlink:href="pall-20221231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ConcentrationOfRisk" xlink:href="pall-20221231.xsd#ConcentrationOfRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Indemnification" xlink:href="pall-20221231.xsd#Indemnification" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:href="pall-20221231.xsd#OrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:href="pall-20221231.xsd#CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:href="pall-20221231.xsd#ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:title="00000002 - Statement - Statements of Assets and Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:title="00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/SchedulesOfInvestments" xlink:title="00000004 - Statement - Schedules of Investments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XPD" xlink:label="loc_currencyXPD_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyXPD_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:label="loc_us-gaapInvestmentOwnedBalanceOtherMeasure_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceOtherMeasure_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities" xlink:label="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilities_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" xlink:label="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetAssetsPercentageOfNetAssets" xlink:label="loc_pallNetAssetsPercentageOfNetAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pallNetAssetsPercentageOfNetAssets_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfOperations" xlink:title="00000005 - Statement - Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:title="00000006 - Statement - Statements of Changes in Net Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/FinancialHighlights" xlink:title="00000007 - Statement - Financial Highlights" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/Organization" xlink:title="00000008 - Disclosure - Organization" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/RelatedParties" xlink:title="00000010 - Disclosure - Related Parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/ConcentrationOfRisk" xlink:title="00000011 - Disclosure - Concentration of Risk" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/Indemnification" xlink:title="00000012 - Disclosure - Indemnification" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000013 - Disclosure - Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:title="00000014 - Disclosure - Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:title="00000015 - Disclosure - Organization (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:title="00000016 - Disclosure - The categorization of the Trust&#8217;s assets is as shown below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:label="loc_us-gaapInvestmentInPhysicalCommoditiesFairValueDisclosure_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentInPhysicalCommoditiesFairValueDisclosure_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:title="00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000018 - Disclosure - Significant Accounting Policies (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>pall-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XPD" xlink:label="currency_XPD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_XPD" xlink:to="currency_XPD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_XPD_lbl" xml:lang="en-US">Palladium Ounces</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="us-gaap_InvestmentInPhysicalCommodities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInPhysicalCommodities" xlink:to="us-gaap_InvestmentInPhysicalCommodities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInPhysicalCommodities_lbl" xml:lang="en-US">Investment in palladium (cost: December 31, 2022: $334,209; December 31, 2021: $334,434)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Fees payable to Sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">NET ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyAbstract" xlink:label="us-gaap_InvestmentCompanyAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyAbstract" xlink:to="us-gaap_InvestmentCompanyAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyAbstract_lbl" xml:lang="en-US">Investment Company [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="us-gaap_InvestmentOwnedAtCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl" xml:lang="en-US">Investment in palladium at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:to="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Common stock, no par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare" xlink:label="us-gaap_NetAssetValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetAssetValuePerShare_lbl" xml:lang="en-US">Net asset value per share (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl" xml:lang="en-US">Investment in palladium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedAtCost_2_lbl" xml:lang="en-US">Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:to="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xml:lang="en-US">% of Net Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities" xlink:label="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities" xlink:to="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities_lbl" xml:lang="en-US">Less liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" xlink:label="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" xlink:to="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets_lbl" xml:lang="en-US">Less liabilities, % of Net Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_2_lbl" xml:lang="en-US">Net Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetAssetsPercentageOfNetAssets" xlink:label="pall_NetAssetsPercentageOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetAssetsPercentageOfNetAssets" xlink:to="pall_NetAssetsPercentageOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_NetAssetsPercentageOfNetAssets_lbl" xml:lang="en-US">Net Assets, % of Net Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ExpensesAbstract" xlink:label="pall_ExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ExpensesAbstract" xlink:to="pall_ExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ExpensesAbstract_lbl" xml:lang="en-US">EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="us-gaap_SponsorFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SponsorFees_lbl" xml:lang="en-US">Sponsor&#8217;s Fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentGainLoss" xlink:label="pall_NetInvestmentGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentGainLoss" xlink:to="pall_NetInvestmentGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="pall_NetInvestmentGainLoss_lbl" xml:lang="en-US">Net investment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingGainsLossesAbstract" xlink:label="us-gaap_NonoperatingGainsLossesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingGainsLossesAbstract" xlink:to="us-gaap_NonoperatingGainsLossesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingGainsLossesAbstract_lbl" xml:lang="en-US">REALIZED AND UNREALIZED GAINS / (LOSSES)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" xlink:label="us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" xlink:to="us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses_lbl" xml:lang="en-US">Realized gain on palladium transferred to pay expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:label="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:to="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares_lbl" xml:lang="en-US">Realized gain on palladium distributed for the redemption of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:label="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:to="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_lbl" xml:lang="en-US">Change in unrealized gain / (loss) on investment in palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TotalGainLossOnBullion" xlink:label="pall_TotalGainLossOnBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TotalGainLossOnBullion" xlink:to="pall_TotalGainLossOnBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="pall_TotalGainLossOnBullion_lbl" xml:lang="en-US">Total gain / (loss) on investment in palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Change in net assets from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net increase / (decrease) in net assets per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Opening balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentGainLoss" xlink:to="pall_NetInvestmentGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_NetInvestmentGainLoss_2_lbl" xml:lang="en-US">Net investment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xml:lang="en-US">Realized gain on investment in palladium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:to="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_2_lbl" xml:lang="en-US">Change in unrealized (loss)/gain on investment in palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Creations (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Creations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Redemptions (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Redemptions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Closing balance (in Shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_StatementFinancialHighlightsAbstract" xlink:label="pall_StatementFinancialHighlightsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_StatementFinancialHighlightsAbstract" xlink:to="pall_StatementFinancialHighlightsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_StatementFinancialHighlightsAbstract_lbl" xml:lang="en-US">Financial Highlights</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:label="pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:to="pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract_lbl" xml:lang="en-US">Per Share Performance (for a Share outstanding throughout the entire period)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NetAssetValuePerShare_2_lbl" xml:lang="en-US">Net asset value per Share at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_IncomeFromInvestmentOperationsAbstract" xlink:label="pall_IncomeFromInvestmentOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_IncomeFromInvestmentOperationsAbstract" xlink:to="pall_IncomeFromInvestmentOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_IncomeFromInvestmentOperationsAbstract_lbl" xml:lang="en-US">Income from investment operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentIncomLossPerShare" xlink:label="pall_NetInvestmentIncomLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentIncomLossPerShare" xlink:to="pall_NetInvestmentIncomLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="pall_NetInvestmentIncomLossPerShare_lbl" xml:lang="en-US">Net investment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:label="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:to="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare_lbl" xml:lang="en-US">Total realized and unrealized gains or losses on investment in palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInNetAssetsFromOperationsPerShare" xlink:label="pall_ChangeInNetAssetsFromOperationsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInNetAssetsFromOperationsPerShare" xlink:to="pall_ChangeInNetAssetsFromOperationsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="pall_ChangeInNetAssetsFromOperationsPerShare_lbl" xml:lang="en-US">Change in net assets from operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NetAssetValuePerShare_3_lbl" xml:lang="en-US">Net asset value per Share at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_AnnualizedRateOfSponsorsFee" xlink:label="pall_AnnualizedRateOfSponsorsFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_AnnualizedRateOfSponsorsFee" xlink:to="pall_AnnualizedRateOfSponsorsFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_AnnualizedRateOfSponsorsFee_lbl" xml:lang="en-US">Expense ratio</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_AnnualizedNetInvestmentIncomeLossRatio" xlink:label="pall_AnnualizedNetInvestmentIncomeLossRatio" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_AnnualizedNetInvestmentIncomeLossRatio" xlink:to="pall_AnnualizedNetInvestmentIncomeLossRatio_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_AnnualizedNetInvestmentIncomeLossRatio_lbl" xml:lang="en-US">Net investment loss ratio</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TotalReturnAtNetAssetValue" xlink:label="pall_TotalReturnAtNetAssetValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TotalReturnAtNetAssetValue" xlink:to="pall_TotalReturnAtNetAssetValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_TotalReturnAtNetAssetValue_lbl" xml:lang="en-US">Total return, net asset value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentration of Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Indemnification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ValuationOfBullionPolicyTextBlock" xlink:label="pall_ValuationOfBullionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ValuationOfBullionPolicyTextBlock" xlink:to="pall_ValuationOfBullionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ValuationOfBullionPolicyTextBlock_lbl" xml:lang="en-US">Valuation of Palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ReceivableAndPayablePolicyTextBlock" xlink:label="pall_ReceivableAndPayablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ReceivableAndPayablePolicyTextBlock" xlink:to="pall_ReceivableAndPayablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ReceivableAndPayablePolicyTextBlock_lbl" xml:lang="en-US">Palladium Receivable and Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" xlink:label="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" xlink:to="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock_lbl" xml:lang="en-US">Creations and Redemptions of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment in Palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ExpensesPolicyTextBlock" xlink:label="pall_ExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ExpensesPolicyTextBlock" xlink:to="pall_ExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ExpensesPolicyTextBlock_lbl" xml:lang="en-US">Expenses / Realized Gains / Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">The categorization of the Trust&#8217;s assets is as shown below:</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_InvestmentsInBullionTableTextBlock" xlink:label="pall_InvestmentsInBullionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_InvestmentsInBullionTableTextBlock" xlink:to="pall_InvestmentsInBullionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_InvestmentsInBullionTableTextBlock_lbl" xml:lang="en-US">Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below:</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:label="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:to="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion_lbl" xml:lang="en-US">Minimum block of shares issued redeemed against palladium</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:label="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:to="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure_lbl" xml:lang="en-US">Investment in palladium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsOuncesOfBullion" xlink:label="pall_CreationsOuncesOfBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsOuncesOfBullion" xlink:to="pall_CreationsOuncesOfBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="pall_CreationsOuncesOfBullion_lbl" xml:lang="en-US">Creations</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RedemptionsOuncesOfBullion" xlink:label="pall_RedemptionsOuncesOfBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_RedemptionsOuncesOfBullion" xlink:to="pall_RedemptionsOuncesOfBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_RedemptionsOuncesOfBullion_lbl" xml:lang="en-US">Redemptions</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TransfersOfBullionOunces" xlink:label="pall_TransfersOfBullionOunces" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TransfersOfBullionOunces" xlink:to="pall_TransfersOfBullionOunces_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_TransfersOfBullionOunces_lbl" xml:lang="en-US">Transfers of palladium to pay expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInPhysicalCommodities" xlink:to="us-gaap_InvestmentInPhysicalCommodities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InvestmentInPhysicalCommodities_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsValueOfBullion" xlink:label="pall_CreationsValueOfBullion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsValueOfBullion" xlink:to="pall_CreationsValueOfBullion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="pall_CreationsValueOfBullion_lbl" xml:lang="en-US">Creations</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:label="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:to="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_lbl" xml:lang="en-US">Redemptions</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CostOfBullionTransferredToPayExpenses" xlink:label="pall_CostOfBullionTransferredToPayExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CostOfBullionTransferredToPayExpenses" xlink:to="pall_CostOfBullionTransferredToPayExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="pall_CostOfBullionTransferredToPayExpenses_lbl" xml:lang="en-US">Transfers of palladium to pay expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:to="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_3_lbl" xml:lang="en-US">Change in unrealized (loss) on investment in palladium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInPhysicalCommodities" xlink:to="us-gaap_InvestmentInPhysicalCommodities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InvestmentInPhysicalCommodities_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_PercentageOfAssetBeingHeldByTrust" xlink:label="pall_PercentageOfAssetBeingHeldByTrust" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_PercentageOfAssetBeingHeldByTrust" xlink:to="pall_PercentageOfAssetBeingHeldByTrust_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_PercentageOfAssetBeingHeldByTrust_lbl" xml:lang="en-US">Percentage of palladium held by sub-custodians</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_BullionReceivableAtMarketValue" xlink:label="pall_BullionReceivableAtMarketValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_BullionReceivableAtMarketValue" xlink:to="pall_BullionReceivableAtMarketValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_BullionReceivableAtMarketValue_lbl" xml:lang="en-US">Palladium receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_BullionPayableAtMarketValue" xlink:label="pall_BullionPayableAtMarketValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_BullionPayableAtMarketValue" xlink:to="pall_BullionPayableAtMarketValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_BullionPayableAtMarketValue_lbl" xml:lang="en-US">Palladium payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xml:lang="en-US">Reserve for uncertain tax positions</link:label>
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_MaximumSponsorFeeForLegalExpenses" xlink:label="pall_MaximumSponsorFeeForLegalExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_MaximumSponsorFeeForLegalExpenses" xlink:to="pall_MaximumSponsorFeeForLegalExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_MaximumSponsorFeeForLegalExpenses_lbl" xml:lang="en-US">Maximum sponsor fee for legal expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SponsorFees_2_lbl" xml:lang="en-US">Sponsor's Fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="us-gaap_OtherCostAndExpenseOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">All other expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentGainLoss" xlink:to="pall_NetInvestmentGainLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_NetInvestmentGainLoss_doc" xml:lang="en-US">Net investment gain (loss).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:to="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares_doc" xml:lang="en-US">Realized gain or loss during the period on bullion distributed for the redemption of Shares. Realized gains or losses are calculated on a trade date basis using average cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:to="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ChangeInUnrealizedGainLossOnInvestmentInBullion_doc" xml:lang="en-US">Change in unrealized gain (loss) on investment in Bullion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentIncomLossPerShare" xlink:to="pall_NetInvestmentIncomLossPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_NetInvestmentIncomLossPerShare_doc" xml:lang="en-US">Net investment income (loss) per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:to="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare_doc" xml:lang="en-US">Net realized and unrealized gains and losses on investment in Bullion per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInNetAssetsFromOperationsPerShare" xlink:to="pall_ChangeInNetAssetsFromOperationsPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ChangeInNetAssetsFromOperationsPerShare_doc" xml:lang="en-US">Change in net assets from operations per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_AnnualizedRateOfSponsorsFee" xlink:to="pall_AnnualizedRateOfSponsorsFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_AnnualizedRateOfSponsorsFee_doc" xml:lang="en-US">Annualized rate of sponsors fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_AnnualizedNetInvestmentIncomeLossRatio" xlink:to="pall_AnnualizedNetInvestmentIncomeLossRatio_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_AnnualizedNetInvestmentIncomeLossRatio_doc" xml:lang="en-US">Annualized net investment income (loss) ratio.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:to="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion_doc" xml:lang="en-US">The minimum block of shares that can be created or redeemed against bullion deposits or distributions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ValuationOfBullionPolicyTextBlock" xlink:to="pall_ValuationOfBullionPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ValuationOfBullionPolicyTextBlock_doc" xml:lang="en-US">Disclosure of valuation of bullion policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ReceivableAndPayablePolicyTextBlock" xlink:to="pall_ReceivableAndPayablePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ReceivableAndPayablePolicyTextBlock_doc" xml:lang="en-US">Disclosure of bullion receivable and payable policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" xlink:to="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_CreationsAndRedemptionsOfSharesPolicyTextBlock_doc" xml:lang="en-US">Disclosure of creation and redemptions of shares policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ExpensesPolicyTextBlock" xlink:to="pall_ExpensesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ExpensesPolicyTextBlock_doc" xml:lang="en-US">Disclosure of expenses policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_InvestmentsInBullionTableTextBlock" xlink:to="pall_InvestmentsInBullionTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_InvestmentsInBullionTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of movement in the investment in bullion in the Trust.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsOuncesOfBullion" xlink:to="pall_CreationsOuncesOfBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_CreationsOuncesOfBullion_doc" xml:lang="en-US">Ounces of bullion received into the Trust's account in respect of creations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_RedemptionsOuncesOfBullion" xlink:to="pall_RedemptionsOuncesOfBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_RedemptionsOuncesOfBullion_doc" xml:lang="en-US">Ounces of bullion paid out of the Trust's account in respect of redemptions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TransfersOfBullionOunces" xlink:to="pall_TransfersOfBullionOunces_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_TransfersOfBullionOunces_doc" xml:lang="en-US">Ounces of bullion transferred to pay Trust's expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsValueOfBullion" xlink:to="pall_CreationsValueOfBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_CreationsValueOfBullion_doc" xml:lang="en-US">Amount of creations of bullion in investment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:to="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_doc" xml:lang="en-US">Value of bullion distributed at average cost for the redemption of Shares excluding bullion payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CostOfBullionTransferredToPayExpenses" xlink:to="pall_CostOfBullionTransferredToPayExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_CostOfBullionTransferredToPayExpenses_doc" xml:lang="en-US">Cost of Bullion transferred to pay Trust's expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_PercentageOfAssetBeingHeldByTrust" xlink:to="pall_PercentageOfAssetBeingHeldByTrust_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_PercentageOfAssetBeingHeldByTrust_doc" xml:lang="en-US">Percentage of asset being held by trust.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_BullionPayableAtMarketValue" xlink:to="pall_BullionPayableAtMarketValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_BullionPayableAtMarketValue_doc" xml:lang="en-US">Amount of bullion payable at market value as of the reporting date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetAssetsPercentageOfNetAssets" xlink:to="pall_NetAssetsPercentageOfNetAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_NetAssetsPercentageOfNetAssets_doc" xml:lang="en-US">Net Assets, Percentage of Net Assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TotalGainLossOnBullion" xlink:to="pall_TotalGainLossOnBullion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_TotalGainLossOnBullion_doc" xml:lang="en-US">The net gain or loss in the period on bullion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TotalReturnAtNetAssetValue" xlink:to="pall_TotalReturnAtNetAssetValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_TotalReturnAtNetAssetValue_doc" xml:lang="en-US">Total return, at net asset value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_BullionReceivableAtMarketValue" xlink:to="pall_BullionReceivableAtMarketValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_BullionReceivableAtMarketValue_doc" xml:lang="en-US">Amount of bullion receivable at market value as of the reporting date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_MaximumSponsorFeeForLegalExpenses" xlink:to="pall_MaximumSponsorFeeForLegalExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="pall_MaximumSponsorFeeForLegalExpenses_doc" xml:lang="en-US">Maximum sponsor fee for legal expenses,</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_TotalGainLossOnBullion" xlink:to="pall_TotalGainLossOnBullion_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_TotalGainLossOnBullion_3_lbl" xml:lang="en-US">Total gain / (loss) on investment in palladium</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_2_lbl" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Redeemed or Called During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_NetInvestmentIncomLossPerShare" xlink:to="pall_NetInvestmentIncomLossPerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_NetInvestmentIncomLossPerShare_3_lbl" xml:lang="en-US">Net investment income (loss) per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ChangeInNetAssetsFromOperationsPerShare" xlink:to="pall_ChangeInNetAssetsFromOperationsPerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ChangeInNetAssetsFromOperationsPerShare_3_lbl" xml:lang="en-US">Change in net assets from operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:to="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure_2_lbl" xml:lang="en-US">Investment in Physical Commodities, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsOuncesOfBullion" xlink:to="pall_CreationsOuncesOfBullion_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_CreationsOuncesOfBullion_3_lbl" xml:lang="en-US">Creations (in Ounces)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CreationsValueOfBullion" xlink:to="pall_CreationsValueOfBullion_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_CreationsValueOfBullion_3_lbl" xml:lang="en-US">Creations [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:to="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_3_lbl" xml:lang="en-US">Redemptions [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="pall_CostOfBullionTransferredToPayExpenses" xlink:to="pall_CostOfBullionTransferredToPayExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="pall_CostOfBullionTransferredToPayExpenses_3_lbl" xml:lang="en-US">Transfers of palladiuim to pay expenses</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>pall-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abrdn.com/role/Cover" xlink:href="pall-20221231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:href="pall-20221231.xsd#StatementsOfAssetsAndLiabilitiesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SchedulesOfInvestments" xlink:href="pall-20221231.xsd#SchedulesOfInvestments" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfOperations" xlink:href="pall-20221231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:href="pall-20221231.xsd#StatementsOfChangesInNetAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/FinancialHighlights" xlink:href="pall-20221231.xsd#FinancialHighlights" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Organization" xlink:href="pall-20221231.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/RelatedParties" xlink:href="pall-20221231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ConcentrationOfRisk" xlink:href="pall-20221231.xsd#ConcentrationOfRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/Indemnification" xlink:href="pall-20221231.xsd#Indemnification" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:href="pall-20221231.xsd#OrganizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:href="pall-20221231.xsd#CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:href="pall-20221231.xsd#ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="pall-20221231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilities" xlink:title="00000002 - Statement - Statements of Assets and Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="loc_us-gaapInvestmentInPhysicalCommodities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInvestmentInPhysicalCommodities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" xlink:title="00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyAbstract" xlink:label="loc_us-gaapInvestmentCompanyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="loc_us-gaapCommonStockSharesAuthorizedUnlimited" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorizedUnlimited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaapCommonStockNoParValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapCommonStockNoParValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare" xlink:label="loc_us-gaapNetAssetValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapNetAssetValuePerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SchedulesOfInvestments" xlink:title="00000004 - Statement - Schedules of Investments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyAbstract" xlink:label="loc_us-gaapInvestmentCompanyAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentCompanyAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCurrencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_XPD" xlink:label="loc_currencyXPD" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyXPD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:label="loc_us-gaapInvestmentOwnedBalanceOtherMeasure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceOtherMeasure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtCost" xlink:label="loc_us-gaapInvestmentOwnedAtCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities" xlink:label="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" xlink:label="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetAssetsPercentageOfNetAssets" xlink:label="loc_pallNetAssetsPercentageOfNetAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pallNetAssetsPercentageOfNetAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfOperations" xlink:title="00000005 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ExpensesAbstract" xlink:label="loc_pallExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_pallExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallExpensesAbstract" xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentGainLoss" xlink:label="loc_pallNetInvestmentGainLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_pallNetInvestmentGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingGainsLossesAbstract" xlink:label="loc_us-gaapNonoperatingGainsLossesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingGainsLossesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" xlink:label="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingGainsLossesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:label="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingGainsLossesAbstract" xlink:to="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:label="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingGainsLossesAbstract" xlink:to="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TotalGainLossOnBullion" xlink:label="loc_pallTotalGainLossOnBullion" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingGainsLossesAbstract" xlink:to="loc_pallTotalGainLossOnBullion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/StatementsOfChangesInNetAssets" xlink:title="00000006 - Statement - Statements of Changes in Net Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentGainLoss" xlink:label="loc_pallNetInvestmentGainLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_pallNetInvestmentGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="loc_us-gaapRealizedInvestmentGainsLosses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapRealizedInvestmentGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:label="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/FinancialHighlights" xlink:title="00000007 - Statement - Financial Highlights">
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_StatementFinancialHighlightsAbstract" xlink:label="loc_pallStatementFinancialHighlightsAbstract" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:label="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallStatementFinancialHighlightsAbstract" xlink:to="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare" xlink:label="loc_us-gaapNetAssetValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:to="loc_us-gaapNetAssetValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_IncomeFromInvestmentOperationsAbstract" xlink:label="loc_pallIncomeFromInvestmentOperationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:to="loc_pallIncomeFromInvestmentOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetInvestmentIncomLossPerShare" xlink:label="loc_pallNetInvestmentIncomLossPerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallIncomeFromInvestmentOperationsAbstract" xlink:to="loc_pallNetInvestmentIncomLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:label="loc_pallNetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallIncomeFromInvestmentOperationsAbstract" xlink:to="loc_pallNetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInNetAssetsFromOperationsPerShare" xlink:label="loc_pallChangeInNetAssetsFromOperationsPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallIncomeFromInvestmentOperationsAbstract" xlink:to="loc_pallChangeInNetAssetsFromOperationsPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare" xlink:label="loc_us-gaapNetAssetValuePerShare_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:to="loc_us-gaapNetAssetValuePerShare_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallPerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_AnnualizedRateOfSponsorsFee" xlink:label="loc_pallAnnualizedRateOfSponsorsFee" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallStatementFinancialHighlightsAbstract" xlink:to="loc_pallAnnualizedRateOfSponsorsFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_AnnualizedNetInvestmentIncomeLossRatio" xlink:label="loc_pallAnnualizedNetInvestmentIncomeLossRatio" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallStatementFinancialHighlightsAbstract" xlink:to="loc_pallAnnualizedNetInvestmentIncomeLossRatio" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TotalReturnAtNetAssetValue" xlink:label="loc_pallTotalReturnAtNetAssetValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pallStatementFinancialHighlightsAbstract" xlink:to="loc_pallTotalReturnAtNetAssetValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Organization" xlink:title="00000008 - Disclosure - Organization">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/RelatedParties" xlink:title="00000010 - Disclosure - Related Parties">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/ConcentrationOfRisk" xlink:title="00000011 - Disclosure - Concentration of Risk">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/Indemnification" xlink:title="00000012 - Disclosure - Indemnification">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000013 - Disclosure - Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ValuationOfBullionPolicyTextBlock" xlink:label="loc_pallValuationOfBullionPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallValuationOfBullionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ReceivableAndPayablePolicyTextBlock" xlink:label="loc_pallReceivableAndPayablePolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallReceivableAndPayablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsAndRedemptionsOfSharesPolicyTextBlock" xlink:label="loc_pallCreationsAndRedemptionsOfSharesPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallCreationsAndRedemptionsOfSharesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ExpensesPolicyTextBlock" xlink:label="loc_pallExpensesPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_us-gaapSubsequentEventsPolicyPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesTables" xlink:title="00000014 - Disclosure - Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_InvestmentsInBullionTableTextBlock" xlink:label="loc_pallInvestmentsInBullionTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallInvestmentsInBullionTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/OrganizationDetailsNarrative" xlink:title="00000015 - Disclosure - Organization (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:label="loc_pallMinimumBlockOfSharesIssuedRedeemedAgainstBullion" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_pallMinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails" xlink:title="00000016 - Disclosure - The categorization of the Trust&#8217;s assets is as shown below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:label="loc_us-gaapInvestmentInPhysicalCommoditiesFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentInPhysicalCommoditiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails" xlink:title="00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:label="loc_us-gaapInvestmentOwnedBalanceOtherMeasure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentOwnedBalanceOtherMeasure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsOuncesOfBullion" xlink:label="loc_pallCreationsOuncesOfBullion" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallCreationsOuncesOfBullion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RedemptionsOuncesOfBullion" xlink:label="loc_pallRedemptionsOuncesOfBullion" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallRedemptionsOuncesOfBullion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_TransfersOfBullionOunces" xlink:label="loc_pallTransfersOfBullionOunces" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallTransfersOfBullionOunces" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:label="loc_us-gaapInvestmentOwnedBalanceOtherMeasure_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentOwnedBalanceOtherMeasure_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="loc_us-gaapInvestmentInPhysicalCommodities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentInPhysicalCommodities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CreationsValueOfBullion" xlink:label="loc_pallCreationsValueOfBullion" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallCreationsValueOfBullion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:label="loc_pallValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:label="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallRealizedGainLossOnBullionDistributedForRedemptionOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_CostOfBullionTransferredToPayExpenses" xlink:label="loc_pallCostOfBullionTransferredToPayExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallCostOfBullionTransferredToPayExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses" xlink:label="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfTrustAssetsToPayExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_ChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:label="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallChangeInUnrealizedGainLossOnInvestmentInBullion" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInPhysicalCommodities" xlink:label="loc_us-gaapInvestmentInPhysicalCommodities_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentInPhysicalCommodities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000018 - Disclosure - Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_PercentageOfAssetBeingHeldByTrust" xlink:label="loc_pallPercentageOfAssetBeingHeldByTrust" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallPercentageOfAssetBeingHeldByTrust" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_BullionReceivableAtMarketValue" xlink:label="loc_pallBullionReceivableAtMarketValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallBullionReceivableAtMarketValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_BullionPayableAtMarketValue" xlink:label="loc_pallBullionPayableAtMarketValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallBullionPayableAtMarketValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:label="loc_pallMinimumBlockOfSharesIssuedRedeemedAgainstBullion" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallMinimumBlockOfSharesIssuedRedeemedAgainstBullion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_AnnualizedRateOfSponsorsFee" xlink:label="loc_pallAnnualizedRateOfSponsorsFee" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallAnnualizedRateOfSponsorsFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="pall-20221231.xsd#pall_MaximumSponsorFeeForLegalExpenses" xlink:label="loc_pallMaximumSponsorFeeForLegalExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pallMaximumSponsorFeeForLegalExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SponsorFees" xlink:label="loc_us-gaapSponsorFees" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>pall-img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pall-img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %H D8# 2(  A$! Q$!_\0
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M"I_A6G10!F?\(5H__0)TS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\
M0)TS_P !4_PH_P"$*T?_ *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P *
M/^$*T?\ Z!.F?^ J?X5IT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A
M6G10!F?\(5H__0)TS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS
M_P !4_PH_P"$*T?_ *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*
MT?\ Z!.F?^ J?X5IT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10
M!F?\(5H__0)TS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !
M4_PH_P"$*T?_ *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*T?\
MZ!.F?^ J?X5IT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10!F?\
M(5H__0)TS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !4_PH
M_P"$*T?_ *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*T?\ Z!.F
M?^ J?X5IT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10!F?\(5H_
M_0)TS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !4_PH_P"$
M*T?_ *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*T?\ Z!.F?^ J
M?X5IT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10!F?\(5H__0)T
MS_P%3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !4_PH_P"$*T?_
M *!.F?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*T?\ Z!.F?^ J?X5I
MT4 9G_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10!F?\(5H__0)TS_P%
M3_"C_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !4_PH_P"$*T?_ *!.
MF?\ @*G^%:=% &9_PA6C_P#0)TS_ ,!4_P */^$*T?\ Z!.F?^ J?X5IT4 9
MG_"%:/\ ] G3/_ 5/\*/^$*T?_H$Z9_X"I_A6G10!F?\(5H__0)TS_P%3_"C
M_A"M'_Z!.F?^ J?X5IT4 9G_  A6C_\ 0)TS_P !4_PH_P"$*T?_ *!.F?\
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M6,&EV26BX;0-.NIKQ)WN+U(_,-Z8%2+>6WRK OT1X_\ V-/AI\41X_\ [?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1K;2K6:X;5/%Z-,T4"(AD*1QJ6(R1&HSA17UA0 4444 %%%% !1110 4444
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M2_\ @A'\9[/X\_\ !'K]GC7+"&2""Q\&VGAUE?J9=+W:9*WT:2S=A[$5]:4
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M</[0O_!W%^Q[X>NM1GTV#3O"6G>)UDCC$A:32;_7=56+!( $K621L>H#D\D
M5_.QXM\&>)OA3?R:;KNE:[X;N=0ME9[6_M9;.2Y@\S*DHX4LGF19'&-T?JM
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MX9^)-9\-WDDK K=RR7/]J"2/'(41ZE&G/.Z-NV*_36@ HHHH **** .&^/\
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MFHZC]HEXQ'^]U;R1V^5.<MBO[._^"L7_ "BR_:6_[)5XH_\ 31=5_('^QO\
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M+?VE]?\ @YIOB_2;SXG>%M+BUK5O#T;,;NQLY/+V2OQMP?.A. <@31D@!UR
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M1\>->^%O_!9#PAX5TZYE&C?$S2-6TC5[;S6$4B6]A/J$4FSH762T4 GD++(
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MB^\;_&_4?$OA3X>Z?;7=Y9OX(\,7?AI)(I#&3!<:CJ=W+&"#G8ZZC*C#H0S
M\&O[>?VQ_@A=?M-?LB?%3X;V-];Z9>_$'P?J_AJWO)T+Q6DEY936RRNHY*J9
M 2!R0*_C#_X)Z?\ !.7XE_\ !3OXT:GX"^%=KH]WXATC1)=?N$U*_6SB%K'/
M;P,0Y!!;?<Q<>A)[4 ?T"_\ !E3_ ,HLO'W_ &574?\ TT:/3?\ @RKB5_\
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ME:WC;E3YCN6W91CNPH _D3_X)._\I3?V:?\ LJOA?_T[VM?V^5_*7_P<%?\
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MW2?^O*'_ - %:=9G@K_D3=)_Z\H?_0!6G0 4444 %%%% !1110 4444 ?/\
M\.?^4IOQD_[)5X#_ /3OXSKZ KY_^'/_ "E-^,G_ &2KP'_Z=_&=?0% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/X!^/["\\&:/I^IZGJ'B)8+IM*.HB"69S(H \Q(H;2...4#;OOG ;#<^3_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-!I<DJQPQYC-PK:H1'OPH"DD\X/W9_P<D_L]ZY_P3[_9J_82^)?@\Q>)]/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHWPH\ :'X6\.:?;Z1X>\-:?;Z5I=C "(K*U@C6*&) >=J(JJ/85L44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PWQ_\ ^1-MO^OU?_0)
M**/C_P#\B;;?]?J_^@244 =-X*_Y$W2?^O*'_P! %:=9G@K_ )$W2?\ KRA_
M] %:= !1110 4444 %%%% !1110!\_\ PY_Y2F_&3_LE7@/_ -._C.OH"OG_
M .'/_*4WXR?]DJ\!_P#IW\9U] 4 %%%% !1110 4444 %%%% !1110 4444
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MXP>,+6ZTK3+:UC2+3GN$U7S+J-+Q]1NT:4Y1M3E10% SUW_#M/X=?]#'\?\
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MO&__ ,MJ /H"BOG_ /X=I_#K_H8_C_\ ^'V\;_\ RVH_X=I_#K_H8_C_ /\
MA]O&_P#\MJ /H"BOF'4/^"67A6Y^)VD:K!\1/V@;;PY9:7?6E]H7_"Z/&;C4
M;N66S>VN_M!U;S(_L\<-W'Y:_+)]M+-S$E;W_#M/X=?]#'\?_P#P^WC?_P"6
MU 'T!17S_P#\.T_AU_T,?Q__ /#[>-__ );4?\.T_AU_T,?Q_P#_  ^WC?\
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M!17S_P#\.T_AU_T,?Q__ /#[>-__ );4?\.T_AU_T,?Q_P#_  ^WC?\ ^6U
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M;:/M-M'-;>8/FB\_S%^9%K>_X=I_#K_H8_C_ /\ A]O&_P#\MJ /H"BOG_\
MX=I_#K_H8_C_ /\ A]O&_P#\MJ/^':?PZ_Z&/X__ /A]O&__ ,MJ /H"BOG_
M /X=I_#K_H8_C_\ ^'V\;_\ RVH_X=I_#K_H8_C_ /\ A]O&_P#\MJ /H"BO
MF'XC?\$LO"OB;P_;VV@?$3]H'PQ?1ZIIUW+>+\:/&=YYUI#>P37=ILDU;:/M
M-M'-;>8/FB\_S%^9%K>_X=I_#K_H8_C_ /\ A]O&_P#\MJ /H"BOG_\ X=I_
M#K_H8_C_ /\ A]O&_P#\MJ/^':?PZ_Z&/X__ /A]O&__ ,MJ /H"BOG_ /X=
MI_#K_H8_C_\ ^'V\;_\ RVH_X=I_#K_H8_C_ /\ A]O&_P#\MJ /H"BOF7QW
M_P $O/"^LZ39+X=^(?Q]\-:C:ZOIM\]VWQD\8Z@L]K;WT$]U:-%-JQ3%S;QS
M6Q?!,8N"Z@L@KZ:H X;X_P#_ ")MM_U^K_Z!)11\?_\ D3;;_K]7_P! DHH
MZ;P5_P B;I/_ %Y0_P#H K3K,\%?\B;I/_7E#_Z *TZ "BBB@ HHHH ****
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MW\7Q'I^O:[_P@-Q_9=MI<=DUJEM9Z>-5$D<H+-*9I;J;+R2#R]FQ8]#XD?\
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M W2-C+''))-:554Y>=\FQ%+FY%S[VU]0KQ/]IS]I?QE^SSXK\/W4'@#3=<\
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M?_H+:9_X%)_C1_PFNC_]!;3/_ I/\:** #_A-='_ .@MIG_@4G^-'_":Z/\
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M_ I/\:** #_A-='_ .@MIG_@4G^-'_":Z/\ ]!;3/_ I/\:** #_ (371_\
MH+:9_P"!2?XT?\)KH_\ T%M,_P# I/\ &BB@ _X371_^@MIG_@4G^-'_  FN
MC_\ 06TS_P "D_QHHH /^$UT?_H+:9_X%)_C1_PFNC_]!;3/_ I/\:** #_A
M-='_ .@MIG_@4G^-'_":Z/\ ]!;3/_ I/\:** #_ (371_\ H+:9_P"!2?XT
M?\)KH_\ T%M,_P# I/\ &BB@ _X371_^@MIG_@4G^-'_  FNC_\ 06TS_P "
MD_QHHH /^$UT?_H+:9_X%)_C1_PFNC_]!;3/_ I/\:** #_A-='_ .@MIG_@
M4G^-'_":Z/\ ]!;3/_ I/\:** #_ (371_\ H+:9_P"!2?XT?\)KH_\ T%M,
M_P# I/\ &BB@ _X371_^@MIG_@4G^-'_  FNC_\ 06TS_P "D_QHHH /^$UT
M?_H+:9_X%)_C1_PFNC_]!;3/_ I/\:** #_A-='_ .@MIG_@4G^-'_":Z/\
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M_ I/\:** #_A-='_ .@MIG_@4G^-'_":Z/\ ]!;3/_ I/\:** #_ (371_\
MH+:9_P"!2?XT?\)KH_\ T%M,_P# I/\ &BB@ _X371_^@MIG_@4G^-'_  FN
MC_\ 06TS_P "D_QHHH XWXW^(+#5_"EO':7MI=2"[5BD,RNP&QQG /3D?G11
%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>pall-img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pall-img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M/^B<> __  G[3_XW7A$W[3_QAM?'4/P@DNOAS_PM*ZU[[%%XJ7P_>?V -/\
M[+;46N3I?V_[090R_9/*^W $L+C<!FW'O?[-GQ9NOCG\"?"_BR^TV/1]1UBR
M62]L8Y_/CM+A24F1),#>@D5@K$ E<$@$X"T[_P!?UH^J9I?^OZ[_ /#V(_\
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M/VG_ ,;H_P"&CO#_ /T#_'G_ (0^M?\ R)1_PT=X?_Z!_CS_ ,(?6O\ Y$H
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M_P"$_:?_ !NC_AE?X8?]$X\!_P#A/VG_ ,;H_P"&CO#_ /T#_'G_ (0^M?\
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M )$H /\ AE?X8?\ 1./ ?_A/VG_QNC_AE?X8?]$X\!_^$_:?_&Z/^&CO#_\
MT#_'G_A#ZU_\B4?\-'>'_P#H'^//_"'UK_Y$H /^&5_AA_T3CP'_ .$_:?\
MQNC_ (97^&'_ $3CP'_X3]I_\;H_X:.\/_\ 0/\ 'G_A#ZU_\B4?\-'>'_\
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MO#__ $#_ !Y_X0^M?_(E'_#1WA__ *!_CS_PA]:_^1* #_AE?X8?]$X\!_\
MA/VG_P ;H_X97^&'_1./ ?\ X3]I_P#&Z/\ AH[P_P#] _QY_P"$/K7_ ,B4
M?\-'>'_^@?X\_P#"'UK_ .1* #_AE?X8?]$X\!_^$_:?_&Z/^&5_AA_T3CP'
M_P"$_:?_ !NC_AH[P_\ ] _QY_X0^M?_ ")1_P -'>'_ /H'^//_  A]:_\
MD2@ _P"&5_AA_P!$X\!_^$_:?_&Z/^&5_AA_T3CP'_X3]I_\;H_X:.\/_P#0
M/\>?^$/K7_R)1_PT=X?_ .@?X\_\(?6O_D2@ _X97^&'_1./ ?\ X3]I_P#&
MZ/\ AE?X8?\ 1./ ?_A/VG_QNC_AH[P__P! _P >?^$/K7_R)1_PT=X?_P"@
M?X\_\(?6O_D2@ _X97^&'_1./ ?_ (3]I_\ &Z/^&5_AA_T3CP'_ .$_:?\
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M@/\ \)^T_P#C==Y10!P?_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\
M\)^T_P#C==Y10!P?_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T
M_P#C==Y10!P?_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C
M==Y10!P?_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y1
M0!P?_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?
M_#*_PP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?_#*_
MPP_Z)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?_#*_PP_Z
M)QX#_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?_#*_PP_Z)QX#
M_P#"?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?_#*_PP_Z)QX#_P#"
M?M/_ (W1_P ,K_##_HG'@/\ \)^T_P#C==Y10!P?_#*_PP_Z)QX#_P#"?M/_
M (W7XQ_\)!?_ //]>?\ ?YO\:_=BOP;H _:C]E?_ )-A^''_ &*^F?\ I)%4
M_P ;/A3K7Q8T>QM=%^(_C3X</:SF6>X\-V^E2S7Z%2/)D_M"RNE5.<YB$;Y'
MW\<5!^RO_P FP_#C_L5],_\ 22*N\I.*>C_K^NW7J%[;'A-G^PS'I5W9I8_$
M[XC6.C>&[/[-X/T>.'16L_!$HM&LTNK,OI[33S)!)*J_;Y+M,S,Q1F"E=*3]
MB+PQ/\$=2\!3:QXJN=+\437-QXLO+F\CN-2\7R7-L]O,UW<21,Z$[HV3[+Y'
MD_9H(X?*AC$->R457,W^5^N]]]]7OWLK[*Q'1W73_AOPUMVN[6N[^ W'[ =G
M=>$+59/B5\26\>V>N?\ "0Q_$#_B4_\ "0"Z^QFPP8_L']G&,V3&W,9L]N#Y
MF//_ 'U>R?#?X?:7\)_A_HOAG187M])T&SBL;1'D,CB.-0HW.W+,<9+'))))
MY-;5%/F?Y?@K+_AA<J5O+3]?Z['!^(?^3GO!_P#V*^N?^E>CUWE<'XA_Y.>\
M'_\ 8KZY_P"E>CUWE2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *_!NOWDK\&Z /VH_97_Y-A^''_8KZ9_Z215WE<'^RO_R;#\./^Q7T
MS_TDBKO* "BBB@ HHHH X/Q#_P G/>#_ /L5]<_]*]'KO*X/Q#_R<]X/_P"Q
M7US_ -*]'KO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "OP;K]Y*_!N@#]J/V5_^38?AQ_V*^F?^DD5=Y7!_LK_ /)L/PX_[%?3/_22
M*N\H **** "BBB@#@_$/_)SW@_\ [%?7/_2O1Z[RN#\0_P#)SW@__L5]<_\
M2O1Z[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\&Z
M_>2OP;H _:C]E?\ Y-A^''_8KZ9_Z215WE<'^RO_ ,FP_#C_ +%?3/\ TDBK
MO* "BBB@ HHHH X/Q#_R<]X/_P"Q7US_ -*]'KO*X/Q#_P G/>#_ /L5]<_]
M*]'KO* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"KJ&LPZ9=V,,F[S-1G-O
M#@9&X1R2\^@VQM^.*M5Y#^T7,\7Q3^&.UF7=JI!P<9_>VX_D2/QKUZ@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"%O^(/^B5^//\ P+T7_P"6%=Y10!P?_"W_ !!_T2OQY_X%Z+_\L*/^%O\
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M_P"%O^(/^B5^//\ P+T7_P"6%=Y10!P?_"W_ !!_T2OQY_X%Z+_\L*/^%O\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\&Z_>2OP;H _:C]E?\
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M:/ USI_[ _[+>N/'##'=>%+&$-_RTGC;0H-F<?PJT$O!/!.0.<U]V4 %%%%
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M3[3:GS$7<R>8F63<AW<,>:^V:_'O_@W6^(G@KX._';]J_P#9W\.Z?;^']/\
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M.ZUT=M+/2Z/TAHK\S[X? VVN[":&Y^''_#%MYX[ G4261^'_ -J_X1]\;O\
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M_P#0G^ __"ON_P#Y64 =Y17!_P#"0_$__H3_  '_ .%?=_\ RLH_X2'XG_\
M0G^ _P#PK[O_ .5E '>45P?_  D/Q/\ ^A/\!_\ A7W?_P K*/\ A(?B?_T)
M_@/_ ,*^[_\ E90!WE%<'_PD/Q/_ .A/\!_^%?=__*RC_A(?B?\ ]"?X#_\
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M_H3_  '_ .%?=_\ RLH_X2'XG_\ 0G^ _P#PK[O_ .5E '>45P?_  D/Q/\
M^A/\!_\ A7W?_P K*/\ A(?B?_T)_@/_ ,*^[_\ E90!WE%<'_PD/Q/_ .A/
M\!_^%?=__*RC_A(?B?\ ]"?X#_\ "ON__E90!WE%<'_PD/Q/_P"A/\!_^%?=
M_P#RLH_X2'XG_P#0G^ __"ON_P#Y64 =Y17!_P#"0_$__H3_  '_ .%?=_\
MRLH_X2'XG_\ 0G^ _P#PK[O_ .5E '>45P?_  D/Q/\ ^A/\!_\ A7W?_P K
M*/\ A(?B?_T)_@/_ ,*^[_\ E90!WE%<'_PD/Q/_ .A/\!_^%?=__*RC_A(?
MB?\ ]"?X#_\ "ON__E90!WE%<'_PD/Q/_P"A/\!_^%?=_P#RLH_X2'XG_P#0
MG^ __"ON_P#Y64 =Y17!_P#"0_$__H3_  '_ .%?=_\ RLH_X2'XG_\ 0G^
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M44 %%%% '!^(?^3GO!__ &*^N?\ I7H]=Y7!^(?^3GO!_P#V*^N?^E>CUWE
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M,%S91R-FXMKJ^2[MSE0P9+I_(? VED !;@GGU^+]OX<_:)L-'TSQ):6_P_\
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M)96/B?58XK<#.U5$OG/\H!;<@8L$3;]B5\O_ /!'K_DR%?\ LH'CW_U,M:H
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MXC_98MFTG]D#X\:;,-MU8_&CQB\J^@N?$LUY%^<-S$?QH ^M+V]W_&G3;?\
MYY:)=R?]]3VP_P#9:ZBO&_"GC>/XH?%RQUJ&TEAMK.]72X96&5D(MM0>3:WN
M/))'^[GL:]DH **** *FLZC-I=GYD&GW>I/N"^5;M$K@>O[QT7'XYYZ5E?\
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MQ%^*GACX/^'X]6\7>)-!\+Z7+<PV27FKZA%8V[SS.$BB$DK*ID=R%5<Y8D
MFCR#S-ZBN+U3]I'X=Z'\4Y/ M[X]\%V?C:'3VU:3P_/K=M'JL=FH+-<FV+^:
M(0JDF0KM !.>*N?"KXW>"_CKX%C\4>"/%WA?QEX9F:1(]7T/58-0L7:,D2 3
MPLT9*D$$9X(YI75K]M?E>WYJWJ'E_6U_RU]#J**\]7]KCX4M\%6^)0^)WP]/
MPYCD\IO%0\1V?]BJ_F^3M-YYGDY\W]WC?G?\O7BN^MKJ.]MHYH9(YH9E#HZ,
M&5U(R""."".]59A_7W;_ ''#^(?^3GO!_P#V*^N?^E>CUWE<'XA_Y.>\'_\
M8KZY_P"E>CUWE( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** (;O4;>P5C//#"%C:4F1PN$7&YN>PR,GH,BOE_\
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M_P#+.N\HH X/_A'OB?\ ]#AX#_\ "0N__EG1_P (]\3_ /H</ ?_ (2%W_\
M+.N\HH X/_A'OB?_ -#AX#_\)"[_ /EG1_PCWQ/_ .AP\!_^$A=__+.N\HH
MX/\ X1[XG_\ 0X> _P#PD+O_ .6='_"/?$__ *'#P'_X2%W_ /+.N\HH X/_
M (1[XG_]#AX#_P#"0N__ )9T?\(]\3_^AP\!_P#A(7?_ ,LZ[RB@#@_^$>^)
M_P#T.'@/_P )"[_^6='_  CWQ/\ ^AP\!_\ A(7?_P LZ[RB@#@_^$>^)_\
MT.'@/_PD+O\ ^6='_"/?$_\ Z'#P'_X2%W_\LZ[RB@#@_P#A'OB?_P!#AX#_
M /"0N_\ Y9T?\(]\3_\ H</ ?_A(7?\ \LZ[RB@#@_\ A'OB?_T.'@/_ ,)"
M[_\ EG1_PCWQ/_Z'#P'_ .$A=_\ RSKO** .#_X1[XG_ /0X> __  D+O_Y9
MT?\ "/?$_P#Z'#P'_P"$A=__ "SKO** .#_X1[XG_P#0X> __"0N_P#Y9T?\
M(]\3_P#H</ ?_A(7?_RSKO** .#_ .$>^)__ $.'@/\ \)"[_P#EG1_PCWQ/
M_P"AP\!_^$A=_P#RSKO** .#_P"$>^)__0X> _\ PD+O_P"6='_"/?$__H</
M ?\ X2%W_P#+.N\HH X/_A'OB?\ ]#AX#_\ "0N__EG1_P (]\3_ /H</ ?_
M (2%W_\ +.N\HH X/_A'OB?_ -#AX#_\)"[_ /EG1_PCWQ/_ .AP\!_^$A=_
M_+.N\HH X/\ X1[XG_\ 0X> _P#PD+O_ .6='_"/?$__ *'#P'_X2%W_ /+.
MN\HH X/_ (1[XG_]#AX#_P#"0N__ )9T?\(]\3_^AP\!_P#A(7?_ ,LZ[RB@
M#@_^$>^)_P#T.'@/_P )"[_^6='_  CWQ/\ ^AP\!_\ A(7?_P LZ[RB@#@_
M^$>^)_\ T.'@/_PD+O\ ^6='_"/?$_\ Z'#P'_X2%W_\LZ[RB@#@_P#A'OB?
M_P!#AX#_ /"0N_\ Y9T?\(]\3_\ H</ ?_A(7?\ \LZ[RB@#@_\ A'OB?_T.
M'@/_ ,)"[_\ EG1_PCWQ/_Z'#P'_ .$A=_\ RSKO** .#_X1[XG_ /0X> __
M  D+O_Y9T?\ "/?$_P#Z'#P'_P"$A=__ "SKO** .#_X1[XG_P#0X> __"0N
M_P#Y9T?\(]\3_P#H</ ?_A(7?_RSKO** .#_ .$>^)__ $.'@/\ \)"[_P#E
MG1_PCWQ/_P"AP\!_^$A=_P#RSKO** .#_P"$>^)__0X> _\ PD+O_P"6='_"
M/?$__H</ ?\ X2%W_P#+.N\HH X/_A'OB?\ ]#AX#_\ "0N__EG1_P (]\3_
M /H</ ?_ (2%W_\ +.N\HH X/_A'OB?_ -#AX#_\)"[_ /EG1_PCWQ/_ .AP
M\!_^$A=__+.N\HH X/\ X1[XG_\ 0X> _P#PD+O_ .6='_"/?$__ *'#P'_X
M2%W_ /+.N\HH X/_ (1[XG_]#AX#_P#"0N__ )9T?\(]\3_^AP\!_P#A(7?_
M ,LZ[RB@#@_^$>^)_P#T.'@/_P )"[_^6='_  CWQ/\ ^AP\!_\ A(7?_P L
MZ[RB@#@_^$>^)_\ T.'@/_PD+O\ ^6='_"/?$_\ Z'#P'_X2%W_\LZ[RB@#@
M_P#A'OB?_P!#AX#_ /"0N_\ Y9T?\(]\3_\ H</ ?_A(7?\ \LZ[RB@#@_\
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M.!CA7[:Z& NS-M7$JX.[[Q^$0^S?\')GC^'[OG?#;5;O;_>W#P5'O_'R=O\
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M\3_^AP\!_P#A(7?_ ,LZ[RB@#@_^$>^)_P#T.'@/_P )"[_^6='_  CWQ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y?\
MM _:/$;-86SR6R^&;)O$LT_E;E=X]PAASN&-VV8DD'&P8SS7J%>!_M7?M-^!
M_P!GM=4;QEKJZ&OC:33O >AM):SR+J&MW<=]);V2F-& =T(.YL(H(W,,B@#X
MU_X*.^%?"_[7_P 6)/"NM0V>L:#X67P9IGB+3S<9:_M/&7Q,T%D@F\MM\;"R
M\.H<95PEY&?[I'ZC5\F_\$__ (6^';SXL?M-7UQI/A[5[F7XDZ-I\NII:Q7
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MR@ HHHH **** "BBB@ K\VOV[?V)/%=[_P %\_V6?C_;ZSHZ>#[ZW7X;SZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKTG0M)NK&TNK#QIX4\2.]VS+&T&E>(M.U2=!M5CYCPV<BH,8+LH)498?/O\
MP;P_#F/X6?\ !%O]G_3(C,RW6@2:N?-/S;KZ\N+UL<#Y<W!Q[8Y/4@'VA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?@W7
M[R5^#= '[4?LK_\ )L/PX_[%?3/_ $DBKO*X/]E?_DV'X<?]BOIG_I)%7>4
M%%%% !1110!P?B'_ ).>\'_]BOKG_I7H]=Y7!^(?^3GO!_\ V*^N?^E>CUWE
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"":7[%FG^$9+<:;J_B@:9XDU[25D\]='UAM!TJRU*(3>;()@]Y8W%QN0A
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MBBB@ HHHH **** "BBB@ HHHH **** "OP;K]Y*_!N@#]J/V5_\ DV'X<?\
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M":+_ /*^@#O**X/_ (5!X@_Z*IX\_P# 31?_ )7T?\*@\0?]%4\>?^ FB_\
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M_"H/$'_15/'G_@)HO_ROH [RBN#_ .%0>(/^BJ>//_ 31?\ Y7T?\*@\0?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5^#=?O)7X-T ?M1^RO_P F
MP_#C_L5],_\ 22*N\K@_V5_^38?AQ_V*^F?^DD5=Y0 4444 %%%% '!^(?\
MDY[P?_V*^N?^E>CUWE<'XA_Y.>\'_P#8KZY_Z5Z/7>4 %%%% !1110 4444
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M= '[4?LK_P#)L/PX_P"Q7TS_ -)(J[RN#_97_P"38?AQ_P!BOIG_ *215WE
M!1110 4444 <'XA_Y.>\'_\ 8KZY_P"E>CUWE<'XA_Y.>\'_ /8KZY_Z5Z/7
M>4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "<]X/\ ^Q7US_TKT>N\J0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJO::K;WUW=0
M0S+)-8N(YT'6)BJN ?JK _C5B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHK ^(/B630]$\NSNK6WU*ZN+:TA,H#F,SSK%OV9&[ +L
M!T.P]@: ,;XA_$"QE^!'BK6YKJ'3;&ULM0C>ZGG6.*%8C+%YK.<!5^3=DD
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M0    ,5<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYTVW$Q#R.EY%<1*HW,PA)&0-U 'HG_#./A__ *"/CS_PN-:_^2Z/^&<?#_\
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MNC_AG'P__P!!'QY_X7&M?_)==Y10!P?_  SCX?\ ^@CX\_\ "XUK_P"2Z/\
MAG'P_P#]!'QY_P"%QK7_ ,EUWE% '!_\,X^'_P#H(^//_"XUK_Y+H_X9Q\/_
M /01\>?^%QK7_P EUWE% '!_\,X^'_\ H(^//_"XUK_Y+H_X9Q\/_P#01\>?
M^%QK7_R77>44 <'_ ,,X^'_^@CX\_P#"XUK_ .2Z/^&<?#__ $$?'G_A<:U_
M\EUWE% '!_\ #./A_P#Z"/CS_P +C6O_ )+H_P"&<?#_ /T$?'G_ (7&M?\
MR77>44 <'_PSCX?_ .@CX\_\+C6O_DNC_AG'P_\ ]!'QY_X7&M?_ "77>44
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M+\6;[45ETO1_"#>(Y7TB2.XF\MK,W"M -X#DK\R?, P&<XYH ZS_ (9Q\/\
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M )+KO** .#_X9Q\/_P#01\>?^%QK7_R71_PSCX?_ .@CX\_\+C6O_DNN\HH
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M.WCAAC2**)0B(B[511P  .@'I0!PW_#./A__ *"/CS_PN-:_^2Z/^&<?#_\
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M\+C6O_DNC_AG'P__ -!'QY_X7&M?_)==Y10!P?\ PSCX?_Z"/CS_ ,+C6O\
MY+H_X9Q\/_\ 01\>?^%QK7_R77>44 <'_P ,X^'_ /H(^//_  N-:_\ DNC_
M (9Q\/\ _01\>?\ A<:U_P#)==Y10!P?_#./A_\ Z"/CS_PN-:_^2ZZ#P3\/
M-/\  $5PEC<:Y<+=%6?^TM:O-3*XSC:;F60IUY"XSQG.!6Y10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X-U^\E?@W0
M!^U'[*__ ";#\./^Q7TS_P!)(J[RN#_97_Y-A^''_8KZ9_Z215WE !1110 4
M444 <'XA_P"3GO!__8KZY_Z5Z/7>5P?B'_DY[P?_ -BOKG_I7H]=Y0 4444
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MVVQHJY9BQQDDGFMZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9?$#7-.EOI+SXD:_%XCU19Y%:.*YCTNPTQ5A 4%8_(TZ D,6.]I#G!"KUU%
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M5GT^\>Q1[N[F%QY<5M+!:H9;6Z5IXT2.6;ZN\.:_:^*_#UCJEB[26>I6\=U
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M1]<?\,K_  P_Z)QX#_\ "?M/_C='_#*_PP_Z)QX#_P#"?M/_ (W0!P/[+O\
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M?M/_ (W0!WE9?@CQ=9_$#P7H^O:?YGV#6[*&_MO,7:_E2HLB;AV.UAD5R_\
MPRO\,/\ HG'@/_PG[3_XW63X#_8V^'/A'P-HNDWG@GP7K%YI=C!:3W]QH%KY
MU\\<:HTSY5CN<@L<DG)/)ZT >I45P?\ PRO\,/\ HG'@/_PG[3_XW1_PRO\
M##_HG'@/_P )^T_^-T =Y17!_P##*_PP_P"B<> __"?M/_C='_#*_P ,/^B<
M> __  G[3_XW0!WE%<'_ ,,K_##_ *)QX#_\)^T_^-T?\,K_  P_Z)QX#_\
M"?M/_C= '4:!XNL_$FJZY9VWF>=X?O5L+O<N!YK6T%R-I[CR[B/GUR.U:E>6
M^'?V-OASHNL:]<S^"?!=]'J]^MW;PR:!:[=/06T$)A3*GY2\+R\ #=,W&<DZ
MW_#*_P ,/^B<> __  G[3_XW0!WE%<'_ ,,K_##_ *)QX#_\)^T_^-T?\,K_
M  P_Z)QX#_\ "?M/_C= '>45P?\ PRO\,/\ HG'@/_PG[3_XW1_PRO\ ##_H
MG'@/_P )^T_^-T =Y67:>+K.]\::AH*>9]OTVRMK^;*_)Y5P]Q''@]SNMI<C
MMQZUR_\ PRO\,/\ HG'@/_PG[3_XW639_L;?#FV\<ZCJS>"?!<MG>V-K:16#
M:!:^3;/#)<N\R_+C=()T5L '$"9)X  /4J*X/_AE?X8?]$X\!_\ A/VG_P ;
MH_X97^&'_1./ ?\ X3]I_P#&Z .\HK@_^&5_AA_T3CP'_P"$_:?_ !NC_AE?
MX8?]$X\!_P#A/VG_ ,;H [RBN#_X97^&'_1./ ?_ (3]I_\ &Z/^&5_AA_T3
MCP'_ .$_:?\ QN@#J-?\76?AO5=#L[GS/.\07K6%IM7(\U;:>Y.X]AY=O)SZ
MX'>M2O+?$7[&WPYUK6-!N8/!/@NQCTB_:[N(8] M=NH(;:>$0OA1\H>9)>01
MNA7C."-;_AE?X8?]$X\!_P#A/VG_ ,;H [RBN#_X97^&'_1./ ?_ (3]I_\
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M!,D\ :W_  RO\,/^B<> _P#PG[3_ .-T =Y17!_\,K_##_HG'@/_ ,)^T_\
MC='_  RO\,/^B<> _P#PG[3_ .-T =Y17!_\,K_##_HG'@/_ ,)^T_\ C='_
M  RO\,/^B<> _P#PG[3_ .-T =Y67K_BZS\-ZKH=G<^9YWB"]:PM-JY'FK;3
MW)W'L/+MY.?7 [UR_P#PRO\ ##_HG'@/_P )^T_^-UD^(OV-OASK6L:#<P>"
M?!=C'I%^UW<0QZ!:[=00VT\(A?"CY0\R2\@C="O&<$ 'J5%<'_PRO\,/^B<>
M _\ PG[3_P"-T?\ #*_PP_Z)QX#_ /"?M/\ XW0!WE%<'_PRO\,/^B<> _\
MPG[3_P"-T?\ #*_PP_Z)QX#_ /"?M/\ XW0!WE%<'_PRO\,/^B<> _\ PG[3
M_P"-T?\ #*_PP_Z)QX#_ /"?M/\ XW0!U'C?Q=9_#_P7K&O:AYGV#1+*:_N?
M+7<_E1(TC[1W.U3@5J5Y;X\_8V^'/B[P-K6DV?@GP7H]YJEC/:07]OH%KYUB
M\D;(LR853N0D,,$'('(ZUK?\,K_##_HG'@/_ ,)^T_\ C= '>45P?_#*_P ,
M/^B<> __  G[3_XW1_PRO\,/^B<> _\ PG[3_P"-T =Y17!_\,K_  P_Z)QX
M#_\ "?M/_C='_#*_PP_Z)QX#_P#"?M/_ (W0!WE%<'_PRO\ ##_HG'@/_P )
M^T_^-T?\,K_##_HG'@/_ ,)^T_\ C= '4>$/%UGXVTJ:\L?,\F&]N[!O,7:?
M-MKF2VEX]/,B?![C!K4KRWP9^QM\.?#&CS6UUX)\%ZK))?WEVLT^@6NY$GN9
M9DA&5/RQ)(L2\XVQC  P!K?\,K_##_HG'@/_ ,)^T_\ C= '>45P?_#*_P ,
M/^B<> __  G[3_XW1_PRO\,/^B<> _\ PG[3_P"-T =Y17!_\,K_  P_Z)QX
M#_\ "?M/_C='_#*_PP_Z)QX#_P#"?M/_ (W0!WE9=IXNL[WQIJ&@IYGV_3;*
MVOYLK\GE7#W$<>#W.ZVER.W'K7+_ /#*_P ,/^B<> __  G[3_XW5CX>? K0
M/A5XYUK5O#NFZ3H=GK5C96DEAIUA':0J]O)=.9CY> S.+D*<C($0Y.<  [2B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_!
MNOWDK\&Z /VH_97_ .38?AQ_V*^F?^DD5=Y7!_LK_P#)L/PX_P"Q7TS_ -)(
MJ[R@ HHHH *X'X]?'S2_@?X<FEN5U"YU)]/N]0M[:RTJZU.58;<1B6X:"V1Y
MGBC>: .(U9_W@VJ2:J?M#?M5>%_V9["TGU^#Q)J#723W#PZ'HMSJLUI:VXC:
MYNYD@1BD$(EB+L?^>B !BP!^+/B_\,?B)\2/VC_"=U9^-/''@GXD>%/%<DFG
MSEVU#0?%^AWLQBCU'36F5X5>"WN(3>:<IC5X[:9O+4BTO(P#V+]A+]K+QI\:
M_B'H\M[_ ,)-K7@'QYX:EUK3K_6].LK6?2-0MY+=9K:">T5(+^QFCN4DAN(U
M;'E.#+)O B^NJ\]_9\^ =O\ !#PP]O))I=QJ5U>WNH3/INGMI]A!+>2K/<BV
MMFEF:&.29?-93*^9'<Y (4>A4 %%%% !117._%7XHZ7\'/ UYX@U9=0FM;,Q
M1K!86<EY=W4LLJ0Q110Q@N[O+)&@ '5QD@9( '?%/XI:%\%?A_JGBKQ-??V;
MH.BQ">]N_)DF%O'N"[RL:LVT9!) X&2< $U\M_%O]L'QIX%^,6L76EZS:75I
MX=\K6XO"UU;V_P!C\>>%I(8Y)=1T2\4!WOK;,V^!I)%?RT!2);F":L3XW_'+
MQ)\2]=L_%'AGQ%XR\"Z/K$87PGXDN[2[71]#UJUGEMKS0_$FF,-L5M-)&%%S
M(@96,JI/$PM_,]N_97_9PM?!'AB.^^SWFE>%=>ALM>T[P!J$$-Q:>!]1=3-<
MK:NT8DC02.-L((2%UE,857"1@'N-%%% !1110 44V:=+:,O(ZQH,99C@#/%?
M'OQM_:RA_: T"&\\'V/Q:?PSH)C?Q3;:-8:CHGB.VTR_1_[/\0Z=$$66]ACE
MM91Y*JXD0SDPR-$(F /1O%W[3&N>*_"^B?$_X43:?\1?AYI+W5IXG\/6%E)_
M;LVV14DEM=Q5A=6AC?=921J\RR2 ,)%B5_8?AG\3= ^,G@+2_%'A?5;36_#^
MM0+<V5];-NBN(SW'<$'((."I!! ((KYU_8]^$6O>*?$=G\1I?&7_ !-A<3:7
MXCU71K.*+2_BM911I_9VI30,FVWO(XV2*62$*=\,T/,:0B+ZCM+2*PM8X((H
MX8(4$<<<:A5C4#   X  XP* )**** "BBB@ KR/XI_$*Z^+/BK5/AO\ #WQ]
M9>$O&^@SVMSX@E.GI=:AIFGS0R21S6T-PIAE\R18H_,*R(H,H^^H YK]H?\
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M(_!#Q_\ $'P7\1_^%>_$#3[K7(?+N9-&\<&6SB;Q"(S'(RSV-N!]E9$F$:N
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M+"YU/1-3L9&E>"[M?(FF69&)*V=W 8XVFC,WL<%SX=_:>TJSU*\M_$EGH7Q
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M:H &YV)9VP.68EB>22>:N44 %%%% !1110 5\TWWPT^(?PPOM=^&\<FK^//
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%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030064055840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">abrdn
Palladium ETF Trust<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001459862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-4733157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1900
Market Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">383-7289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">abrdn
    Physical Palladium Shares ETF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PALL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEArca<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339,320,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New
York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030064021408">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statements of Assets and Liabilities - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInPhysicalCommodities', window );">Investment in palladium (cost: December 31, 2022: $334,209; December 31, 2021: $334,434)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 295,638,000<span></span>
</td>
<td class="nump">$ 358,161,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">295,638,000<span></span>
</td>
<td class="nump">358,161,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Fees payable to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146,803<span></span>
</td>
<td class="nump">189,455<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">147,000<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">NET ASSETS</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 295,491,000<span></span>
</td>
<td class="nump">$ 357,971,000<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Authorized
    share capital is <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20220101__20221231_z7eyZpVVt1pd" title="Common stock, shares authorized::XDX::Unlimited"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20210101__20211231_zVrHC2cowuCj" title="::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0074"><span style="-sec-ix-hidden: xdx2ixbrl0075">unlimited</span></span></span></span> with <span id="xdx_90E_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20221231_zrgnOraAZenk" title="Common stock, no par value (in dollars per share)"><span id="xdx_908_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20211231_zcBNPMoO3Nm5">no</span></span> par value per Share. Shares issued and outstanding at December 31, 2022 were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zI71TChXSDha" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zsgDKQ89FR91" title="Common stock, shares outstanding">1,800,000</span></span>
    and at December 31, 2021 were <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zeK3V8mFcFP8"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zkvXQs821sIb">1,950,000</span></span>. Net asset values per Share at December 31, 2022 and December 31, 2021 were $<span id="xdx_90C_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20221231_zSmno3ZdzZv3" title="Net asset value per share (in dollars per share)">164.16</span>
    and $<span id="xdx_90F_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20211231_zWGkOMZkRWs6">183.58</span>, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInPhysicalCommodities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments held in physical commodities, such as gold, silver, platinum, crude oil, coal, sugar, rice, wheat.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInPhysicalCommodities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030058743088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Assets and Liabilities (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyAbstract', window );"><strong>Investment Company [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Investment in palladium at cost</a></td>
<td class="nump">$ 334,209<span></span>
</td>
<td class="nump">$ 334,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorizedUnlimited', window );">Common stock, shares authorized</a></td>
<td class="text">Unlimited<span></span>
</td>
<td class="text">Unlimited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,950,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net asset value per share (in dollars per share)</a></td>
<td class="nump">$ 164.16<span></span>
</td>
<td class="nump">$ 183.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorizedUnlimited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is "Unlimited".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorizedUnlimited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:authorizedUnlimitedItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL7495116-110257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 59<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL6740821-110257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030058764512">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedules of Investments<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Investment in palladium | oz</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">166,556.4<span></span>
</td>
<td class="nump">181,531.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 334,209<span></span>
</td>
<td class="nump">$ 334,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 295,638<span></span>
</td>
<td class="nump">$ 358,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">% of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.05%<span></span>
</td>
<td class="nump">100.05%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities', window );">Less liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (147)<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets', window );">Less liabilities, % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.05%)<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 295,491<span></span>
</td>
<td class="nump">$ 357,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_NetAssetsPercentageOfNetAssets', window );">Net Assets, % of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XPD', window );">Palladium Ounces</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Investment in palladium | oz</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">166,556.4<span></span>
</td>
<td class="nump">181,531.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 334,209<span></span>
</td>
<td class="nump">$ 334,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 295,638<span></span>
</td>
<td class="nump">$ 358,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">% of Net Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.05%<span></span>
</td>
<td class="nump">100.05%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Authorized
    share capital is <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20220101__20221231_z7eyZpVVt1pd" title="Common stock, shares authorized::XDX::Unlimited"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20210101__20211231_zVrHC2cowuCj" title="::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0074"><span style="-sec-ix-hidden: xdx2ixbrl0075">unlimited</span></span></span></span> with <span id="xdx_90E_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20221231_zrgnOraAZenk" title="Common stock, no par value (in dollars per share)"><span id="xdx_908_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20211231_zcBNPMoO3Nm5">no</span></span> par value per Share. Shares issued and outstanding at December 31, 2022 were <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zI71TChXSDha" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zsgDKQ89FR91" title="Common stock, shares outstanding">1,800,000</span></span>
    and at December 31, 2021 were <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zeK3V8mFcFP8"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zkvXQs821sIb">1,950,000</span></span>. Net asset values per Share at December 31, 2022 and December 31, 2021 were $<span id="xdx_90C_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20221231_zSmno3ZdzZv3" title="Net asset value per share (in dollars per share)">164.16</span>
    and $<span id="xdx_90F_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20211231_zWGkOMZkRWs6">183.58</span>, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_NetAssetsPercentageOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Assets, Percentage of Net Assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_NetAssetsPercentageOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceOtherMeasure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Quantity of the investment. Indicate the measure in the unit of measure. This is commonly used for investments other than securities. For example, if the investment is gold, the balance would be the number of ounces and the unit of measure would indicate "ounces".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceOtherMeasure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net of non investment assets and liabilities. This amount represents the difference between the aggregate value of the investments, including long and short positions, and net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percent of net assets of non investment assets and liabilities. This represents the percentage difference between the investments, including long and short positions, and net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XPD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XPD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030064288944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ExpensesAbstract', window );"><strong>EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Sponsor&#8217;s Fee</a></td>
<td class="nump">$ 2,226,662<span></span>
</td>
<td class="nump">$ 2,447,225<span></span>
</td>
<td class="nump">$ 2,012,865<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total expenses</a></td>
<td class="nump">2,227,000<span></span>
</td>
<td class="nump">2,447,000<span></span>
</td>
<td class="nump">2,013,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_NetInvestmentGainLoss', window );">Net investment loss</a></td>
<td class="num">(2,227,000)<span></span>
</td>
<td class="num">(2,447,000)<span></span>
</td>
<td class="num">(2,013,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingGainsLossesAbstract', window );"><strong>REALIZED AND UNREALIZED GAINS / (LOSSES)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses', window );">Realized gain on palladium transferred to pay expenses</a></td>
<td class="nump">155,000<span></span>
</td>
<td class="nump">743,000<span></span>
</td>
<td class="nump">773,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares', window );">Realized gain on palladium distributed for the redemption of Shares</a></td>
<td class="nump">3,889,000<span></span>
</td>
<td class="nump">37,317,000<span></span>
</td>
<td class="nump">60,188,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion', window );">Change in unrealized gain / (loss) on investment in palladium</a></td>
<td class="num">(62,298,000)<span></span>
</td>
<td class="num">(108,531,000)<span></span>
</td>
<td class="nump">1,660,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_TotalGainLossOnBullion', window );">Total gain / (loss) on investment in palladium</a></td>
<td class="num">(58,254,000)<span></span>
</td>
<td class="num">(70,471,000)<span></span>
</td>
<td class="nump">62,621,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Change in net assets from operations</a></td>
<td class="num">$ (60,481,000)<span></span>
</td>
<td class="num">$ (72,918,000)<span></span>
</td>
<td class="nump">$ 60,608,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net increase / (decrease) in net assets per Share</a></td>
<td class="num">$ (32.12)<span></span>
</td>
<td class="num">$ (39.95)<span></span>
</td>
<td class="nump">$ 37.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Shares</a></td>
<td class="nump">1,882,740<span></span>
</td>
<td class="nump">1,825,342<span></span>
</td>
<td class="nump">1,615,779<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrealized gain (loss) on investment in Bullion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ChangeInUnrealizedGainLossOnInvestmentInBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_NetInvestmentGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net investment gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_NetInvestmentGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized gain or loss during the period on bullion distributed for the redemption of Shares. Realized gains or losses are calculated on a trade date basis using average cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_TotalGainLossOnBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain or loss in the period on bullion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_TotalGainLossOnBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingGainsLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingGainsLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030061373200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Changes in Net Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Opening balance (in shares)</a></td>
<td class="nump">1,950,000<span></span>
</td>
<td class="nump">1,625,000<span></span>
</td>
<td class="nump">1,675,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Opening balance</a></td>
<td class="nump">$ 357,971<span></span>
</td>
<td class="nump">$ 356,238<span></span>
</td>
<td class="nump">$ 300,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_NetInvestmentGainLoss', window );">Net investment loss</a></td>
<td class="num">(2,227)<span></span>
</td>
<td class="num">(2,447)<span></span>
</td>
<td class="num">(2,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized gain on investment in palladium</a></td>
<td class="nump">4,044<span></span>
</td>
<td class="nump">38,060<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion', window );">Change in unrealized (loss)/gain on investment in palladium</a></td>
<td class="num">$ (62,298)<span></span>
</td>
<td class="num">$ (108,531)<span></span>
</td>
<td class="nump">$ 1,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Creations (in shares)</a></td>
<td class="nump">625,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Creations</a></td>
<td class="nump">$ 145,623<span></span>
</td>
<td class="nump">$ 205,730<span></span>
</td>
<td class="nump">$ 150,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemptions (in shares)</a></td>
<td class="num">(775,000)<span></span>
</td>
<td class="num">(575,000)<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemptions</a></td>
<td class="num">$ (147,622)<span></span>
</td>
<td class="num">$ (131,079)<span></span>
</td>
<td class="num">$ (155,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Closing balance (in Shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,950,000<span></span>
</td>
<td class="nump">1,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Closing balance</a></td>
<td class="nump">$ 295,491<span></span>
</td>
<td class="nump">$ 357,971<span></span>
</td>
<td class="nump">$ 356,238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrealized gain (loss) on investment in Bullion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ChangeInUnrealizedGainLossOnInvestmentInBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_NetInvestmentGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net investment gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_NetInvestmentGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030061429632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract', window );"><strong>Per Share Performance (for a Share outstanding throughout the entire period)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net asset value per Share at beginning of period</a></td>
<td class="nump">$ 183.58<span></span>
</td>
<td class="nump">$ 219.22<span></span>
</td>
<td class="nump">$ 179.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_IncomeFromInvestmentOperationsAbstract', window );"><strong>Income from investment operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_NetInvestmentIncomLossPerShare', window );">Net investment loss</a></td>
<td class="num">(1.18)<span></span>
</td>
<td class="num">(1.34)<span></span>
</td>
<td class="num">(1.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare', window );">Total realized and unrealized gains or losses on investment in palladium</a></td>
<td class="num">(18.24)<span></span>
</td>
<td class="num">(34.30)<span></span>
</td>
<td class="nump">41.08<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ChangeInNetAssetsFromOperationsPerShare', window );">Change in net assets from operations</a></td>
<td class="num">(19.42)<span></span>
</td>
<td class="num">(35.64)<span></span>
</td>
<td class="nump">39.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net asset value per Share at end of period</a></td>
<td class="nump">$ 164.16<span></span>
</td>
<td class="nump">$ 183.58<span></span>
</td>
<td class="nump">$ 219.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Shares</a></td>
<td class="nump">1,882,740<span></span>
</td>
<td class="nump">1,825,342<span></span>
</td>
<td class="nump">1,615,779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_AnnualizedRateOfSponsorsFee', window );">Expense ratio</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_AnnualizedNetInvestmentIncomeLossRatio', window );">Net investment loss ratio</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_TotalReturnAtNetAssetValue', window );">Total return, net asset value</a></td>
<td class="num">(10.58%)<span></span>
</td>
<td class="num">(16.26%)<span></span>
</td>
<td class="nump">22.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_AnnualizedNetInvestmentIncomeLossRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annualized net investment income (loss) ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_AnnualizedNetInvestmentIncomeLossRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_AnnualizedRateOfSponsorsFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annualized rate of sponsors fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_AnnualizedRateOfSponsorsFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ChangeInNetAssetsFromOperationsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in net assets from operations per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ChangeInNetAssetsFromOperationsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_IncomeFromInvestmentOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_IncomeFromInvestmentOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_NetInvestmentIncomLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net investment income (loss) per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_NetInvestmentIncomLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net realized and unrealized gains and losses on investment in Bullion per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_TotalReturnAtNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total return, at net asset value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_TotalReturnAtNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL7495116-110257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 59<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL6740821-110257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030148086784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text"><p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zYtXWpqb2pWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;<span id="xdx_82D_zV0exrfC3Y25">Organization</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&#160;abrdn
Palladium ETF Trust&#160;(the &#8220;Trust&#8221;) is a common law trust formed on&#160;December 30, 2009&#160;under New York
law pursuant to a depositary trust agreement (the &#8220;Trust Agreement&#8221;) executed by abrdn ETFs Sponsor LLC&#160;(the
&#8220;Sponsor&#8221;) and The Bank of New York Mellon as Trustee (the &#8220;Trustee&#8221;). The Trust holds palladium and issues abrdn
Physical Palladium Shares ETF (&#8220;Shares&#8221;) in minimum blocks of&#160;<span id="xdx_904_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zj3kuZLQSNXe" title="Minimum block of shares issued redeemed against palladium">25,000</span> Shares (also referred to as &#8220;Baskets&#8221;)
in exchange for deposits of palladium and distributes palladium in connection with the redemption of Baskets. Shares
represent units of fractional undivided beneficial interest in and ownership of the Trust which are issued by the Trust. The Sponsor
is a Delaware limited liability company and a wholly-owned subsidiary of abrdn Inc. abrdn Inc. is a wholly-owned indirect subsidiary
of abrdn (formerly known as Standard Life Aberdeen) plc. The Trust is governed by the Trust Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investment objective of the Trust is for the Shares to reflect the performance of the price of&#160;palladium, less the Trust&#8217;s
expenses and liabilities. The Trust is designed to provide an individual owner of beneficial interests in the Shares (a &#8220;Shareholder&#8221;)
an opportunity to participate in the&#160;palladium market through an investment in securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 25, 2021, Christopher Demetriou resigned as President and Chief Executive Officer of the Sponsor. Mr. Demetriou had served
as Principal Executive Officer of the Registrant. Effective June 25, 2021, Steven Dunn was appointed President and Chief Executive
Officer of the Sponsor. Mr. Dunn will serve as Principal Executive Officer of the Registrant.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030148079344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zWqVQLp2nsXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;<span id="xdx_821_zRBS6OIsABl1">Significant
Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in accordance with U.S. GAAP requires those responsible for preparing financial statements
to make estimates and assumptions that affect the reported amounts and disclosures. Actual results could differ from those estimates.
The following is a summary of significant accounting policies followed by the Trust.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVX9OD50j5oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.1.&#160;&#160;&#160;&#160;<span id="xdx_864_z2oBD0gm7I2d">Basis
of Accounting</span></i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has determined that the Trust falls within the scope of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting
Standards Codification (&#8220;ASC&#8221;) 946, <i>Financial Services&#8212;Investment Companies</i>, and has concluded that for
reporting purposes, the Trust is classified as an Investment Company. The Trust is not registered as an investment company under
the Investment Company Act of 1940 and is not required to register under such act.</span></p>

<p id="xdx_856_z162Nle2gcqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--ValuationOfBullionPolicyTextBlock_zfBdzQQh9Occ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.2.&#160;&#160;&#160;<span id="xdx_867_znJwFlVY3Kdk">&#160;Valuation
of&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust follows the provisions of ASC 820, <i>Fair Value Measurement </i>(&#8220;ASC 820&#8221;). ASC 820 provides guidance for
determining fair value and requires increased disclosure regarding the inputs to valuation techniques used to measure fair value.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium&#160;is held by JPMorgan Chase Bank, N.A. (the &#8220;Custodian&#8221;), on behalf of the Trust, at its London,
England vaulting premises. The Trust&#8217;s palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold
the Trust&#8217;s palladium in the Trust&#8217;s allocated account in the firm&#8217;s&#160;vault premises on a segregated basis
and whose appointment has been approved by the Sponsor. At December 31, 2022, approximately <span id="xdx_906_ecustom--PercentageOfAssetBeingHeldByTrust_iI_pid_dp_uPure_c20221231_ziSQF4DBkcI1" title="Percentage of palladium held by sub-custodians">20.47</span>%&#160;of the Trust&#8217;s palladium
was held by one or more sub-custodians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium is recorded at fair value. The cost of palladium is determined according to the average cost method and the
fair value is based on the afternoon session of the twice daily fix of an ounce of&#160;palladium administered by the London Metal
Exchange (&#8220;LME&#8221;) (the &#8220;LME PM Fix&#8221;). Realized gains and losses on transfers of palladium, or palladium
distributed for the redemption of Shares, are calculated on a trade date basis as the difference between the fair value and average&#160;cost
of&#160;palladium transferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
LME is responsible for the administration of the electronic&#160;palladium price fixing system (&#8220;LMEbullion&#8221;) that
replicates electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium Fixing
Company Ltd (&#8220;LPPFCL&#8221;), as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. LMEbullion, like the previous London palladium fix processes, establishes
and publishes fixed prices for troy ounces of palladium twice each London trading day during fixing sessions beginning at 9:45
a.m. London time (the&#8221; LME AM Fix&#8221;) and 2:00 p.m. London time (the &#8220;LME PM Fix&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the value of&#160;&#160;palladium has been determined, the net asset value (the &#8220;NAV&#8221;) is computed by the Trustee
by deducting all accrued fees, expenses and other liabilities of the Trust, including the remuneration due to the Sponsor (the
&#8220;Sponsor&#8217;s Fee&#8221;), from the fair value of the&#160;palladium and all other assets held by the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust recognizes changes in fair value of the investment in&#160;palladium as changes in unrealized gains or losses on investment
in&#160;palladium through the Statement of Operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
per Share amount of&#160;palladium exchanged for a purchase or redemption is calculated daily by the Trustee using the LME PM
Fix to calculate the&#160;palladium amount in respect of any liabilities for which covering palladium&#160;sales have not yet
been made, and represents the per Share amount of&#160;palladium held by the Trust, after giving effect to its liabilities, to
cover expenses and liabilities and any losses that may have occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value Hierarchy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
1.&#160;Unadjusted quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
2.&#160;Observable inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly
or indirectly. These inputs&#160;may&#160;include&#160;quoted&#160;prices&#160;for&#160;the&#160;identical&#160;instrument on
an inactive market, prices for similar instruments and similar data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
3.&#160;Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Trust&#8217;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for
instruments categorized in level 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes,
the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the
lowest level input that is significant to the fair value measurement in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s investment in&#160;palladium is classified as a level&#160;1 asset,&#160;as its value&#160;is calculated using unadjusted
quoted prices from primary market sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zR0dpGA3xbo1">The
categorization of the Trust&#8217;s assets is as shown below: </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-style: italic">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">(Amounts in 000&#8217;s of US$)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Investment in palladium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">295,638</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">358,161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_z62gJcmPBYBb" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">There were no transfers between levels during the years ended December 31, 2022 and 2021.</p>



<p id="xdx_857_zN7yT67E2rW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84A_ecustom--ReceivableAndPayablePolicyTextBlock_zuO1ETszXTrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.3.&#160;&#160;&#160;&#160;<span id="xdx_86E_znNotwyp1dD1">Palladium
Receivable and Payable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium&#160;receivable
or payable represents the quantity of&#160;palladium covered by contractually binding orders for the creation or redemption of
Shares respectively, where the&#160;palladium has not yet been transferred to or from the Trust&#8217;s account. Generally, ownership
of palladium is transferred within two business days of the trade date. At December 31, 2022, the Trust had <span id="xdx_90A_ecustom--BullionReceivableAtMarketValue_iI_do_c20221231_zUittAsF6Uph" title="Palladium receivable"><span id="xdx_90B_ecustom--BullionPayableAtMarketValue_iI_do_c20221231_zx8AJtIWBDkj" title="Palladium payable">no</span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares. At December 31, 2021, the Trust had <span id="xdx_901_ecustom--BullionReceivableAtMarketValue_iI_do_c20211231_zS4NHmQilRsg"><span id="xdx_908_ecustom--BullionPayableAtMarketValue_iI_do_c20211231_z9xhUtsvDwP8">no</span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares.</span></p>

<p id="xdx_85A_zN1BU7rDlGW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--CreationsAndRedemptionsOfSharesPolicyTextBlock_zZGfc1ABPnFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.4.&#160;&#160;&#160;&#160;<span id="xdx_866_zZlM1LQjydrd">Creations
and Redemptions of Shares</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust expects to create and redeem Shares from time to time, but only in one or more Baskets (a Basket equals a block of&#160;<span id="xdx_909_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zhLvOmikeqR6" title="Minimum block of shares issued redeemed against palladium">25,000</span>&#160;Shares).
The Trust issues Shares in Baskets to Authorized Participants on an ongoing basis. Individual investors cannot purchase or redeem
Shares in direct transactions with the Trust. An Authorized Participant is a person who (1) is a registered broker-dealer or other
securities market participant such as a bank or other financial institution which is not required to register as a broker-dealer
to engage in securities transactions; (2) is a participant in The Depository Trust Company; (3) has entered into an Authorized
Participant Agreement with the Trustee and the Sponsor; and (4) has established an Authorized Participant Unallocated Account
with the Trust&#8217;s Custodian or other&#160;palladium bullion clearing bank. An Authorized Participant Agreement is an agreement
entered into by each Authorized Participant, the Sponsor and the Trustee which provides the procedures for the creation and redemption
of Baskets and for the delivery of the&#160;palladium&#160;required for such creations and redemptions. An Authorized Participant
Unallocated Account is an unallocated&#160;palladium account, either loco London or loco Zurich, established with the Custodian
or a&#160;palladium bullion clearing bank by an Authorized Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants may, on any business day, place an order with the Trustee to create or redeem one or more Baskets. The typical settlement
period for Shares is two business days. In the event of a trade date at period end, where a settlement is pending, a respective
account receivable and/or payable will be recorded. When&#160;palladium is exchanged in settlement of a redemption, it is considered
a sale of&#160;palladium for financial statement purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of&#160;palladium represented by the Baskets created or redeemed can only be settled to the nearest 1/1000th of an ounce.
As a result, the value attributed to the creation or redemption of Shares may differ from&#160;the value of palladium&#160;to
be delivered or distributed by the Trust. In order to ensure that the correct amount of&#160;palladium is available at all times
to back the Shares, the Sponsor accepts an adjustment to its management fees in the event of any shortfall or excess on each transaction.
For each transaction, this amount is not more than 1/1000th of an ounce of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Shares of the Trust are subject to redemption at the option of Authorized Participants, the Trust has classified the outstanding
Shares as Net Assets. Changes in the number of Shares outstanding are presented in the Statement of Changes in Net Assets.</span></p>

<p id="xdx_85D_zkp8ratMYYKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zGsBuQ9vK4Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.5.&#160;&#160;&#160;&#160;<span id="xdx_86B_zEMvHfnQ2Yq4">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is classified as a &#8220;grantor trust&#8221; for U.S. federal income tax purposes. As a result, the Trust itself will
not be subject to U.S. federal income tax. Instead, the Trust&#8217;s income and expenses will &#8220;flow through&#8221; to the
Shareholders, and the Trustee will report the Trust&#8217;s proceeds, income, deductions, gains, and losses to the Internal Revenue
Service on that basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has evaluated whether or not there are uncertain tax positions that require financial statement recognition and has determined
that <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20221231_zWw9Q0QsbWu4" title="Reserve for uncertain tax positions"><span id="xdx_905_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20211231_zU2AuJnuPpnj">no</span></span> reserves for uncertain tax positions are required as of&#160;December 31, 2022&#160;or December 31, 2021.</span></p>

<p id="xdx_858_zV91jJmwlgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_z0UdHI5CSAYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.6.&#160;&#160;&#160;&#160;<span id="xdx_863_zNgBIJumV7D6">Investment
in&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zFcOCpBhTyle">Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$, except for ounces data)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Ounces of palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Opening balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">181,531.1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">152,187.5</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,004.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,977.6</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71,914.8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(53,626.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Transfers of palladium to pay expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,064.7</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,007.4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">166,556.4</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,531.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">358,161</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">356,424</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,730</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(147,622</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131,079</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,317</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfers of palladium to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,270</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,443</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(62,298</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(108,531</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">295,638</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_z0IUIE3rgb17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_85F_zu6wiNN5xk3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_846_ecustom--ExpensesPolicyTextBlock_zoPL2gXTg5Ge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.7.&#160;&#160;&#160;&#160;<span id="xdx_86B_znnk1INfGa4e">Expenses
/ Realized Gains / Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The primary expense of the Trust is the Sponsor&#8217;s Fee, which is paid by the Trust through in-kind transfers of palladium
to the Sponsor.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust will transfer&#160;palladium to the Sponsor to pay the Sponsor&#8217;s Fee that accrues daily at an annualized rate equal
to <span id="xdx_908_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_c20220101__20221231_ztWNltr81rL1" title="Expense ratio">0.60</span>% of the adjusted daily net asset value (&#8220;ANAV&#8221;) of the Trust, paid monthly in arrears.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to assume administrative and marketing expenses incurred by the Trust, including the Trustee&#8217;s monthly
fee and out of pocket expenses, the Custodian&#8217;s fee and the reimbursement of the Custodian&#8217;s expenses, exchange listing
fees, United States Securities and Exchange Commission (the &#8220;SEC&#8221;) registration fees, printing and mailing costs,
audit fees and up to $<span id="xdx_907_ecustom--MaximumSponsorFeeForLegalExpenses_c20220101__20221231_zTgGEOsqRtv1" title="Maximum sponsor fee for legal expenses">100,000</span> per annum in legal expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the&#160;years ended&#160;December 31, 2022,&#160;2021&#160;and 2020, the Sponsor&#8217;s Fee&#160;was&#160;$<span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231_ziAQYh2kocma" title="Sponsor's Fee">2,226,662</span>, $<span id="xdx_905_eus-gaap--SponsorFees_c20210101__20211231_zqADh61kOPuc">2,447,225</span>&#160;and
$<span id="xdx_906_eus-gaap--SponsorFees_c20200101__20201231_zodEoWbJxNT4">2,012,865</span>, respectively.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At&#160;December
31, 2022 and at&#160;December 31, 2021, the fees payable to the Sponsor were&#160;$<span id="xdx_900_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20221231_zva69Tdjou3k" title="Fees payable to Sponsor">146,803</span> and $<span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231_z1HU8xY1KYsf">189,455</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to expenses not otherwise assumed by the Sponsor, the Trustee will, at the direction of the Sponsor or in its own discretion,
sell the Trust&#8217;s&#160;palladium as necessary to pay these expenses. When selling&#160;palladium to pay expenses, the Trustee
will endeavor to sell the smallest amounts of&#160;palladium needed to pay these expenses in order to minimize the Trust&#8217;s
holdings of assets other than palladium. Other than the Sponsor&#8217;s Fee, the Trust had <span id="xdx_900_eus-gaap--OtherCostAndExpenseOperating_do_c20220101__20221231_zBsd76ZaumSb" title="All other expenses"><span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_do_c20210101__20211231_zAg3RzIYOa9f">no</span></span> expenses during the years ended&#160;December
31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise directed by the Sponsor, when selling&#160;palladium the Trustee will endeavor to sell at the price established by the
LME PM Fix. The Trustee will place orders with dealers (which may include the Custodian) through which the Trustee expects to
receive the most favorable price and execution of orders. The Custodian may be the purchaser of such&#160;palladium only if the
sale transaction is made at the next LME PM Fix or such other publicly available price that the Sponsor deems fair, in each case
as set following the sale order. A gain or loss is recognized based on the difference between the selling price and the average
cost of the&#160;palladium sold. Neither the Trustee nor the Sponsor is liable for depreciation or loss incurred by reason of
any sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
gains and losses result from the transfer of&#160;palladium for Share redemptions and / or to pay expenses and are recognized
on a trade date basis as the difference between the fair value and average cost of&#160;palladium transferred.</span></p>

<p id="xdx_85B_zuPgsJk2Yyp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zG0PUfyVNrve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.8.&#160;&#160;&#160;&#160;<span id="xdx_860_zyMMjOjio31h">Subsequent
Events</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the provisions set forth in FASB ASC 855-10, <i>Subsequent Events</i>, the Trust&#8217;s management has evaluated
the possibility of subsequent events impacting the Trust&#8217;s financial statements through the filing date. In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.
Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.</span></p>

<p id="xdx_85A_zzT4fWXDg9Ai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030148016064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zetJUQRPy8B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;<span id="xdx_826_zioxwO2LEDua">Related
Parties</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and the Trustee are considered to be related parties to the Trust. The Trustee and the Custodian and their affiliates
may from time to time act as Authorized Participants and purchase or sell Shares for their own account, as agent for their customers
and for accounts over which they exercise investment discretion. In addition, the Trustee and the Custodian and their affiliates
may from time to time purchase or sell&#160;palladium directly, for their own account, as agent for their customers and for accounts
over which they exercise investment discretion. The Trustee&#8217;s and Custodian&#8217;s fees are paid by the Sponsor and are
not separate expenses of the Trust.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030148086784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Risk</a></td>
<td class="text"><p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zsGconhwKTJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.&#160;&#160;&#160;&#160;<span id="xdx_827_zLfDGREXIJ1i">Concentration
of Risk</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s sole business activity is the investment in&#160;palladium, and substantially all the Trust&#8217;s assets are holdings
of&#160;palladium, which creates a concentration of risk associated with fluctuations in the price of palladium. Several factors
could affect the price of palladium, including: (i) global palladium supply and demand, which is influenced by factors such as
production and cost levels in major palladium-producing countries, recycling, autocatalyst demand, industrial demand, jewelry
demand, investment demand, and sales of existing stockpiles of palladium, which have been a key source of supply and are likely
to be exhausted soon, placing a higher burden on new mine supply; (ii) investors&#8217; expectations with respect to the rate
of inflation; (iii) currency exchange rates; (iv) interest rates; (v) investment and trading activities of hedge funds and commodity
funds; and (vi) global or regional political, economic or financial events and situations. In addition, there is no assurance
that&#160;palladium will maintain its long-term value in terms of purchasing power in the future. In the event that the price
of&#160;palladium declines, the Sponsor expects the value of an investment in the Shares to decline proportionately. Each of these
events could have a material effect on the Trust&#8217;s financial position and results of operations.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030062731312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indemnification<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Indemnification</a></td>
<td class="text"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlcboV76bHP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.&#160;&#160;&#160;&#160;<span id="xdx_823_zXHkNdhUbMS6">Indemnification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Trust&#8217;s organizational documents, the Trustee (and its directors, employees and agents) and the Sponsor (and its members,
managers, directors, officers, employees and affiliates) are indemnified by the Trust against any liability, cost or expense it
incurs without gross negligence, bad faith, willful misconduct or willful malfeasance on its part and without reckless disregard
on its part of its obligations and duties under the Trust&#8217;s organizational documents. The Trust&#8217;s maximum exposure
under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred.&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030058779840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text"><p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVX9OD50j5oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.1.&#160;&#160;&#160;&#160;<span id="xdx_864_z2oBD0gm7I2d">Basis
of Accounting</span></i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has determined that the Trust falls within the scope of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting
Standards Codification (&#8220;ASC&#8221;) 946, <i>Financial Services&#8212;Investment Companies</i>, and has concluded that for
reporting purposes, the Trust is classified as an Investment Company. The Trust is not registered as an investment company under
the Investment Company Act of 1940 and is not required to register under such act.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ValuationOfBullionPolicyTextBlock', window );">Valuation of Palladium</a></td>
<td class="text"><p id="xdx_847_ecustom--ValuationOfBullionPolicyTextBlock_zfBdzQQh9Occ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.2.&#160;&#160;&#160;<span id="xdx_867_znJwFlVY3Kdk">&#160;Valuation
of&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust follows the provisions of ASC 820, <i>Fair Value Measurement </i>(&#8220;ASC 820&#8221;). ASC 820 provides guidance for
determining fair value and requires increased disclosure regarding the inputs to valuation techniques used to measure fair value.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium&#160;is held by JPMorgan Chase Bank, N.A. (the &#8220;Custodian&#8221;), on behalf of the Trust, at its London,
England vaulting premises. The Trust&#8217;s palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold
the Trust&#8217;s palladium in the Trust&#8217;s allocated account in the firm&#8217;s&#160;vault premises on a segregated basis
and whose appointment has been approved by the Sponsor. At December 31, 2022, approximately <span id="xdx_906_ecustom--PercentageOfAssetBeingHeldByTrust_iI_pid_dp_uPure_c20221231_ziSQF4DBkcI1" title="Percentage of palladium held by sub-custodians">20.47</span>%&#160;of the Trust&#8217;s palladium
was held by one or more sub-custodians.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s palladium is recorded at fair value. The cost of palladium is determined according to the average cost method and the
fair value is based on the afternoon session of the twice daily fix of an ounce of&#160;palladium administered by the London Metal
Exchange (&#8220;LME&#8221;) (the &#8220;LME PM Fix&#8221;). Realized gains and losses on transfers of palladium, or palladium
distributed for the redemption of Shares, are calculated on a trade date basis as the difference between the fair value and average&#160;cost
of&#160;palladium transferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
LME is responsible for the administration of the electronic&#160;palladium price fixing system (&#8220;LMEbullion&#8221;) that
replicates electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium Fixing
Company Ltd (&#8220;LPPFCL&#8221;), as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. LMEbullion, like the previous London palladium fix processes, establishes
and publishes fixed prices for troy ounces of palladium twice each London trading day during fixing sessions beginning at 9:45
a.m. London time (the&#8221; LME AM Fix&#8221;) and 2:00 p.m. London time (the &#8220;LME PM Fix&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the value of&#160;&#160;palladium has been determined, the net asset value (the &#8220;NAV&#8221;) is computed by the Trustee
by deducting all accrued fees, expenses and other liabilities of the Trust, including the remuneration due to the Sponsor (the
&#8220;Sponsor&#8217;s Fee&#8221;), from the fair value of the&#160;palladium and all other assets held by the Trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust recognizes changes in fair value of the investment in&#160;palladium as changes in unrealized gains or losses on investment
in&#160;palladium through the Statement of Operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
per Share amount of&#160;palladium exchanged for a purchase or redemption is calculated daily by the Trustee using the LME PM
Fix to calculate the&#160;palladium amount in respect of any liabilities for which covering palladium&#160;sales have not yet
been made, and represents the per Share amount of&#160;palladium held by the Trust, after giving effect to its liabilities, to
cover expenses and liabilities and any losses that may have occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair
Value Hierarchy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
1.&#160;Unadjusted quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
2.&#160;Observable inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly
or indirectly. These inputs&#160;may&#160;include&#160;quoted&#160;prices&#160;for&#160;the&#160;identical&#160;instrument on
an inactive market, prices for similar instruments and similar data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;&#160;Level
3.&#160;Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Trust&#8217;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for
instruments categorized in level 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes,
the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the
lowest level input that is significant to the fair value measurement in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust&#8217;s investment in&#160;palladium is classified as a level&#160;1 asset,&#160;as its value&#160;is calculated using unadjusted
quoted prices from primary market sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zR0dpGA3xbo1">The
categorization of the Trust&#8217;s assets is as shown below: </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-style: italic">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">(Amounts in 000&#8217;s of US$)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Investment in palladium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">295,638</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">358,161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A2_z62gJcmPBYBb" style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">There were no transfers between levels during the years ended December 31, 2022 and 2021.</p>



<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ReceivableAndPayablePolicyTextBlock', window );">Palladium Receivable and Payable</a></td>
<td class="text"><p id="xdx_84A_ecustom--ReceivableAndPayablePolicyTextBlock_zuO1ETszXTrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.3.&#160;&#160;&#160;&#160;<span id="xdx_86E_znNotwyp1dD1">Palladium
Receivable and Payable</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium&#160;receivable
or payable represents the quantity of&#160;palladium covered by contractually binding orders for the creation or redemption of
Shares respectively, where the&#160;palladium has not yet been transferred to or from the Trust&#8217;s account. Generally, ownership
of palladium is transferred within two business days of the trade date. At December 31, 2022, the Trust had <span id="xdx_90A_ecustom--BullionReceivableAtMarketValue_iI_do_c20221231_zUittAsF6Uph" title="Palladium receivable"><span id="xdx_90B_ecustom--BullionPayableAtMarketValue_iI_do_c20221231_zx8AJtIWBDkj" title="Palladium payable">no</span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares. At December 31, 2021, the Trust had <span id="xdx_901_ecustom--BullionReceivableAtMarketValue_iI_do_c20211231_zS4NHmQilRsg"><span id="xdx_908_ecustom--BullionPayableAtMarketValue_iI_do_c20211231_z9xhUtsvDwP8">no</span></span> palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_CreationsAndRedemptionsOfSharesPolicyTextBlock', window );">Creations and Redemptions of Shares</a></td>
<td class="text"><p id="xdx_841_ecustom--CreationsAndRedemptionsOfSharesPolicyTextBlock_zZGfc1ABPnFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.4.&#160;&#160;&#160;&#160;<span id="xdx_866_zZlM1LQjydrd">Creations
and Redemptions of Shares</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust expects to create and redeem Shares from time to time, but only in one or more Baskets (a Basket equals a block of&#160;<span id="xdx_909_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zhLvOmikeqR6" title="Minimum block of shares issued redeemed against palladium">25,000</span>&#160;Shares).
The Trust issues Shares in Baskets to Authorized Participants on an ongoing basis. Individual investors cannot purchase or redeem
Shares in direct transactions with the Trust. An Authorized Participant is a person who (1) is a registered broker-dealer or other
securities market participant such as a bank or other financial institution which is not required to register as a broker-dealer
to engage in securities transactions; (2) is a participant in The Depository Trust Company; (3) has entered into an Authorized
Participant Agreement with the Trustee and the Sponsor; and (4) has established an Authorized Participant Unallocated Account
with the Trust&#8217;s Custodian or other&#160;palladium bullion clearing bank. An Authorized Participant Agreement is an agreement
entered into by each Authorized Participant, the Sponsor and the Trustee which provides the procedures for the creation and redemption
of Baskets and for the delivery of the&#160;palladium&#160;required for such creations and redemptions. An Authorized Participant
Unallocated Account is an unallocated&#160;palladium account, either loco London or loco Zurich, established with the Custodian
or a&#160;palladium bullion clearing bank by an Authorized Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
Participants may, on any business day, place an order with the Trustee to create or redeem one or more Baskets. The typical settlement
period for Shares is two business days. In the event of a trade date at period end, where a settlement is pending, a respective
account receivable and/or payable will be recorded. When&#160;palladium is exchanged in settlement of a redemption, it is considered
a sale of&#160;palladium for financial statement purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="margin: 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of&#160;palladium represented by the Baskets created or redeemed can only be settled to the nearest 1/1000th of an ounce.
As a result, the value attributed to the creation or redemption of Shares may differ from&#160;the value of palladium&#160;to
be delivered or distributed by the Trust. In order to ensure that the correct amount of&#160;palladium is available at all times
to back the Shares, the Sponsor accepts an adjustment to its management fees in the event of any shortfall or excess on each transaction.
For each transaction, this amount is not more than 1/1000th of an ounce of palladium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Shares of the Trust are subject to redemption at the option of Authorized Participants, the Trust has classified the outstanding
Shares as Net Assets. Changes in the number of Shares outstanding are presented in the Statement of Changes in Net Assets.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zGsBuQ9vK4Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.5.&#160;&#160;&#160;&#160;<span id="xdx_86B_zEMvHfnQ2Yq4">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is classified as a &#8220;grantor trust&#8221; for U.S. federal income tax purposes. As a result, the Trust itself will
not be subject to U.S. federal income tax. Instead, the Trust&#8217;s income and expenses will &#8220;flow through&#8221; to the
Shareholders, and the Trustee will report the Trust&#8217;s proceeds, income, deductions, gains, and losses to the Internal Revenue
Service on that basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has evaluated whether or not there are uncertain tax positions that require financial statement recognition and has determined
that <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20221231_zWw9Q0QsbWu4" title="Reserve for uncertain tax positions"><span id="xdx_905_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20211231_zU2AuJnuPpnj">no</span></span> reserves for uncertain tax positions are required as of&#160;December 31, 2022&#160;or December 31, 2021.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in Palladium</a></td>
<td class="text"><p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_z0UdHI5CSAYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.6.&#160;&#160;&#160;&#160;<span id="xdx_863_zNgBIJumV7D6">Investment
in&#160;Palladium</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zFcOCpBhTyle">Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$, except for ounces data)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Ounces of palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Opening balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">181,531.1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">152,187.5</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,004.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,977.6</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71,914.8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(53,626.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Transfers of palladium to pay expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,064.7</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,007.4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">166,556.4</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,531.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">358,161</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">356,424</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,730</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(147,622</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131,079</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,317</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfers of palladium to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,270</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,443</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(62,298</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(108,531</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">295,638</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_z0IUIE3rgb17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ExpensesPolicyTextBlock', window );">Expenses / Realized Gains / Losses</a></td>
<td class="text"><p id="xdx_846_ecustom--ExpensesPolicyTextBlock_zoPL2gXTg5Ge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.7.&#160;&#160;&#160;&#160;<span id="xdx_86B_znnk1INfGa4e">Expenses
/ Realized Gains / Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
The primary expense of the Trust is the Sponsor&#8217;s Fee, which is paid by the Trust through in-kind transfers of palladium
to the Sponsor.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust will transfer&#160;palladium to the Sponsor to pay the Sponsor&#8217;s Fee that accrues daily at an annualized rate equal
to <span id="xdx_908_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_c20220101__20221231_ztWNltr81rL1" title="Expense ratio">0.60</span>% of the adjusted daily net asset value (&#8220;ANAV&#8221;) of the Trust, paid monthly in arrears.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to assume administrative and marketing expenses incurred by the Trust, including the Trustee&#8217;s monthly
fee and out of pocket expenses, the Custodian&#8217;s fee and the reimbursement of the Custodian&#8217;s expenses, exchange listing
fees, United States Securities and Exchange Commission (the &#8220;SEC&#8221;) registration fees, printing and mailing costs,
audit fees and up to $<span id="xdx_907_ecustom--MaximumSponsorFeeForLegalExpenses_c20220101__20221231_zTgGEOsqRtv1" title="Maximum sponsor fee for legal expenses">100,000</span> per annum in legal expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the&#160;years ended&#160;December 31, 2022,&#160;2021&#160;and 2020, the Sponsor&#8217;s Fee&#160;was&#160;$<span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231_ziAQYh2kocma" title="Sponsor's Fee">2,226,662</span>, $<span id="xdx_905_eus-gaap--SponsorFees_c20210101__20211231_zqADh61kOPuc">2,447,225</span>&#160;and
$<span id="xdx_906_eus-gaap--SponsorFees_c20200101__20201231_zodEoWbJxNT4">2,012,865</span>, respectively.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At&#160;December
31, 2022 and at&#160;December 31, 2021, the fees payable to the Sponsor were&#160;$<span id="xdx_900_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20221231_zva69Tdjou3k" title="Fees payable to Sponsor">146,803</span> and $<span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231_z1HU8xY1KYsf">189,455</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to expenses not otherwise assumed by the Sponsor, the Trustee will, at the direction of the Sponsor or in its own discretion,
sell the Trust&#8217;s&#160;palladium as necessary to pay these expenses. When selling&#160;palladium to pay expenses, the Trustee
will endeavor to sell the smallest amounts of&#160;palladium needed to pay these expenses in order to minimize the Trust&#8217;s
holdings of assets other than palladium. Other than the Sponsor&#8217;s Fee, the Trust had <span id="xdx_900_eus-gaap--OtherCostAndExpenseOperating_do_c20220101__20221231_zBsd76ZaumSb" title="All other expenses"><span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_do_c20210101__20211231_zAg3RzIYOa9f">no</span></span> expenses during the years ended&#160;December
31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise directed by the Sponsor, when selling&#160;palladium the Trustee will endeavor to sell at the price established by the
LME PM Fix. The Trustee will place orders with dealers (which may include the Custodian) through which the Trustee expects to
receive the most favorable price and execution of orders. The Custodian may be the purchaser of such&#160;palladium only if the
sale transaction is made at the next LME PM Fix or such other publicly available price that the Sponsor deems fair, in each case
as set following the sale order. A gain or loss is recognized based on the difference between the selling price and the average
cost of the&#160;palladium sold. Neither the Trustee nor the Sponsor is liable for depreciation or loss incurred by reason of
any sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
gains and losses result from the transfer of&#160;palladium for Share redemptions and / or to pay expenses and are recognized
on a trade date basis as the difference between the fair value and average cost of&#160;palladium transferred.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zG0PUfyVNrve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2.8.&#160;&#160;&#160;&#160;<span id="xdx_860_zyMMjOjio31h">Subsequent
Events</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the provisions set forth in FASB ASC 855-10, <i>Subsequent Events</i>, the Trust&#8217;s management has evaluated
the possibility of subsequent events impacting the Trust&#8217;s financial statements through the filing date. In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.
Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_CreationsAndRedemptionsOfSharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of creation and redemptions of shares policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_CreationsAndRedemptionsOfSharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of expenses policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ReceivableAndPayablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of bullion receivable and payable policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ReceivableAndPayablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ValuationOfBullionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of valuation of bullion policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ValuationOfBullionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030062676768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">The categorization of the Trust&#8217;s assets is as shown below:</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zR0dpGA3xbo1">The
categorization of the Trust&#8217;s assets is as shown below: </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<tr style="vertical-align: bottom">
    <td style="font-style: italic">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">(Amounts in 000&#8217;s of US$)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic">Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Investment in palladium</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">295,638</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">358,161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_InvestmentsInBullionTableTextBlock', window );">Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below:</a></td>
<td class="text"><p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zFcOCpBhTyle">Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,
    2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-style: italic; text-align: left">(Amounts in 000&#8217;s of US$, except for ounces data)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold">Ounces of palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left">Opening balance</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">181,531.1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">152,187.5</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,004.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83,977.6</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(71,914.8</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(53,626.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Transfers of palladium to pay expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,064.7</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,007.4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">166,556.4</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">181,531.1</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Investment in palladium</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Opening balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">358,161</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">356,424</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Creations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">145,623</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,730</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White">
    <td>Redemptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(147,622</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(131,079</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium distributed for the redemption of Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,317</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfers of palladium to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,270</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,443</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Realized gain on palladium transferred to pay expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in unrealized (loss) on investment in palladium</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(62,298</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(108,531</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">295,638</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">358,161</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_InvestmentsInBullionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of movement in the investment in bullion in the Trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_InvestmentsInBullionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030148085984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion', window );">Minimum block of shares issued redeemed against palladium</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum block of shares that can be created or redeemed against bullion deposits or distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030064102992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The categorization of the Trust&#8217;s assets is as shown below: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure', window );">Investment in palladium</a></td>
<td class="nump">$ 295,638<span></span>
</td>
<td class="nump">$ 358,161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment held in physical commodities, for example, but not limited to, gold, silver, platinum, crude oil, coal, sugar, rice, wheat.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030065382752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Opening balance | oz</a></td>
<td class="nump">181,531.1<span></span>
</td>
<td class="nump">152,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_CreationsOuncesOfBullion', window );">Creations | oz</a></td>
<td class="nump">58,004.8<span></span>
</td>
<td class="nump">83,977.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_RedemptionsOuncesOfBullion', window );">Redemptions | oz</a></td>
<td class="num">(71,914.8)<span></span>
</td>
<td class="num">(53,626.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_TransfersOfBullionOunces', window );">Transfers of palladium to pay expenses | oz</a></td>
<td class="num">(1,064.7)<span></span>
</td>
<td class="num">(1,007.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Closing balance | oz</a></td>
<td class="nump">166,556.4<span></span>
</td>
<td class="nump">181,531.1<span></span>
</td>
<td class="nump">152,187.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInPhysicalCommodities', window );">Opening balance</a></td>
<td class="nump">$ 358,161<span></span>
</td>
<td class="nump">$ 356,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_CreationsValueOfBullion', window );">Creations</a></td>
<td class="nump">145,623<span></span>
</td>
<td class="nump">205,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable', window );">Redemptions</a></td>
<td class="num">(147,622)<span></span>
</td>
<td class="num">(131,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares', window );">Realized gain on palladium distributed for the redemption of Shares</a></td>
<td class="nump">3,889<span></span>
</td>
<td class="nump">37,317<span></span>
</td>
<td class="nump">$ 60,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_CostOfBullionTransferredToPayExpenses', window );">Transfers of palladium to pay expenses</a></td>
<td class="num">(2,270)<span></span>
</td>
<td class="num">(2,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses', window );">Realized gain on palladium transferred to pay expenses</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">743<span></span>
</td>
<td class="nump">773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion', window );">Change in unrealized (loss) on investment in palladium</a></td>
<td class="num">(62,298)<span></span>
</td>
<td class="num">(108,531)<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInPhysicalCommodities', window );">Closing balance</a></td>
<td class="nump">$ 295,638<span></span>
</td>
<td class="nump">$ 358,161<span></span>
</td>
<td class="nump">$ 356,424<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ChangeInUnrealizedGainLossOnInvestmentInBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in unrealized gain (loss) on investment in Bullion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ChangeInUnrealizedGainLossOnInvestmentInBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_CostOfBullionTransferredToPayExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of Bullion transferred to pay Trust's expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_CostOfBullionTransferredToPayExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_CreationsOuncesOfBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ounces of bullion received into the Trust's account in respect of creations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_CreationsOuncesOfBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_CreationsValueOfBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of creations of bullion in investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_CreationsValueOfBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized gain or loss during the period on bullion distributed for the redemption of Shares. Realized gains or losses are calculated on a trade date basis using average cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_RedemptionsOuncesOfBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ounces of bullion paid out of the Trust's account in respect of redemptions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_RedemptionsOuncesOfBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_TransfersOfBullionOunces">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ounces of bullion transferred to pay Trust's expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_TransfersOfBullionOunces</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of bullion distributed at average cost for the redemption of Shares excluding bullion payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInPhysicalCommodities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments held in physical commodities, such as gold, silver, platinum, crude oil, coal, sugar, rice, wheat.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInPhysicalCommodities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceOtherMeasure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Quantity of the investment. Indicate the measure in the unit of measure. This is commonly used for investments other than securities. For example, if the investment is gold, the balance would be the number of ounces and the unit of measure would indicate "ounces".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceOtherMeasure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140030061463120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_PercentageOfAssetBeingHeldByTrust', window );">Percentage of palladium held by sub-custodians</a></td>
<td class="nump">20.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_BullionReceivableAtMarketValue', window );">Palladium receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_BullionPayableAtMarketValue', window );">Palladium payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion', window );">Minimum block of shares issued redeemed against palladium</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Reserve for uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_AnnualizedRateOfSponsorsFee', window );">Expense ratio</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_pall_MaximumSponsorFeeForLegalExpenses', window );">Maximum sponsor fee for legal expenses</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SponsorFees', window );">Sponsor's Fee</a></td>
<td class="nump">2,226,662<span></span>
</td>
<td class="nump">$ 2,447,225<span></span>
</td>
<td class="nump">$ 2,012,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Fees payable to Sponsor</a></td>
<td class="nump">146,803<span></span>
</td>
<td class="nump">189,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">All other expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_AnnualizedRateOfSponsorsFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annualized rate of sponsors fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_AnnualizedRateOfSponsorsFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_BullionPayableAtMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of bullion payable at market value as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_BullionPayableAtMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_BullionReceivableAtMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of bullion receivable at market value as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_BullionReceivableAtMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_MaximumSponsorFeeForLegalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum sponsor fee for legal expenses,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_MaximumSponsorFeeForLegalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum block of shares that can be created or redeemed against bullion deposits or distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pall_PercentageOfAssetBeingHeldByTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of asset being held by trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pall_PercentageOfAssetBeingHeldByTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pall_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SponsorFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SponsorFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>pall-10k_123122_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pall="http://abrdn.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pall-20221231.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-02-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2023-02-23</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_currency_XPD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XPD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_currency_XPD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XPD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001459862</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="OZ">
        <measure>utr:oz</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-12-31">0001459862</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-12-31">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2022-01-01to2022-12-31" id="xdx2ixbrl0074">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0075">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <dei:DocumentType contextRef="From2022-01-01to2022-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2022-01-01to2022-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-12-31">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-12-31">001-34589</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-12-31">abrdn Palladium ETF Trust</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-12-31">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-12-31">26-4733157</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-12-31">1900 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-12-31">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-12-31">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-12-31">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-12-31">19103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-12-31">(844)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-12-31">383-7289</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-01-01to2022-12-31">abrdn     Physical Palladium Shares ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-01to2022-12-31">PALL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-01to2022-12-31">NYSEArca</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-01-01to2022-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-01-01to2022-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-12-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-12-31">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2022-01-01to2022-12-31">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-12-31">false</dei:EntityShellCompany>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">339320992</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-02-23" decimals="INF" unitRef="Shares">1925000</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2022-01-01to2022-12-31">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2022-01-01to2022-12-31">New York, NY</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2022-01-01to2022-12-31">185</dei:AuditorFirmId>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">334209000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">334434000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295638000</us-gaap:InvestmentInPhysicalCommodities>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">358161000</us-gaap:InvestmentInPhysicalCommodities>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295638000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">358161000</us-gaap:Assets>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">147000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="-4" unitRef="USD">190000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">147000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">190000</us-gaap:Liabilities>
    <us-gaap:AssetsNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000070"
      unitRef="USD">295491000</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact000071"
      unitRef="USD">357971000</us-gaap:AssetsNet>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1800000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1800000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1950000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1950000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">164.16</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">183.58</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure
      contextRef="AsOf2022-12-31_currency_XPD"
      decimals="1"
      unitRef="OZ">166556.4</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2022-12-31_currency_XPD"
      decimals="-3"
      unitRef="USD">334209000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="AsOf2022-12-31_currency_XPD"
      decimals="-3"
      unitRef="USD">295638000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="AsOf2022-12-31_currency_XPD"
      decimals="INF"
      unitRef="Pure">1.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2022-12-31" decimals="1" unitRef="OZ">166556.4</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">334209000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295638000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="AsOf2022-12-31" decimals="INF" unitRef="Pure">1.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-147000</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets contextRef="AsOf2022-12-31" decimals="INF" unitRef="Pure">-0.0005</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:AssetsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295491000</us-gaap:AssetsNet>
    <pall:NetAssetsPercentageOfNetAssets contextRef="AsOf2022-12-31" decimals="INF" unitRef="Pure">1.0000</pall:NetAssetsPercentageOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure
      contextRef="AsOf2021-12-31_currency_XPD"
      decimals="1"
      unitRef="OZ">181531.1</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="AsOf2021-12-31_currency_XPD"
      decimals="-3"
      unitRef="USD">334434000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="AsOf2021-12-31_currency_XPD"
      decimals="-3"
      unitRef="USD">358161000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="AsOf2021-12-31_currency_XPD"
      decimals="INF"
      unitRef="Pure">1.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2021-12-31" decimals="1" unitRef="OZ">181531.1</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedAtCost contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">334434000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">358161000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure">1.0005</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">-190000</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure">-0.0005</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:AssetsNet contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">357971000</us-gaap:AssetsNet>
    <pall:NetAssetsPercentageOfNetAssets contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure">1.0000</pall:NetAssetsPercentageOfNetAssets>
    <us-gaap:SponsorFees
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2227000</us-gaap:SponsorFees>
    <us-gaap:SponsorFees
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2447000</us-gaap:SponsorFees>
    <us-gaap:SponsorFees
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2013000</us-gaap:SponsorFees>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2227000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2447000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">2013000</us-gaap:OperatingExpenses>
    <pall:NetInvestmentGainLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-2227000</pall:NetInvestmentGainLoss>
    <pall:NetInvestmentGainLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-2447000</pall:NetInvestmentGainLoss>
    <pall:NetInvestmentGainLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-2013000</pall:NetInvestmentGainLoss>
    <us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">155000</us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses>
    <us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">743000</us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses>
    <us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">773000</us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses>
    <pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3889000</pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares>
    <pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">37317000</pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares>
    <pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">60188000</pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-62298000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-108531000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1660000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <pall:TotalGainLossOnBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-58254000</pall:TotalGainLossOnBullion>
    <pall:TotalGainLossOnBullion
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-70471000</pall:TotalGainLossOnBullion>
    <pall:TotalGainLossOnBullion
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">62621000</pall:TotalGainLossOnBullion>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-60481000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-72918000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">60608000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">-32.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">-39.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">37.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="Shares">1882740</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="Shares">1825342</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="Shares">1615779</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1950000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">357971000</us-gaap:StockholdersEquity>
    <pall:NetInvestmentGainLoss
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-2227000</pall:NetInvestmentGainLoss>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">4044000</us-gaap:RealizedInvestmentGainsLosses>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-62298000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">145623000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">775000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">147622000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:SharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">1800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295491000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1625000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">356238000</us-gaap:StockholdersEquity>
    <pall:NetInvestmentGainLoss
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-2447000</pall:NetInvestmentGainLoss>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">38060000</us-gaap:RealizedInvestmentGainsLosses>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-108531000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">205730000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">575000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">131079000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">1950000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">357971000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">1675000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">300485000</us-gaap:StockholdersEquity>
    <pall:NetInvestmentGainLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-2013000</pall:NetInvestmentGainLoss>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">60961000</us-gaap:RealizedInvestmentGainsLosses>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1660000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">150950000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">800000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">155805000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1625000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">356238000</us-gaap:StockholdersEquity>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">183.58</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">219.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">179.39</us-gaap:NetAssetValuePerShare>
    <pall:NetInvestmentIncomLossPerShare
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">-1.18</pall:NetInvestmentIncomLossPerShare>
    <pall:NetInvestmentIncomLossPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">-1.34</pall:NetInvestmentIncomLossPerShare>
    <pall:NetInvestmentIncomLossPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">-1.25</pall:NetInvestmentIncomLossPerShare>
    <pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">-18.24</pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare>
    <pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">-34.30</pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare>
    <pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">41.08</pall:NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare>
    <pall:ChangeInNetAssetsFromOperationsPerShare
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="USDPShares">-19.42</pall:ChangeInNetAssetsFromOperationsPerShare>
    <pall:ChangeInNetAssetsFromOperationsPerShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">-35.64</pall:ChangeInNetAssetsFromOperationsPerShare>
    <pall:ChangeInNetAssetsFromOperationsPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">39.83</pall:ChangeInNetAssetsFromOperationsPerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">164.16</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">183.58</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">219.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="Shares">1882740</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="Shares">1825342</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="Shares">1615779</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <pall:AnnualizedRateOfSponsorsFee
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.0060</pall:AnnualizedRateOfSponsorsFee>
    <pall:AnnualizedRateOfSponsorsFee
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.0060</pall:AnnualizedRateOfSponsorsFee>
    <pall:AnnualizedRateOfSponsorsFee
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.0060</pall:AnnualizedRateOfSponsorsFee>
    <pall:AnnualizedNetInvestmentIncomeLossRatio
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">-0.0060</pall:AnnualizedNetInvestmentIncomeLossRatio>
    <pall:AnnualizedNetInvestmentIncomeLossRatio
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">-0.0060</pall:AnnualizedNetInvestmentIncomeLossRatio>
    <pall:AnnualizedNetInvestmentIncomeLossRatio
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">-0.0060</pall:AnnualizedNetInvestmentIncomeLossRatio>
    <pall:TotalReturnAtNetAssetValue
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">-0.1058</pall:TotalReturnAtNetAssetValue>
    <pall:TotalReturnAtNetAssetValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">-0.1626</pall:TotalReturnAtNetAssetValue>
    <pall:TotalReturnAtNetAssetValue
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.2220</pall:TotalReturnAtNetAssetValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_806_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zYtXWpqb2pWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.&#160;&#160;&#160;&#160;&lt;span id="xdx_82D_zV0exrfC3Y25"&gt;Organization&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The&#160;abrdn
Palladium ETF Trust&#160;(the &#x201c;Trust&#x201d;) is a common law trust formed on&#160;December 30, 2009&#160;under New York
law pursuant to a depositary trust agreement (the &#x201c;Trust Agreement&#x201d;) executed by abrdn ETFs Sponsor LLC&#160;(the
&#x201c;Sponsor&#x201d;) and The Bank of New York Mellon as Trustee (the &#x201c;Trustee&#x201d;). The Trust holds palladium and issues abrdn
Physical Palladium Shares ETF (&#x201c;Shares&#x201d;) in minimum blocks of&#160;&lt;span id="xdx_904_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zj3kuZLQSNXe" title="Minimum block of shares issued redeemed against palladium"&gt;25,000&lt;/span&gt; Shares (also referred to as &#x201c;Baskets&#x201d;)
in exchange for deposits of palladium and distributes palladium in connection with the redemption of Baskets. Shares
represent units of fractional undivided beneficial interest in and ownership of the Trust which are issued by the Trust. The Sponsor
is a Delaware limited liability company and a wholly-owned subsidiary of abrdn Inc. abrdn Inc. is a wholly-owned indirect subsidiary
of abrdn (formerly known as Standard Life Aberdeen) plc. The Trust is governed by the Trust Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
investment objective of the Trust is for the Shares to reflect the performance of the price of&#160;palladium, less the Trust&#x2019;s
expenses and liabilities. The Trust is designed to provide an individual owner of beneficial interests in the Shares (a &#x201c;Shareholder&#x201d;)
an opportunity to participate in the&#160;palladium market through an investment in securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
June 25, 2021, Christopher Demetriou resigned as President and Chief Executive Officer of the Sponsor. Mr. Demetriou had served
as Principal Executive Officer of the Registrant. Effective June 25, 2021, Steven Dunn was appointed President and Chief Executive
Officer of the Sponsor. Mr. Dunn will serve as Principal Executive Officer of the Registrant.&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">25000</pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zWqVQLp2nsXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.&#160;&#160;&#160;&#160;&lt;span id="xdx_821_zRBS6OIsABl1"&gt;Significant
Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in accordance with U.S. GAAP requires those responsible for preparing financial statements
to make estimates and assumptions that affect the reported amounts and disclosures. Actual results could differ from those estimates.
The following is a summary of significant accounting policies followed by the Trust.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVX9OD50j5oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.1.&#160;&#160;&#160;&#160;&lt;span id="xdx_864_z2oBD0gm7I2d"&gt;Basis
of Accounting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has determined that the Trust falls within the scope of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting
Standards Codification (&#x201c;ASC&#x201d;) 946, &lt;i&gt;Financial Services&#x2014;Investment Companies&lt;/i&gt;, and has concluded that for
reporting purposes, the Trust is classified as an Investment Company. The Trust is not registered as an investment company under
the Investment Company Act of 1940 and is not required to register under such act.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_z162Nle2gcqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--ValuationOfBullionPolicyTextBlock_zfBdzQQh9Occ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.2.&#160;&#160;&#160;&lt;span id="xdx_867_znJwFlVY3Kdk"&gt;&#160;Valuation
of&#160;Palladium&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust follows the provisions of ASC 820, &lt;i&gt;Fair Value Measurement &lt;/i&gt;(&#x201c;ASC 820&#x201d;). ASC 820 provides guidance for
determining fair value and requires increased disclosure regarding the inputs to valuation techniques used to measure fair value.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s palladium&#160;is held by JPMorgan Chase Bank, N.A. (the &#x201c;Custodian&#x201d;), on behalf of the Trust, at its London,
England vaulting premises. The Trust&#x2019;s palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold
the Trust&#x2019;s palladium in the Trust&#x2019;s allocated account in the firm&#x2019;s&#160;vault premises on a segregated basis
and whose appointment has been approved by the Sponsor. At December 31, 2022, approximately &lt;span id="xdx_906_ecustom--PercentageOfAssetBeingHeldByTrust_iI_pid_dp_uPure_c20221231_ziSQF4DBkcI1" title="Percentage of palladium held by sub-custodians"&gt;20.47&lt;/span&gt;%&#160;of the Trust&#x2019;s palladium
was held by one or more sub-custodians.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s palladium is recorded at fair value. The cost of palladium is determined according to the average cost method and the
fair value is based on the afternoon session of the twice daily fix of an ounce of&#160;palladium administered by the London Metal
Exchange (&#x201c;LME&#x201d;) (the &#x201c;LME PM Fix&#x201d;). Realized gains and losses on transfers of palladium, or palladium
distributed for the redemption of Shares, are calculated on a trade date basis as the difference between the fair value and average&#160;cost
of&#160;palladium transferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
LME is responsible for the administration of the electronic&#160;palladium price fixing system (&#x201c;LMEbullion&#x201d;) that
replicates electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium Fixing
Company Ltd (&#x201c;LPPFCL&#x201d;), as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. LMEbullion, like the previous London palladium fix processes, establishes
and publishes fixed prices for troy ounces of palladium twice each London trading day during fixing sessions beginning at 9:45
a.m. London time (the&#x201d; LME AM Fix&#x201d;) and 2:00 p.m. London time (the &#x201c;LME PM Fix&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the value of&#160;&#160;palladium has been determined, the net asset value (the &#x201c;NAV&#x201d;) is computed by the Trustee
by deducting all accrued fees, expenses and other liabilities of the Trust, including the remuneration due to the Sponsor (the
&#x201c;Sponsor&#x2019;s Fee&#x201d;), from the fair value of the&#160;palladium and all other assets held by the Trust.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust recognizes changes in fair value of the investment in&#160;palladium as changes in unrealized gains or losses on investment
in&#160;palladium through the Statement of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
per Share amount of&#160;palladium exchanged for a purchase or redemption is calculated daily by the Trustee using the LME PM
Fix to calculate the&#160;palladium amount in respect of any liabilities for which covering palladium&#160;sales have not yet
been made, and represents the per Share amount of&#160;palladium held by the Trust, after giving effect to its liabilities, to
cover expenses and liabilities and any losses that may have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
Value Hierarchy&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
1.&#160;Unadjusted quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
2.&#160;Observable inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly
or indirectly. These inputs&#160;may&#160;include&#160;quoted&#160;prices&#160;for&#160;the&#160;identical&#160;instrument on
an inactive market, prices for similar instruments and similar data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
3.&#160;Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Trust&#x2019;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for
instruments categorized in level 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes,
the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the
lowest level input that is significant to the fair value measurement in its entirety.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s investment in&#160;palladium is classified as a level&#160;1 asset,&#160;as its value&#160;is calculated using unadjusted
quoted prices from primary market sources.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zR0dpGA3xbo1"&gt;The
categorization of the Trust&#x2019;s assets is as shown below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;(Amounts in 000&#x2019;s of US$)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z62gJcmPBYBb" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;There were no transfers between levels during the years ended December 31, 2022 and 2021.&lt;/p&gt;



&lt;p id="xdx_857_zN7yT67E2rW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--ReceivableAndPayablePolicyTextBlock_zuO1ETszXTrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.3.&#160;&#160;&#160;&#160;&lt;span id="xdx_86E_znNotwyp1dD1"&gt;Palladium
Receivable and Payable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Palladium&#160;receivable
or payable represents the quantity of&#160;palladium covered by contractually binding orders for the creation or redemption of
Shares respectively, where the&#160;palladium has not yet been transferred to or from the Trust&#x2019;s account. Generally, ownership
of palladium is transferred within two business days of the trade date. At December 31, 2022, the Trust had &lt;span id="xdx_90A_ecustom--BullionReceivableAtMarketValue_iI_do_c20221231_zUittAsF6Uph" title="Palladium receivable"&gt;&lt;span id="xdx_90B_ecustom--BullionPayableAtMarketValue_iI_do_c20221231_zx8AJtIWBDkj" title="Palladium payable"&gt;no&lt;/span&gt;&lt;/span&gt; palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares. At December 31, 2021, the Trust had &lt;span id="xdx_901_ecustom--BullionReceivableAtMarketValue_iI_do_c20211231_zS4NHmQilRsg"&gt;&lt;span id="xdx_908_ecustom--BullionPayableAtMarketValue_iI_do_c20211231_z9xhUtsvDwP8"&gt;no&lt;/span&gt;&lt;/span&gt; palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zN1BU7rDlGW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--CreationsAndRedemptionsOfSharesPolicyTextBlock_zZGfc1ABPnFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.4.&#160;&#160;&#160;&#160;&lt;span id="xdx_866_zZlM1LQjydrd"&gt;Creations
and Redemptions of Shares&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust expects to create and redeem Shares from time to time, but only in one or more Baskets (a Basket equals a block of&#160;&lt;span id="xdx_909_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zhLvOmikeqR6" title="Minimum block of shares issued redeemed against palladium"&gt;25,000&lt;/span&gt;&#160;Shares).
The Trust issues Shares in Baskets to Authorized Participants on an ongoing basis. Individual investors cannot purchase or redeem
Shares in direct transactions with the Trust. An Authorized Participant is a person who (1) is a registered broker-dealer or other
securities market participant such as a bank or other financial institution which is not required to register as a broker-dealer
to engage in securities transactions; (2) is a participant in The Depository Trust Company; (3) has entered into an Authorized
Participant Agreement with the Trustee and the Sponsor; and (4) has established an Authorized Participant Unallocated Account
with the Trust&#x2019;s Custodian or other&#160;palladium bullion clearing bank. An Authorized Participant Agreement is an agreement
entered into by each Authorized Participant, the Sponsor and the Trustee which provides the procedures for the creation and redemption
of Baskets and for the delivery of the&#160;palladium&#160;required for such creations and redemptions. An Authorized Participant
Unallocated Account is an unallocated&#160;palladium account, either loco London or loco Zurich, established with the Custodian
or a&#160;palladium bullion clearing bank by an Authorized Participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Authorized
Participants may, on any business day, place an order with the Trustee to create or redeem one or more Baskets. The typical settlement
period for Shares is two business days. In the event of a trade date at period end, where a settlement is pending, a respective
account receivable and/or payable will be recorded. When&#160;palladium is exchanged in settlement of a redemption, it is considered
a sale of&#160;palladium for financial statement purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amount of&#160;palladium represented by the Baskets created or redeemed can only be settled to the nearest 1/1000th of an ounce.
As a result, the value attributed to the creation or redemption of Shares may differ from&#160;the value of palladium&#160;to
be delivered or distributed by the Trust. In order to ensure that the correct amount of&#160;palladium is available at all times
to back the Shares, the Sponsor accepts an adjustment to its management fees in the event of any shortfall or excess on each transaction.
For each transaction, this amount is not more than 1/1000th of an ounce of palladium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the Shares of the Trust are subject to redemption at the option of Authorized Participants, the Trust has classified the outstanding
Shares as Net Assets. Changes in the number of Shares outstanding are presented in the Statement of Changes in Net Assets.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zkp8ratMYYKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zGsBuQ9vK4Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.5.&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zEMvHfnQ2Yq4"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust is classified as a &#x201c;grantor trust&#x201d; for U.S. federal income tax purposes. As a result, the Trust itself will
not be subject to U.S. federal income tax. Instead, the Trust&#x2019;s income and expenses will &#x201c;flow through&#x201d; to the
Shareholders, and the Trustee will report the Trust&#x2019;s proceeds, income, deductions, gains, and losses to the Internal Revenue
Service on that basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has evaluated whether or not there are uncertain tax positions that require financial statement recognition and has determined
that &lt;span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20221231_zWw9Q0QsbWu4" title="Reserve for uncertain tax positions"&gt;&lt;span id="xdx_905_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20211231_zU2AuJnuPpnj"&gt;no&lt;/span&gt;&lt;/span&gt; reserves for uncertain tax positions are required as of&#160;December 31, 2022&#160;or December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_858_zV91jJmwlgNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_z0UdHI5CSAYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.6.&#160;&#160;&#160;&#160;&lt;span id="xdx_863_zNgBIJumV7D6"&gt;Investment
in&#160;Palladium&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zFcOCpBhTyle"&gt;Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;(Amounts in 000&#x2019;s of US$, except for ounces data)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Ounces of palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;152,187.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,004.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,977.6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(71,914.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(53,626.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,064.7&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,007.4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;166,556.4&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;356,424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;145,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(147,622&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131,079&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium distributed for the redemption of Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,270&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,443&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium transferred to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in unrealized (loss) on investment in palladium&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(62,298&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(108,531&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_z0IUIE3rgb17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_85F_zu6wiNN5xk3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--ExpensesPolicyTextBlock_zoPL2gXTg5Ge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.7.&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_znnk1INfGa4e"&gt;Expenses
/ Realized Gains / Losses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
The primary expense of the Trust is the Sponsor&#x2019;s Fee, which is paid by the Trust through in-kind transfers of palladium
to the Sponsor.
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust will transfer&#160;palladium to the Sponsor to pay the Sponsor&#x2019;s Fee that accrues daily at an annualized rate equal
to &lt;span id="xdx_908_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_c20220101__20221231_ztWNltr81rL1" title="Expense ratio"&gt;0.60&lt;/span&gt;% of the adjusted daily net asset value (&#x201c;ANAV&#x201d;) of the Trust, paid monthly in arrears.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed to assume administrative and marketing expenses incurred by the Trust, including the Trustee&#x2019;s monthly
fee and out of pocket expenses, the Custodian&#x2019;s fee and the reimbursement of the Custodian&#x2019;s expenses, exchange listing
fees, United States Securities and Exchange Commission (the &#x201c;SEC&#x201d;) registration fees, printing and mailing costs,
audit fees and up to $&lt;span id="xdx_907_ecustom--MaximumSponsorFeeForLegalExpenses_c20220101__20221231_zTgGEOsqRtv1" title="Maximum sponsor fee for legal expenses"&gt;100,000&lt;/span&gt; per annum in legal expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the&#160;years ended&#160;December 31, 2022,&#160;2021&#160;and 2020, the Sponsor&#x2019;s Fee&#160;was&#160;$&lt;span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231_ziAQYh2kocma" title="Sponsor's Fee"&gt;2,226,662&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--SponsorFees_c20210101__20211231_zqADh61kOPuc"&gt;2,447,225&lt;/span&gt;&#160;and
$&lt;span id="xdx_906_eus-gaap--SponsorFees_c20200101__20201231_zodEoWbJxNT4"&gt;2,012,865&lt;/span&gt;, respectively.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At&#160;December
31, 2022 and at&#160;December 31, 2021, the fees payable to the Sponsor were&#160;$&lt;span id="xdx_900_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20221231_zva69Tdjou3k" title="Fees payable to Sponsor"&gt;146,803&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231_z1HU8xY1KYsf"&gt;189,455&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
respect to expenses not otherwise assumed by the Sponsor, the Trustee will, at the direction of the Sponsor or in its own discretion,
sell the Trust&#x2019;s&#160;palladium as necessary to pay these expenses. When selling&#160;palladium to pay expenses, the Trustee
will endeavor to sell the smallest amounts of&#160;palladium needed to pay these expenses in order to minimize the Trust&#x2019;s
holdings of assets other than palladium. Other than the Sponsor&#x2019;s Fee, the Trust had &lt;span id="xdx_900_eus-gaap--OtherCostAndExpenseOperating_do_c20220101__20221231_zBsd76ZaumSb" title="All other expenses"&gt;&lt;span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_do_c20210101__20211231_zAg3RzIYOa9f"&gt;no&lt;/span&gt;&lt;/span&gt; expenses during the years ended&#160;December
31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise directed by the Sponsor, when selling&#160;palladium the Trustee will endeavor to sell at the price established by the
LME PM Fix. The Trustee will place orders with dealers (which may include the Custodian) through which the Trustee expects to
receive the most favorable price and execution of orders. The Custodian may be the purchaser of such&#160;palladium only if the
sale transaction is made at the next LME PM Fix or such other publicly available price that the Sponsor deems fair, in each case
as set following the sale order. A gain or loss is recognized based on the difference between the selling price and the average
cost of the&#160;palladium sold. Neither the Trustee nor the Sponsor is liable for depreciation or loss incurred by reason of
any sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
gains and losses result from the transfer of&#160;palladium for Share redemptions and / or to pay expenses and are recognized
on a trade date basis as the difference between the fair value and average cost of&#160;palladium transferred.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zuPgsJk2Yyp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zG0PUfyVNrve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.8.&#160;&#160;&#160;&#160;&lt;span id="xdx_860_zyMMjOjio31h"&gt;Subsequent
Events&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the provisions set forth in FASB ASC 855-10, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Trust&#x2019;s management has evaluated
the possibility of subsequent events impacting the Trust&#x2019;s financial statements through the filing date. In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.
Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zzT4fWXDg9Ai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVX9OD50j5oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.1.&#160;&#160;&#160;&#160;&lt;span id="xdx_864_z2oBD0gm7I2d"&gt;Basis
of Accounting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has determined that the Trust falls within the scope of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting
Standards Codification (&#x201c;ASC&#x201d;) 946, &lt;i&gt;Financial Services&#x2014;Investment Companies&lt;/i&gt;, and has concluded that for
reporting purposes, the Trust is classified as an Investment Company. The Trust is not registered as an investment company under
the Investment Company Act of 1940 and is not required to register under such act.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <pall:ValuationOfBullionPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_847_ecustom--ValuationOfBullionPolicyTextBlock_zfBdzQQh9Occ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.2.&#160;&#160;&#160;&lt;span id="xdx_867_znJwFlVY3Kdk"&gt;&#160;Valuation
of&#160;Palladium&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust follows the provisions of ASC 820, &lt;i&gt;Fair Value Measurement &lt;/i&gt;(&#x201c;ASC 820&#x201d;). ASC 820 provides guidance for
determining fair value and requires increased disclosure regarding the inputs to valuation techniques used to measure fair value.
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s palladium&#160;is held by JPMorgan Chase Bank, N.A. (the &#x201c;Custodian&#x201d;), on behalf of the Trust, at its London,
England vaulting premises. The Trust&#x2019;s palladium may also be held by UBS AG, or any other firm selected by the Custodian to hold
the Trust&#x2019;s palladium in the Trust&#x2019;s allocated account in the firm&#x2019;s&#160;vault premises on a segregated basis
and whose appointment has been approved by the Sponsor. At December 31, 2022, approximately &lt;span id="xdx_906_ecustom--PercentageOfAssetBeingHeldByTrust_iI_pid_dp_uPure_c20221231_ziSQF4DBkcI1" title="Percentage of palladium held by sub-custodians"&gt;20.47&lt;/span&gt;%&#160;of the Trust&#x2019;s palladium
was held by one or more sub-custodians.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s palladium is recorded at fair value. The cost of palladium is determined according to the average cost method and the
fair value is based on the afternoon session of the twice daily fix of an ounce of&#160;palladium administered by the London Metal
Exchange (&#x201c;LME&#x201d;) (the &#x201c;LME PM Fix&#x201d;). Realized gains and losses on transfers of palladium, or palladium
distributed for the redemption of Shares, are calculated on a trade date basis as the difference between the fair value and average&#160;cost
of&#160;palladium transferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
LME is responsible for the administration of the electronic&#160;palladium price fixing system (&#x201c;LMEbullion&#x201d;) that
replicates electronically the manual London palladium fix processes previously employed by the London Platinum and Palladium Fixing
Company Ltd (&#x201c;LPPFCL&#x201d;), as well as providing electronic market clearing processes for palladium bullion transactions
at the fixed prices established by the LME pricing mechanism. LMEbullion, like the previous London palladium fix processes, establishes
and publishes fixed prices for troy ounces of palladium twice each London trading day during fixing sessions beginning at 9:45
a.m. London time (the&#x201d; LME AM Fix&#x201d;) and 2:00 p.m. London time (the &#x201c;LME PM Fix&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the value of&#160;&#160;palladium has been determined, the net asset value (the &#x201c;NAV&#x201d;) is computed by the Trustee
by deducting all accrued fees, expenses and other liabilities of the Trust, including the remuneration due to the Sponsor (the
&#x201c;Sponsor&#x2019;s Fee&#x201d;), from the fair value of the&#160;palladium and all other assets held by the Trust.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust recognizes changes in fair value of the investment in&#160;palladium as changes in unrealized gains or losses on investment
in&#160;palladium through the Statement of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
per Share amount of&#160;palladium exchanged for a purchase or redemption is calculated daily by the Trustee using the LME PM
Fix to calculate the&#160;palladium amount in respect of any liabilities for which covering palladium&#160;sales have not yet
been made, and represents the per Share amount of&#160;palladium held by the Trust, after giving effect to its liabilities, to
cover expenses and liabilities and any losses that may have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
Value Hierarchy&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820 establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The three levels of inputs
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
1.&#160;Unadjusted quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
2.&#160;Observable inputs other than quoted prices included in level 1 that are observable for the asset or liability either directly
or indirectly. These inputs&#160;may&#160;include&#160;quoted&#160;prices&#160;for&#160;the&#160;identical&#160;instrument on
an inactive market, prices for similar instruments and similar data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013;&#160;Level
3.&#160;Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing
the Trust&#x2019;s own assumptions about the assumptions that a market participant would use in valuing the asset or liability,
and that would be based on the best information available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination
of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for
instruments categorized in level 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes,
the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the
lowest level input that is significant to the fair value measurement in its entirety.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s investment in&#160;palladium is classified as a level&#160;1 asset,&#160;as its value&#160;is calculated using unadjusted
quoted prices from primary market sources.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zR0dpGA3xbo1"&gt;The
categorization of the Trust&#x2019;s assets is as shown below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;(Amounts in 000&#x2019;s of US$)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_z62gJcmPBYBb" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;There were no transfers between levels during the years ended December 31, 2022 and 2021.&lt;/p&gt;



</pall:ValuationOfBullionPolicyTextBlock>
    <pall:PercentageOfAssetBeingHeldByTrust contextRef="AsOf2022-12-31" decimals="INF" unitRef="Pure">0.2047</pall:PercentageOfAssetBeingHeldByTrust>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_z0LJrORo84s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zR0dpGA3xbo1"&gt;The
categorization of the Trust&#x2019;s assets is as shown below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfH6KUNB1anj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyoKGFRvuRE2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;(Amounts in 000&#x2019;s of US$)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic"&gt;Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InvestmentInPhysicalCommoditiesFairValueDisclosure_iI_pn3n3_z3hTXT3qlRok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">295638000</us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure>
    <us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">358161000</us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure>
    <pall:ReceivableAndPayablePolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84A_ecustom--ReceivableAndPayablePolicyTextBlock_zuO1ETszXTrb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.3.&#160;&#160;&#160;&#160;&lt;span id="xdx_86E_znNotwyp1dD1"&gt;Palladium
Receivable and Payable&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Palladium&#160;receivable
or payable represents the quantity of&#160;palladium covered by contractually binding orders for the creation or redemption of
Shares respectively, where the&#160;palladium has not yet been transferred to or from the Trust&#x2019;s account. Generally, ownership
of palladium is transferred within two business days of the trade date. At December 31, 2022, the Trust had &lt;span id="xdx_90A_ecustom--BullionReceivableAtMarketValue_iI_do_c20221231_zUittAsF6Uph" title="Palladium receivable"&gt;&lt;span id="xdx_90B_ecustom--BullionPayableAtMarketValue_iI_do_c20221231_zx8AJtIWBDkj" title="Palladium payable"&gt;no&lt;/span&gt;&lt;/span&gt; palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares. At December 31, 2021, the Trust had &lt;span id="xdx_901_ecustom--BullionReceivableAtMarketValue_iI_do_c20211231_zS4NHmQilRsg"&gt;&lt;span id="xdx_908_ecustom--BullionPayableAtMarketValue_iI_do_c20211231_z9xhUtsvDwP8"&gt;no&lt;/span&gt;&lt;/span&gt; palladium&#160;receivable
or payable for the&#160;creation&#160;or redemption of Shares.&lt;/span&gt;&lt;/p&gt;

</pall:ReceivableAndPayablePolicyTextBlock>
    <pall:BullionReceivableAtMarketValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</pall:BullionReceivableAtMarketValue>
    <pall:BullionPayableAtMarketValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</pall:BullionPayableAtMarketValue>
    <pall:BullionReceivableAtMarketValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</pall:BullionReceivableAtMarketValue>
    <pall:BullionPayableAtMarketValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</pall:BullionPayableAtMarketValue>
    <pall:CreationsAndRedemptionsOfSharesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_841_ecustom--CreationsAndRedemptionsOfSharesPolicyTextBlock_zZGfc1ABPnFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.4.&#160;&#160;&#160;&#160;&lt;span id="xdx_866_zZlM1LQjydrd"&gt;Creations
and Redemptions of Shares&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust expects to create and redeem Shares from time to time, but only in one or more Baskets (a Basket equals a block of&#160;&lt;span id="xdx_909_ecustom--MinimumBlockOfSharesIssuedRedeemedAgainstBullion_pid_uShares_c20220101__20221231_zhLvOmikeqR6" title="Minimum block of shares issued redeemed against palladium"&gt;25,000&lt;/span&gt;&#160;Shares).
The Trust issues Shares in Baskets to Authorized Participants on an ongoing basis. Individual investors cannot purchase or redeem
Shares in direct transactions with the Trust. An Authorized Participant is a person who (1) is a registered broker-dealer or other
securities market participant such as a bank or other financial institution which is not required to register as a broker-dealer
to engage in securities transactions; (2) is a participant in The Depository Trust Company; (3) has entered into an Authorized
Participant Agreement with the Trustee and the Sponsor; and (4) has established an Authorized Participant Unallocated Account
with the Trust&#x2019;s Custodian or other&#160;palladium bullion clearing bank. An Authorized Participant Agreement is an agreement
entered into by each Authorized Participant, the Sponsor and the Trustee which provides the procedures for the creation and redemption
of Baskets and for the delivery of the&#160;palladium&#160;required for such creations and redemptions. An Authorized Participant
Unallocated Account is an unallocated&#160;palladium account, either loco London or loco Zurich, established with the Custodian
or a&#160;palladium bullion clearing bank by an Authorized Participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
creation and redemption of Baskets is only made in exchange for the delivery to the Trust or the distribution by the Trust of
the amount of&#160;palladium represented by the Baskets being created or redeemed, the amount of which is based on the combined
NAV of the number of Shares included in the Baskets being created or redeemed determined on the day the order to create or redeem
Baskets is properly received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Authorized
Participants may, on any business day, place an order with the Trustee to create or redeem one or more Baskets. The typical settlement
period for Shares is two business days. In the event of a trade date at period end, where a settlement is pending, a respective
account receivable and/or payable will be recorded. When&#160;palladium is exchanged in settlement of a redemption, it is considered
a sale of&#160;palladium for financial statement purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;



&lt;p style="margin: 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
amount of&#160;palladium represented by the Baskets created or redeemed can only be settled to the nearest 1/1000th of an ounce.
As a result, the value attributed to the creation or redemption of Shares may differ from&#160;the value of palladium&#160;to
be delivered or distributed by the Trust. In order to ensure that the correct amount of&#160;palladium is available at all times
to back the Shares, the Sponsor accepts an adjustment to its management fees in the event of any shortfall or excess on each transaction.
For each transaction, this amount is not more than 1/1000th of an ounce of palladium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the Shares of the Trust are subject to redemption at the option of Authorized Participants, the Trust has classified the outstanding
Shares as Net Assets. Changes in the number of Shares outstanding are presented in the Statement of Changes in Net Assets.&lt;/span&gt;&lt;/p&gt;

</pall:CreationsAndRedemptionsOfSharesPolicyTextBlock>
    <pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Shares">25000</pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zGsBuQ9vK4Re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.5.&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zEMvHfnQ2Yq4"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust is classified as a &#x201c;grantor trust&#x201d; for U.S. federal income tax purposes. As a result, the Trust itself will
not be subject to U.S. federal income tax. Instead, the Trust&#x2019;s income and expenses will &#x201c;flow through&#x201d; to the
Shareholders, and the Trustee will report the Trust&#x2019;s proceeds, income, deductions, gains, and losses to the Internal Revenue
Service on that basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has evaluated whether or not there are uncertain tax positions that require financial statement recognition and has determined
that &lt;span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20221231_zWw9Q0QsbWu4" title="Reserve for uncertain tax positions"&gt;&lt;span id="xdx_905_eus-gaap--LiabilityForUncertainTaxPositionsNoncurrent_iI_do_c20211231_zU2AuJnuPpnj"&gt;no&lt;/span&gt;&lt;/span&gt; reserves for uncertain tax positions are required as of&#160;December 31, 2022&#160;or December 31, 2021.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_846_eus-gaap--InvestmentPolicyTextBlock_z0UdHI5CSAYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.6.&#160;&#160;&#160;&#160;&lt;span id="xdx_863_zNgBIJumV7D6"&gt;Investment
in&#160;Palladium&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zFcOCpBhTyle"&gt;Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;(Amounts in 000&#x2019;s of US$, except for ounces data)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Ounces of palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;152,187.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,004.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,977.6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(71,914.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(53,626.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,064.7&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,007.4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;166,556.4&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;356,424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;145,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(147,622&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131,079&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium distributed for the redemption of Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,270&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,443&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium transferred to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in unrealized (loss) on investment in palladium&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(62,298&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(108,531&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_z0IUIE3rgb17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <pall:InvestmentsInBullionTableTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_896_ecustom--InvestmentsInBullionTableTextBlock_zjx6lyJcBPcj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zFcOCpBhTyle"&gt;Changes
in ounces of&#160;palladium and their respective values for the years&#160;ended&#160;December 31, 2022 and&#160;2021 are set
out below:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zsI3esvEM0Ng" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210101__20211231_zGJ5RziK5yDg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended&lt;br/&gt; December 31,
    2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;(Amounts in 000&#x2019;s of US$, except for ounces data)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Ounces of palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iS_pp1p0_uOZ_z7bFMmfzgWCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;152,187.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CreationsOuncesOfBullion_pp1p0_uOZ_zc1G1Rsg5BU3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,004.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83,977.6&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RedemptionsOuncesOfBullion_pp1p0_uOZ_zgzkIVXARs73" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(71,914.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(53,626.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--TransfersOfBullionOunces_pp1p0_uOZ_zesSykhaZ1eg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,064.7&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,007.4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--InvestmentOwnedBalanceOtherMeasure_iE_pp1p0_uOZ_z3u1ExSKg1K6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;166,556.4&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;181,531.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Investment in palladium&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--InvestmentInPhysicalCommodities_iS_pn3n3_uUSD_zaOIFmCmGCa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;356,424&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--CreationsValueOfBullion_pn3n3_uUSD_znC5zds6SSpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Creations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;145,623&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable_iN_pn3n3_di_uUSD_zs62kko2f7Ga" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Redemptions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(147,622&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(131,079&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--RealizedGainLossOnBullionDistributedForRedemptionOfShares_pn3n3_uUSD_zevsnH8he6j1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium distributed for the redemption of Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CostOfBullionTransferredToPayExpenses_iN_pn3n3_di_uUSD_zBh7UGmCj8Of" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Transfers of palladium to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,270&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,443&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--GainLossOnSaleOfTrustAssetsToPayExpenses_pn3n3_uUSD_zuEYVl1exuq9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Realized gain on palladium transferred to pay expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--ChangeInUnrealizedGainLossOnInvestmentInBullion_pn3n3_uUSD_zOtt9BfiWpFc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in unrealized (loss) on investment in palladium&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(62,298&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(108,531&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InvestmentInPhysicalCommodities_iE_pn3n3_zoxWCURuD9w8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Closing balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;295,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;358,161&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</pall:InvestmentsInBullionTableTextBlock>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2021-12-31" decimals="1" unitRef="OZ">181531.1</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2020-12-31" decimals="1" unitRef="OZ">152187.5</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <pall:CreationsOuncesOfBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="1"
      unitRef="OZ">58004.8</pall:CreationsOuncesOfBullion>
    <pall:CreationsOuncesOfBullion
      contextRef="From2021-01-012021-12-31"
      decimals="1"
      unitRef="OZ">83977.6</pall:CreationsOuncesOfBullion>
    <pall:RedemptionsOuncesOfBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="1"
      unitRef="OZ">-71914.8</pall:RedemptionsOuncesOfBullion>
    <pall:RedemptionsOuncesOfBullion
      contextRef="From2021-01-012021-12-31"
      decimals="1"
      unitRef="OZ">-53626.6</pall:RedemptionsOuncesOfBullion>
    <pall:TransfersOfBullionOunces
      contextRef="From2022-01-01to2022-12-31"
      decimals="1"
      unitRef="OZ">-1064.7</pall:TransfersOfBullionOunces>
    <pall:TransfersOfBullionOunces
      contextRef="From2021-01-012021-12-31"
      decimals="1"
      unitRef="OZ">-1007.4</pall:TransfersOfBullionOunces>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2022-12-31" decimals="1" unitRef="OZ">166556.4</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="AsOf2021-12-31" decimals="1" unitRef="OZ">181531.1</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">358161000</us-gaap:InvestmentInPhysicalCommodities>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">356424000</us-gaap:InvestmentInPhysicalCommodities>
    <pall:CreationsValueOfBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">145623000</pall:CreationsValueOfBullion>
    <pall:CreationsValueOfBullion
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">205730000</pall:CreationsValueOfBullion>
    <pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">147622000</pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable>
    <pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">131079000</pall:ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable>
    <pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">3889000</pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares>
    <pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">37317000</pall:RealizedGainLossOnBullionDistributedForRedemptionOfShares>
    <pall:CostOfBullionTransferredToPayExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">2270000</pall:CostOfBullionTransferredToPayExpenses>
    <pall:CostOfBullionTransferredToPayExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">2443000</pall:CostOfBullionTransferredToPayExpenses>
    <us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">155000</us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses>
    <us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">743000</us-gaap:GainLossOnSaleOfTrustAssetsToPayExpenses>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2022-01-01to2022-12-31"
      decimals="-3"
      unitRef="USD">-62298000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <pall:ChangeInUnrealizedGainLossOnInvestmentInBullion
      contextRef="From2021-01-012021-12-31"
      decimals="-3"
      unitRef="USD">-108531000</pall:ChangeInUnrealizedGainLossOnInvestmentInBullion>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">295638000</us-gaap:InvestmentInPhysicalCommodities>
    <us-gaap:InvestmentInPhysicalCommodities contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">358161000</us-gaap:InvestmentInPhysicalCommodities>
    <pall:ExpensesPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_846_ecustom--ExpensesPolicyTextBlock_zoPL2gXTg5Ge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.7.&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_znnk1INfGa4e"&gt;Expenses
/ Realized Gains / Losses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
The primary expense of the Trust is the Sponsor&#x2019;s Fee, which is paid by the Trust through in-kind transfers of palladium
to the Sponsor.
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust will transfer&#160;palladium to the Sponsor to pay the Sponsor&#x2019;s Fee that accrues daily at an annualized rate equal
to &lt;span id="xdx_908_ecustom--AnnualizedRateOfSponsorsFee_pid_dp_uPure_c20220101__20221231_ztWNltr81rL1" title="Expense ratio"&gt;0.60&lt;/span&gt;% of the adjusted daily net asset value (&#x201c;ANAV&#x201d;) of the Trust, paid monthly in arrears.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed to assume administrative and marketing expenses incurred by the Trust, including the Trustee&#x2019;s monthly
fee and out of pocket expenses, the Custodian&#x2019;s fee and the reimbursement of the Custodian&#x2019;s expenses, exchange listing
fees, United States Securities and Exchange Commission (the &#x201c;SEC&#x201d;) registration fees, printing and mailing costs,
audit fees and up to $&lt;span id="xdx_907_ecustom--MaximumSponsorFeeForLegalExpenses_c20220101__20221231_zTgGEOsqRtv1" title="Maximum sponsor fee for legal expenses"&gt;100,000&lt;/span&gt; per annum in legal expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the&#160;years ended&#160;December 31, 2022,&#160;2021&#160;and 2020, the Sponsor&#x2019;s Fee&#160;was&#160;$&lt;span id="xdx_900_eus-gaap--SponsorFees_c20220101__20221231_ziAQYh2kocma" title="Sponsor's Fee"&gt;2,226,662&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--SponsorFees_c20210101__20211231_zqADh61kOPuc"&gt;2,447,225&lt;/span&gt;&#160;and
$&lt;span id="xdx_906_eus-gaap--SponsorFees_c20200101__20201231_zodEoWbJxNT4"&gt;2,012,865&lt;/span&gt;, respectively.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At&#160;December
31, 2022 and at&#160;December 31, 2021, the fees payable to the Sponsor were&#160;$&lt;span id="xdx_900_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20221231_zva69Tdjou3k" title="Fees payable to Sponsor"&gt;146,803&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AccountsPayableRelatedPartiesCurrent_iI_c20211231_z1HU8xY1KYsf"&gt;189,455&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
respect to expenses not otherwise assumed by the Sponsor, the Trustee will, at the direction of the Sponsor or in its own discretion,
sell the Trust&#x2019;s&#160;palladium as necessary to pay these expenses. When selling&#160;palladium to pay expenses, the Trustee
will endeavor to sell the smallest amounts of&#160;palladium needed to pay these expenses in order to minimize the Trust&#x2019;s
holdings of assets other than palladium. Other than the Sponsor&#x2019;s Fee, the Trust had &lt;span id="xdx_900_eus-gaap--OtherCostAndExpenseOperating_do_c20220101__20221231_zBsd76ZaumSb" title="All other expenses"&gt;&lt;span id="xdx_90C_eus-gaap--OtherCostAndExpenseOperating_do_c20210101__20211231_zAg3RzIYOa9f"&gt;no&lt;/span&gt;&lt;/span&gt; expenses during the years ended&#160;December
31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise directed by the Sponsor, when selling&#160;palladium the Trustee will endeavor to sell at the price established by the
LME PM Fix. The Trustee will place orders with dealers (which may include the Custodian) through which the Trustee expects to
receive the most favorable price and execution of orders. The Custodian may be the purchaser of such&#160;palladium only if the
sale transaction is made at the next LME PM Fix or such other publicly available price that the Sponsor deems fair, in each case
as set following the sale order. A gain or loss is recognized based on the difference between the selling price and the average
cost of the&#160;palladium sold. Neither the Trustee nor the Sponsor is liable for depreciation or loss incurred by reason of
any sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
gains and losses result from the transfer of&#160;palladium for Share redemptions and / or to pay expenses and are recognized
on a trade date basis as the difference between the fair value and average cost of&#160;palladium transferred.&lt;/span&gt;&lt;/p&gt;

</pall:ExpensesPolicyTextBlock>
    <pall:AnnualizedRateOfSponsorsFee
      contextRef="From2022-01-01to2022-12-31"
      decimals="INF"
      unitRef="Pure">0.0060</pall:AnnualizedRateOfSponsorsFee>
    <pall:MaximumSponsorFeeForLegalExpenses
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">100000</pall:MaximumSponsorFeeForLegalExpenses>
    <us-gaap:SponsorFees
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">2226662</us-gaap:SponsorFees>
    <us-gaap:SponsorFees
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">2447225</us-gaap:SponsorFees>
    <us-gaap:SponsorFees
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2012865</us-gaap:SponsorFees>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">146803</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">189455</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2022-01-01to2022-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_84D_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zG0PUfyVNrve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;2.8.&#160;&#160;&#160;&#160;&lt;span id="xdx_860_zyMMjOjio31h"&gt;Subsequent
Events&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the provisions set forth in FASB ASC 855-10, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Trust&#x2019;s management has evaluated
the possibility of subsequent events impacting the Trust&#x2019;s financial statements through the filing date. In connection with her retirement, Andrea Melia has resigned as Chief Financial Officer and Treasurer of the Sponsor, to be effective
on February 28, 2023, immediately after the filing of this report. Ms. Melia has served as Principal Financial Officer of the Registrant.
Brian Kordeck was appointed as Chief Financial Officer and Treasurer of the Sponsor, to be effective on February 28, 2023, immediately
after the filing of this report. Mr. Kordeck will serve as Principal Financial Officer of the Registrant.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zetJUQRPy8B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&#160;&#160;&#160;&#160;&lt;span id="xdx_826_zioxwO2LEDua"&gt;Related
Parties&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor and the Trustee are considered to be related parties to the Trust. The Trustee and the Custodian and their affiliates
may from time to time act as Authorized Participants and purchase or sell Shares for their own account, as agent for their customers
and for accounts over which they exercise investment discretion. In addition, the Trustee and the Custodian and their affiliates
may from time to time purchase or sell&#160;palladium directly, for their own account, as agent for their customers and for accounts
over which they exercise investment discretion. The Trustee&#x2019;s and Custodian&#x2019;s fees are paid by the Sponsor and are
not separate expenses of the Trust.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_801_eus-gaap--ConcentrationRiskDisclosureTextBlock_zsGconhwKTJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.&#160;&#160;&#160;&#160;&lt;span id="xdx_827_zLfDGREXIJ1i"&gt;Concentration
of Risk&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust&#x2019;s sole business activity is the investment in&#160;palladium, and substantially all the Trust&#x2019;s assets are holdings
of&#160;palladium, which creates a concentration of risk associated with fluctuations in the price of palladium. Several factors
could affect the price of palladium, including: (i) global palladium supply and demand, which is influenced by factors such as
production and cost levels in major palladium-producing countries, recycling, autocatalyst demand, industrial demand, jewelry
demand, investment demand, and sales of existing stockpiles of palladium, which have been a key source of supply and are likely
to be exhausted soon, placing a higher burden on new mine supply; (ii) investors&#x2019; expectations with respect to the rate
of inflation; (iii) currency exchange rates; (iv) interest rates; (v) investment and trading activities of hedge funds and commodity
funds; and (vi) global or regional political, economic or financial events and situations. In addition, there is no assurance
that&#160;palladium will maintain its long-term value in terms of purchasing power in the future. In the event that the price
of&#160;palladium declines, the Sponsor expects the value of an investment in the Shares to decline proportionately. Each of these
events could have a material effect on the Trust&#x2019;s financial position and results of operations.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-12-31">&lt;p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlcboV76bHP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.&#160;&#160;&#160;&#160;&lt;span id="xdx_823_zXHkNdhUbMS6"&gt;Indemnification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Trust&#x2019;s organizational documents, the Trustee (and its directors, employees and agents) and the Sponsor (and its members,
managers, directors, officers, employees and affiliates) are indemnified by the Trust against any liability, cost or expense it
incurs without gross negligence, bad faith, willful misconduct or willful malfeasance on its part and without reckless disregard
on its part of its obligations and duties under the Trust&#x2019;s organizational documents. The Trust&#x2019;s maximum exposure
under these arrangements is unknown as this would involve future claims that may be made against the Trust that have not yet occurred.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000070"
          xlink:label="Fact000070"
          xlink:type="locator"/>
        <link:footnote id="Footnote000072" xlink:label="Footnote000072" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Authorized
    share capital is <xhtml:span
  id="xdx_90A_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20220101__20221231_z7eyZpVVt1pd"
  title="Common stock, shares authorized::XDX::Unlimited"><xhtml:span
      id="xdx_906_eus-gaap--CommonStockSharesAuthorizedUnlimited_pip0_dxL_c20210101__20211231_zVrHC2cowuCj"
      title="::XDX::Unlimited"><xhtml:span style="-sec-ix-hidden: xdx2ixbrl0074"><xhtml:span style="-sec-ix-hidden: xdx2ixbrl0075">unlimited</xhtml:span></xhtml:span></xhtml:span></xhtml:span> with <xhtml:span
  id="xdx_90E_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20221231_zrgnOraAZenk"
  title="Common stock, no par value (in dollars per share)"><xhtml:span id="xdx_908_eus-gaap--CommonStockNoParValue_iI_pip0_do_uUSDPShares_c20211231_zcBNPMoO3Nm5">no</xhtml:span></xhtml:span> par value per Share. Shares issued and outstanding at December 31, 2022 were <xhtml:span
  id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zI71TChXSDha"
  title="Common stock, shares issued"><xhtml:span
      id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zsgDKQ89FR91"
      title="Common stock, shares outstanding">1,800,000</xhtml:span></xhtml:span>
    and at December 31, 2021 were <xhtml:span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zeK3V8mFcFP8"><xhtml:span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zkvXQs821sIb">1,950,000</xhtml:span></xhtml:span>. Net asset values per Share at December 31, 2022 and December 31, 2021 were $<xhtml:span
  id="xdx_90C_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20221231_zSmno3ZdzZv3"
  title="Net asset value per share (in dollars per share)">164.16</xhtml:span>
    and $<xhtml:span id="xdx_90F_eus-gaap--NetAssetValuePerShare_iI_pid_uUSDPShares_c20211231_zWGkOMZkRWs6">183.58</xhtml:span>, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000070"
          xlink:to="Footnote000072"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000072"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>33
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^1[KJ>&2=L^R/MPP^<05?!.2<_VESVAL,*56IE@$!QOW^RC%^Y704L0EIVD
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M(LHW%YSY7&8'P/N/0JCM3O8!NQ]P]/\'4$L#!!0    (  .+8583(&A<3 ,
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ME,F@@P&B:0>\X+OK&)[TF:?CCC5J)SQN.7@/FC8?=9K=U#)CG'XAZ4\BPYR
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M)$22>,;9'G"M5M[T0Q/,QEKA%[6>]Z7DZFNA[&2\E$12-8]2 +8"BYS4:RI
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MKH:)W-1$;F8'@]N\,MGY$SL<;J_!SI_94]_,;M:QF[T^NE'8[-&X-GL:B<+
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MQM,+'885?1*AY0VT7AKCMQ,^8/C(FO\-4$L#!!0    (  .+85:BI,(WMA(
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MXQF^QML*"B='<A81/J,)NZ]X5=V22"9P#;VI]8:'+MF\:?E[]BFUVU6F=)9
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M7\0E/*H2S-_0Z..%L)'1XIQB&><3!&3NJRQK7?XBJ"L<U/V7@1ZAC <"P@)
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MF\X=S1+AH-VP'VQA\"E*/N/MN5=;Z7%56)AQF^I^KW5%/144!*&-X5B.<AZ
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M94!L(&=7#*D\T E-4M@FD5%,%,LNBI/,$A*@1.L<Q-H#0E3<K+.ICZ^W\:!
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M8,4/( N1J[8\IHGS=$;I*.6!&(N)D3*<L'4!R&E(SIM:/RG$0VL%C_?\>C0
M 0A5$R')/TEAVEK2F@,-$L?\E>&;0!_L:"V+G"]V_-\/GP#41<7O0>L23*/Z
MEO!?TMN47^*<3NKW"$6Y$I67?<)!  NY%L42F0G6D7"P%=48_E%7N:X2]JY:
M%:!0_H1 B?8 GE$J(TV*'/)3')9BQT5A-,P16/UZ]\AO?X:9:RZJ'=<P:<V7
MJBZYA7E)7R$K@5W>:+[61<Z:,W,Y,^Z_AK<:3 ]H"FN;_C.<,'Q%JPI+0ID(
M8&95RQ4-79"CX?*W:PW2%9N-5I6U272RA905/@3%=LP[+TSY;<,!\62Y@&5Z
MU$OLY\\*(I(L=O LG<Q_I.M:9KK.<2GHO6 M3V@M5@&9!BL##?8&1,Z/JZ]S
M5!R($MD33[*&@&T'EK)9:_BH0I20K"..5#!<YB@3&K8$DI6&.Q"4<>Z#+YHM
M^"S/A8+5+-4S/@:]@<0SV>=+Y,"1,D"FDY6U,K#[1A3LW7.V%A6PYK'BXZ=W
M 2MB:X;G_.$3(,>S?YWR+U(4ZD^@O()<QM"*"FV<4B$@5&8I:]/CB"PQW+$<
M>*O5HD7%0[Y$_ &KLMQXM'A<"P@+H,(:Q">*K"W(2LAJ8(H<Q=!(:S5<6*<'
M"(2))4IC(9LM&@Q982=I9#56"NM)S;,.G)#"&2Z>;,*@G:E%(0.W7L)UP#=\
M2KY5ZTIE$=E-C5H#?:%EF!UHI8S%OFB+ D@$Z6,(8;7<% CG(-..)E"TJBQ%
MU0*(.XUV,Z%-@,4#KJ,RP-6>E&X-# +!%GIW8 L/(%15H;V 7#I(?4^L,AL)
M=OQCTT6BCP\/[^\_=L@&DM]"GHA_"7+)^B,I0/[Z#1+FK)"BMHCFN5O&!L&=
M$*P*!*6A  :-0Y%GX)RD"-(PC5@4"M*X;C&@)7R+]$N)=JU,F?).M DOU#?I
MXH*5R0]DET3S6%#:M.ZNSPZ90ZUWU@G[-N_<58IL[:=#RT4V<X#LO"6)>+NP
MGHXXMU)5A8]@^3<O)U,F4ER-(P!Y/OFG4P$M_K;GGZ3,T<O!@&^.#3SGV)]A
M#03_UEMZBPD8W %>0B*M0+\"A-:X4?$DO]S^%M@"1\K HMHH]A .2\G@%B"W
MS2CH"32G+*M;Q 9)NGB&R@IM!E=F0UFAQ$(5JE%6YE%,5556M!:$"53*MI+.
M27/@SB&S3]^06>:8=<]"7'@O96?HRUJ7^VCB)HY@%^$%V+<\DE"Z["'PF$8Y
M"X8;*"O^A&580#88.P_G4%V"IF*K%;UQ;57WH1E6V"%S1X/U:#3K6K>KM95+
M YA#T\#$GS=.<C8!87!K<9F+DL)\ST"D"RD6T05X3)U1G@1W$;:C&71X;F-9
MWQQX:[SZK)$R,%)47!BW+_;2)QV(U( ]-C#N>E:"3&W7"GPQ@PS"@E&@8$0!
MGZPA-/!*-WPG&T:V7D*@24BM ,A8IE2-RR_/BN) Y8F-Z7REG@@@(4X!E[ D
M3/\B+L&C-"/^^D8?+X2,#!=G%4L5!Z: Q+W.LM;&+TQUF4UU_Z5 CZ",'2;"
M#!+A&-U 4^OPGH@!M.D:YOJ3C H<UB"G3R&7;P!C*_6]A=<M9BWPLK3)]$'&
M!*8%^BSDDRS(3RTY1G(S/F%_26@Q1####QE475\KD?^!QI#S[ZUN.KQ5OCOA
M(HO5J\I!,1@?O<_I/D+L565KER_8#W:X   < .!TCQ.H.CXOL#85&/J=+*QS
M \GJ@#=$'K@')FG)?&AGQN7JCDY((0@T(U8A3BLBGBO A:;8,5Q;Y>](I";P
M@3IW4^XQXB?HQ )8T-2M]>L*XAD\Z(DQB8<:5:I"U-$@:W3^.21>8E]28]29
M/I#5F:4Z();/#7)%<JHA<7C"]LHA(10A>J9X L# %TGGD9BK'!8E>EOAM*V%
M':"PT&WCF0E/K7Y\FK(1-<A+;9"'K6[!B5N2-YFTQZ3#M23,)O7"CUK(?D*_
M '\#,K8S2!TVOPS0J6;[<NA<+:X,2IV3%]7!*;UM 7:96&;P2=M7ALL:K:HI
M579!/!344<BIY?<63 XL3 /Q/]I\A3:04N.!RIMBYXFLT+UAM/\(EB'K3!GK
M!'X22G-ZY0Z,P]P6:_::Q7:&*>\*T.?/V(W&-ORX99_&''();+G 4/C EP--
M!$![$3P@7\H_0+758G00E/^AY4*5D@'*XB00S#8:7Y"R+%OJH+SH@-2U?&S
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M>8JC%-PUD&7'R4;%9AT^8%01VO=[Z=;W%HP:HT8OS:)$R583F:ZH$]U2C;S
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M,!F)ET7!4]=HG*$PM-PP=4$V16[7P&K^'9.S9J8\'A^HDF-?Y,N-1NF^#N0
M: )Q4V'"%8F\/)^2*/,BFKTZ4J$79H'A$GIQ')UFHG>8:/T9$$T2DL61TQ>Y
M"=ZFE7NH$49>C0T8?Z%KC%(D,K7IID%NDG$D8:]M+?ZC6[D!N;9O#T7LG=-?
MT,/J\+PY[V_UP_;^;?2)R37'K-6P0M5@DN&YE_U[HY]HT=D[?BDTOACLL,(G
M&DBS >4K(?1^8@P,C[[%OU!+ P04    "  #BV%67U)E:E0"  #R!   &0
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M/W]S0<"D#4N&TUV<ZHUV?D?BL?6/$IH0X.^W6KN#$0J,SUSU!U!+ P04
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MF- &\'[!N3K<Z ^TQTR3?P%02P,$%     @  XMA5AND=R/I P  G0\  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULK5?;;N,V$/T50BW:7: ;2;0L
MVZEMP(EVL7U(8<38]J'H RV-+2*4J)+T)7]?4E+DFTP[@5]LD9HYG'.&''&&
M&RY>9 J@T#9CN1PYJ5+%O>O*.(6,R#M>0*[?++C(B-)#L71E(8 DI5/&7.QY
MH9L1FCOC83DW%>,A7RE&<Y@*)%=91L3K S"^&3F^\S;Q3)>I,A/N>%B0)<Q
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M74^S$U4O6 T4+\KN:,Z5[K7*QU3WSR",@7Z_X%R]#<P"34<^_A]02P,$%
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M]I9$49+X$<#\#J((0^!MQ!', 7C D"BJS\&]\RC<G%-A]]^KR2-02P,$%
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MH%(K'9/G#3W&QMEI&D!CFCSN"EO6-%7>ZZ90D?;%VI;?*-F>D%-G5X-UXW%
M!:DX26AW?@;L^U[7$$)30C)7(;XH0U5BHP7&K0;,^R5.>'15U110NF)EJ"5'
M'T"56 -$H_.=Z*"?'.F$87>5%_,[F3X@5<Z#\T@3"W ^[C"2MCOS) 0A-OVO
M>"22],7O!^VT2RA_R:;C_7!AV<T#1;=<?L9?9WS4/]/'B(F/*R8^KIGXN&'B
M8\S$QRT3'W=,?-PS\2&'7(QP253))5(EETR57$)5<DE5R256)9=<E?\9K._.
M+?_ZF[M=<Z,:>^"+[L=F]@E02P$"% ,4    "  #BV%6!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M  .+85:H 2$L[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    (  .+85:97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @  XMA5I2Y
M)DUZ!P  S#$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    (  .+8583(&A<3 ,  !H*   8
M  " @;T/  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  #
MBV%6E;W.O"H#  !["0  &               @($_$P  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @  XMA5HDTZ;"S P  F0T  !@
M         ("!GQ8  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   (  .+85:GN)4 5@0  .L/   8              " @8@:  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  #BV%6[&\I,0P$  #D#@
M&               @($4'P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @  XMA5@-ET!4C!   30\  !@              ("!5B,  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  .+858,U):+)00
M ' )   8              " @:\G  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    "  #BV%6HJ3"-[82   ),P  &               @($*
M+   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @  XMA5K"2
M%;X) P  90<  !D              ("!]CX  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    "  #BV%6E> JV: $   F"@  &0
M    @($V0@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M  .+858JQQ@Y4@,  %D'   9              " @0U'  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @  XMA5O1L.Z_3$@  :34  !D
M             ("!EDH  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    "  #BV%6_4:_O?4#    "@  &0              @(&@70  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  .+859?4F5J5 (
M /($   9              " @<QA  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @  XMA5A2Q!L:5 @  <P8  !D              ("!
M5V0  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  #BV%6
MZ:U6=*4$  !R$@  &0              @($C9P  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    (  .+858;I'<CZ0,  )T/   9
M      " @?]K  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @  XMA5KS#OLPL P  RA(   T              ( !'W   'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    "  #BV%6EXJ[',     3 @  "P
M@ %V<P  7W)E;',O+G)E;'-02P$"% ,4    "  #BV%6W["@'WT"  #3#
M#P              @ %?=   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M XMA5C\.W4P5 0  K0L  !H              ( !"7<  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  XMA5D% I&9; 0  X P  !,
M             ( !5G@  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     !H
,&@#M!@  XGD

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>106</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Statements of Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/StatementsOfAssetsAndLiabilities</Role>
      <ShortName>Statements of Assets and Liabilities</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical</Role>
      <ShortName>Statements of Assets and Liabilities (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Schedules of Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/SchedulesOfInvestments</Role>
      <ShortName>Schedules of Investments</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/StatementsOfOperations</Role>
      <ShortName>Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Statements of Changes in Net Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/StatementsOfChangesInNetAssets</Role>
      <ShortName>Statements of Changes in Net Assets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Financial Highlights</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/FinancialHighlights</Role>
      <ShortName>Financial Highlights</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Concentration of Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/ConcentrationOfRisk</Role>
      <ShortName>Concentration of Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Indemnification</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/Indemnification</Role>
      <ShortName>Indemnification</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://abrdn.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://abrdn.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Organization (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/OrganizationDetailsNarrative</Role>
      <ShortName>Organization (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://abrdn.com/role/Organization</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - The categorization of the Trust???s assets is as shown below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails</Role>
      <ShortName>The categorization of the Trust???s assets is as shown below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails</Role>
      <ShortName>Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pall-10k_123122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://abrdn.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>18</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate -  pall-10k_123122.htm 30</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="pall-10k_123122.htm">pall-10k_123122.htm</File>
    <File>ex23-1.htm</File>
    <File>ex31-1.htm</File>
    <File>ex31-2.htm</File>
    <File>ex32-1.htm</File>
    <File>ex32-2.htm</File>
    <File>pall-20221231.xsd</File>
    <File>pall-20221231_cal.xml</File>
    <File>pall-20221231_def.xml</File>
    <File>pall-20221231_lab.xml</File>
    <File>pall-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pall-img001.jpg</File>
    <File>pall-img002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="129">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>39
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pall-10k_123122.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 129,
    "http://xbrl.sec.gov/dei/2022": 38
   },
   "contextCount": 13,
   "dts": {
    "calculationLink": {
     "local": [
      "pall-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pall-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pall-10k_123122.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pall-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pall-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pall-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 159,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 27,
   "keyStandard": 79,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "pall",
   "nsuri": "http://abrdn.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://abrdn.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Related Parties",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://abrdn.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Concentration of Risk",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://abrdn.com/role/ConcentrationOfRisk",
     "shortName": "Concentration of Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Indemnification",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://abrdn.com/role/Indemnification",
     "shortName": "Indemnification",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "13",
     "role": "http://abrdn.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "14",
     "role": "http://abrdn.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "pall:MinimumBlockOfSharesIssuedRedeemedAgainstBullion",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Organization (Details Narrative)",
     "menuCat": "Details",
     "order": "15",
     "role": "http://abrdn.com/role/OrganizationDetailsNarrative",
     "shortName": "Organization (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - The categorization of the Trust\u2019s assets is as shown below: (Details)",
     "menuCat": "Details",
     "order": "16",
     "role": "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails",
     "shortName": "The categorization of the Trust\u2019s assets is as shown below: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentInPhysicalCommoditiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceOtherMeasure",
      "reportCount": 1,
      "unitRef": "OZ",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)",
     "menuCat": "Details",
     "order": "17",
     "role": "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
     "shortName": "Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "pall:InvestmentsInBullionTableTextBlock",
       "us-gaap:InvestmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "1",
      "lang": null,
      "name": "pall:CreationsOuncesOfBullion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "OZ",
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "pall:PercentageOfAssetBeingHeldByTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Significant Accounting Policies (Details Narrative)",
     "menuCat": "Details",
     "order": "18",
     "role": "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "shortName": "Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "pall:ValuationOfBullionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "pall:PercentageOfAssetBeingHeldByTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentInPhysicalCommodities",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Statements of Assets and Liabilities",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://abrdn.com/role/StatementsOfAssetsAndLiabilities",
     "shortName": "Statements of Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtCost",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Statements of Assets and Liabilities (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical",
     "shortName": "Statements of Assets and Liabilities (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceOtherMeasure",
      "reportCount": 1,
      "unitRef": "OZ",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Schedules of Investments",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://abrdn.com/role/SchedulesOfInvestments",
     "shortName": "Schedules of Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "pall:ExpensesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SponsorFees",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Statements of Operations",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://abrdn.com/role/StatementsOfOperations",
     "shortName": "Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Statements of Changes in Net Assets",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://abrdn.com/role/StatementsOfChangesInNetAssets",
     "shortName": "Statements of Changes in Net Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetAssetValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Financial Highlights",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://abrdn.com/role/FinancialHighlights",
     "shortName": "Financial Highlights",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:NetAssetValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Organization",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://abrdn.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://abrdn.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "pall-10k_123122.htm",
      "contextRef": "From2022-01-01to2022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_XPD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Palladium Ounces"
       }
      }
     },
     "localname": "XPD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://abrdn.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "pall_AnnualizedNetInvestmentIncomeLossRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annualized net investment income (loss) ratio.",
        "label": "Net investment loss ratio"
       }
      }
     },
     "localname": "AnnualizedNetInvestmentIncomeLossRatio",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "percentItemType"
    },
    "pall_AnnualizedRateOfSponsorsFee": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annualized rate of sponsors fee.",
        "label": "Expense ratio"
       }
      }
     },
     "localname": "AnnualizedRateOfSponsorsFee",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights",
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "pall_BullionPayableAtMarketValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of bullion payable at market value as of the reporting date.",
        "label": "Palladium payable"
       }
      }
     },
     "localname": "BullionPayableAtMarketValue",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_BullionReceivableAtMarketValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of bullion receivable at market value as of the reporting date.",
        "label": "Palladium receivable"
       }
      }
     },
     "localname": "BullionReceivableAtMarketValue",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_ChangeInNetAssetsFromOperationsPerShare": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/FinancialHighlights": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in net assets from operations per share.",
        "label": "Change in net assets from operations",
        "totalLabel": "Change in net assets from operations"
       }
      }
     },
     "localname": "ChangeInNetAssetsFromOperationsPerShare",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "perShareItemType"
    },
    "pall_ChangeInUnrealizedGainLossOnInvestmentInBullion": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "pall_TotalGainLossOnBullion",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in unrealized gain (loss) on investment in Bullion.",
        "label": "Change in unrealized gain / (loss) on investment in palladium",
        "terseLabel": "Change in unrealized (loss) on investment in palladium",
        "verboseLabel": "Change in unrealized (loss)/gain on investment in palladium"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnInvestmentInBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
      "http://abrdn.com/role/StatementsOfChangesInNetAssets",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_CostOfBullionTransferredToPayExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of Bullion transferred to pay Trust's expenses.",
        "label": "Transfers of palladiuim to pay expenses",
        "negatedLabel": "Transfers of palladium to pay expenses"
       }
      }
     },
     "localname": "CostOfBullionTransferredToPayExpenses",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_CreationsAndRedemptionsOfSharesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of creation and redemptions of shares policy.",
        "label": "Creations and Redemptions of Shares"
       }
      }
     },
     "localname": "CreationsAndRedemptionsOfSharesPolicyTextBlock",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pall_CreationsOuncesOfBullion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ounces of bullion received into the Trust's account in respect of creations.",
        "label": "Creations (in Ounces)",
        "verboseLabel": "Creations"
       }
      }
     },
     "localname": "CreationsOuncesOfBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "massItemType"
    },
    "pall_CreationsValueOfBullion": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of creations of bullion in investment.",
        "label": "Creations [Default Label]",
        "verboseLabel": "Creations"
       }
      }
     },
     "localname": "CreationsValueOfBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_ExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EXPENSES"
       }
      }
     },
     "localname": "ExpensesAbstract",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "pall_ExpensesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of expenses policy.",
        "label": "Expenses / Realized Gains / Losses"
       }
      }
     },
     "localname": "ExpensesPolicyTextBlock",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pall_IncomeFromInvestmentOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income from investment operations:"
       }
      }
     },
     "localname": "IncomeFromInvestmentOperationsAbstract",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "pall_InvestmentsInBullionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of movement in the investment in bullion in the Trust.",
        "label": "Changes in ounces of palladium and their respective values for the years ended December 31, 2022 and 2021 are set out below:"
       }
      }
     },
     "localname": "InvestmentsInBullionTableTextBlock",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pall_MaximumSponsorFeeForLegalExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum sponsor fee for legal expenses,",
        "label": "Maximum sponsor fee for legal expenses"
       }
      }
     },
     "localname": "MaximumSponsorFeeForLegalExpenses",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_MinimumBlockOfSharesIssuedRedeemedAgainstBullion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum block of shares that can be created or redeemed against bullion deposits or distributions.",
        "label": "Minimum block of shares issued redeemed against palladium"
       }
      }
     },
     "localname": "MinimumBlockOfSharesIssuedRedeemedAgainstBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/OrganizationDetailsNarrative",
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "pall_NetAssetsPercentageOfNetAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Assets, Percentage of Net Assets.",
        "label": "Net Assets, % of Net Assets"
       }
      }
     },
     "localname": "NetAssetsPercentageOfNetAssets",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "percentItemType"
    },
    "pall_NetInvestmentGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net investment gain (loss).",
        "label": "Net investment loss",
        "totalLabel": "Net investment loss"
       }
      }
     },
     "localname": "NetInvestmentGainLoss",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_NetInvestmentIncomLossPerShare": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/FinancialHighlights": {
       "order": 1.0,
       "parentTag": "pall_ChangeInNetAssetsFromOperationsPerShare",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net investment income (loss) per share.",
        "label": "Net investment income (loss) per share",
        "verboseLabel": "Net investment loss"
       }
      }
     },
     "localname": "NetInvestmentIncomLossPerShare",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "perShareItemType"
    },
    "pall_NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/FinancialHighlights": {
       "order": 2.0,
       "parentTag": "pall_ChangeInNetAssetsFromOperationsPerShare",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net realized and unrealized gains and losses on investment in Bullion per share.",
        "label": "Total realized and unrealized gains or losses on investment in palladium"
       }
      }
     },
     "localname": "NetRealizedAndUnrealizedGainsAndLossesOnInvestmentInBullionPerShare",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "perShareItemType"
    },
    "pall_PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per Share Performance (for a Share outstanding throughout the entire period)"
       }
      }
     },
     "localname": "PerSharePerformanceForShareOutstandingThroughoutEntirePeriodAbstract",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "pall_PercentageOfAssetBeingHeldByTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of asset being held by trust.",
        "label": "Percentage of palladium held by sub-custodians"
       }
      }
     },
     "localname": "PercentageOfAssetBeingHeldByTrust",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "pall_RealizedGainLossOnBullionDistributedForRedemptionOfShares": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "pall_TotalGainLossOnBullion",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Realized gain or loss during the period on bullion distributed for the redemption of Shares. Realized gains or losses are calculated on a trade date basis using average cost.",
        "label": "Realized gain on palladium distributed for the redemption of Shares"
       }
      }
     },
     "localname": "RealizedGainLossOnBullionDistributedForRedemptionOfShares",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_ReceivableAndPayablePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of bullion receivable and payable policy.",
        "label": "Palladium Receivable and Payable"
       }
      }
     },
     "localname": "ReceivableAndPayablePolicyTextBlock",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pall_RedemptionsOuncesOfBullion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ounces of bullion paid out of the Trust's account in respect of redemptions.",
        "label": "Redemptions"
       }
      }
     },
     "localname": "RedemptionsOuncesOfBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "massItemType"
    },
    "pall_StatementFinancialHighlightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights"
       }
      }
     },
     "localname": "StatementFinancialHighlightsAbstract",
     "nsuri": "http://abrdn.com/20221231",
     "xbrltype": "stringItemType"
    },
    "pall_TotalGainLossOnBullion": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain or loss in the period on bullion.",
        "label": "Total gain / (loss) on investment in palladium",
        "totalLabel": "Total gain / (loss) on investment in palladium"
       }
      }
     },
     "localname": "TotalGainLossOnBullion",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pall_TotalReturnAtNetAssetValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total return, at net asset value.",
        "label": "Total return, net asset value"
       }
      }
     },
     "localname": "TotalReturnAtNetAssetValue",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights"
     ],
     "xbrltype": "percentItemType"
    },
    "pall_TransfersOfBullionOunces": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ounces of bullion transferred to pay Trust's expenses.",
        "label": "Transfers of palladium to pay expenses"
       }
      }
     },
     "localname": "TransfersOfBullionOunces",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "massItemType"
    },
    "pall_ValuationOfBullionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation of bullion policy.",
        "label": "Valuation of Palladium"
       }
      }
     },
     "localname": "ValuationOfBullionPolicyTextBlock",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pall_ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of bullion distributed at average cost for the redemption of Shares excluding bullion payable.",
        "label": "Redemptions [Default Label]",
        "negatedLabel": "Redemptions"
       }
      }
     },
     "localname": "ValueOfBullionDistributedForRedemptionOfSharesExcludingBullionPayable",
     "nsuri": "http://abrdn.com/20221231",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r6",
      "r23",
      "r24",
      "r154"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Fees payable to Sponsor"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r25",
      "r27",
      "r38",
      "r45",
      "r65",
      "r67",
      "r69",
      "r72",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r97",
      "r99",
      "r106",
      "r131",
      "r157",
      "r158",
      "r161"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r0",
      "r30",
      "r34",
      "r35",
      "r36"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "totalLabel": "NET ASSETS"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments",
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r16",
      "r73",
      "r74",
      "r122",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Indemnification"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/Indemnification"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common stock, no par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\".",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "authorizedUnlimitedItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r3",
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/ConcentrationOfRisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r43",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r57",
      "r58",
      "r60",
      "r61",
      "r62",
      "r63",
      "r101",
      "r102",
      "r116",
      "r117",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Net increase / (decrease) in net assets per Share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r104",
      "r112",
      "r113",
      "r114",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r84",
      "r85",
      "r90",
      "r104",
      "r112",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r112",
      "r113",
      "r114",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfTrustAssetsToPayExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "pall_TotalGainLossOnBullion",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.",
        "label": "Realized gain on palladium transferred to pay expenses"
       }
      }
     },
     "localname": "GainLossOnSaleOfTrustAssetsToPayExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentCompanyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company [Abstract]"
       }
      }
     },
     "localname": "InvestmentCompanyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentInPhysicalCommodities": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in physical commodities, such as gold, silver, platinum, crude oil, coal, sugar, rice, wheat.",
        "label": "Investment in palladium (cost: December 31, 2022: $334,209; December 31, 2021: $334,434)",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "InvestmentInPhysicalCommodities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentInPhysicalCommoditiesFairValueDisclosure": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment held in physical commodities, for example, but not limited to, gold, silver, platinum, crude oil, coal, sugar, rice, wheat.",
        "label": "Investment in Physical Commodities, Fair Value Disclosure",
        "verboseLabel": "Investment in palladium"
       }
      }
     },
     "localname": "InvestmentInPhysicalCommoditiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/CategorizationOfTrustsAssetsIsAsShownBelowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtCost": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of the investment.",
        "label": "Investment in palladium at cost",
        "verboseLabel": "Cost"
       }
      }
     },
     "localname": "InvestmentOwnedAtCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments",
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r33",
      "r118",
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Fair Value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceOtherMeasure": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantity of the investment. Indicate the measure in the unit of measure. This is commonly used for investments other than securities. For example, if the investment is gold, the balance would be the number of ounces and the unit of measure would indicate \"ounces\".",
        "label": "Investment in palladium",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceOtherMeasure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/ChangesInOuncesOfPalladiumAndTheirRespectiveValuesForYearsEndedDecember312022And2021AreSetOutBelowDetails",
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "massItemType"
    },
    "us-gaap_InvestmentOwnedPercentOfNetAssets": {
     "auth_ref": [
      "r33",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category.",
        "label": "% of Net Assets"
       }
      }
     },
     "localname": "InvestmentOwnedPercentOfNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r71",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment in Palladium"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r7",
      "r45",
      "r72",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r98",
      "r99",
      "r100",
      "r106",
      "r124",
      "r157",
      "r161",
      "r162"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Reserve for uncertain tax positions"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetAssetValuePerShare": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.",
        "label": "Net asset value per share (in dollars per share)",
        "periodEndLabel": "Net asset value per Share at end of period",
        "periodStartLabel": "Net asset value per Share at beginning of period"
       }
      }
     },
     "localname": "NetAssetValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights",
      "http://abrdn.com/role/StatementsOfAssetsAndLiabilitiesParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r10",
      "r12",
      "r26",
      "r28",
      "r37",
      "r39",
      "r40",
      "r42",
      "r45",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r55",
      "r56",
      "r59",
      "r65",
      "r66",
      "r68",
      "r70",
      "r72",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r102",
      "r106",
      "r125",
      "r157"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Change in net assets from operations"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net of non investment assets and liabilities. This amount represents the difference between the aggregate value of the investments, including long and short positions, and net assets.",
        "label": "Less liabilities"
       }
      }
     },
     "localname": "NonInvestmentAssetsLessNonInvestmentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percent of net assets of non investment assets and liabilities. This represents the percentage difference between the investments, including long and short positions, and net assets.",
        "label": "Less liabilities, % of Net Assets"
       }
      }
     },
     "localname": "NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NonoperatingGainsLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REALIZED AND UNREALIZED GAINS / (LOSSES)"
       }
      }
     },
     "localname": "NonoperatingGainsLossesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "pall_NetInvestmentGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "All other expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized gain on investment in palladium"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r110",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "The categorization of the Trust\u2019s assets is as shown below:"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Closing balance (in Shares)",
        "periodStartLabel": "Opening balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r13",
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SponsorFees": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://abrdn.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.",
        "label": "Sponsor\u2019s Fee",
        "verboseLabel": "Sponsor's Fee"
       }
      }
     },
     "localname": "SponsorFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r64",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SchedulesOfInvestments"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r2",
      "r3",
      "r17",
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Creations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r2",
      "r3",
      "r17",
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Creations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Shares",
        "negatedLabel": "Redemptions (in shares)"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Value",
        "negatedLabel": "Redemptions"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r15",
      "r131",
      "r153",
      "r155",
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/StatementsOfChangesInNetAssets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r57",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average number of Shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://abrdn.com/role/FinancialHighlights",
      "http://abrdn.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r132": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r133": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r134": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r135": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r136": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r137": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r138": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r139": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r141": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r142": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r143": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r144": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r145": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r146": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r147": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r148": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r149": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r151": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "59",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>40
<FILENAME>0001387131-23-002699-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-23-002699-xbrl.zip
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M)DZU@3:3/4H+2)0@76E1Q.%O+PTX93WT,E(0G&:PAR461(OHC__&@BB1F-A
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M,! 2@CGH%,KG#N70J6(X\=P?<=#J!7Y(^.I$Z*<S0)G]0/@ZSV >""U\18D
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M9:M^QO .^TS,I";TZ4S$1*R@?JG+8N.P_I>'C18<M*\256 JZ3WE8,:<?_Y
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M*\?YVY_#^=M?A?/3',9A\.&_YZ^^&:(SW,DQ:I_6%^HK%X"YG?G>T$O>R.D
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M"$Y9^795N,)7B8W.GJH_ )+?$) +!<<I@5%,A3^G;W_^Y>AH+QGOK<Q55@(
MD%QXIZO,U+ZMF^%4)0@?1+9!F, G?Z4>6K5@S(XP\SRBHI"XV,KMBC!291"9
MK?LY-/LJ1[._AWX:)$Y$R>517)+,/OK?V>'NR]OP9G5NW86)-S3Z+6GT9B(I
M^VB!4+?;3WA-$V"D2**N  W5T*E-P .I'H"!%<V:^IU%PK6=.UHT(C7C]U3
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M+(]A074>>==D:5N#O(9_QNSG?(?\8)J-UM^U1VLBCDHP(-(XI6H&Y;BFV6Z
M7<=9!C/8&=A;+H'-40BKU]1W ^E[\CK[PJ0IQPD8$$G!%[<SP,S2QQCZ"=RE
MCV>^$RQ_&(4?[3$,,!05(HO";"RBD=L_TYI$G(['"!O%D(8R0GI)YDWQ!_HK
MIAX\'=%MR3$[#LHIA]S54QE)]-7/(JD:2\<T(TY('!JPBK\&"2#8*GC*IJ:0
MA8%Q!$94&/$G7G =^M=2</TM?I(&_'ODQ5<*OF&8^FZ]-G1TF!0&2"E2%J<^
M8 B]U&3FP80-4(VNI4].<RJ3 ..14N##-((/)KB/M#3Z$% !ABV8OV8HKF3!
M38T\HAC7&XUH<?4:WJ)$#O91FJ3LQ__\^070"/:E4\&VZ<SWV(//Q2BE6]*L
MU]ZIS</- :3@CF2A9""FH<3084K^? ^!8A>1!.R5C]M0_3KB&8A>> &6[IC0
M#[J6!.YQ.(+Y+^F.*?0($"TFSI7$BE01#GQ]5!$0<A'Y<XHJ.# W8H["U$1!
M\,2G0,)G=$@)T$:A* R">]$PG>()&")=C1+E"K> %!QILN-1X7!(M3+L<$N#
M[+R[:O!_H'6^4H^2ZU+"@N/7:S&(;VH;'B2?9@,<),<X]-U\"(\+*@0FZO@.
M6(0X4</$2A0A 7C!^NWEW69(9V-Q;"R.?X;%<7GX\O5QO?;V1!R]/;O\O@R-
M:I9WW57&T<=2(D(5Z$H2 =II-=N=72]83,E4'P,2'3&)T(_^KQEH4.W6%89H
M.QVGU6JOF%3.#]]=BM,<>3@/[/FLEGGPPV,31/<+;A^X]PY\:@,Z*]Z 4Y#/
MHMT4.J_]B[;B.\!_=_\3&]!=>6M$5,/?DLWE7<L-_C^!_]Z*\?\6H+WV, 67
M#:4L GBJ3,L*;TFO$ENRN^HMF4E]V]7BGO!-(U7F4KN5V)*]%6_)A1R&F( ^
M5SL@5$?#"F_$024V8G_%&_&[XZ?F;&3G HURS"]+$_/E&>S281S#3WRGRH*E
M&CMU\"B"_?@6LWQEE3E6OQ+H[Z\8_4>1Y*. 1^.==.5TID\&I_94>$?:K2IL
M27NE+K,[MN022Z54VMB)K#*G:E="NK=7;85C.$!=3+ARY"/*OB6N5FTPF]!)
MM0EUKQ*$NG)C&9!_!+@/7<\)JHS^_4J@?]6V\FF 5]<O:9^KYQG[WQ9OJS9H
M7\EX&'EKI']40B-OK]J(9<YAJNN(BYN:CT>DYOZW1>.J3=#W@8<A7+K$,@:%
MS961XV,A2S@%I#JW8(B"Q<-QS]53^;?&YJK-Q.-WIQ>'2B/V*9<!T>>YR@56
M93;1Z50@(M)>M>'($9'#9BXY8>6[T.E^2Z1U5FW:,=)>-L7[ $0;)H01@QB-
MT"M%"2 KQV"W]TTQN&H;C##8:8KS*)PAV(_ .K\QQAXE=-EMBM=RC)5;43B4
MU%[ZNT/<JJTH0ERO*=YX =C]SD@F<_'*B[&F-7T,Q?21T:>3%AXK\Z,Z G<9
ML,?&:2E-KMJTY$20+\L$>>3P]Y?X_KXD1T_E._%/O6&Y?6S=M5.K-F:)>^PV
M=2 0N_<O7YXKN-Q7'/^54OJTUFVI_G<2^M@6Z0UV95)9Y'Q-D3A/H^'$B26E
M+?.[5CE"P0W#SHN'7Q)?R*)6X:5L?<8Y6K6-2[NSC[NSU-T*67P:Q]H!?V@U
MISDQW7O ^. D8&624'X\/F*"\E6V2+I?Q>_VJ3U=M<'->PH6R?]A!Q\/0[S7
MDO8'/O#UWY8$%\X@3!-]0M&.6?F>]=K?%,6KML()Q0=-ZR!<6*GK6">5SF8^
M_8U)$'AQ1X6/0:\*AGGG40SS?E,<44D:MN&CG0&Z=\:15'M%714/N3.>0_4F
M@?Z3KFT/7&N/[2.S^A/R32W\[J-8^'U@0B AL.DA'PNRNMQ'L1I6>!R^2IK<
MIS;D41P&_9=-\9:*<4X#[I."HKO*>_%5)/3&)/SZ)F%WU?X=91*NWB;L'7Q3
M1O H[IQVJPGB#)M4AA$\?FS:1+[5;2(Y13":A7@=A?@9NT.B'%Q]%L,W1N_*
M@]Z$WG;3PNF1U;OS>T/?H[@+VIVFMN/GE99.7R7P_:DM>!2?0+L+JAN7\;(W
M!DWYB3>+<[%'*Q4O;BCUFID*ED/(&?9I> R>L<(M_"KIK)_:PD=Q ;1[&![R
M BQZ]VVKYD2JNNP+K&5YC*C["NLCODINZT8!7 .<&AWO]QR]5@>W5> DCY/>
ML(OJS,0;>-@VI,#I)2Z&$[#K_=5S^MUOZCCL/4[BPUY3MW?Z35RDTZE3Z:K!
MW:]2R;EAP=85/'?W!ND6MBA\SH5;WU'K$!L'>O7/Q>5\!HL\C)R!-WPNSIRI
M9 R=A;CN3J[?AGX+O]DT(MDT(KF;.6>=KHOZ6/!Y10VD7LL[F=9DA=7O*'7G
M'G3,'J 0K=>L+A3B,;;CGX7Z2^P".4NC&=YBPQGOZ@[ZTN[PVZJ'7RP.!Q)D
MBPQ0(:1[QPJ?GT4>=VE[XT3#B>BV^<J#)V(;T^M5LT.39=]I/W^"UP7A"SC-
MS(Q(5Z6-9(2WYW!3.36!%PBI.U!BGHFZET%=.:0N4U"PJ^FXMD+/!UJN Y#1
MAW@- _<?B^LU1XQ4)WC0>M, F"K=J3:0@1QYI K3)5^2@:"69S>!C-!ADBL?
M: HL2<)[P[);EM2*$==#3.6.22)+'PL/^&.S]'IMD/H^0-'D+[*^?#=XEQFH
ME-A<,!"OY%!.84_4M1*M/MX@@W !=%Z"X+H2-MJCMIH98G&0J>/*)40BF(A%
M]/_2+0+)32A>.C'V5A#;CMX[_D3WJ%2+H77NMK"KOJID>;)^O=HJ!2$=U9CK
M+W-$1!<"T7&%0Q?K$DWQ^O71G6=UZ>&%@UIX3M7SYN1PD\B$*QV7H,+O7CK!
M%3<:N!%_AM&5>"-]'XAUZ?1+J4?574?%4!?QX6"_GK\)HS'\?H2Y7SSN6?.P
MV:C77H>!"T.^! X!@-LCFS)  W&5MWA-B#!?$J6NP*#+S8#"IM3ZC._.<>4P
MPI:@KJ"6JO_N[NXW^OOM1F_O )_/^!736AN)[]^=_FZCUV\U]ON]HH<Z#;[#
M+ _$R(OQ8HZY="(A [<IK'M#-(2JFR13YP)H[48_QZQ*P6LW#EKT8+U6_F1G
M0V4KHC(\^-CP=DJ)BJ[PO2L0I'C3'D4HJ502[^+C'KPHPJY!&I-OZEI.O*$O
M6?;JBVVH?ZV;14#-]7@PBIS._' N9=P4ITF]YH:2YY;!&,TFDO!SW>P7>YRZ
M$ON?LCH2#BAFXN#-JR.0L$15S$Z]*=[&RAV-_1 O#Q74XMCEFP5-FA)^KV^*
M6M  F,\N?"@F8-3E]9L;S_>YI^\ 3Y\/*%'JTLS1%X1.TT W3L+>P4J5TH*@
MA-GC(:O73C(>W0 LQDGD#=*$)SA,DTD8P2:B%AAQSUW,K-K6]](-I!_>/,&%
M@HH0J )A2L1BN.S>&UK)0&TNA$5NMY\(O)05-SK>":0D-<R)64_$M?'ZI>JC
M0OL&^E8ZS31 M9J&V.X\T>BFAL 6_D"9FWH!52RB#/*]OU+/I3\]T@=)@Z,V
MS]O=)]0W&;-J;KQ89C<[PG2^H^[J':<<0MOP@Q7S ^M25.P,']@'7U^*R-?J
MXN:>9E^JZ_6RYO*]%C<HU^.J7:2NTCP'#P2Z%S;L=H:)S5$,D^ .]W#Z\ ],
M7:?#'RFU>HAY[BYS#6XJ'O.UP YV?M?G33\U-V:%Z?R._;#IRD_*XO(".'HI
MIS(J(LOH_,B,DNO+G].*C@^S<XSX<X'J-3Z7ACEA@'$'J)L7?>5QBGANU)/+
MHR45[LQ1YI,:!9M-A6 ZT4G7YMC9R6%FBUW:&B2AUJ /F].'H4_&B3):C3T%
M:S*3:LD,YAP.4([>AMU9/Y">N6Y3L\- F4%*0R7+U&I]GYUP0F,&J" X0\J&
M1W4]RGV9*$0Z[K474WOZ0I[(R[ P4J\I"3;R;I%&%;<B5@XDL.$R7\YE+O(&
MEG7MZA1;F].%'##?*5WN+4'BR@$8U!*UP)N;FR;984W8Z:=I_%0F.$@4IN.)
M:KI?<I.DP[> \ V0>&&?=0](0_R5@CR5$778IP?L>T+^C_,OZ&X,TTR?+R76
M3_-EY["F41K!*9_<?2L\,)KV[K9KKI1^T#T?ZK38#S;X;@EDA,ZUX_ED'HPB
MMA;AL6B,GA$0\WR&4"D'?C'@BRA0V1K2&Z;]_QRT.%"F!FC+%JQ,JS/6'=J
M'@-0">NZ.#[*&)#=X-ZS\F7Q>M"(SFVF,$Q!]7#\F"Z3&(5IX*HK&(0:D;;W
M^-7/A^_PA#IX/Z@FE5@.F^/P>G-H'\]WW#6^8\4^BQOH5G!9U4<\<4M+ZPHU
M:I>\0-J5J*3RPGT=UITJ^DUS7>Y,7;BY:/@H=VBC7O,Q#+#D#N#GM3'  M32
M"?AZ'F86Z*Y,O"1%%BYBO)Z%:Z:&89SL2+ZRXIKO42)58^I<<86(I7'B/1B
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MSF7&MXA@WCC1<"+V61EJ("85[_S/OPXZ[?WG>&RNG9B\.B/-%5!)2E%?PF&
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M7EM*;AS+0'*,(1R"-*%P#PE"C[,E45^AJ(+&C4+Y<1H!KP-DTX-_AQ@@PF"
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M!(&R$"PT7QJTX:89+,O8*.%ZLQ [UT[JXPXTU.K02S1&X+2B-T,]BLT>S /
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M'6BRU D+Z"B9-.NU"T#IC]X+?=^1W9<'9U^\.$1U<D?;X0$M;96@P61%U2^
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M=3EM2_*II?9%?K-:3"<6MJC/"HY0L.6!1<M)KA:E(Q1SOR\AIZ6@"F1#%E?
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M4CU1$)(DTMQ&12Q^+> 'TA(DJNO1OB1<_J/E4S$UI?1.][5\NI0/^=0]?+U
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M+T772YLY^;%> [.8Q%4R33SX4>7=3>5MZY?SE4N&OGK[^MV)^ 1O-;[R,F+
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MGEB)!5:N)^%ZU$W?:.1OM%;AZAAV+3!/>H K:J<!OL$^:"@6:?6N@Z!Y2R0
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MK&MI#^ST1QO%N[?GBG_IY>TQ\W=0N7ON6&@O850;.R<ZM* C(JA[M?\+?Q0
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M.X56A))TO=2(419OO(,::%-;":(Y,U4+I2*5$%ER:#0.):9]."*9BV_XX$W
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MFPI=*&]00P?9=W53 #HQ23Z%%<R2MJGXN6C;RQ$SM@0LI11T.4<524NJQ87
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MI98C!4%JA/0/'?MS[/7$?*K@AQ<Y,V8%[(8N0Z,!4]>@D/TK35:(LFZ7$@[
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M3M\)(XE!\D(%V9\]#I9JHA:*\EJ!.[<6THX9R@M0Z"6;$0W:V%&U%1T\A/G
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M*M[3S6L*+?$7F>>V&U)OK-Z&8@Q<%_E%.8^![D9J*\$)@PPH]$G:H':.8%4
MOI@+V2;X.?M$^%LDDK1F'N+O(87&+I5.1A\&NS1OPX107XL@*<KR[SW(?M+6
M'XX>+NVXE+X/_3/*:5E(P0;KMJI%$$QD/5^[]4N@W.N@%I+7.>1F2OO\;5G[
M\7+:S>7T"<?#<X+Q'X$P/!V4XVUUA"Z)RG4H,"25R!522E\%9O",+K3_6,*8
MJ3O4[[(T<\-6M (PH6YQ!IW4"Y(GY;9X%&1L?:G@DA;H'"5 A3R.#L23>OYD
M54^AQ.V1DQ@:[.9JOVJ*<GFZ(2LL9+/J?MV-T$,4Y$M7WJ1&29R#EBR48)G>
M@SU]]3(F5Y$_TS&KG%NPS$O&%$]K#F;D9%6L^7O\Z6:%M?Z?H\/#R2$Z(B#R
M6572ZV%1G*&QKPY1.(>9)WFE&S'E[;>M2#0-8WEU+T\!\2P3;HKLZV*:;Y2X
M+D$S:$D),U76:'. RYN3_9I]YQN==)V9'Z(E3Z^VZEU$5D*<L/?^>D268;+Z
M6@ZX=)0XV$5.>>JL;?GAE7^X8K+#!7-KJ<0<3&03D>.UQ:!R%['JWB]P4P<N
M@NMN%824@JKSA![HQKK@8'\/^D;94&,P_<3<0.[)5)@<SSD^=^DHI9SUZH1A
MXN$L32$ER]+VHB%7<K2*[A9<"6@C/WG757"5#RQ\GO^.+P+DFQ_85>U)IYT/
M>UYXNA'.(E,&\KG(#=.Y-P4?.F<C^_KXIJ3U,CZ9R3;3A?2\,-7(J+WM$]'<
M*!@5E2;-C5?(C2OSQ'RYL(,#5@NG#K1  ?6F%L:5K:>W=9J0$X,3*3?G/Z0V
M%]>CW':<;/OY;9KTI,Q:6I\\2KA(SB^./HQ.RGV";EZ,H!L&W7PU@FY&T,T.
MKS\.HOK[ZL9]E5UA.*<&"V4"OT4S;N-?9N!( "<I7%I/Z/9,BZ>VE$/Y^H1X
M+E&M)E^5 8-0/;_QK9[<!=(?42_=\-**KGB8>5SS/ZK^N\6G3O_T]O6[O[W;
MWWO[ZLW)^U??9.^_S][_Y57V\L=W[[__YI_9]]]F/YR\>7/RS>L?O_OC[T['
M8,?NX'9#N"3K$.X!W+"!)MDL7Y*"99MPO@YK([5/43[E[C1C2&I'3%JE=#?6
M*F+%B#42$>J!BJ7;Z(IL:??6MGM<%M&NZT51'60GO&&]Q. ==T&KRQ"F9(2F
M5<5R/\M\O6G@W@OWR"-#Y*%0E@9]_N]-_D'B">>;I0)(D+[P7P1"L"'W!<0"
MZS49<8^%T\6" OM[ :])+[XDX 9+.Q.G5-_;N\L\7+%X^(+;JUX<=*BLC$O5
MEU;$Q2CJ@%DMI27Y-9E/CY"07%-,T2F5KNJS'!47H8&Q#AB7)K'M$H4@Y9_:
M<O3=YO2)^\0U2-;4('TV=9]Q@[&BC06,K8$81F/Y$)Q>C+MN^SGMTD.+N)!D
MT:H:T<@60+\V$WJ84;7N,A7M0@PLEX6V9(\XMKU,&,RN#:18&0RYI3ORHVAK
MMVG1D(/#!0[Y+)%FG[9E>FR@ 5%C+$S#@)>LFE+(%CK=4/!D$T'2_:?DG^6>
M!I&1V$G!\F)A\6X7Z7;FO=)A[.\YDJ_@8)+;/.7,-_]7J5V[$JY#[4HT+9'
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M>G'!J6?F>>'O1_:E42MXB07P44SG\,Q8<+]_=BF_5N+ ](_>!J="WA2JCS
M0=0(3K'E+MN<B.:-T?+U*XL8F]8;WK@M*SX>GUV6U;@6,]*N<,[8J%7=:EU
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M.[N,>L)%*]BG*2H?D9=H:?;US'',H <4R>&E&,D9ZHPV=$<*V8) E?[\)=W
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M)9]!%-QI/H/HSQ9?3.L@POM]67J4E:*L**JD5/;<L4,X,69WIUH0+E4=<#,
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M+$0N9>IPF)#>G&L-EU7K9;%2G$DK91E>S>SFB^4:6)*9*NJM;KXBEI20$[#
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M_,BS8=H] -YB:* ,/@9I(?OJ-?L0TE8YGW%Q% XQVQH6"%$>(U@XF41C([]
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MU'%O&TZ_@\MBU! X/V#2BP?Y;70\EN12/[$6#H?D=\P-&$N9P%)! )FAIG"
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M@ \$;BR - ;O'  PZ^[GE 35 <-K:J_L*-0?^/9<;^1Z8[^8?;WA^\J@"YY
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MTJ71>YH//W^V/!2U4JGG5 L(0%&J%AA^X!UW1O#6:I%U[!!"_9-F3S5)#\A
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M^3EFVB-HAJ[!9[>0+,*1@6*__U6GZH9J. LD^^:X<7UT($;T:6IH('4@+=#
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M[ZBVMWJ40R,XS.K@9?(/.ITJ@R,U+5M#'%N Z0Y!>^BK-^J%/Q/P(N'?$Z]
M4X/^Y3!PRL<S4]'@?\<;Y_L:>>(L'! -0"OB"7 7X->69Q0"'G"FW3)JRXY1
MI[5A[PTJBI=XVL1,,11$P,N%:L"J40>)OI))/SW@8H(2&@P<76/CZ@'SQC/:
M)I5_C-*M672HA#LZHLVO:."N-5ML"DFY)@+F&'N584X:G;&/N:%AJ[==QPO
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MH-==VBS#NB+OC!MU%,P^4%^U-0*>5<JUOWY\/GMY&/56F'0 KB3PZROI" \
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M/479\A9O3?5^7;N9%.OAA:,'F::+?'BK&ZHGVTY2"KP]/+&!J&O T_P,N]#
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MPK@:-HMA\.>/@F;#,NVH/3% A2Y &NRX,CQ8/V;1#.70S,>9<3?!4>IC%U?
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M=ZKX#ZK<LU7)*:V#  />W)LJ\"MV_(H?<;)?*"$)D"TDHH=M^/6WNV=&&H'
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MO ^OLV2U%?D3\'8V/0;]6,,H))_>G: >T/N,OFO_PAA,%#"F-F!02V\"759
M:%J@<J-V*H$12(Y XNOWI!QW\/V&9=^Q90/+<9 /L[12U.)UF[Y IT* :K0N
M^;?)DZY0\H\S A:-O^&1D(X5WEN6*QQPL:>.U'8F.P<2XDW0QE>D-O];;X)P
MYB:Q%@8]2,B^Y9#%<GAV[&&$6]D&N<^"B*IRLM'<2 4+MY&3F[;NBJN@*G3
M?=WIIES3*IXL1F../-?T7+58V'5[#EZ .QWL,=(>X+SM(.5'GH83L#-2* 8%
MU"E@O6I=*,U]%6D2Y;X7HJ^P:_L#I%FP$!,;+(87Z1:=R$QYF/4RKK*EOX9O
M/="R4"]A>ICX&;Y1_(KAD_86;PQ1 Q:DU<-;34 Q;1VQ<$_&)W</$MFCNM7!
M:P(? E=)]A#[ IO34\K+*OOY ]FPSDB9C*#64I.V,)%([UE@,>&=;EEP#%\
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M_*NI-%>+RV-4(%-4HNG(,9:!9Y(2X\<ZD>"55/0J49^'J<$I:N2>8L:0*-K
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M3<OOA#+FX,QIT](LM\>U<N_0&)RU?K82'Y+D3LFK:DERX66YZ\"0\2WEWJ*
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M&A/33?#.0,Y&NIO8M'!U>=)-[,!-*NB+A;A\OFF08-2V*E65/RF2.2CWQ8S
M5#? ),<@1)(QP@,2/'>'2]F.U0<Q+;0%$GW\!]P: ]T>K'D& 5F@D8N6&;Y"
MCV,-&RM#W-3)4)M (!3'"8;D9J"2!/R;=Q]D(V.7!>+>-L,^_K3TQR>%RPZ
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MN<=!A$>(C,46":;HX94RJ)!8PT)W$2XTY2*R[8-!AR(+H 0?ZKM_(@,QDF!
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M/<!D,G<M%L;DIS%=GNDVBP?//9N[#VM@;/D0DJE[B$R&YD+H['BM=K[#^4Q
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M,$UYVOTZZN 0YW%DJ+1!UB=GK'"[W-$*!A^_7-#I]U B-D;EA'<[<R+__G[
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MC=TB"V,L&@>HY%*2L=Y(--V-\T*=[(E0IFO^<GM][)H!V.)2%0UQ;&K0..2
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M\TX44A"8KME#@,8\[#E6TNS2;!?L,. "F_IBTNC7OO>H3S)6,^S*Y465>J8
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MCV"%_,RQ<RH;9?F?.LP5USO"HDZ>K;AI6/@,?5LURNG/H4U$6;6$U1<'O.#
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ML;9AAS_86HX:-=;UK:EGZ4;D-DE12+0J'/$9%HHTM=NBGVAE0#BML9G0*6K
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M+@WXY2W;WWLII>;D:%ZZ,F@@P(!4]W_)^SX^@2'=CUD[61)RE)8:<H<\8--
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M:1;-;;MERO/S?;;Z<Z3BV"F-8VUQ^VU8- ""AX(9T,. N!2WH/<#R-FA3/\
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M<RJ(&!$85/NL,ID!Z538#DY FY)WZ#$/?:?YW0[[Q[O>\3D>K'=N8MQ*_FZ
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MZ8KD1PW#?I\U>J?'J]/$->\$%ZXHNOI!9MS$]14OZ[>>4]1.&G.7H.P,%WK
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MSPL#E&Y'9C]O>/:^_>WA%I+'02"M@L[AB!J&5\IUFH,$9FS_WF8'E'V%_IO
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MXB<N(Q%0-:(*O $<Z%Q>!^?IO9BJC:@B]WO88^V(-[9.>,[[-$KS'/=!3%I
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ME<[92U:E<P4<\"!M6N!<Z[[!.+[E$]K5XQM'K7 .?T:5!*'R_DD%VV:, :G
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M)[FWCY.]&3\-!,?*J2@/F-FQELZPL(D,$IB,,#Y[@<KQ,6PVO;1<\:$])=8
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M%-=6R]^'Z^]B;T:DQ0B) O0C3X-/V\$A M3]1Y 5S]26/KJ^!R<X,A873=L
M90QM^24D(T#TWX'\P\&/S@G^!-7;/8:Y//S;F7\0VV]LKMP\L(C4#M0#W%2.
MGRERZ]"9&I]8?^E'O97KDX2XP,.O>G+%O6:=*I: ![EME6ORF\W_Z1PV:0.D
M4[SM^^[-])6_ ]D Q?CR3#9 KY(%M,P'HP2<O$R),(_((^+^+BCY'XP^NP_"
MW^5%AZ%B*<0R2+LM9<>WMLP&M\2"I*@-D$A^IX_!0GU!4U@VJ584]BF-*='K
M"\Z@:>,\]C1]_-V\ =H[" 1M@,YMAJQYYE3C#=!,'2A\B\7?VA[\'1B8Q83$
MP'_I\P2+;&-.X?BP*\+]TDZ;[2G^/<#N'P_>5HQKT6[2"F";7AB^ <1R3X^A
M[_= B;7$?A(]$-W;F1^LC4<A@SF/RD)2UG-.^$\MC\ZD,0NRGZ422'0*;B_I
MN^??4BYB-ET8'OZEV$O-RES!L?Q'4#Y_7Q%K@1^]F4,.A#>A-D ]?J"UK7$"
M3O\[$,@_&OQ9D!B@GAGECSWDJU@.EH#X**'V.OL&CV12Y'BZR0H";3.3T<M\
MP^\/0AV#U'2)CF-=>-7AM34!DHXK?PUA_I-4OU<@ K97LRKZVIFJ#H\8AYC;
MD/0>'=VU >YFRY$O4\:*B>/5Y.8Z&F5OQ:P5!TUO3.Z!9]CB,_P]+E+_*M+\
M9PG_)AO'D^QI;1A];*834( YO_XR$+;OT+6PYMN?,#[L%UV<]5?5#5%($6)%
M@RCAV)CK:@JO:S$2TJ@Z\M]SR&+Q J<TPUUFI.D,'?%":_.4\[[.F>1/+!AY
M3EDE_( 0F*+I0UH^;K^1_<AW&91OGY)G(;<DULDJ_UUDC%7]&^,Q4&)C8SZ;
M= S> [<J]1V]3]7K3%:@AHP\H;883A1V&R+SF49?>I&S8L_U()_@6;+_6O#_
MWX*S,,$"QFMB$6M>D_5BL =XX:R1?$39'*'O 4W!S+-8FX-?Z;<-\OEB4R;=
MT=L4 )-KT8^/G!?97UE8_!>U</NW1\D@6M,YTB#JS $Y!=3-5.%9Q,PI*'^W
M\!1M!SJF7>#DZ;4B%;L80E7]$/J^06TSCY6&!T7K-<%!"/_,S,).2%6WB'.O
MVH*RTW[++;%%'M+K#@^JF\LCA2_,:I[W_^YF5]5R9.>'OCL):W&K(BT"KS\Y
M/@.^MRX>+,F[S3)J9HPEBW\%6KLZ9 5:X$V%[O0PTSLQ _H]]WJ&5KPG2APO
MRQ*Q4T8O3\AO58=3M'@F\,$L=RJ&0(.2@Y#V!%5"1T6C.P7^D3L&<_ME_0O*
MQ0*%7>_=P<0A<UEM$Q+O4!4@UG%O#/W\<"UM[^>U].8XJ&C;V31J2%GP'K8F
M_O$=R?+*[7'%Z[G)$%^< L9XO<@,3+>Q?Z_HP])+"@HQ$-5K%T<G%@Z+,GP)
M<K/6!L-U7S.>U65 C)FW3W.M_]#RKS1E]RW*L(VO R>+?$ST.E#;R>C(I<[X
M*9K4/"4WPA_U<MA0OI*YA,ROQ<<[1%!@ELC\Q_D]]U0[=WA)^J<T])IRO( J
M,#.))ADD%DO=/F)V E\U-Q(J.OI0MX,:?]LSGFGG//&F_*!5?8YZ2D'&B-/N
M$I6++RL.4[[84]<XP $"+.#G6*7N&TZ5U&!V9@T!%^=(@BXOT_+]*&XUWR]J
MYKWVO/VD0^2HY9-BM8-3.HO'3O-Z,44EN);3O+#)/G$@LQ6K#MCD7^>=QIL(
M\U0;O&(2W%<N#PF,/?\?%<B!Y5]?NS@G#R!.OG[A&3>]\[V^P>+9W-(W(TYU
M3T[/*7?L3)P0*34ZH7Y&08&9DFL'/X ^SM_%9M_OH8]4>3+@"=0=HTVP>PPE
ML/QU((]&'QXN&'_>7,ZN[@Z76I#LN'<'R9!MI6[Q4TU6@>6#SI=Q+7 QT+4
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MQT:'RZ\8 ,9>^=NSB[Z)!=\4^S>^5OGT^#PY(\$ J"?0G7P["E*L3&N&C3*
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M*(S[QPF[OGMT;5):3XQ0',[PI4),?8[^P/7D9\+5KF][3[!^?LC2'=;- '[
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M9H-S+R*P,_-A@=2VH*H=S)+.M/NW:)-OT3=YDQ+$G$S>'TSBD&FS>H:$!3
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M02M^1=?VT56J(3[(]4'$\\4/0Q?*CQP[Q0I 0I@4RCKLH'$ELD,"[2YY;^K
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M?I31/XF&>.O::87?0; 7EQLM^97;>J-07G:V>I-:>WV].-RWC([V3'15L0]
MUNLF:1@4G3"^1?N'L &AQ(S#?/0>[4!"+[.GT481<O[E6'?M.*HA\?F!B_D
M5K*HIZA\^KN%;#7Q9J+G)CQZK5/^&^?ZM7UWD!UO]+2R\6Y4_B%<8*Q*8.C+
MK@-Y<1J' _VQ6K'U=KQ($8V-$H(WT>(R^&N_E.FGNNQR<;-RO@-!5[J2MN[T
MBY\M"HJ_.*YPMMYV.WGO\[B(_2H?."W3(7K,8-4*Y74![9@:.=#R-MXG##3:
M[\YJ6K<8;-Y9PV]6O]WVO>M#2+*XS$*.^OWJAG^5>]@#NF[^1 JN(;_"KL+3
MQY5XS$;,ALU]/'RG3.9TK2URE]1WYV6!+R:54JV/@^).=LR0D?7J;XU;6 ,^
MXQ+\)!8E?*\RHS<JSED8M"36?%CNR4K/>PEZ6TUNM,DOD7?F5\B?@K>>2'-"
M0/WVSVLFP'O.@[O@"ZN@3 ;!N( ^"JN+(<3JQ?N+?_Z.%*C<&#S!4<5#E#S1
M?Z%QY%I3^)K5BUQ/%<+XX[2CLJ=]ST"";1)@B'.OB:N)F\F2IG+=,\]]+7"?
M+_'7M[ZYD7E>(G0B_53/RI/ULGFVMERT7I@4'=OLG0SU@@J']=L[I_3P1:,Y
M>Y-5_3-N\6HH/3+.<:E+K(C&VM9D.ID<,8C3=Q4&-E=!I86>?,@*E!3GJ4>'
MRP^W"P6-6LD?%I,P:58?-E@R/C1>+"N1X#M;BYR+@Q$O/F4 #SW"NK.0D:Z-
M![Q0^/#BH%3G$6N+TWZAU^LDC_1??F3^[;T\7["+CT\3QQFO\]*1A@I#R+D2
MV+X*I#L4X\;D@=FE<+HBL1)-8-4K*;@]28<<-PR6#W?+=[JM-2P[4A@K;GZJ
M.CP\L;%#=CYB,'3[?[ZOB&<JB/OJ&')NH<VB>]_TSV$_Y%3ZJ%E+7I"44_=D
M7%51N.:BPCV[+Q+AX;7/7=U^WMY>Q?U\^FNOAAW8AAANS(2\0[)V2#R;WUL1
MU/:<B:M8]+=M/CT%_FJ2]R]B,P0EFA#TE-7HG#84C5XN@A'HA&LR89+0C18W
M%[!6$*9O\X#9_13Q<"0HAUZ9E(@;[H.\0_,H*?$(RYC4OY=^<'KG/[0C@6UY
M*^5_\;YMZXP>BP0Z!&2?"T:8XH/KE4(/S :]R I1EE^][,Z3Q.\T@CDL*;T[
M<:0F\FQZ@-7N">\_=5IO,GE4UQ3/-Z73<\ BLO509="\\X2R85I#1M&,[?3%
MA<\W^V>_.+SC/],WD%T];$LR;0F#3%*ELJ,; M;IZ$JR"MA)'@&]Y_AB,^B"
M$_73;6I71^^4M.>&)![8]GO[NH,<>]V!F9]7DN\]OG7E3DIFUS5T1F,6FKA,
MKB)"NE:C[S-1745]2*6J/C'[0O-R4,SY5B)M(OI&E!>$$-!(TC_]9I_V!9[J
M4O>OQF+6/&%NM%*D&\&%7 ;68+JP''2M[_L\VB7'U&E60W%U^MY54S-VIRCR
M:1ZT<G61YE>SV384EUYWCCK_D%@7Q20/2(U6=QD#<(7&907&J2+,YF&/\L2J
M'%88P+1-LXY6C.>U:FX7[S(SMSTYM>4:;TSIO=Z'C=N.%.-/8A:>>W_8;K1$
M#V5AO&:S*Y71FGW9?7*OO$?-8-8;]IOCM]-0(2$C8;-H'A@N).CU[5QIRH&E
M" -Z/S._63#;+3(2N[^5=$<=6<, W#/-T3LFEMZIWA0&L EM15TB>B?XH1Z%
M"8QJ$+@OU8[7.=V>T%GFGK8S>.W4(1V39'"]4^GP;OZQ ]M\EJ O27H1/YOS
M/]A[[[ FNS0/.(J*U- 1$(+25)I254KD19J(V.@E*KV+" 0)!$%Z$W@!!061
M+@0$ DB-0&@B(EU"29,B-0&%1Q+"%V=F]YIO9O;;V6MG=K]KK_DCP!\G#_=]
MSMU^YSGG_E&7H4_:91RN@/E#MN"'EA\I;_^L86 SS&C&V6N8J1Z"O2X!X]T[
M9?*S%3]C-8ROK>ZD;43N@^H:GR!4RU%%C_*>WWF]J64YZ\>Y?C7=2.3]1\_U
M#Z4L)_3>OVG8!RE5-)*1RK'$8.<MGV^[#(E4J_9!/OA?GE1R5"8C8Q_U%-*N
MP^%=Y"$AZ["Z2Q.E<7I^)9I?GCIX7.J"/'>?,IPI>JZ)69_D/'!GUHU^!LR#
M'+Y-760<=,?0J\M/;9RJ C,$6>.@2V_@6TS'4X,QK(;W0>Q16,AW"^V0?5!$
MCO(^2'Z)I?77Y<K;$K^Z[Y63A^B'AI$_849_\;A_NV-\'1[%2"A-A5+X?W6G
M"X-0RK3U]D$&MWKS ;9???S:([0^R$<Q,;4>";Q[)N]7[STSX7U0YG=DYRLJ
MZYZ@N022()NX#_JP"_J7?/^2[U_R_4N^?Y9\/UD9W.J @S_-B%DSZ"P YG<K
MEIHUZJGRV/;CPVH>@:>O^@\B_4F*LB-J/Q]T6R@5/^^4>F=\+%I2-);!AJ0,
M,(ZUD#81FA-J#E"]<6TQFBK]/&.F<30+>E*,9K<A&-86FZ71MVD_J)8L^6E'
M"9N.'0V_"#C2R/BU1)HJ@+2>;#6M]!)%)BQ0,UM+K]2^,U/Z@._$Q>*401JN
MN'-^9<NV"L:;Y4]UOLJ8W$&)D,4Y;$:AA"H)#6:%EOC#S,N6"NE,92L+NX3K
MNC\1946]^%%C6I_G[(E3GX+XM#_R1[Z.T/W21DT>[^TXW:HG-!#Z34VU3':X
MR>EIQP(GRQC+"BPV7!FX0,T@E=)YLI23\W&,TY2AE'8%>&X/DK]^H'M4(IBR
M& ..K$_T"M,,<;E[-]"CR)UJH/548-;VK)4[F6O7AVR>O N.0A+R4JD9#*'8
MI$!ST#ZH4U@7<TC(TM;.;LZVN]0T\&MO^[#KF>'.OJ;?+WR@$UZ.SR.%F,C2
M7 S!R<2*\%8S8JH ?* [Q[>1L#$UL6(Z_IVG^?)$0Z/0G"B\!+WE5.\&'Q\N
MG,L0DG0VOB8:H06.Q8/I4&H=@]V?TH(5196DEL$+B<H1"'W4@ )G"=E\+'!Z
MX!@AY*K/9M,HZ9U%RB5_\;E+D-/5C?);?@PV"$79%MBA;FQ'[Y6KP>(;!PC*
M*;BVO&PBV_>>VJ8QY<I6[9T<^=E9-O1\S+D'$^5J)@>_7OX@[>J?MO,OG_GO
MR>? &HF0*X-;RD>W4PV;2*[/R@W'7M<E39,O<&R[GSB^^+*CF=/I183OWZK]
M_Z./%6$V?)/Y Q0^%OZ7]!KR47]U;?K?VSBP_C4$_FN<_/<WA?AG?*R1?'Z^
M"G3Q!PT!ZJCQKT^G]%52[H;,&^NG[I@N4E ??GIM3^_5U<-B\MGI'LI/6K4D
M6DA@[EF;:??M8,X;ZF8V51,<6JX^'WAEQR0^<6:Q\M60DT"(G_N@0^-[16+;
M[YF \3%<RY+2EO)2[HDV&X5/T0W69#JDLF4RT0H+*5X6:O9>-I[I+UEZV[[T
M^YNZLZZ'7E5G[(,(&$Q#$(H&07:XJ)LJ<\&M'*ENB0SU\(\W$8J4^?;D^_?:
MT&/U9D$_?:I.LB=M7M36]W9GT:J-,+*E:3&X:O<BZ7=IW(Q.VW3ZM1%^$R"?
MA.>UYW(4J;PI/R!F=H[?N ;M,=:(N\/[I1ZK<GKS TSH:JP28XV:S6"[16ED
MFI* /G%C395DOC8]!$&HCF2;C"C8V@4/3_'@U1X,L'1^<DTQW<D4=[Z9KL_"
M*:@5H2M+"9OOJ=@''<$/%@+1:TZ?UY!NIOT/]:03^<W+JJ,EOEXN/?$2JV)Z
MZMJ#F@M?I9R^0QGL;)0*>V"-=ACA2X%&KTY>IRHGM;)4+3TRJ[CZ-#&W!741
M?B*IY6E\L]&-IK@;+])9U7^J4G0'.J"4ZQO)0M"WOMG[(#;'J)+P00R_MAX9
MS., <QC2OA@;\W#-SN(SD8(%+Z Z8LRDKH\J)J%.8U6NO/.)@*[+@. [='[:
MMC[3H>Y4?\$0>SO%P0/IDQVB:I;!PD?%+1D_^G,V5[Q:?M]:+\KS>9Q0FEM_
M_]6!5;5_=,./_UO[3+=<7RJ./DRI*;_SJN:]]%/0;OHEB867?Z:NN=<^B')K
MZ&CX)*1>9G)UF((WS,7.G6?&PPXB5[ 5)H9XMW'4![WF$CAXF_]DA;&"TS"6
MTY#%'%'V7#(DOP@JTOJ@!G!=Z#)[9_QC?MQ[38&8UO!S*UZQ!/2H:DI8FO!
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MXL$>8X@\=&%R-5$3BS_ &&>:_#ZH:R#U^-*$+@O $4 :BMZMPOCS6R-];2"
MZ=KK+/<=M7/%J,9(H9NF&U9M_?<J;3%!7EO3/3"*7@LX$<K>K@Q '8 TD@[?
M- G2DVQ.\HFI>.6=>KU^5%WKM**ZN 3L'/O/!_IE*_ZG[:-I]XSU2<8O6 KV
M2J!^+1M3*]M;>YD,H>7=,\LYI4E5=#./2IAT=\Z<O*+2A<)TZ16IP85.;,VQ
M:<GI=(WOX8I[19#MT+W"=DZ E23SZ15# 7CN7VE"]! 0JSZC=8B).$5)#E]2
MSGDL^"QC6SBYY3<K2"49U-'MX+VWX1)5V9S(8ZT.O]YM4GT?$\U\MV4:&W.[
M<R#QA/JZT2O=9['!AJ.K$]YZF>D/1K/O<T9-0%TA !-TI3+K].>8FHUDQAG$
M/:!4,S$P-1;I0E7,2WP]-Z03&ZMFZF!U91RA+U,W<[+.4SA(5*^!O>*XLU)O
ML$T=#^O:1&Z%G1>O\7:=] #G$$LF],'E>Y6E,SP&B%O,\&,.W&)=:ZM G /$
M20.A:,",JM\K+"$ZZ5+W_&Y[EBF,RRNGR/Q0]+4N\?G,BJB8FQ/1U@)!AFM,
MR:;=B/L@+,>: T-L.<VK_?!PH!9*RQZC))N.VYQ#UJ#[/DP[Q_A]MWOR<$8Z
M85[Z.LL=.&:UBP!)PC=,T@5$>\F*&PEJ0]R,(20[XD;E-!S9^1J"GEW9K13"
MY;V4+5CPG3[*M_((U?H,9[[M4/L,'_S\&.N29FRK3BE@=*EFY&&NF(ZRZ<@:
M&5U7AXZ^VXB.46<[?J/GU9F39>R"ET @4+?]/[.%RW^-&I*%!,99,=C(9%@2
MI'X?%(<(93IY=2>&WV.W(3/@M=C*/HC/4U2IN&SIED?[+<!U62Q4I-#+;4S0
MM_MG9FE$$V_79N0T!@PEO&!(4V)7)ZDL'?Q>UV>]8$(G6\8"'7R9"X%K;Y&+
MV4@7<T</F :4H7<T)][&Q:>;5-U5Z.L^D2S+:[<7;<"[X_2AQ6X^E/'H9TMC
M9<G7KS]+2A5]=GS\!LQ-%0L/0Q(",5]&R8X8*@R;+R $CKGHE]PNYZZIRT&5
M2&\_T=8TBH"6H(/Z?4(]'C[\'CH=YRC_W*SUJ6T1QIOWYY(DG^DV-!JAY4<$
M<WQK-JO:J/T65&.K_VZ^P?"QL-PDR&+WS.N?3OV"+DST9KY86?1C8O,1KE\_
M&9>!9QRRFC]6;5S5Z-=-]Z.X&4T@/<%@D6IMZWS<Q2/U@<III.1K>"?4Q.^@
MU(%WL--0^%2*3MG]HO)3+8^& #?(+P9HH]Y\P-X+1L_^#[CE5%-_T4)+,2&G
MDGHUP[20(=+[BX*:E[K($!:=W ?)3/Z1J>B3[B_6Y]14*.7=!.:G4NI?/OY/
M1$5=YP$D(U+W%^TU^1?M=3.4^ (!W0?I02201'\4<M,A.-,(JRL[2I<I[0U\
MXSCML5T[,SU55-<G99D3DG[4Z= ^2""]7_34LLT8MQDH)!;+S .L1.XHMW)X
M%%;B_.CJQ@\?Z.7&8&I[ V)Z@-;GC;H'<G!3UJ8J-ZSF'5#__#=$H$,;]AIT
M+R([_-J/P\*',]P3*7A"[&I$8#4$I^_VQNA^NR)5*9WB&609K$&;,-A4$-7@
M>X93/?&4A38BM8?8BT/ZI7(PQC!O-Y@*)MHVU!'WV/WB)X(LS5@^^MR]N)45
MN6C6R,^S>='1P)^O;.;C"6EGKK$#2_G_Z9Q9[H/<D<D7_5:G:5!@A21;XQ<8
M6 BP=DTRI-ICQEBT/]M,F_B?[&$#-5GWB4@ZIW@M[H.FE;>[8KN1%$,\/]V6
M$@J/O3K6+DL_G^)WJ,/-=\MS[<U*E@=WJI_ _777)J^6@=L'5&,N+*E>DF!Z
M$B?Y%Y/XT5\<5!S)3#B8_HN5V_\7*_<A1 @3"/8P/; _L.?7T4#ZW3>(W_9!
MD?<90SA&4UC &R_;Q2X_[F71Z+6NC9QUDH,2SD0F:/WCZD?S!V:A@?]8 _DC
ME=7?)^T?Z;;^YXWX?U-&>/[:+1H<SKI]B\*UW5(%).K'3 R9MHQ+6+8964LU
MNEN\3&,+NNZF%WTHR_D2Q\7/K#?"*&*=..^&FAG/N8OQU3*;)[C(R5X[J?6Y
M[ON@*ROUU@S!GXLTIOP=MNW<C#YH/==.5YM7MZ.VB0)=,PRUT-5CFSG>UI2@
MU9DV>*&5,_N!XNL!P19.XPR[Z LO^.>AO!B_5!S+]C.*9A+4 QFK>]PK/Q(*
M1K@4RT7/CRCZB6$A@@[K:]]#$[7D;UY!%3V8G3&6<U;1GK!<$M8-,6]H_44&
MTUD'S#)_86H (^J9P8<.?B2-\B)@DJ3SCG>V_M-K=3M%2]HU%2S!A _U=O3>
M[\8+6NZ27<92!R*T61EL,K003VBC7,^@9H>$+@6)A1Q<;I<"W+RH$,,<'=NM
MJXEV;_EP7\Q50S3#'ZQBO-Z]LF*71J?,^11^/(S1Q_SEXB*8Q=?AXU1D@BXH
M?":_#MSMY2,]@] >_3J)X""M6>@;XTY/E Q_RINS_9JF,Y>75?#%VZ@Y5<;T
M1'79]_SD.0CF\_>6EL2EU:_C"E_;C,64EM(JU)[CP+-?]OQ?EHIH7S\,^:O8
M_)?647WZ+=/[4N&.D^2&)@K-NOGSPWV0H/LN0O1W'-O89\^)F@^UQ\:)VG68
M+&=VD$M<_#%O%Z=Q1.!>5:L6I7#[)%6Y.W?-P&7D._*H9MQ\V$GC==E-W,<9
M^4N:$5^K/^:?Y3P2D.+.4ODWK/4A\J^L/W;[.K#F1#-C?&KGIR[D9 ]/P7/Z
M'+K%O\L?_JH?H-1/OGDYH&K&Y)B<4XP]U<$UEIPLAVVN_Y&<_%U3.,?KV?IK
M^_7HQV?TAMY))8 6D'\YVY"_M/@_W<S[>R3[XRVKOW2DX;_AF'^Z9?6?S?N_
M7;+Z1\IXNO9:FK;GIS<C#6.'"$T=YR5*0;]V'SK_GCCC@[A"Q0%B[R]FU?F)
MSK4]8SON^4#TEF32Z=["%[R3D1<G$^AZ>_5V7>TRE*P,,9MO[=+C)]K2';A_
MII^NAY[4&:FO/;?E;&SA''PNZBTX-P'$G(\XO(2N!)QE>S.*T)IWEJJ>AX+$
M5-)-PDIFX"TW4DB;N-#<W/N43Y,2#V.$DIWAA7Z98D%'57@W-]8&:-8(3>K0
MFB !/U7C':ZTK'L!:*L$G*>GIO#X.2,?XLXD2MC"HQY2SU'F%"KF8V%MJ/':
MV.Z!\]L,<O!J8F7X"!/9,\O<>LO\DI6<Q@2H:RK_DL0AYA3&?#\<2?+C\>"=
MGG8 4C]&$L$O_96R43.]WD_[^>,+[/GF_9=A%#^Y50-2:BRTCCN1VD660)7
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M_P$^M7ZDC_=2XLO5A**S,N:$H=4NJO#V>ZK<ZB*E$.O(U4PMJ?$G\@MW(L%
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M+X>8P2SR1Z6B1I513L/HS,O>MYMK7Q<G6=H>,,?_93"QT3VYE]Q^?,6V)RJ
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MBL.55?=V54I#C0YV0O3K*>P7H*XK&_,(!R]*87.-9..Q$PZ:$J@Q4,#;(_@
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M@TCU!]?F;_G=O8]UNL<8E:1-"N+<C4:*G'=5\XSQJ092?QB.M9XH7]TOR-*
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M3E3O5G-_>3S?LFF'.#G:Y5UE2^_F/EO-9+%(EHYKJ7@.*(-:[_)M\?C"6T<
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MT?3_ %!+ 0(4 Q0    (  .+858+C:7^'00  $H,   *              "
M 0    !E>#(S+3$N:'1M4$L! A0#%     @  XMA5C$  :IL"   :QX   H
M             ( !100  &5X,S$M,2YH=&U02P$"% ,4    "  #BV%6#'%;
M@) (  "*'@  "@              @ '9#   97@S,2TR+FAT;5!+ 0(4 Q0
M   (  .+85;Q%"W . 4  (H1   *              "  9$5  !E>#,R+3$N
M:'1M4$L! A0#%     @  XMA5H++ZN)3!0  ZA$   H              ( !
M\1H  &5X,S(M,BYH=&U02P$"% ,4    "  #BV%6/"+LRIE[ 0 -SPL $P
M            @ %L(   <&%L;"TQ,&M?,3(S,3(R+FAT;5!+ 0(4 Q0    (
M  .+859QP,CX)0D  .)$   1              "  3:< 0!P86QL+3(P,C(Q
M,C,Q+GAS9%!+ 0(4 Q0    (  2+858JH" \FP8  &8S   5
M  "  8JE 0!P86QL+3(P,C(Q,C,Q7V-A;"YX;6Q02P$"% ,4    "  $BV%6
MXY'T"LD'  ")0P  %0              @ %8K $ <&%L;"TR,#(R,3(S,5]D
M968N>&UL4$L! A0#%     @ !(MA5N&@4IL?(@  K=(! !4
M ( !5+0! '!A;&PM,C R,C$R,S%?;&%B+GAM;%!+ 0(4 Q0    (  2+859N
MOQV9IQ8  ,4\ 0 5              "  :;6 0!P86QL+3(P,C(Q,C,Q7W!R
M92YX;6Q02P$"% ,4    "  $BV%60T9MU1AJ   3B   #P
M@ & [0$ <&%L;"UI;6<P,#$N:G!G4$L! A0#%     @ !(MA5GF,F#,CHP
MU/,   \              ( !Q5<" '!A;&PM:6UG,# R+FIP9U!+!08
..#0 - !X#   5^P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
